data_2lkb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lkb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -136.7 161.81 34.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -0.88 . . . . 0.0 109.409 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -95.1 143.41 26.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.16 -0.962 . . . . 0.0 109.108 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -99.79 -65.0 0.99 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.164 -0.96 . . . . 0.0 110.445 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 2.6 m-85 -109.15 0.9 20.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 70.3 mt -106.68 142.04 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 110.433 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.07 -22.7 3.13 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -103.99 157.01 34.87 Favored Pre-proline 0 N--CA 1.487 1.419 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 8' ' ' LYS . 43.9 Cg_exo -34.02 -110.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.444 2.763 . . . . 0.0 113.376 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -85.49 -2.78 58.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.768 -1.208 . . . . 0.0 109.308 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -100.28 151.48 21.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.331 -0.855 . . . . 0.0 109.466 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.67 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 57.2 m -108.27 166.18 10.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.526 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.97 133.04 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.165 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 32.3 p90 -60.71 -41.44 95.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.583 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 82.4 tt0 -175.24 93.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.279 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 47' ' ' GLY . 19.5 p -68.58 134.54 50.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.059 -1.026 . . . . 0.0 108.576 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.692 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 2.6 p90 -109.67 -152.55 0.5 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.299 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.692 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.2 m-20 -57.6 139.24 54.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.044 -1.035 . . . . 0.0 109.192 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.36 9.05 3.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.381 -0.825 . . . . 0.0 109.827 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -51.96 -42.91 63.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 108.896 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.6 m -84.69 7.12 21.52 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.339 -0.85 . . . . 0.0 108.907 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 26' ' ' GLY . 70.5 m 54.38 27.12 7.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.406 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -60.18 -52.81 63.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.1 t -66.39 -51.83 53.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 0.0 108.835 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.703 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.0 OUTLIER -58.65 -36.25 73.81 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.537 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . . . -57.07 -43.42 93.28 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.13 -47.11 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -1.205 . . . . 0.0 109.09 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.7 m -70.49 -24.76 62.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.635 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 67.6 m -63.16 -30.39 71.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.232 -0.918 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 26' ' ' GLY . 12.7 mptt -51.94 -33.39 37.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.921 -1.112 . . . . 0.0 110.112 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -56.48 -33.67 66.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.04 -1.038 . . . . 0.0 109.349 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.26 2.63 54.19 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.02 -26.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -1.084 . . . . 0.0 109.132 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.631 ' CE ' ' SG ' ' A' ' 50' ' ' CYS . 15.7 tttp -52.67 137.88 29.98 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -118.23 135.15 54.44 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.143 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.535 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -144.4 162.12 27.93 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.275 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.416 ' HA ' HD22 ' A' ' 25' ' ' ASN . 33.1 p90 -140.65 169.87 16.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -1.078 . . . . 0.0 109.062 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 11.7 t -99.06 124.43 44.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.949 -1.095 . . . . 0.0 110.959 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 40' ' ' ILE . 4.9 tt0 -119.87 -139.88 0.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.401 ' H ' ' HG2' ' A' ' 39' ' ' GLN . 30.3 pt -110.96 142.86 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 109.699 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.0 tp -58.73 -37.28 75.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.198 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.84 -59.33 0.62 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.65 -70.63 0.76 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -1.022 . . . . 0.0 108.806 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -128.4 148.94 50.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.575 -0.703 . . . . 0.0 109.223 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.2 -168.23 35.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 16' ' ' CYS . 24.9 m120 -120.93 165.26 15.48 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.47 -1.018 . . . . 0.0 109.608 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -134.94 151.49 20.45 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -99.53 140.56 33.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -1.17 . . . . 0.0 109.755 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.486 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 8.9 t-105 -113.45 128.19 56.36 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.631 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -126.09 135.8 52.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 109.036 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.457 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 4.5 mt -117.16 136.51 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.36 -0.837 . . . . 0.0 111.101 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 1' ' ' ALA . . . 162.17 168.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 54' ' ' PRO . 3.3 tp -129.24 73.97 81.33 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.674 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 50.3 Cg_exo -49.73 -174.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.643 2.229 . . . . 0.0 111.341 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 56' ' ' ASN . 92.2 m-20 -52.1 -39.06 59.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.972 -1.08 . . . . 0.0 108.801 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER 159.97 -174.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 109.19 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.3 t 57.15 68.59 1.99 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.76 -65.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.683 2.255 . . . . 0.0 112.038 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.5 mt -117.29 125.84 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.523 -0.736 . . . . 0.0 109.103 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.83 1.68 14.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.485 -0.76 . . . . 0.0 109.193 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.491 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -132.11 155.18 81.64 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.416 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.4 -0.43 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.585 2.19 . . . . 0.0 111.685 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 61' ' ' ILE . . . 102.42 -1.42 49.94 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -85.21 130.45 34.6 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -1.129 . . . . 0.0 109.479 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.67 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 2.5 m -115.03 158.98 21.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.431 -0.793 . . . . 0.0 109.471 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.424 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 58.3 t-80 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.757 HH21 ' HE1' ' A' ' 49' ' ' TRP . 76.1 ttt180 -126.52 132.32 51.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -100.17 143.96 29.76 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -106.32 -83.94 0.52 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.462 -0.774 . . . . 0.0 109.266 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -99.78 -29.83 12.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.533 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 11' ' ' ASN . 69.9 mt -102.01 138.12 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.521 -0.737 . . . . 0.0 109.665 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.0 20.72 13.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.443 -0.786 . . . . 0.0 110.398 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -126.35 153.13 74.74 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.083 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.409 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 11.3 Cg_endo -57.84 -29.35 85.84 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.533 2.156 . . . . 0.0 112.272 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 9' ' ' PRO . 88.5 m-70 -151.65 -6.8 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.199 -0.938 . . . . 0.0 109.316 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.569 ' OD1' ' NZ ' ' A' ' 64' ' ' LYS . 56.8 m-80 -105.63 171.16 7.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.779 . . . . 0.0 109.413 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.9 m -120.85 177.08 5.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.446 -0.784 . . . . 0.0 109.466 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.54 133.51 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.968 . . . . 0.0 109.402 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -48.68 78.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.376 -0.827 . . . . 0.0 109.317 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' CYS . 11.6 pt-20 177.14 80.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 109.23 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -44.75 156.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.067 -1.021 . . . . 0.0 109.122 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.718 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 3.2 p90 -132.56 -149.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 109.331 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.718 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 59.3 t0 -57.41 132.6 53.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.128 -0.983 . . . . 0.0 109.654 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 22' ' ' SER . . . -74.98 4.48 6.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.0 109.918 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -49.82 -42.75 47.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.066 -1.022 . . . . 0.0 108.859 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.422 ' C ' ' OG ' ' A' ' 22' ' ' SER . 82.6 p -82.35 -5.48 58.63 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 0.0 109.095 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 63.29 34.36 13.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 109.577 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.95 -48.65 80.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.999 -1.063 . . . . 0.0 109.872 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.16 -52.95 28.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 109.031 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.693 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.1 m120 -58.49 -37.64 75.98 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.328 -0.857 . . . . 0.0 108.794 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.53 93.84 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.82 -42.31 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.353 -1.087 . . . . 0.0 108.798 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.0 m -61.66 -32.96 73.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.818 . . . . 0.0 109.372 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.3 m -57.4 -45.73 84.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 109.476 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -64.54 -43.47 93.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 108.81 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.77 -28.96 70.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.558 -0.713 . . . . 0.0 109.153 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.46 -0.87 53.35 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.443 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -67.39 148.4 51.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.38 -1.071 . . . . 0.0 109.263 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.419 ' HG3' ' H ' ' A' ' 35' ' ' SER . 2.5 pttt -64.82 -60.34 3.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.063 -1.023 . . . . 0.0 110.284 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.419 ' H ' ' HG3' ' A' ' 34' ' ' LYS . 84.2 p -144.21 160.91 40.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.873 -1.142 . . . . 0.0 110.567 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.411 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.71 156.17 26.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 49' ' ' TRP . 17.6 m-85 -123.65 146.21 48.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -1.102 . . . . 0.0 109.472 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 37.8 t -99.89 121.63 41.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.19 -0.944 . . . . 0.0 109.076 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -118.38 165.55 13.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.471 -0.768 . . . . 0.0 109.446 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.8 pt -103.45 144.01 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 110.117 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 41' ' ' LEU . 4.2 mm? -107.08 139.91 40.75 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.67 -0.644 . . . . 0.0 109.508 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.8 -28.62 52.95 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 44' ' ' TYR . 45.8 p -94.82 -72.88 0.6 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -1.167 . . . . 0.0 110.649 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.448 ' N ' ' OG1' ' A' ' 43' ' ' THR . 91.7 m-85 -61.82 -39.28 91.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 110.155 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.91 -34.93 4.84 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.174 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.33 129.64 31.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -1.229 . . . . 0.0 110.293 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 160.14 26.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -111.26 135.23 52.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.378 -1.072 . . . . 0.0 109.831 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.757 ' HE1' HH21 ' A' ' 2' ' ' ARG . 4.7 t-105 -113.33 111.66 22.37 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 5.5 t -107.76 122.82 47.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.114 -0.991 . . . . 0.0 108.906 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.1 mt -117.81 135.56 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.603 -0.686 . . . . 0.0 110.096 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -174.29 -32.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.41 160.05 54.71 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.531 -0.731 . . . . 0.0 109.155 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -42.03 -78.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.471 2.114 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 51.0 p30 -177.03 39.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.187 -0.945 . . . . 0.0 109.511 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.63 133.85 46.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.827 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 1' ' ' ALA . 2.8 t 47.49 70.12 2.28 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.305 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.44 ' CB ' ' O ' ' A' ' 2' ' ' ARG . 68.2 Cg_endo -82.11 -68.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.832 2.355 . . . . 0.0 112.312 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.89 158.21 43.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.327 -0.858 . . . . 0.0 109.388 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -117.06 122.22 43.55 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.25 81.65 13.53 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.541 -0.724 . . . . 0.0 110.062 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.42 -4.55 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.687 2.258 . . . . 0.0 111.744 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.86 -5.52 58.15 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.569 ' NZ ' ' OD1' ' A' ' 11' ' ' ASN . 29.3 ttpt -60.06 -35.65 75.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -1.183 . . . . 0.0 109.508 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 15.1 m -73.34 154.03 40.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.885 . . . . 0.0 109.514 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.42 ' CE1' ' O ' ' A' ' 64' ' ' LYS . 77.5 m80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.489 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.494 HH21 ' CB ' ' A' ' 54' ' ' PRO . 40.1 ttm180 -127.77 135.33 49.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.434 -0.792 . . . . 0.0 109.65 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.441 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 84.2 m-20 -95.92 145.58 25.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.831 . . . . 0.0 108.898 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -105.1 -83.27 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.883 . . . . 0.0 110.051 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -100.93 13.02 36.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.865 . . . . 0.0 109.536 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.407 ' CG2' ' SG ' ' A' ' 12' ' ' CYS . 27.5 pt -121.68 161.38 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.744 . . . . 0.0 109.987 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.404 ' O ' ' CG1' ' A' ' 27' ' ' VAL . . . -128.43 -2.97 5.52 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.404 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -111.04 153.2 43.97 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.517 -0.739 . . . . 0.0 109.111 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -58.55 -26.58 79.22 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.762 2.308 . . . . 0.0 113.14 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.551 ' ND1' HH12 ' A' ' 60' ' ' ARG . 57.4 t60 -145.15 -15.31 0.51 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.962 -1.086 . . . . 0.0 109.728 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -103.54 159.41 15.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.0 109.085 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.407 ' SG ' ' CG2' ' A' ' 6' ' ' ILE . 59.0 m -115.88 172.24 7.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 109.765 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.4 t -99.36 134.42 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.833 . . . . 0.0 109.297 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.426 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.3 p90 -67.85 -36.35 80.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.839 . . . . 0.0 109.45 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.0 tt0 -174.29 95.38 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 108.902 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -63.25 112.88 2.88 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.2 -0.938 . . . . 0.0 109.207 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.7 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 3.2 p90 -76.3 -157.07 0.07 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.191 -0.943 . . . . 0.0 108.911 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.7 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.6 m-20 -61.54 130.51 46.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.025 -1.047 . . . . 0.0 109.255 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.29 26.65 10.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.468 -0.77 . . . . 0.0 109.261 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.22 -45.86 75.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 109.578 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.601 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.0 m -62.46 -50.45 71.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 0.0 109.469 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.601 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.9 m 150.51 33.24 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.43 -71.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.801 -1.187 . . . . 0.0 109.996 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.5 t -61.86 -49.78 74.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 36' ' ' GLY . 2.0 m120 -57.79 -37.53 73.89 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -58.23 -40.86 94.45 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.404 ' CG1' ' O ' ' A' ' 7' ' ' ALA . 64.7 t -61.95 -48.7 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -1.207 . . . . 0.0 109.063 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.5 m -70.8 -22.07 62.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.378 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 64.8 m -63.1 -38.23 90.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.344 -0.848 . . . . 0.0 111.28 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -32.08 51.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.016 . . . . 0.0 109.91 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -55.33 -31.5 61.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 109.333 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.64 3.96 52.52 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 179.4 -26.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -1.154 . . . . 0.0 109.68 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HZ3' ' CB ' ' A' ' 50' ' ' CYS . 32.6 tttt -55.08 130.9 43.64 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.7 p -112.83 140.03 47.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.68 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.588 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.7 166.96 26.81 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.041 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.649 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -140.54 160.46 39.97 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 47.1 t -99.83 121.4 41.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.983 -1.073 . . . . 0.0 109.757 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.556 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 25.1 mt-30 -109.05 167.22 10.26 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.2 pt -93.97 137.47 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.078 -1.013 . . . . 0.0 109.593 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 45' ' ' GLY . 5.8 tt -59.9 -35.04 74.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 108.735 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.434 ' C ' ' OG1' ' A' ' 43' ' ' THR . . . 133.01 -28.36 3.35 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.434 ' OG1' ' C ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 177.55 -40.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -1.021 . . . . 0.0 109.168 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -65.28 -34.72 79.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.787 . . . . 0.0 110.119 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 41' ' ' LEU . . . 175.27 -154.34 17.72 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.349 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 19.6 m120 -121.06 159.9 24.75 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.524 -0.986 . . . . 0.0 109.394 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.1 161.35 25.96 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.489 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -105.89 129.72 53.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -1.044 . . . . 0.0 109.674 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.556 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 0.9 OUTLIER -111.04 116.87 31.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 108.812 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.59 ' CB ' ' HZ3' ' A' ' 34' ' ' LYS . 3.9 t -107.62 119.68 40.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.93 134.8 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.561 -0.712 . . . . 0.0 110.444 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 179.16 -42.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' A' ' 1' ' ' ALA . 46.3 tp -130.03 73.16 81.62 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.497 -0.752 . . . . 0.0 109.677 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.494 ' CB ' HH21 ' A' ' 2' ' ' ARG . 72.0 Cg_endo -84.87 33.02 0.48 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.943 2.428 . . . . 0.0 112.343 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -51.48 -36.26 43.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.095 -1.003 . . . . 0.0 109.126 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -130.07 -24.49 2.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 109.632 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 57' ' ' VAL . 94.6 t 50.4 64.09 8.9 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 109.636 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -94.71 156.65 1.88 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.376 2.717 . . . . 0.0 111.561 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.66 122.26 63.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.422 -0.799 . . . . 0.0 109.137 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.551 HH12 ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -97.97 90.97 5.1 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.24 -0.913 . . . . 0.0 109.579 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -128.88 77.53 77.62 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.492 -0.755 . . . . 0.0 109.709 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -79.03 16.77 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.769 2.313 . . . . 0.0 111.717 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.61 -20.79 43.01 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -60.85 -39.52 89.43 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.403 -1.057 . . . . 0.0 109.47 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 14.1 t -59.15 -34.94 72.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.312 -0.867 . . . . 0.0 109.602 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.446 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.448 ' NH1' ' CZ2' ' A' ' 49' ' ' TRP . 66.0 ttp85 -124.38 130.63 52.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.792 . . . . 0.0 109.514 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -100.06 145.11 28.3 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.093 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -108.56 -85.46 0.53 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.52 -0.738 . . . . 0.0 109.073 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -99.36 -28.28 13.36 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.169 -0.957 . . . . 0.0 109.344 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.9 mt -103.56 139.89 23.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.56 -0.713 . . . . 0.0 110.196 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.77 -7.78 18.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.495 -0.753 . . . . 0.0 109.104 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.3 mtmt -126.43 89.54 51.99 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.93 -27.82 6.32 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.278 1.985 . . . . 0.0 112.185 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.556 ' C ' HD21 ' A' ' 11' ' ' ASN . 76.8 m80 -86.01 -19.95 29.58 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.229 -0.92 . . . . 0.0 108.89 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.556 HD21 ' C ' ' A' ' 10' ' ' HIS . 1.7 m-80 -140.62 -150.7 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.801 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 69.0 m -140.65 178.38 7.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.623 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.79 128.15 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.001 . . . . 0.0 109.238 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.484 ' OH ' ' OH ' ' A' ' 23' ' ' TYR . 30.8 p90 -68.27 -34.79 76.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -172.15 93.74 0.14 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.539 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -71.06 125.12 26.03 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.993 -1.067 . . . . 0.0 108.164 179.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 70.5 t80 -91.83 160.09 15.48 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 109.821 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.493 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 89.2 m-20 -42.45 126.81 3.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.69 -11.88 60.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.54 -0.725 . . . . 0.0 109.506 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -52.21 -46.24 65.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.352 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 27.2 m -66.55 -62.23 1.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.178 -0.951 . . . . 0.0 109.25 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.0 m 153.12 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.484 ' OH ' ' OH ' ' A' ' 14' ' ' TYR . 65.9 t80 -58.79 -53.59 56.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.996 . . . . 0.0 110.54 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.7 t -65.68 -40.54 92.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.077 -1.014 . . . . 0.0 109.075 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.626 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.4 m120 -59.41 -38.64 81.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.461 -0.775 . . . . 0.0 109.207 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.427 ' O ' ' CD ' ' A' ' 30' ' ' LYS . . . -62.97 -48.59 79.33 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.19 -43.18 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -1.163 . . . . 0.0 109.065 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.1 t -63.84 -35.05 79.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.51 -0.744 . . . . 0.0 109.71 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 55.3 m -56.13 -42.37 76.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 13.4 mptt -59.87 -38.03 81.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.026 -1.046 . . . . 0.0 109.202 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -58.97 -29.18 66.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.346 -0.846 . . . . 0.0 109.021 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.5 -0.36 55.62 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.63 150.46 47.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.43 -1.041 . . . . 0.0 109.501 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.513 ' H ' ' CB ' ' A' ' 52' ' ' ALA . 7.8 ttmt -57.66 -60.15 4.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.879 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -143.85 161.49 38.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.237 -0.915 . . . . 0.0 109.433 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.27 158.5 27.27 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.582 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 49' ' ' TRP . 30.5 m-85 -136.01 161.2 36.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.504 -0.997 . . . . 0.0 109.16 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 17' ' ' PHE . 0.8 OUTLIER -99.05 123.8 43.6 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.085 -1.009 . . . . 0.0 109.516 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.523 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 33.2 tt0 -106.14 154.17 21.06 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.6 pt -93.45 147.1 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.903 -1.123 . . . . 0.0 110.785 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 43' ' ' THR . 78.9 mt -82.4 154.38 25.23 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -44.74 -18.84 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 45' ' ' GLY . 19.3 p -117.74 173.42 6.76 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.76 -0.847 . . . . 0.0 108.783 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -47.7 -8.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 109.888 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -62.32 162.74 27.99 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 51.8 t-20 -140.66 155.77 46.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -1.109 . . . . 0.0 109.842 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 46' ' ' ASN . . . -140.87 174.7 22.55 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -106.32 158.09 17.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -1.099 . . . . 0.0 109.563 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.491 ' N ' ' O ' ' A' ' 37' ' ' TYR . 7.2 t-105 -130.66 140.75 50.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.0 m -135.08 131.49 37.03 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.027 -1.046 . . . . 0.0 110.058 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -125.32 132.87 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.464 -0.772 . . . . 0.0 109.673 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.513 ' CB ' ' H ' ' A' ' 34' ' ' LYS . . . -178.52 -43.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tp -132.84 74.9 73.62 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 109.514 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.27 166.58 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.973 2.449 . . . . 0.0 112.652 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 57.07 45.84 20.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.627 -0.671 . . . . 0.0 110.137 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' A' ' 57' ' ' VAL . 22.0 t-20 -146.11 158.99 43.89 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.152 -0.967 . . . . 0.0 109.355 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 56' ' ' ASN . 2.4 t -37.38 100.24 0.2 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.671 -0.643 . . . . 0.0 109.388 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.427 ' N ' ' O ' ' A' ' 56' ' ' ASN . 98.2 Cg_endo -85.71 -67.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.39 2.06 . . . . 0.0 112.828 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.405 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 72.0 mt -121.48 133.31 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -0.804 . . . . 0.0 109.764 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -130.34 82.76 2.08 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.7 mt -128.3 86.04 58.92 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.513 -0.742 . . . . 0.0 109.755 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.94 -19.37 5.49 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.3 2.0 . . . . 0.0 111.918 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.13 -0.34 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -59.19 -35.44 73.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -1.178 . . . . 0.0 109.683 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.55 130.6 45.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 109.526 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.438 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.73 ' NE ' ' HE1' ' A' ' 49' ' ' TRP . 65.2 ttt180 -128.06 133.74 49.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.773 . . . . 0.0 109.705 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -110.79 151.04 28.26 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -99.5 -69.78 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.239 -0.913 . . . . 0.0 110.728 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -101.16 -4.26 27.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 0.0 110.46 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.9 mt -109.09 139.07 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.885 . . . . 0.0 110.509 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.28 13.44 15.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.406 -0.809 . . . . 0.0 109.226 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.576 ' NZ ' ' CG1' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -125.0 154.77 71.3 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.497 -0.752 . . . . 0.0 109.248 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.34 -36.59 55.11 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.439 2.092 . . . . 0.0 112.352 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -138.55 -3.7 1.67 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -112.11 169.12 9.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -0.816 . . . . 0.0 109.467 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.2 m -116.65 -179.9 3.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.413 -0.804 . . . . 0.0 109.56 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.42 134.39 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.194 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.732 ' HH ' ' HH ' ' A' ' 23' ' ' TYR . 31.2 p90 -69.4 -43.02 74.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.855 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 81.4 tt0 -175.51 99.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.003 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -69.32 103.02 1.86 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.069 -1.019 . . . . 0.0 109.023 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 0.7 OUTLIER -45.62 150.79 0.47 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 108.725 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 60.5 t0 -72.17 115.02 10.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.17 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.48 150.17 35.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.234 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' ' CB ' ' A' ' 21' ' ' SER . 97.4 m-85 -59.36 -40.37 86.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.958 . . . . 0.0 109.241 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER 170.06 78.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.404 -0.81 . . . . 0.0 109.278 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.45 -66.66 0.14 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.033 -1.042 . . . . 0.0 110.024 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.732 ' HH ' ' HH ' ' A' ' 14' ' ' TYR . 66.5 t80 -58.46 -50.73 72.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.952 . . . . 0.0 109.961 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.9 t -68.94 -44.33 73.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.344 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.663 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.2 m120 -59.55 -38.85 82.17 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.389 -0.819 . . . . 0.0 109.286 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.85 98.28 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.576 ' CG1' ' NZ ' ' A' ' 8' ' ' LYS . 83.2 t -66.1 -42.04 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.427 -1.043 . . . . 0.0 109.232 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.2 t -61.87 -34.62 76.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.451 -0.781 . . . . 0.0 109.549 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.0 m -55.54 -42.46 74.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.728 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -60.19 -37.06 79.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.129 -0.982 . . . . 0.0 109.01 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -57.81 -29.82 65.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.465 -0.772 . . . . 0.0 109.03 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.88 -2.36 48.38 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.04 146.67 53.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 109.303 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -57.53 -53.35 59.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.531 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.9 p -144.4 160.49 40.98 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.354 -0.842 . . . . 0.0 109.288 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.84 149.41 21.41 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.351 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 49' ' ' TRP . 85.6 m-85 -125.18 151.36 45.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.576 -0.955 . . . . 0.0 108.804 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.567 ' SG ' ' OD1' ' A' ' 46' ' ' ASN . 48.9 t -100.23 122.82 43.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.042 -1.037 . . . . 0.0 110.219 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.594 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 94.9 mt-30 -120.01 -167.16 1.39 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.1 pt -115.54 156.03 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.443 -0.786 . . . . 0.0 109.793 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.25 -23.53 64.16 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.418 -0.802 . . . . 0.0 109.207 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.14 50.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 p -154.55 -81.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.8 142.09 51.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.498 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.68 -177.05 41.78 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 39' ' ' GLN . 16.8 t-20 -140.57 160.6 39.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.455 -1.027 . . . . 0.0 108.886 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.24 163.49 26.36 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.548 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.1 m -105.99 153.62 21.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.531 -0.982 . . . . 0.0 109.142 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.73 ' HE1' ' NE ' ' A' ' 2' ' ' ARG . 11.5 t-105 -116.81 137.57 52.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.343 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.7 m -132.63 134.23 44.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.241 -0.912 . . . . 0.0 109.855 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mt -123.6 135.31 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.598 -0.689 . . . . 0.0 110.025 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.33 -59.21 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.388 -0.82 . . . . 0.0 109.326 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.48 79.71 72.94 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -50.13 -179.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.957 2.438 . . . . 0.0 112.665 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 56.64 42.85 26.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.62 -0.675 . . . . 0.0 109.482 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.34 117.42 6.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.257 -0.902 . . . . 0.0 109.34 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 57' ' ' VAL . 13.6 p -124.33 74.43 60.31 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.673 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 59' ' ' ILE . 69.2 Cg_endo -79.76 -61.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.843 2.362 . . . . 0.0 112.118 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 83.3 mt 40.25 61.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.472 -0.768 . . . . 0.0 109.977 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -51.48 -34.57 36.23 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.3 mp -64.43 129.53 94.21 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.51 29.06 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.069 1.846 . . . . 0.0 112.186 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.401 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 97.19 3.32 58.9 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -126.76 136.04 51.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.484 -1.01 . . . . 0.0 109.164 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 75.5 m -60.18 -27.33 67.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.938 . . . . 0.0 109.549 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.516 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.71 ' H1 ' ' N ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -125.96 132.87 51.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.422 -0.799 . . . . 0.0 109.317 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -96.99 136.97 36.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.143 -0.973 . . . . 0.0 109.302 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.541 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -103.32 -59.29 1.74 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.388 -0.82 . . . . 0.0 110.333 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -112.5 9.63 19.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.365 -0.835 . . . . 0.0 110.57 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.4 pt -124.99 163.94 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -0.964 . . . . 0.0 110.252 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.24 -13.28 3.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.469 -0.77 . . . . 0.0 109.038 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.39 152.89 38.39 Favored Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.338 -0.851 . . . . 0.0 109.157 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.35 -34.23 67.38 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.543 2.162 . . . . 0.0 112.875 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.707 ' HD1' ' NH2' ' A' ' 60' ' ' ARG . 91.7 m-70 -133.21 3.15 3.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 110.06 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -131.37 168.9 16.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.814 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 40.6 m -114.8 179.65 3.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.504 -0.748 . . . . 0.0 109.505 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.6 t -95.96 135.06 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.23 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.563 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 32.2 p90 -65.18 -44.43 88.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.563 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 83.3 tt0 -175.56 96.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.059 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.411 ' HB3' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -66.23 135.46 54.51 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 108.6 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.714 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 2.1 p90 -108.75 -149.47 0.44 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.485 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.714 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 59.0 t0 -56.56 131.88 49.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.048 -1.033 . . . . 0.0 109.39 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.3 4.48 2.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.793 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -51.5 -43.21 62.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.065 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.9 m -85.06 6.45 25.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.031 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 26' ' ' GLY . 38.1 m 48.39 37.94 9.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.856 . . . . 0.0 109.397 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -59.31 -49.8 76.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.975 . . . . 0.0 109.959 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 33.8 t -69.02 -57.23 5.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.19 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.669 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.2 m120 -57.85 -35.65 71.24 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.07 -40.46 95.62 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.95 -46.72 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.266 -1.138 . . . . 0.0 108.852 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.9 m -70.3 -25.55 63.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.404 -0.81 . . . . 0.0 109.511 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 m -62.79 -29.78 70.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.277 -0.889 . . . . 0.0 111.225 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.489 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 3.9 mptp? -52.86 -34.14 53.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.95 -1.094 . . . . 0.0 110.477 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.64 -33.29 66.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.977 -1.077 . . . . 0.0 109.368 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.45 2.93 55.53 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -171.09 -28.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -1.078 . . . . 0.0 108.903 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.658 ' NZ ' ' SG ' ' A' ' 50' ' ' CYS . 24.4 tttt -53.34 134.37 39.84 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.7 m -116.79 139.24 50.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.4 -0.812 . . . . 0.0 109.618 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.19 156.24 26.4 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 49' ' ' TRP . 49.6 m-85 -127.08 154.18 45.03 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.5 t -99.52 122.51 42.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.004 -1.06 . . . . 0.0 109.275 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -123.99 -172.88 2.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.556 -0.715 . . . . 0.0 109.511 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.62 145.58 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.882 . . . . 0.0 109.403 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 29.7 tp -53.22 -39.19 63.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.15 -56.43 0.74 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.8 m -97.99 -67.88 0.83 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.518 -0.989 . . . . 0.0 108.67 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.64 159.58 41.85 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.87 -164.77 46.87 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.411 HD21 ' HB3' ' A' ' 16' ' ' CYS . 15.8 t30 -140.77 161.69 37.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.3 -1.118 . . . . 0.0 109.389 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.29 159.11 26.14 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.709 -1.234 . . . . 0.0 110.16 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.68 157.45 17.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.352 -1.087 . . . . 0.0 109.168 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 4' ' ' ALA . 7.5 t-105 -125.68 122.12 35.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.528 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.658 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -123.2 135.87 54.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.0 109.118 179.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.1 mt -117.95 134.51 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.699 0.761 . . . . 0.0 111.043 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 1' ' ' ALA . . . 169.07 147.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.71 73.7 81.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.673 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -84.37 -93.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.992 2.461 . . . . 0.0 112.367 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -94.37 11.41 30.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 0.0 109.449 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.26 45.01 7.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.407 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.71 ' N ' ' H1 ' ' A' ' 1' ' ' ALA . 10.2 t -68.95 119.58 70.67 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.343 -0.848 . . . . 0.0 109.285 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.88 165.07 7.41 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.277 1.984 . . . . 0.0 111.032 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.3 mm -109.02 130.83 61.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.176 -0.953 . . . . 0.0 109.663 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.707 ' NH2' ' HD1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -119.28 86.72 2.6 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.455 HD12 HG21 ' A' ' 61' ' ' ILE . 1.9 pt -124.43 81.53 59.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.811 . . . . 0.0 109.745 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -53.31 -18.92 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.666 2.244 . . . . 0.0 112.048 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.402 ' HA2' ' HD1' ' A' ' 66' ' ' HIS . . . 162.66 -12.5 0.11 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -58.75 -33.13 69.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -1.171 . . . . 0.0 109.62 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.0 t -56.62 -33.39 66.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.441 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.402 ' HD1' ' HA2' ' A' ' 63' ' ' GLY . 78.8 m80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -128.46 138.1 52.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.379 -0.826 . . . . 0.0 109.858 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 90.3 m-20 -108.05 150.38 27.23 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.77 -85.46 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -98.67 5.95 47.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.954 -1.091 . . . . 0.0 109.572 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 48' ' ' CYS . 21.5 pt -111.42 149.06 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.544 -0.722 . . . . 0.0 109.744 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.437 ' O ' ' CG1' ' A' ' 27' ' ' VAL . . . -102.57 -1.92 29.46 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.242 -0.911 . . . . 0.0 108.977 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.454 ' HZ3' ' C ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -131.47 173.27 6.07 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.535 -0.728 . . . . 0.0 109.289 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -48.63 -76.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.644 2.23 . . . . 0.0 113.367 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.703 ' ND1' HH11 ' A' ' 60' ' ' ARG . 78.2 m-70 -107.52 -8.87 16.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.162 -0.961 . . . . 0.0 110.159 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -102.31 155.55 18.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.396 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.454 ' C ' ' HZ3' ' A' ' 8' ' ' LYS . 13.9 p -120.98 177.04 5.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.124 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.8 t -104.97 136.24 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 0.0 110.004 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -82.68 -32.28 28.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.0 109.049 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -174.3 98.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.777 . . . . 0.0 109.077 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.411 ' H ' ' ND2' ' A' ' 46' ' ' ASN . 3.7 p -66.18 104.78 1.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.118 -0.989 . . . . 0.0 108.52 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 6.0 p90 -53.58 -42.76 67.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 110.34 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.561 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 54.7 t0 -148.1 78.45 1.44 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.966 -1.084 . . . . 0.0 109.836 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.7 -30.87 71.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.199 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.88 -40.86 73.56 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.433 -0.792 . . . . 0.0 109.256 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.592 ' O ' ' CB ' ' A' ' 22' ' ' SER . 17.5 t -57.57 -52.11 66.73 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.5 m 155.47 10.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.72 -0.613 . . . . 0.0 110.091 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -60.04 -63.22 1.38 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.81 -1.181 . . . . 0.0 110.142 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.28 -51.86 57.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.114 -0.991 . . . . 0.0 108.958 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.57 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.7 m120 -60.02 -35.7 75.65 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -57.81 -43.51 94.63 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 7' ' ' ALA . 91.6 t -62.94 -43.42 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -1.173 . . . . 0.0 108.689 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 60.0 m -64.12 -31.67 72.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.848 . . . . 0.0 109.168 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.4 m -58.83 -48.65 80.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.655 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -64.27 -41.9 96.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.398 -0.814 . . . . 0.0 109.192 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -62.28 -30.82 71.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.535 -0.728 . . . . 0.0 109.048 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.99 2.7 56.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.493 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -66.92 152.9 44.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.335 -1.097 . . . . 0.0 109.631 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.577 ' H ' ' CB ' ' A' ' 52' ' ' ALA . 9.5 ttmt -58.46 -71.3 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 110.111 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.0 p -144.77 169.33 18.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.315 -0.866 . . . . 0.0 110.22 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.515 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -142.12 151.06 22.6 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.13 135.82 54.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.27 -1.135 . . . . 0.0 109.895 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.63 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.5 t -111.48 115.23 28.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.239 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -131.66 166.13 22.15 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.5 pt -104.87 145.86 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.977 . . . . 0.0 111.267 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.08 142.32 41.7 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.21 -30.04 53.92 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.2 m -92.09 -74.07 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.083 -1.245 . . . . 0.0 110.772 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -61.52 -40.62 95.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.191 -0.943 . . . . 0.0 110.482 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.47 -31.31 7.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.411 ' ND2' ' H ' ' A' ' 16' ' ' CYS . 20.3 t-20 -140.47 125.08 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.261 . . . . 0.0 110.008 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.31 112.52 0.81 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.63 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -110.6 117.57 33.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -1.087 . . . . 0.0 109.53 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.37 131.44 54.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.493 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 7.1 t -105.45 122.65 46.43 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -112.53 132.67 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.831 . . . . 0.0 110.429 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.577 ' CB ' ' H ' ' A' ' 34' ' ' LYS . . . -175.39 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.665 -0.647 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.93 84.51 62.87 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.57 -0.706 . . . . 0.0 109.732 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.55 -13.07 22.57 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.285 1.99 . . . . 0.0 112.616 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -57.65 -37.46 73.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.051 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.507 ' O ' ' C ' ' A' ' 57' ' ' VAL . 89.2 m-20 -67.05 -40.78 87.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.053 -1.029 . . . . 0.0 110.497 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.507 ' C ' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER 32.93 67.63 1.03 Allowed Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.795 -0.566 . . . . 0.0 109.962 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.471 ' O ' ' C ' ' A' ' 59' ' ' ILE . 68.7 Cg_endo -78.75 -65.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.8 2.333 . . . . 0.0 112.708 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.471 ' C ' ' O ' ' A' ' 58' ' ' PRO . 95.8 mt 39.93 58.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.353 -0.842 . . . . 0.0 109.259 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.703 HH11 ' ND1' ' A' ' 10' ' ' HIS . 12.6 ptm180 -55.03 -37.45 66.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.972 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.97 154.33 38.98 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.184 -0.948 . . . . 0.0 109.545 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.68 -20.33 70.67 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.555 2.17 . . . . 0.0 112.107 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.98 15.95 0.1 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -92.65 155.92 17.42 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.267 -1.137 . . . . 0.0 109.239 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.09 -36.43 65.64 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 83.1 t60 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.423 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -128.11 135.3 49.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.435 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -96.86 147.18 24.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.941 . . . . 0.0 109.376 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -113.45 -94.25 0.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 109.35 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -98.83 7.54 45.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.012 -1.055 . . . . 0.0 108.952 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.5 pt -117.34 155.79 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.701 -0.624 . . . . 0.0 109.87 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.12 5.13 18.39 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.14 165.25 21.38 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.48 -59.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.408 2.072 . . . . 0.0 112.147 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -105.79 -6.4 19.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.798 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -114.31 164.28 14.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.422 -0.799 . . . . 0.0 109.799 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.6 m -112.43 176.89 4.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.614 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.9 t -102.08 130.99 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.236 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.436 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.2 p90 -74.13 -36.32 64.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.294 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.1 tt0 -174.76 99.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -65.5 109.34 2.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.59 ' CE2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -61.45 162.09 8.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.59 ' O ' ' CE2' ' A' ' 17' ' ' PHE . 61.1 t0 -44.22 107.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.113 -0.992 . . . . 0.0 108.993 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.532 ' CB ' ' H ' ' A' ' 24' ' ' CYS . . . -95.61 29.94 2.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.814 . . . . 0.0 109.829 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -53.49 -46.08 69.89 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.115 -0.991 . . . . 0.0 108.865 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.587 ' O ' ' CB ' ' A' ' 22' ' ' SER . 20.2 m -64.53 -49.44 71.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.319 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.587 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.4 m 152.2 26.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -58.61 -56.78 17.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.744 -1.223 . . . . 0.0 109.767 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.532 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 38.1 t -67.27 -42.42 83.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 108.832 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.724 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.0 OUTLIER -59.46 -38.85 81.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.87 -39.3 97.85 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.48 -47.79 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.197 -1.178 . . . . 0.0 109.349 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.74 -31.36 68.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.336 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.8 m -53.46 -48.52 68.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.231 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -64.93 -38.17 90.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.442 -0.786 . . . . 0.0 109.0 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -59.59 -28.43 67.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -0.79 . . . . 0.0 108.988 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.36 0.2 40.57 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.29 145.68 55.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -1.114 . . . . 0.0 109.14 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -60.56 -52.6 64.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 110.135 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -143.55 160.47 40.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.127 -0.983 . . . . 0.0 110.317 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.602 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -139.05 140.15 10.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -130.14 136.72 49.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -1.097 . . . . 0.0 109.755 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.0 t -105.05 130.94 53.13 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.353 -0.842 . . . . 0.0 109.501 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.688 ' NE2' ' N ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -134.67 173.0 12.15 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.493 -0.755 . . . . 0.0 109.274 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.2 pt -95.77 141.3 15.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.13 -34.95 72.65 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.293 -0.88 . . . . 0.0 109.245 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.57 -60.82 0.52 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.67 -70.44 0.75 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.38 -1.071 . . . . 0.0 109.063 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -129.44 151.16 50.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.609 -0.682 . . . . 0.0 109.538 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.45 174.8 40.3 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.44 167.11 22.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.322 -1.105 . . . . 0.0 109.578 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.489 ' O ' ' OE1' ' A' ' 39' ' ' GLN . . . -140.41 150.41 21.59 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -134.0 125.6 28.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -1.067 . . . . 0.0 109.231 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.547 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 2.8 p90 -120.69 141.27 50.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.113 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.9 m -128.98 145.0 51.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.451 -0.78 . . . . 0.0 109.103 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.69 137.85 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.407 ' C ' ' CD2' ' A' ' 53' ' ' LEU . . . -169.66 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.926 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.407 ' CD2' ' C ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -128.0 78.45 75.24 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.892 . . . . 0.0 109.659 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -60.7 -23.66 76.71 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.382 2.055 . . . . 0.0 111.782 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.07 -36.45 77.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 109.785 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.476 ' O ' ' C ' ' A' ' 57' ' ' VAL . 50.6 t-20 -68.06 129.08 38.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.476 ' C ' ' O ' ' A' ' 56' ' ' ASN . 52.5 t -38.15 100.42 0.21 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.803 -0.561 . . . . 0.0 109.539 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 59' ' ' ILE . 75.4 Cg_endo -90.3 155.76 4.58 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.627 2.218 . . . . 0.0 111.69 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 58' ' ' PRO . 89.3 mt 41.25 55.17 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 109.607 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -58.57 -35.87 73.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 63' ' ' GLY . 10.0 pt -60.62 148.56 81.26 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 0.0 109.35 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.79 1.22 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.465 2.11 . . . . 0.0 112.006 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 61' ' ' ILE . . . 100.11 5.82 54.36 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -103.46 122.62 45.28 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.388 -1.066 . . . . 0.0 108.816 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.407 ' O ' ' OXT' ' A' ' 66' ' ' HIS . 81.1 m -64.26 -22.99 67.14 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.428 -0.795 . . . . 0.0 110.006 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.407 ' OXT' ' O ' ' A' ' 65' ' ' CYS . 37.5 m80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.425 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -129.05 135.78 49.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.424 -0.797 . . . . 0.0 109.687 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 87.3 m-20 -103.37 155.91 18.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 108.89 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -110.5 -93.48 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 110.323 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -98.2 -10.88 23.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.067 -1.02 . . . . 0.0 109.64 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.491 ' CG2' ' O ' ' A' ' 11' ' ' ASN . 60.8 mt -111.0 130.58 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.555 -0.716 . . . . 0.0 109.544 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.64 -12.61 19.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.422 -0.799 . . . . 0.0 110.107 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.489 ' HZ1' ' CG2' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -104.08 153.26 39.03 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.274 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.12 -35.8 62.27 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.487 2.125 . . . . 0.0 112.942 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -131.14 -0.9 4.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.948 . . . . 0.0 110.11 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.491 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 34.6 m-80 -125.91 164.55 20.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.342 -0.849 . . . . 0.0 109.78 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.7 m -115.42 160.33 20.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.0 109.476 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.78 131.59 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 29.9 p90 -75.13 -43.46 52.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.93 . . . . 0.0 109.459 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.535 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.3 tt0 -175.9 100.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 109.215 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -68.38 93.37 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.089 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.527 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 21.2 p90 -63.42 -43.32 97.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 109.895 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.527 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 47.8 t0 -153.49 89.45 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.126 -0.984 . . . . 0.0 109.849 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.58 -28.68 69.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.128 -0.983 . . . . 0.0 109.275 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -54.49 -40.37 68.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.473 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 20.6 m -58.64 -48.91 79.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.122 -0.986 . . . . 0.0 109.623 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.8 m 153.57 3.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.75 -0.594 . . . . 0.0 109.944 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.08 -79.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.923 -1.11 . . . . 0.0 110.485 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 t -58.43 -48.29 81.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 36' ' ' GLY . 2.6 m120 -58.35 -36.27 73.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.0 108.835 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.91 -41.12 97.65 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.489 ' CG2' ' HZ1' ' A' ' 8' ' ' LYS . 73.1 t -62.09 -44.32 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.237 -1.154 . . . . 0.0 109.049 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 62.6 m -64.7 -30.76 71.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 109.389 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.8 m -58.81 -44.68 90.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.726 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt -63.1 -44.7 94.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.011 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.74 -30.23 71.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.274 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.71 4.28 58.04 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.518 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.73 155.0 35.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.365 -1.079 . . . . 0.0 109.608 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.563 ' H ' ' CB ' ' A' ' 52' ' ' ALA . 5.6 ttmt -56.24 -71.63 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 110.235 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.58 ' HG ' ' H ' ' A' ' 36' ' ' GLY . 20.7 t -144.34 168.66 19.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 110.05 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.586 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -137.2 154.78 22.51 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -129.78 143.93 51.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -1.102 . . . . 0.0 109.641 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -125.45 128.43 48.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.569 -0.707 . . . . 0.0 109.345 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -140.3 -138.53 0.12 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.221 -0.924 . . . . 0.0 109.589 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.5 pt -93.71 153.21 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.262 -0.898 . . . . 0.0 109.962 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.4 tp -86.68 138.2 31.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.437 -0.789 . . . . 0.0 109.187 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.74 -35.95 8.0 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.2 p -100.52 -99.04 0.25 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.181 -1.187 . . . . 0.0 109.209 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -122.34 147.55 46.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 0.0 109.287 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.34 -162.44 25.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -114.81 166.41 11.79 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.487 -1.008 . . . . 0.0 109.725 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.59 155.48 21.59 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER -137.2 121.33 17.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -1.144 . . . . 0.0 109.974 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -111.31 136.06 50.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.394 -0.817 . . . . 0.0 108.857 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.518 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 6.9 t -111.31 126.65 55.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.0 108.981 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.1 mt -115.45 135.22 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 110.242 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.563 ' CB ' ' H ' ' A' ' 34' ' ' LYS . . . -171.18 -55.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.524 -0.735 . . . . 0.0 109.057 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.86 76.52 76.99 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.481 -0.762 . . . . 0.0 109.235 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.87 -21.37 40.33 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.915 2.41 . . . . 0.0 112.684 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.403 ' C ' HD21 ' A' ' 56' ' ' ASN . 92.3 m-20 -48.74 -35.44 14.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 108.494 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.403 HD21 ' C ' ' A' ' 55' ' ' ASP . 3.1 m120 -109.24 125.53 52.35 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.63 -0.668 . . . . 0.0 109.387 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.7 t -138.29 66.25 44.21 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.915 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -95.2 152.32 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.507 2.804 . . . . 0.0 111.75 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -128.1 121.62 56.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.1 tpt85 -54.97 -36.27 65.19 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.356 -0.84 . . . . 0.0 110.795 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 pp -132.65 154.43 81.49 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.031 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.35 -19.57 28.93 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.479 2.119 . . . . 0.0 112.036 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.79 26.87 0.11 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -104.17 148.18 26.59 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.231 -1.158 . . . . 0.0 109.467 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 71.1 m -117.35 159.76 22.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.489 -0.757 . . . . 0.0 109.148 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.408 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -127.04 129.97 49.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.84 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.456 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 5.3 t0 -108.55 153.57 23.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.432 -0.793 . . . . 0.0 109.106 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.587 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -100.28 -81.67 0.46 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.528 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.3 -4.77 31.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.001 . . . . 0.0 109.786 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.456 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 65.7 mt -106.77 143.95 16.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.464 -0.773 . . . . 0.0 110.099 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.84 -10.16 1.34 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.305 -0.872 . . . . 0.0 109.19 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -104.75 157.21 34.66 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 8' ' ' LYS . 45.6 Cg_exo -34.16 -109.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.332 2.688 . . . . 0.0 113.151 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.44 -1.23 57.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.756 -1.215 . . . . 0.0 109.335 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -105.22 154.82 19.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.639 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.3 m -108.1 161.81 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.234 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -66.41 134.31 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.947 . . . . 0.0 109.434 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.7 p90 -78.13 -34.7 49.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 76.9 tt0 -167.61 95.0 0.44 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.265 -0.897 . . . . 0.0 109.08 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' CB ' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -60.6 148.51 37.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.95 -1.094 . . . . 0.0 108.411 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 13.7 t80 -115.69 166.48 11.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.511 -0.743 . . . . 0.0 109.281 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.585 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 88.0 m-20 -42.8 137.21 2.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 109.401 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.96 -8.91 48.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 110.037 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -51.34 -43.79 61.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.045 -1.034 . . . . 0.0 108.726 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -86.11 6.01 31.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.354 -0.841 . . . . 0.0 108.893 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 m 55.33 20.42 3.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.602 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -58.62 -49.41 77.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.774 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.5 t -65.34 -47.96 74.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.152 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.671 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.2 m120 -60.05 -37.63 80.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.389 -0.82 . . . . 0.0 109.185 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.52 -42.22 99.01 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.33 -43.91 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 109.12 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.8 t -64.27 -32.42 74.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.475 -0.765 . . . . 0.0 109.19 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.5 m -59.23 -41.1 87.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.406 -0.809 . . . . 0.0 109.975 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -58.77 -31.2 68.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.128 -0.983 . . . . 0.0 109.272 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.505 ' OD1' ' NZ ' ' A' ' 34' ' ' LYS . 18.2 t-20 -52.6 -34.89 52.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 108.925 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 33' ' ' ALA . . . 157.35 -35.57 0.55 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 32' ' ' GLY . . . 161.45 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -1.152 . . . . 0.0 109.362 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.505 ' NZ ' ' OD1' ' A' ' 31' ' ' ASN . 22.2 mttt -42.87 139.51 1.65 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.434 -0.791 . . . . 0.0 109.96 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.4 p -125.81 113.63 17.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.59 -141.48 4.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.554 ' O ' ' N ' ' A' ' 49' ' ' TRP . 10.3 m-85 -139.82 171.5 14.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.209 -1.171 . . . . 0.0 109.828 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.465 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 13.0 t -99.68 125.63 45.57 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.325 -0.86 . . . . 0.0 109.534 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.659 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 26.7 mt-30 -118.07 -177.5 3.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.641 -0.662 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 pt -108.93 157.82 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 110.102 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.7 mt -79.05 144.52 34.55 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.37 -0.832 . . . . 0.0 109.517 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -54.13 -34.93 53.58 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.1 p -94.14 -120.88 0.09 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.331 -1.1 . . . . 0.0 109.073 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.14 136.63 51.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.01 -166.6 18.7 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.465 ' ND2' ' SG ' ' A' ' 38' ' ' CYS . 17.3 t30 -140.51 157.95 44.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.322 -1.105 . . . . 0.0 108.927 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.24 163.67 25.98 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.8 m -107.43 140.41 40.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.476 -1.014 . . . . 0.0 109.758 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.659 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 4.6 t-105 -106.34 128.67 54.18 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.397 -0.815 . . . . 0.0 108.895 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.4 m -115.9 128.51 55.84 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 69.2 mt -126.37 138.36 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 110.327 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.91 -40.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.329 -0.857 . . . . 0.0 109.537 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mp -128.63 159.11 69.71 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.514 -0.741 . . . . 0.0 109.313 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -42.55 -72.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.591 2.194 . . . . 0.0 112.325 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 50.0 p30 -175.37 47.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.44 -0.787 . . . . 0.0 109.534 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -101.2 121.9 42.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.26 -0.9 . . . . 0.0 109.751 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 1' ' ' ALA . 23.7 t 55.73 66.82 3.37 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.623 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.74 -64.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.65 2.233 . . . . 0.0 112.12 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -119.92 113.78 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -0.788 . . . . 0.0 109.203 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -67.49 -35.63 79.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 109.054 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 63' ' ' GLY . 1.6 mp -73.7 136.93 77.14 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.691 -0.63 . . . . 0.0 109.543 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -46.64 -5.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.898 1.732 . . . . 0.0 111.892 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 103.67 5.41 45.1 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 66' ' ' HIS . 33.0 mtmt -58.28 -36.75 73.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.107 -1.231 . . . . 0.0 109.385 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 50.7 t 51.64 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.631 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.716 ' H ' ' ND1' ' A' ' 66' ' ' HIS . 9.9 p-80 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.552 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -108.91 146.05 34.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.427 -0.796 . . . . 0.0 109.306 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.47 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 8.9 t0 -136.58 154.31 50.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.874 . . . . 0.0 109.098 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -99.6 -78.31 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 110.898 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.65 -8.96 23.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.067 . . . . 0.0 110.096 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.47 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 68.3 mt -104.65 143.45 16.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.461 -0.774 . . . . 0.0 110.177 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.577 ' O ' ' ND2' ' A' ' 31' ' ' ASN . . . -118.51 13.28 13.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.823 . . . . 0.0 109.354 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.24 155.27 71.56 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -64.86 -39.68 24.46 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.437 2.091 . . . . 0.0 112.416 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -134.57 -1.08 2.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.639 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -116.16 170.21 8.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.47 -0.769 . . . . 0.0 109.488 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 62.5 m -114.46 177.27 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.518 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 t -99.97 135.68 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -70.78 77.44 0.62 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.067 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 55.9 97.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 109.346 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.7 t -64.68 113.21 3.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 108.975 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 8.4 t80 -70.06 139.56 52.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 88.9 m-20 -70.1 131.77 44.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 110.084 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.72 155.05 37.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.406 -0.809 . . . . 0.0 109.109 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 21' ' ' SER . 96.7 m-85 -56.93 -41.02 77.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.09 -1.006 . . . . 0.0 109.24 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 1.4 t 168.98 86.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.409 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.2 t -170.24 -64.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.057 -1.027 . . . . 0.0 110.021 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.78 -56.95 15.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 109.912 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.2 t -70.66 -52.64 19.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.653 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.625 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.5 m120 -57.68 -37.99 74.37 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.408 -0.807 . . . . 0.0 109.469 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.74 -46.66 93.74 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.3 t -67.72 -43.27 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -1.131 . . . . 0.0 109.383 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.5 t -61.22 -38.06 85.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.357 -0.839 . . . . 0.0 109.333 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.8 m -56.93 -40.21 75.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -59.14 -38.34 79.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.012 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 7' ' ' ALA . 82.0 m-20 -59.24 -28.52 66.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.83 . . . . 0.0 109.03 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.72 -0.12 52.51 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.78 148.21 51.55 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -1.064 . . . . 0.0 109.452 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.538 ' H ' ' CB ' ' A' ' 52' ' ' ALA . 3.8 ttmt -58.31 -55.56 33.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.782 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t -144.62 158.81 43.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.347 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -141.74 154.23 24.66 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.563 -1.304 . . . . 0.0 110.211 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 49' ' ' TRP . 48.8 m-85 -127.18 152.83 46.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.489 -1.006 . . . . 0.0 109.242 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.8 t -99.44 119.54 38.17 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.176 -0.953 . . . . 0.0 109.087 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -116.68 -170.82 1.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.696 -0.628 . . . . 0.0 109.693 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 pt -93.57 152.17 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.239 -0.913 . . . . 0.0 109.726 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' GLY . 29.8 tp -88.85 133.95 34.11 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.301 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -45.11 -30.19 2.52 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.8 p -109.45 178.85 4.31 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -50.75 160.58 0.43 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.763 -1.211 . . . . 0.0 109.174 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.59 -167.05 30.76 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -138.97 171.91 13.62 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.338 -1.095 . . . . 0.0 109.407 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.13 163.66 26.29 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.05 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.1 m -103.57 152.2 22.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.424 -1.045 . . . . 0.0 109.255 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.579 ' N ' ' O ' ' A' ' 37' ' ' TYR . 17.3 t-105 -116.2 139.06 50.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.826 . . . . 0.0 109.566 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.8 m -134.38 124.05 25.11 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.287 -0.883 . . . . 0.0 109.9 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 mt -123.98 132.34 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.536 -0.728 . . . . 0.0 109.875 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.538 ' CB ' ' H ' ' A' ' 34' ' ' LYS . . . -177.11 -66.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.822 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 1' ' ' ALA . 17.6 tp -133.14 89.0 34.57 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.417 -0.802 . . . . 0.0 109.9 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -75.61 -25.16 11.2 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.074 1.849 . . . . 0.0 112.292 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -57.96 -35.83 71.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 57' ' ' VAL . 48.9 t-20 -73.29 144.72 46.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.645 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.503 ' C ' ' O ' ' A' ' 56' ' ' ASN . 90.9 t -33.85 97.84 0.12 Allowed Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.949 -0.469 . . . . 0.0 109.795 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' ASN . 89.5 Cg_endo -85.5 -63.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.575 2.184 . . . . 0.0 112.426 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.425 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 73.6 mt -118.21 131.97 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -138.49 -21.9 1.01 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.301 -0.874 . . . . 0.0 109.507 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.23 154.09 38.86 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -67.21 -9.87 26.64 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.696 2.264 . . . . 0.0 112.195 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.3 22.22 45.42 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 66' ' ' HIS . 17.3 tttp -56.38 -35.04 67.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.557 -0.967 . . . . 0.0 109.651 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 57.8 m 57.12 -77.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.414 -0.803 . . . . 0.0 109.592 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 64' ' ' LYS . 94.9 m-70 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.728 ' H1 ' ' H ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -131.93 134.59 45.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.47 -0.769 . . . . 0.0 109.44 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 83.4 m-20 -95.79 150.11 20.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.136 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -109.86 -92.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.511 -0.743 . . . . 0.0 109.955 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -97.91 -17.3 19.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.346 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 11' ' ' ASN . 64.7 mt -106.91 137.61 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.525 -0.734 . . . . 0.0 109.62 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.416 ' C ' ' CD ' ' A' ' 8' ' ' LYS . . . -113.24 14.42 19.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.476 -0.765 . . . . 0.0 109.853 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.466 ' HZ1' ' HH ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -126.23 153.52 74.46 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.346 -0.846 . . . . 0.0 109.15 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.86 -27.74 80.58 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.637 2.225 . . . . 0.0 112.896 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -147.64 -5.99 0.47 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.077 -1.015 . . . . 0.0 109.501 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.439 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 51.2 m-80 -111.52 165.92 11.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.768 . . . . 0.0 109.38 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 m -119.59 162.19 19.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -0.823 . . . . 0.0 109.089 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.9 130.96 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.104 -0.998 . . . . 0.0 109.207 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.523 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.4 p90 -76.04 -42.11 48.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.523 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 45.1 tp10 -175.29 99.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -63.63 148.65 48.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.162 -0.961 . . . . 0.0 109.024 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.676 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -122.12 -161.14 0.91 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.676 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 89.1 m-20 -57.08 142.45 42.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.988 -1.07 . . . . 0.0 109.308 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.7 7.58 3.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.867 . . . . 0.0 110.103 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -52.25 -45.52 65.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.058 -1.026 . . . . 0.0 109.256 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 t -88.87 -2.58 58.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.949 . . . . 0.0 109.128 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' GLY . 3.1 m 55.6 52.55 10.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.511 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.466 ' HH ' ' HZ1' ' A' ' 8' ' ' LYS . 65.4 t80 -61.75 -53.61 53.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 0.0 109.833 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -70.98 -51.87 23.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.897 . . . . 0.0 109.294 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.634 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.5 m120 -58.76 -37.54 76.47 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.13 -39.47 97.18 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.85 -44.15 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -1.125 . . . . 0.0 109.071 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.2 m -63.78 -32.93 74.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.183 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.2 m -60.98 -50.39 73.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.663 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -65.59 -41.01 93.32 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.44 -0.788 . . . . 0.0 109.359 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -61.26 -30.25 70.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.461 -0.775 . . . . 0.0 109.259 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.36 0.39 50.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -66.85 150.95 48.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.438 -1.036 . . . . 0.0 109.388 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -57.91 -76.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 109.87 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.2 m -143.16 158.87 43.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.329 -0.857 . . . . 0.0 109.681 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.42 162.27 26.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -126.35 140.03 52.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -1.041 . . . . 0.0 109.833 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -116.21 119.37 35.55 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -137.45 176.83 8.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.189 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -92.83 140.29 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.979 -1.076 . . . . 0.0 109.285 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -64.42 -39.42 93.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 108.939 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.512 ' C ' ' HG1' ' A' ' 43' ' ' THR . . . 88.45 5.87 74.76 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.512 ' HG1' ' C ' ' A' ' 42' ' ' GLY . 57.6 m -157.44 -81.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 109.849 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -62.29 -37.0 83.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.917 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 41' ' ' LEU . . . 162.88 -119.08 0.85 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.405 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 17.4 m120 -111.33 150.54 29.57 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.519 -0.989 . . . . 0.0 110.093 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.3 117.53 2.3 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 4' ' ' ALA . 32.9 t -114.95 115.98 27.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.464 -1.021 . . . . 0.0 109.143 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -109.55 137.56 47.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.357 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.425 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 8.2 t -109.39 132.55 54.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.1 122.83 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 0.0 109.814 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.421 ' O ' ' CD1' ' A' ' 53' ' ' LEU . . . -179.07 -146.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.585 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.7 OUTLIER 176.43 -44.71 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.42 -0.8 . . . . 0.0 109.823 179.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 53' ' ' LEU . 42.8 Cg_exo -54.78 -32.68 77.76 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.086 1.858 . . . . 0.0 111.95 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.35 -38.3 86.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.299 -0.876 . . . . 0.0 108.98 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 53' ' ' LEU . 14.5 m120 56.88 46.42 19.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.728 ' H ' ' H1 ' ' A' ' 1' ' ' ALA . 91.9 t -120.62 85.92 39.24 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.365 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -90.91 -172.83 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.293 2.662 . . . . 0.0 111.689 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mm -114.28 130.5 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 7.51 41.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 0.0 110.521 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.63 151.94 61.73 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.778 -1.201 . . . . 0.0 109.865 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.607 ' C ' ' H ' ' A' ' 64' ' ' LYS . 11.3 Cg_endo -57.84 159.74 16.89 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.703 2.269 . . . . 0.0 112.155 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.74 28.25 0.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.607 ' H ' ' C ' ' A' ' 62' ' ' PRO . 35.0 tttt -56.68 -35.63 68.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.104 -1.233 . . . . 0.0 109.303 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 33.8 m 58.46 -74.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.614 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 64' ' ' LYS . 84.6 t60 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -136.52 161.52 35.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.341 -0.849 . . . . 0.0 109.242 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -95.44 145.54 25.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.121 -0.987 . . . . 0.0 109.343 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.512 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -103.08 -81.42 0.5 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 110.797 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -99.52 -15.18 18.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.051 -1.031 . . . . 0.0 110.261 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.9 mt -95.91 143.92 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.367 -0.833 . . . . 0.0 110.12 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.94 21.32 3.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.34 -0.85 . . . . 0.0 109.6 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -115.37 152.15 46.65 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.47 -0.769 . . . . 0.0 109.213 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.21 -32.75 90.88 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.569 2.18 . . . . 0.0 112.816 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -149.65 12.08 0.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.996 -1.065 . . . . 0.0 109.805 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -130.88 -164.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.62 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.1 m -121.0 -178.08 3.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.357 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -98.89 131.95 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.265 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.7 p90 -66.34 -37.45 85.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.531 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.443 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 80.9 tt0 -174.56 99.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.279 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -75.54 125.58 29.31 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.101 -0.999 . . . . 0.0 108.715 179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 18' ' ' ASP . 20.0 t80 -90.87 141.14 29.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.904 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.587 ' O ' ' CE2' ' A' ' 17' ' ' PHE . 60.0 t0 -78.52 121.03 24.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -0.811 . . . . 0.0 109.88 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.82 159.06 43.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.465 -0.772 . . . . 0.0 108.936 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.448 ' O ' ' CB ' ' A' ' 21' ' ' SER . 71.3 t80 -53.62 -43.41 68.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.081 -1.012 . . . . 0.0 109.203 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.503 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER 168.97 78.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.429 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 26' ' ' GLY . 3.5 t -156.01 -66.94 0.11 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.037 -1.039 . . . . 0.0 110.149 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -60.37 -57.26 13.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -68.36 -48.31 65.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 108.943 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.631 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.4 m120 -59.08 -37.17 76.47 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -60.4 -41.48 98.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -62.03 -44.92 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.16 . . . . 0.0 109.128 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.3 m -67.8 -31.59 71.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.798 . . . . 0.0 109.53 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 m -56.88 -48.43 78.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.62 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -65.02 -40.48 94.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.417 -0.802 . . . . 0.0 109.487 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -60.74 -30.18 69.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.402 -0.811 . . . . 0.0 109.297 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.84 0.02 56.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.421 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.95 150.0 48.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.418 -1.049 . . . . 0.0 109.423 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -57.6 -60.24 3.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -0.94 . . . . 0.0 109.947 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.6 p -144.9 161.74 38.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.997 . . . . 0.0 110.193 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.581 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -144.14 154.72 25.86 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.596 ' O ' ' N ' ' A' ' 49' ' ' TRP . 21.6 m-85 -139.8 156.34 46.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.171 -1.194 . . . . 0.0 109.456 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.21 124.75 44.51 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.066 -1.021 . . . . 0.0 109.188 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.565 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 26.0 mt-30 -116.28 179.03 4.11 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.6 pt -93.29 143.25 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.061 -1.024 . . . . 0.0 110.043 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' O ' ' C ' ' A' ' 42' ' ' GLY . 36.0 tp -91.36 142.78 27.31 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.468 -0.77 . . . . 0.0 109.215 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -43.67 -31.76 1.86 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.563 ' HG1' ' H ' ' A' ' 45' ' ' GLY . 21.6 p -87.23 167.51 14.05 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.41 -1.053 . . . . 0.0 108.87 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -54.35 -10.05 0.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 109.49 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.563 ' H ' ' HG1' ' A' ' 43' ' ' THR . . . -82.56 -173.23 49.01 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -137.18 171.23 14.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.481 -1.011 . . . . 0.0 109.109 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -140.17 167.1 25.56 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.034 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -101.31 151.67 21.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.413 -1.051 . . . . 0.0 109.135 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.596 ' N ' ' O ' ' A' ' 37' ' ' TYR . 13.6 t-105 -115.57 137.35 52.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.469 -0.77 . . . . 0.0 109.329 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.421 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -130.31 133.63 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.369 -0.832 . . . . 0.0 109.153 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.81 121.16 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.804 . . . . 0.0 109.691 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 1' ' ' ALA . . . -169.98 158.64 7.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.37 75.52 73.98 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 0.0 109.777 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.08 -65.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.743 2.295 . . . . 0.0 111.838 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -154.99 -71.02 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.558 -0.714 . . . . 0.0 109.148 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 56' ' ' ASN . 6.4 p30 -173.39 29.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.355 -0.84 . . . . 0.0 109.564 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.5 t -126.98 77.7 74.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 109.866 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.73 -65.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.668 2.245 . . . . 0.0 112.099 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 59' ' ' ILE . 29.3 mm -113.89 130.0 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.69 1.6 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.723 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -130.63 154.43 81.73 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.716 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -72.83 23.91 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.701 2.267 . . . . 0.0 112.073 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 61' ' ' ILE . . . 95.57 10.29 56.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -73.8 136.25 43.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.413 -1.051 . . . . 0.0 109.104 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' HIS . 72.7 m -116.72 159.29 22.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.577 -0.702 . . . . 0.0 109.382 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' CYS . 83.7 t60 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.54 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.755 ' HE ' ' HE1' ' A' ' 49' ' ' TRP . 76.8 ttt180 -128.26 133.67 48.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.44 -0.787 . . . . 0.0 109.571 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -95.67 140.38 30.57 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.558 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -99.83 -79.74 0.49 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -0.91 . . . . 0.0 109.696 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -106.67 15.11 26.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.783 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.57 156.44 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.354 -0.841 . . . . 0.0 109.778 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.03 -18.57 17.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 109.11 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -137.25 154.99 76.03 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.372 -0.83 . . . . 0.0 109.179 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.38 -29.93 30.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.66 2.24 . . . . 0.0 112.679 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -94.67 -23.68 17.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.133 -0.979 . . . . 0.0 110.295 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -140.72 -179.54 6.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.04 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.528 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 24.6 p -140.07 -177.79 5.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.51 -0.744 . . . . 0.0 109.232 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.7 t -107.33 131.87 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.425 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 28.1 p90 -73.68 -34.59 64.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.144 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.425 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 43.8 tp10 -151.19 89.38 1.51 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.44 -0.787 . . . . 0.0 108.89 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.565 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -59.21 109.49 0.87 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 109.353 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 1.8 t80 -63.15 165.19 7.5 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.368 -0.833 . . . . 0.0 108.943 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.602 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 60.3 t0 -43.54 106.39 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 109.298 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.36 -5.11 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -50.79 -43.61 58.67 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.163 -0.961 . . . . 0.0 109.186 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.7 m -62.7 -50.63 70.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.192 -0.943 . . . . 0.0 109.446 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.6 t 151.49 12.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.35 -71.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.008 -1.058 . . . . 0.0 110.541 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.4 t -60.64 -51.29 70.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.163 -0.961 . . . . 0.0 109.148 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.469 ' O ' ' OG1' ' A' ' 29' ' ' THR . 2.3 m120 -57.72 -36.01 71.44 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 108.666 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.34 -40.18 95.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.83 -48.02 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -1.173 . . . . 0.0 108.855 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.38 -22.57 62.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 51.2 m -64.07 -31.26 72.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.413 -0.804 . . . . 0.0 110.976 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 1.8 mptt -52.77 -35.12 55.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.004 -1.06 . . . . 0.0 110.159 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -56.92 -33.59 67.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.051 -1.03 . . . . 0.0 109.337 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.84 2.17 56.2 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.1 -26.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -1.036 . . . . 0.0 109.216 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.623 ' CE ' ' SG ' ' A' ' 50' ' ' CYS . 16.7 tttp -54.33 131.83 42.73 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.6 p -113.65 139.68 48.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.424 -0.798 . . . . 0.0 109.589 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.19 158.02 27.1 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.526 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -128.81 155.71 44.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.643 -0.916 . . . . 0.0 108.735 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 42.4 t -99.07 122.77 42.75 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.049 -1.032 . . . . 0.0 108.917 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.498 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 24.4 mt-30 -115.68 177.81 4.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.634 -0.666 . . . . 0.0 109.965 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.4 mt -93.69 133.44 34.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.402 -0.811 . . . . 0.0 110.1 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.47 -27.35 68.92 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.617 0.722 . . . . 0.0 109.209 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.29 -7.34 40.18 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.605 -2.198 . . . . 0.0 107.605 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 45' ' ' GLY . 12.8 p -127.79 172.44 10.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 43' ' ' THR . 23.8 p90 -46.48 -12.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.019 -1.051 . . . . 0.0 109.44 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -87.87 -176.92 47.98 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.556 ' ND2' ' SG ' ' A' ' 38' ' ' CYS . 61.8 t30 -140.2 164.54 29.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.531 -0.981 . . . . 0.0 108.889 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 157.82 25.66 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.46 -1.353 . . . . 0.0 110.545 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -107.39 153.45 22.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.488 -1.007 . . . . 0.0 109.354 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.755 ' HE1' ' HE ' ' A' ' 2' ' ' ARG . 5.6 t-105 -125.72 129.46 49.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.372 -0.83 . . . . 0.0 109.256 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.623 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 1.8 t -132.76 131.09 40.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.121 -0.987 . . . . 0.0 109.748 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mt -123.1 140.47 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.746 . . . . 0.0 110.499 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.59 -28.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.711 . . . . 0.0 109.643 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.567 ' C ' ' H ' ' A' ' 55' ' ' ASP . 3.0 mp -129.1 165.96 28.57 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 109.717 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.593 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 50.3 Cg_exo -49.72 -0.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.59 2.194 . . . . 0.0 112.705 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 12.5 t0 89.9 49.8 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.27 0.557 . . . . 0.0 109.785 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -103.53 131.87 50.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.304 -0.872 . . . . 0.0 108.996 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.0 t 52.92 67.69 3.63 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.088 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HG2' ' H ' ' A' ' 59' ' ' ILE . 59.5 Cg_endo -75.65 -65.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.761 2.307 . . . . 0.0 112.471 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.407 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 69.3 mt -116.13 124.68 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.473 -0.767 . . . . 0.0 109.412 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -1.61 10.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.531 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -68.98 149.22 97.9 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.557 -0.714 . . . . 0.0 109.521 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.28 5.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.556 2.171 . . . . 0.0 112.139 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 61' ' ' ILE . . . 99.99 8.12 51.55 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -37.48 71.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.176 -1.19 . . . . 0.0 109.239 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -107.95 158.57 17.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.557 -0.714 . . . . 0.0 109.543 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.436 -179.912 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -136.9 159.4 41.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.589 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -101.35 149.52 23.95 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.291 -0.881 . . . . 0.0 109.129 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -99.34 -65.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.256 -0.903 . . . . 0.0 110.654 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -100.45 -0.94 37.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 109.927 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.5 mt -111.71 133.83 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.935 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.97 -9.25 17.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.419 -0.801 . . . . 0.0 109.549 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.634 ' NZ ' ' CG1' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.09 166.35 12.04 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.502 -0.749 . . . . 0.0 109.246 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.74 -59.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.581 2.187 . . . . 0.0 112.433 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.699 ' HE2' ' NH1' ' A' ' 60' ' ' ARG . 78.4 m80 -102.95 -4.71 24.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.348 -0.845 . . . . 0.0 109.782 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -121.66 161.79 21.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.419 -0.801 . . . . 0.0 109.645 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.5 m -124.14 179.5 4.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.353 -0.842 . . . . 0.0 109.514 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -98.87 134.18 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.312 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.3 p90 -70.27 -42.04 72.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.851 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 39.1 tp10 -174.68 99.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.097 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB3' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -70.0 143.58 52.54 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.144 -0.973 . . . . 0.0 108.955 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.614 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -120.12 179.31 4.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.404 -0.81 . . . . 0.0 109.033 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.614 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 88.6 m-20 -44.7 128.35 6.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -0.968 . . . . 0.0 109.355 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.607 ' C ' ' H ' ' A' ' 21' ' ' SER . . . -65.17 -36.24 83.59 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.202 -0.936 . . . . 0.0 109.759 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.564 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 66.9 t80 49.25 7.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.17 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.607 ' H ' ' C ' ' A' ' 19' ' ' ALA . 1.2 t 173.3 -54.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.354 -0.842 . . . . 0.0 108.856 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER 160.98 45.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.621 -0.674 . . . . 0.0 109.202 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -60.31 -51.85 67.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.999 -1.063 . . . . 0.0 109.716 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.9 t -70.35 -50.42 39.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.191 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.724 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.0 OUTLIER -59.55 -38.73 81.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 109.296 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.87 -44.04 98.39 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.634 ' CG1' ' NZ ' ' A' ' 8' ' ' LYS . 76.9 t -60.56 -43.55 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -1.179 . . . . 0.0 109.542 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.446 ' SG ' ' CD ' ' A' ' 34' ' ' LYS . 3.6 t -65.07 -35.08 80.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.252 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 m -61.95 -39.16 91.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 110.557 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -56.98 -29.97 63.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.005 -1.059 . . . . 0.0 109.779 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.706 ' ND2' ' HZ1' ' A' ' 34' ' ' LYS . 13.9 t30 -53.59 -35.61 61.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.074 -1.016 . . . . 0.0 109.294 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.03 -42.76 0.27 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 34' ' ' LYS . . . 174.52 -21.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.048 -1.266 . . . . 0.0 109.59 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.706 ' HZ1' ' ND2' ' A' ' 31' ' ' ASN . 13.3 ptpt -43.63 145.37 0.65 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.511 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 91.4 p -103.61 147.77 26.81 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.48 159.96 27.59 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.229 -1.463 . . . . 0.0 111.252 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 49' ' ' TRP . 37.3 m-85 -127.54 154.21 45.43 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.618 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 40.6 t -98.92 118.89 36.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.894 -1.128 . . . . 0.0 109.323 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.609 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 25.9 mt-30 -112.75 171.52 7.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.1 pt -93.25 134.17 31.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.063 -1.023 . . . . 0.0 110.042 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.408 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 41.3 tp -62.79 -28.15 69.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.637 -0.664 . . . . 0.0 109.211 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.75 -6.8 41.38 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 45' ' ' GLY . 20.3 p -127.02 172.62 10.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' THR . 24.6 p90 -44.65 -16.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.033 -1.042 . . . . 0.0 109.367 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -89.26 -178.2 45.75 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.618 ' ND2' ' SG ' ' A' ' 38' ' ' CYS . 7.4 t30 -140.65 168.1 20.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.527 -0.984 . . . . 0.0 108.853 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.4 150.38 21.56 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.473 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -99.99 145.33 28.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.41 -1.053 . . . . 0.0 108.986 179.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.609 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 11.7 t-105 -111.25 127.89 55.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.392 -0.817 . . . . 0.0 109.408 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.4 m -124.31 134.24 53.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.273 -0.892 . . . . 0.0 109.616 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.574 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 5.2 mt -120.14 141.61 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.544 -0.722 . . . . 0.0 110.076 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 51' ' ' ILE . . . 90.89 65.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.566 0.698 . . . . 0.0 109.574 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.2 tp -128.83 81.46 70.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.606 -0.684 . . . . 0.0 109.173 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.41 -21.29 29.24 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.643 2.229 . . . . 0.0 111.867 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -56.62 -34.3 67.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.72 45.64 5.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.423 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 31.7 m -124.72 77.63 64.44 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.559 -0.713 . . . . 0.0 109.259 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HG2' ' H ' ' A' ' 59' ' ' ILE . 65.6 Cg_endo -79.83 -67.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.679 2.253 . . . . 0.0 112.223 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.424 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 70.4 mt -119.48 129.49 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.699 ' NH1' ' HE2' ' A' ' 10' ' ' HIS . 13.6 ptm180 -153.95 -33.17 0.11 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 108.99 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.405 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -75.92 156.43 84.36 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.607 -0.683 . . . . 0.0 109.419 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.82 -6.86 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.878 2.385 . . . . 0.0 112.227 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 61' ' ' ILE . . . 98.52 11.92 46.22 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -56.17 -35.26 67.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.133 . . . . 0.0 109.467 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.8 p -68.07 151.26 47.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.466 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.404 ' HB2' ' H ' ' A' ' 56' ' ' ASN . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -136.57 158.21 44.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.401 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 2.8 t0 -104.98 150.51 24.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.344 -0.847 . . . . 0.0 109.568 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.532 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -99.35 -76.67 0.54 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -108.02 3.49 24.09 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.196 -0.94 . . . . 0.0 109.845 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.454 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 59.2 mt -111.3 138.38 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 110.161 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.93 12.68 22.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.455 -0.778 . . . . 0.0 109.421 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.87 155.3 77.73 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.482 -0.761 . . . . 0.0 109.231 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.31 -36.06 47.63 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.551 2.167 . . . . 0.0 112.56 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -138.07 -3.08 1.81 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.536 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.443 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 52.7 m-80 -114.25 167.95 10.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.485 -0.759 . . . . 0.0 109.357 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 62.3 m -118.61 177.06 4.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.412 -0.805 . . . . 0.0 109.828 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.08 135.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 109.086 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 28.2 p90 -66.89 -45.73 77.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.698 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.579 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 82.7 tt0 -175.95 97.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.057 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 144.46 56.54 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 108.589 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.698 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 2.5 p90 -120.67 -153.75 0.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.458 -0.776 . . . . 0.0 109.208 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.698 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.6 m-20 -57.53 141.8 46.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.978 -1.076 . . . . 0.0 109.473 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.89 9.23 3.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.354 -0.841 . . . . 0.0 109.864 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -49.88 -43.44 49.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.982 -1.074 . . . . 0.0 108.597 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.472 ' O ' ' OG ' ' A' ' 22' ' ' SER . 33.6 p -90.15 4.99 48.81 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.432 -0.792 . . . . 0.0 109.075 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 21' ' ' SER . 83.3 p 51.82 33.43 11.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 109.351 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -59.25 -47.1 86.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -65.76 -57.5 7.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.422 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.652 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.3 m120 -60.86 -35.74 77.37 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.472 -0.768 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -58.27 -44.0 95.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.44 -44.36 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -1.118 . . . . 0.0 109.2 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 t -70.04 -31.13 68.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.486 -0.758 . . . . 0.0 109.326 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 48.5 m -61.57 -31.47 71.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 110.673 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.76 -27.14 4.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.984 -1.073 . . . . 0.0 109.885 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -54.82 -30.76 58.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.1 -1.0 . . . . 0.0 109.107 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.96 3.29 45.61 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 176.77 -25.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -1.192 . . . . 0.0 109.629 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -55.25 134.25 49.73 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -112.58 140.79 47.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.397 -0.814 . . . . 0.0 108.984 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.69 164.68 27.38 Favored Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.995 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' TRP . 32.7 m-85 -132.12 160.5 35.83 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.506 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 43.5 t -99.24 120.86 40.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.998 -1.064 . . . . 0.0 109.294 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.503 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 26.1 mt-30 -115.72 174.57 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 109.32 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.9 pt -99.15 155.42 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.898 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.8 mt -78.25 148.44 33.93 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.432 -0.792 . . . . 0.0 109.578 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.68 -35.93 39.17 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 47.7 p -96.07 -125.16 0.12 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.318 -1.107 . . . . 0.0 108.644 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -109.72 126.57 53.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 108.921 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 141.45 -173.87 23.21 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.599 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 54.6 t-20 -140.77 150.33 43.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -1.102 . . . . 0.0 109.559 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.599 ' N ' ' OD1' ' A' ' 46' ' ' ASN . . . -140.11 167.25 25.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.5 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.6 m -101.97 150.26 23.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.236 -1.155 . . . . 0.0 109.621 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.532 ' CE3' ' O ' ' A' ' 4' ' ' ALA . 16.8 t-105 -120.92 121.22 37.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 109.161 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.8 m -117.74 130.38 56.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.324 -0.86 . . . . 0.0 109.682 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 mt -127.76 145.56 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.417 -0.802 . . . . 0.0 110.545 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 176.19 -22.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 tp -153.02 133.15 7.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 108.916 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -38.08 158.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.205 1.937 . . . . 0.0 112.225 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 61.1 t0 -79.0 116.34 19.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 110.063 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.481 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 82.0 m-20 -147.86 -47.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.74 72.2 81.99 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.76 -100.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.829 2.353 . . . . 0.0 112.527 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.42 ' CD1' ' O ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -127.28 125.99 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.349 -0.844 . . . . 0.0 109.417 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -61.58 -34.18 75.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.303 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.416 HG23 ' H ' ' A' ' 63' ' ' GLY . 4.0 mt -62.63 136.73 96.26 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.425 -0.797 . . . . 0.0 108.967 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.78 -1.71 2.91 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.004 1.803 . . . . 0.0 112.483 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.416 ' H ' HG23 ' A' ' 61' ' ' ILE . . . 95.62 11.4 55.47 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.603 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 11.9 pttp -58.62 -32.47 69.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -1.12 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 61.3 m 56.43 -0.61 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.277 -0.889 . . . . 0.0 109.913 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.603 ' ND1' ' O ' ' A' ' 64' ' ' LYS . 72.4 m80 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.417 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.306 0.574 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.0 ptt-85 -137.6 167.45 21.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.378 -0.826 . . . . 0.0 109.511 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 83.7 m-20 -94.35 147.13 23.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 108.691 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -109.93 -83.25 0.56 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.371 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -99.23 6.24 46.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.008 -1.057 . . . . 0.0 109.629 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 pt -117.16 159.17 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.0 110.443 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.414 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . . . -123.39 -20.29 5.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.21 161.27 50.71 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.62 -66.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.43 2.087 . . . . 0.0 112.91 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.534 ' C ' ' ND2' ' A' ' 11' ' ' ASN . 67.6 m-70 -56.81 -39.44 74.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 110.436 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.662 HD21 ' N ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -134.51 173.72 11.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 0.0 110.096 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.2 m -108.24 171.24 7.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.185 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.412 HG13 HD21 ' A' ' 46' ' ' ASN . 1.5 p -49.09 135.24 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.037 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.664 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 19.5 p90 -69.64 -50.43 44.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.051 -1.031 . . . . 0.0 109.345 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.664 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 48.8 tp10 -177.38 91.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.2 t -54.12 97.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 108.926 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 19.3 p90 -76.67 -46.17 26.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 109.689 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 52.9 t0 -145.4 101.01 3.54 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.312 -0.868 . . . . 0.0 109.096 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 22' ' ' SER . . . -60.63 -24.43 65.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.214 -0.929 . . . . 0.0 109.049 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -52.16 -42.22 63.24 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.434 ' C ' ' OG ' ' A' ' 22' ' ' SER . 84.0 p -66.04 -16.17 63.68 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER 72.48 39.25 0.74 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.618 -0.676 . . . . 0.0 110.029 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -60.63 -60.51 3.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.978 -1.076 . . . . 0.0 109.06 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.414 ' SG ' ' CB ' ' A' ' 7' ' ' ALA . 8.1 t -70.58 -48.65 54.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.352 -0.843 . . . . 0.0 108.75 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.9 m120 -57.82 -38.93 76.46 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.8 -39.59 97.67 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.2 -41.52 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.354 -1.086 . . . . 0.0 109.531 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.3 m -61.04 -41.2 96.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.523 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 m -58.22 -51.26 70.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.14 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -67.79 -39.45 84.03 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.54 -0.725 . . . . 0.0 109.125 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.56 ' CG ' HD22 ' A' ' 56' ' ' ASN . 42.0 t-20 -59.29 -31.13 68.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.553 -0.717 . . . . 0.0 109.275 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.27 -0.06 50.63 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.61 149.5 48.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -1.059 . . . . 0.0 109.221 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -58.0 -49.15 77.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 110.245 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.572 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 49.5 m -143.57 162.81 34.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.037 . . . . 0.0 110.198 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -142.72 126.83 2.98 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.543 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 87.2 m-85 -126.11 135.54 51.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.448 -1.03 . . . . 0.0 109.547 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.433 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -110.6 129.94 55.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 0.0 109.888 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.69 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -134.1 168.34 19.0 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.0 pt -98.81 133.43 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.974 . . . . 0.0 109.588 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.2 tp -64.24 -30.59 71.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 109.36 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.95 -4.5 49.43 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 45' ' ' GLY . 18.3 p -126.57 173.72 9.22 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 43' ' ' THR . 26.8 p90 -44.07 -21.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.441 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -87.23 -174.25 48.74 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.412 HD21 HG13 ' A' ' 13' ' ' VAL . 13.0 t30 -137.98 169.83 17.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -1.008 . . . . 0.0 108.911 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' GLN . . . -140.55 125.93 3.01 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.447 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 42.7 t -136.28 128.91 30.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -1.092 . . . . 0.0 108.674 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.69 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 4.1 p90 -113.95 141.29 47.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 109.857 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 35' ' ' SER . 6.0 t -124.72 153.62 42.09 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.1 mm -109.22 126.83 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 109.074 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -173.09 -130.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.978 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.619 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -127.4 166.4 23.27 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.364 -0.835 . . . . 0.0 109.9 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.84 -34.31 24.4 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.466 2.111 . . . . 0.0 112.244 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -56.41 -33.49 65.86 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.56 HD22 ' CG ' ' A' ' 31' ' ' ASN . 46.2 t-20 -96.75 120.13 36.52 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.554 -0.716 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.2 t 57.4 65.87 3.32 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.717 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.69 15.03 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.146 2.564 . . . . 0.0 112.425 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 62.9 mt 55.25 52.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.391 -0.818 . . . . 0.0 109.333 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.408 ' CB ' ' NH1' ' A' ' 60' ' ' ARG . 6.1 ptm85 -61.61 -39.22 90.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.507 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -74.75 154.12 87.2 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.462 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.73 -11.12 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.663 2.242 . . . . 0.0 111.929 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.95 3.82 57.93 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 66' ' ' HIS . 34.2 ttpt -57.8 -36.95 72.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -1.102 . . . . 0.0 109.42 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 84.9 m 54.8 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.819 . . . . 0.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.586 ' N ' ' O ' ' A' ' 64' ' ' LYS . 83.3 t60 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.516 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -127.06 136.77 52.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.811 . . . . 0.0 109.809 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -95.92 144.16 26.48 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.242 -0.911 . . . . 0.0 109.038 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -108.25 -83.55 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 110.212 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -99.54 12.92 35.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.676 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 pt -126.67 165.98 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 110.011 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.79 -0.81 10.07 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.11 168.72 8.88 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -80.25 -59.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.537 2.158 . . . . 0.0 112.447 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -104.94 -3.74 22.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.964 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -116.88 175.46 5.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.394 -0.816 . . . . 0.0 109.804 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.2 p -128.66 -179.64 5.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.408 -0.807 . . . . 0.0 109.86 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.88 136.52 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.546 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.7 p90 -65.48 -40.54 93.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 83.8 tt0 -175.32 98.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB3' HD21 ' A' ' 46' ' ' ASN . 10.7 t -68.99 141.7 54.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.035 -1.04 . . . . 0.0 108.524 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.71 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 2.0 p90 -119.3 -154.3 0.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.366 -0.833 . . . . 0.0 109.599 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.71 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 88.4 m-20 -59.68 143.42 50.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.004 . . . . 0.0 109.532 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.62 9.63 7.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.882 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -51.7 -42.92 62.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.04 -1.037 . . . . 0.0 108.535 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.501 ' O ' ' OG ' ' A' ' 22' ' ' SER . 60.1 p -86.49 6.04 32.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.36 -0.837 . . . . 0.0 108.815 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 26' ' ' GLY . 10.5 p 50.19 36.02 11.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.684 . . . . 0.0 109.796 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -61.55 -51.73 67.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.099 -1.001 . . . . 0.0 109.439 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.458 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 29.3 t -68.37 -56.24 9.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 108.871 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.66 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.2 m120 -58.43 -34.88 71.29 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -57.2 -42.88 93.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.93 -47.58 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.241 -1.152 . . . . 0.0 108.628 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 95.2 m -70.37 -24.73 63.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 109.3 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 62.5 m -61.89 -31.12 71.38 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.418 -0.801 . . . . 0.0 110.95 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.47 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 1.8 mptt -52.52 -33.56 45.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.0 110.066 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -56.68 -34.01 66.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 109.404 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.44 4.71 56.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.92 -26.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -1.094 . . . . 0.0 109.29 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.66 ' NZ ' ' SG ' ' A' ' 50' ' ' CYS . 24.6 tttt -51.29 135.22 26.91 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -117.66 139.98 50.28 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.507 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.13 156.46 26.49 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.858 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' TRP . 41.9 m-85 -130.6 153.41 48.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.621 -0.929 . . . . 0.0 108.787 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -99.41 125.66 45.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.972 -1.08 . . . . 0.0 109.64 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.588 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 96.3 mt-30 -111.11 -162.05 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.599 -0.688 . . . . 0.0 109.315 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.0 pt -114.65 157.45 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -0.753 . . . . 0.0 109.807 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.8 mt -86.62 146.39 26.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.306 -0.871 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.77 -33.16 34.48 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.5 p -97.57 -124.12 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.431 -1.04 . . . . 0.0 108.94 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -111.73 132.18 54.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 109.117 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 133.31 -163.96 24.29 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 39' ' ' GLN . 2.3 t30 -140.29 165.72 26.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.222 -1.164 . . . . 0.0 109.386 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.57 162.08 26.17 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 1.0 OUTLIER -107.59 135.69 48.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.401 -1.058 . . . . 0.0 109.512 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CE3' ' OE1' ' A' ' 39' ' ' GLN . 11.4 t-105 -112.18 121.95 46.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.382 -0.824 . . . . 0.0 109.14 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.66 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 1.8 t -125.8 129.92 50.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.222 -0.923 . . . . 0.0 109.523 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mt -121.09 138.64 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.53 -0.731 . . . . 0.0 110.62 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.96 -52.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.526 -0.734 . . . . 0.0 109.534 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.6 tp -127.48 78.76 74.32 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.549 -0.719 . . . . 0.0 109.931 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' ASP . 32.3 Cg_exo -54.03 171.03 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.937 2.425 . . . . 0.0 112.321 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' PRO . 49.4 t0 59.88 146.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 64.08 48.34 3.04 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.312 -0.868 . . . . 0.0 109.142 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.63 103.23 48.34 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -91.31 130.66 1.34 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.626 2.217 . . . . 0.0 110.892 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.613 ' C ' ' H ' ' A' ' 61' ' ' ILE . 3.3 mt -64.38 -32.55 58.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.114 -0.991 . . . . 0.0 110.506 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 55.24 1.53 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.306 -0.871 . . . . 0.0 109.14 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.613 ' H ' ' C ' ' A' ' 59' ' ' ILE . 5.1 mt -130.61 81.05 68.75 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.494 -0.754 . . . . 0.0 109.672 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.11 54.04 4.58 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.916 2.411 . . . . 0.0 111.944 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.77 0.09 75.82 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.81 -40.59 84.56 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.705 -0.879 . . . . 0.0 109.785 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.9 t -59.85 -32.72 70.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.476 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -127.7 138.56 52.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.177 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 79.3 m-20 -99.32 148.59 24.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.012 -1.055 . . . . 0.0 109.396 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.81 -82.88 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 110.473 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -99.03 5.84 46.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.631 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 48' ' ' CYS . 33.5 pt -117.34 161.46 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 110.34 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.03 -5.79 11.96 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.57 156.0 39.52 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.51 -51.5 0.53 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.47 2.114 . . . . 0.0 112.598 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -114.88 1.76 14.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.145 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -125.72 170.4 11.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 109.925 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.8 m -110.23 178.1 4.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.442 -0.787 . . . . 0.0 109.319 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.11 126.85 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.612 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -74.75 -32.51 62.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.096 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -172.15 98.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.452 -0.78 . . . . 0.0 108.99 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.3 t -73.46 108.35 6.27 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.014 -1.054 . . . . 0.0 109.004 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.6 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -48.32 148.06 2.06 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.6 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 59.6 t0 -73.43 116.79 14.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.96 . . . . 0.0 110.516 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.52 147.97 40.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.809 . . . . 0.0 109.138 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -58.57 -44.67 89.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.012 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 t 172.93 73.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.42 -0.8 . . . . 0.0 109.244 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 p -152.94 -50.47 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.113 -0.992 . . . . 0.0 110.087 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -58.16 -51.84 68.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.976 -1.078 . . . . 0.0 109.848 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -66.29 -44.35 83.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.148 -0.97 . . . . 0.0 108.757 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.692 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.1 m120 -58.44 -37.38 75.3 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.48 -42.03 98.89 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.67 -43.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -1.116 . . . . 0.0 109.148 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.0 m -63.93 -30.03 71.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.396 -0.815 . . . . 0.0 109.394 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.4 m -57.82 -42.61 84.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -61.91 -45.39 93.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -0.954 . . . . 0.0 108.894 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.28 -29.31 69.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.445 -0.785 . . . . 0.0 109.323 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.22 7.6 55.93 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.487 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -69.85 175.41 4.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -1.014 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -78.62 -77.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.026 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.7 p -143.76 166.7 24.15 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -142.58 154.56 25.26 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.568 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 57.9 m-85 -122.27 133.95 54.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.357 -1.084 . . . . 0.0 109.552 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.649 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 1.1 m -99.81 121.54 41.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.367 -0.833 . . . . 0.0 109.191 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -141.07 -136.54 0.11 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.091 -1.006 . . . . 0.0 109.623 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.1 mt -95.81 139.66 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.2 tp -55.99 -37.13 68.68 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.46 -69.0 0.27 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.4 p -105.66 -63.44 1.25 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -126.84 148.72 49.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.79 -178.86 39.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -122.72 150.94 42.08 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.483 -1.01 . . . . 0.0 109.667 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.92 162.59 26.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.649 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 4.2 t -140.2 135.94 32.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -1.087 . . . . 0.0 109.754 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.18 133.9 51.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.219 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.487 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 12.2 t -99.92 125.51 45.93 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.9 mm -99.46 131.46 46.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 109.48 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.56 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.045 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.84 94.71 48.98 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.383 -0.823 . . . . 0.0 110.305 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.12 -8.95 17.81 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.183 1.922 . . . . 0.0 112.101 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -56.34 -35.81 68.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.324 -0.86 . . . . 0.0 109.935 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 57' ' ' VAL . 3.4 m120 -78.96 142.35 36.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.93 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.516 ' CG1' ' O ' ' A' ' 57' ' ' VAL . 12.2 p -39.72 102.38 0.26 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.629 -0.669 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 59' ' ' ILE . 50.1 Cg_endo -90.61 159.35 4.31 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.714 2.276 . . . . 0.0 111.888 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.514 ' CG2' ' O ' ' A' ' 59' ' ' ILE . 86.0 mt 39.75 60.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.372 -0.83 . . . . 0.0 110.209 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -51.51 -34.55 36.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.451 ' CG2' ' H ' ' A' ' 63' ' ' GLY . 1.4 mp -61.04 130.64 91.47 Favored Pre-proline 0 C--N 1.301 -1.53 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.677 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.29 -25.33 6.97 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.862 1.708 . . . . 0.0 111.949 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.451 ' H ' ' CG2' ' A' ' 61' ' ' ILE . . . 138.41 3.66 1.82 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -106.28 129.62 54.28 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.319 -1.107 . . . . 0.0 109.025 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.516 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 86.3 m -58.6 -28.34 65.51 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.569 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.516 ' CG ' ' O ' ' A' ' 65' ' ' CYS . 98.0 m-70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.482 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -138.24 169.23 18.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -94.14 142.57 27.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 108.42 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -106.07 -84.45 0.51 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 111.101 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -98.89 -19.21 17.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.055 . . . . 0.0 110.402 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.5 mt -106.24 132.87 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.323 -0.861 . . . . 0.0 110.15 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.59 17.74 12.81 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.404 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -124.09 155.32 67.84 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.16 -35.91 61.21 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.483 2.122 . . . . 0.0 112.27 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.542 ' CE1' HH11 ' A' ' 60' ' ' ARG . 74.4 m80 -141.8 -3.97 1.1 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.139 -0.976 . . . . 0.0 109.453 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -109.5 172.33 6.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 109.428 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.4 m -122.2 177.26 5.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.629 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -101.05 138.05 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.032 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.29 -61.26 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.456 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -173.89 98.72 0.11 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.414 -0.804 . . . . 0.0 109.121 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 29.7 p -50.62 103.24 0.05 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.253 -0.905 . . . . 0.0 108.906 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.506 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 23.7 p90 -59.91 -39.77 86.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.445 -0.785 . . . . 0.0 110.033 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.506 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 57.6 t0 -143.55 91.54 2.26 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.243 -0.91 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.64 -25.0 67.9 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.245 -0.91 . . . . 0.0 109.046 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -53.76 -38.45 64.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 108.81 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.484 ' O ' ' OG ' ' A' ' 22' ' ' SER . 74.6 m -77.57 7.71 5.23 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 26' ' ' GLY . 12.7 p 60.76 36.37 19.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.565 -0.709 . . . . 0.0 110.045 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -61.89 -54.99 34.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.957 -1.09 . . . . 0.0 108.863 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.31 -52.31 23.76 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.695 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.1 m120 -58.37 -36.74 73.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -60.29 -42.77 98.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.48 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 58.1 t -61.07 -46.94 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -1.157 . . . . 0.0 109.518 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.5 m -70.23 -33.34 71.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.272 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 38.4 m -57.32 -50.5 72.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -65.71 -37.87 87.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.414 -0.804 . . . . 0.0 109.337 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 27' ' ' VAL . 24.4 m120 -58.96 -25.47 63.57 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.42 44.05 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.17 145.68 55.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.445 -1.033 . . . . 0.0 109.248 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -59.37 -51.96 67.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 0.0 109.792 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.4 p -144.35 166.89 23.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.189 -0.945 . . . . 0.0 110.201 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.582 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.38 135.17 6.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -128.46 136.92 51.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -1.08 . . . . 0.0 109.573 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.9 t -109.0 128.62 55.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.462 -0.774 . . . . 0.0 109.585 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.612 ' NE2' ' CH2' ' A' ' 49' ' ' TRP . 0.3 OUTLIER -134.56 171.55 14.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.446 -0.784 . . . . 0.0 109.116 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.9 pt -98.13 134.62 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.13 -0.981 . . . . 0.0 109.503 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 45' ' ' GLY . 24.2 tp -130.1 125.21 34.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.651 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.23 -27.58 73.08 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.6 m -59.37 -46.55 88.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.029 -1.277 . . . . 0.0 110.039 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -125.64 16.3 8.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.447 -0.783 . . . . 0.0 109.156 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 41' ' ' LEU . . . 83.9 -56.85 5.05 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -140.77 146.05 37.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -1.131 . . . . 0.0 109.642 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.27 132.23 5.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.483 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -111.25 126.62 55.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.388 -1.066 . . . . 0.0 109.28 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.612 ' CH2' ' NE2' ' A' ' 39' ' ' GLN . 4.7 p90 -118.36 138.86 52.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.868 . . . . 0.0 109.125 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.3 m -126.1 156.15 40.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mm -110.11 122.89 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.422 -0.799 . . . . 0.0 109.296 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 1' ' ' ALA . . . -179.57 -145.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 tp -133.1 78.99 63.58 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.552 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -87.64 22.31 0.92 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.35 2.7 . . . . 0.0 112.057 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -52.45 -35.55 52.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.574 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -56.39 -35.35 67.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 57' ' ' VAL . 13.5 p -131.06 77.9 74.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.359 -0.838 . . . . 0.0 109.585 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 59' ' ' ILE . 73.7 Cg_endo -95.27 87.98 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 123.596 2.864 . . . . 0.0 112.287 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' PRO . 45.8 mt 43.31 55.66 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.031 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.542 HH11 ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -59.72 -41.0 89.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.135 -0.978 . . . . 0.0 109.891 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -62.96 149.72 89.68 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -46.0 -23.59 1.86 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.174 1.916 . . . . 0.0 112.05 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.404 ' H ' HG12 ' A' ' 61' ' ' ILE . . . 138.04 2.93 2.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -93.39 145.97 24.09 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.282 -1.128 . . . . 0.0 109.283 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 66' ' ' HIS . 8.6 t -58.01 -47.19 83.79 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 65' ' ' CYS . 61.8 t60 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.65 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -136.7 161.81 34.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -0.88 . . . . 0.0 109.409 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -95.1 143.41 26.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.16 -0.962 . . . . 0.0 109.108 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -99.79 -65.0 0.99 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.164 -0.96 . . . . 0.0 110.445 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 2.6 m-85 -109.15 0.9 20.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 70.3 mt -106.68 142.04 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 110.433 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.07 -22.7 3.13 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -103.99 157.01 34.87 Favored Pre-proline 0 N--CA 1.487 1.419 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 8' ' ' LYS . 43.9 Cg_exo -34.02 -110.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.444 2.763 . . . . 0.0 113.376 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -85.49 -2.78 58.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.768 -1.208 . . . . 0.0 109.308 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -100.28 151.48 21.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.331 -0.855 . . . . 0.0 109.466 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.67 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 57.2 m -108.27 166.18 10.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.526 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.97 133.04 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.165 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 32.3 p90 -60.71 -41.44 95.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.583 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 82.4 tt0 -175.24 93.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.279 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 47' ' ' GLY . 19.5 p -68.58 134.54 50.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.059 -1.026 . . . . 0.0 108.576 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.692 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 2.6 p90 -109.67 -152.55 0.5 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.299 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.692 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.2 m-20 -57.6 139.24 54.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.044 -1.035 . . . . 0.0 109.192 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.36 9.05 3.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.381 -0.825 . . . . 0.0 109.827 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -51.96 -42.91 63.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 108.896 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.6 m -84.69 7.12 21.52 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.339 -0.85 . . . . 0.0 108.907 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 26' ' ' GLY . 70.5 m 54.38 27.12 7.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.406 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -60.18 -52.81 63.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.1 t -66.39 -51.83 53.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 0.0 108.835 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.703 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.0 OUTLIER -58.65 -36.25 73.81 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.537 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . . . -57.07 -43.42 93.28 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.13 -47.11 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -1.205 . . . . 0.0 109.09 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.7 m -70.49 -24.76 62.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.635 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 67.6 m -63.16 -30.39 71.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.232 -0.918 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.537 ' NZ ' ' O ' ' A' ' 26' ' ' GLY . 12.7 mptt -51.94 -33.39 37.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.921 -1.112 . . . . 0.0 110.112 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -56.48 -33.67 66.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.04 -1.038 . . . . 0.0 109.349 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.26 2.63 54.19 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.02 -26.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -1.084 . . . . 0.0 109.132 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.631 ' CE ' ' SG ' ' A' ' 50' ' ' CYS . 15.7 tttp -52.67 137.88 29.98 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -118.23 135.15 54.44 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.143 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.535 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -144.4 162.12 27.93 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.275 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.416 ' HA ' HD22 ' A' ' 25' ' ' ASN . 33.1 p90 -140.65 169.87 16.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -1.078 . . . . 0.0 109.062 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 11.7 t -99.06 124.43 44.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.949 -1.095 . . . . 0.0 110.959 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 40' ' ' ILE . 4.9 tt0 -119.87 -139.88 0.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.401 ' H ' ' HG2' ' A' ' 39' ' ' GLN . 30.3 pt -110.96 142.86 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 109.699 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.0 tp -58.73 -37.28 75.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.198 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.84 -59.33 0.62 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.65 -70.63 0.76 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -1.022 . . . . 0.0 108.806 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -128.4 148.94 50.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.575 -0.703 . . . . 0.0 109.223 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.2 -168.23 35.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 16' ' ' CYS . 24.9 m120 -120.93 165.26 15.48 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.47 -1.018 . . . . 0.0 109.608 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -134.94 151.49 20.45 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -99.53 140.56 33.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -1.17 . . . . 0.0 109.755 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.486 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 8.9 t-105 -113.45 128.19 56.36 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.631 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -126.09 135.8 52.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 109.036 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.457 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 4.5 mt -117.16 136.51 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.36 -0.837 . . . . 0.0 111.101 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 1' ' ' ALA . . . 162.17 168.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 54' ' ' PRO . 3.3 tp -129.24 73.97 81.33 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.674 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 50.3 Cg_exo -49.73 -174.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.643 2.229 . . . . 0.0 111.341 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 56' ' ' ASN . 92.2 m-20 -52.1 -39.06 59.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.972 -1.08 . . . . 0.0 108.801 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER 159.97 -174.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 109.19 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.3 t 57.15 68.59 1.99 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.76 -65.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.683 2.255 . . . . 0.0 112.038 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.5 mt -117.29 125.84 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.523 -0.736 . . . . 0.0 109.103 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.83 1.68 14.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.485 -0.76 . . . . 0.0 109.193 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.491 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -132.11 155.18 81.64 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.416 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.4 -0.43 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.585 2.19 . . . . 0.0 111.685 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 61' ' ' ILE . . . 102.42 -1.42 49.94 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -85.21 130.45 34.6 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -1.129 . . . . 0.0 109.479 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.67 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 2.5 m -115.03 158.98 21.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.431 -0.793 . . . . 0.0 109.471 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.424 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 58.3 t-80 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.757 HH21 ' HE1' ' A' ' 49' ' ' TRP . 76.1 ttt180 -126.52 132.32 51.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -100.17 143.96 29.76 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -106.32 -83.94 0.52 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.462 -0.774 . . . . 0.0 109.266 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -99.78 -29.83 12.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.533 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 11' ' ' ASN . 69.9 mt -102.01 138.12 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.521 -0.737 . . . . 0.0 109.665 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -117.0 20.72 13.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.443 -0.786 . . . . 0.0 110.398 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -126.35 153.13 74.74 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.083 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.409 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 11.3 Cg_endo -57.84 -29.35 85.84 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.533 2.156 . . . . 0.0 112.272 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 9' ' ' PRO . 88.5 m-70 -151.65 -6.8 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.199 -0.938 . . . . 0.0 109.316 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.569 ' OD1' ' NZ ' ' A' ' 64' ' ' LYS . 56.8 m-80 -105.63 171.16 7.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.779 . . . . 0.0 109.413 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.9 m -120.85 177.08 5.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.446 -0.784 . . . . 0.0 109.466 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.54 133.51 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.968 . . . . 0.0 109.402 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -48.68 78.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.376 -0.827 . . . . 0.0 109.317 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' CYS . 11.6 pt-20 177.14 80.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 109.23 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -44.75 156.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.067 -1.021 . . . . 0.0 109.122 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.718 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 3.2 p90 -132.56 -149.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 109.331 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.718 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 59.3 t0 -57.41 132.6 53.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.128 -0.983 . . . . 0.0 109.654 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 22' ' ' SER . . . -74.98 4.48 6.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.0 109.918 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -49.82 -42.75 47.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.066 -1.022 . . . . 0.0 108.859 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.422 ' C ' ' OG ' ' A' ' 22' ' ' SER . 82.6 p -82.35 -5.48 58.63 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 0.0 109.095 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 63.29 34.36 13.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 109.577 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.95 -48.65 80.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.999 -1.063 . . . . 0.0 109.872 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.16 -52.95 28.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 109.031 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.693 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.1 m120 -58.49 -37.64 75.98 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.328 -0.857 . . . . 0.0 108.794 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.53 93.84 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.82 -42.31 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.353 -1.087 . . . . 0.0 108.798 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 65.0 m -61.66 -32.96 73.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.818 . . . . 0.0 109.372 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.3 m -57.4 -45.73 84.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 109.476 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -64.54 -43.47 93.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 108.81 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.77 -28.96 70.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.558 -0.713 . . . . 0.0 109.153 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.46 -0.87 53.35 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.443 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -67.39 148.4 51.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.38 -1.071 . . . . 0.0 109.263 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.419 ' HG3' ' H ' ' A' ' 35' ' ' SER . 2.5 pttt -64.82 -60.34 3.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.063 -1.023 . . . . 0.0 110.284 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.419 ' H ' ' HG3' ' A' ' 34' ' ' LYS . 84.2 p -144.21 160.91 40.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.873 -1.142 . . . . 0.0 110.567 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.71 156.17 26.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 49' ' ' TRP . 17.6 m-85 -123.65 146.21 48.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -1.102 . . . . 0.0 109.472 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 37.8 t -99.89 121.63 41.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.19 -0.944 . . . . 0.0 109.076 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -118.38 165.55 13.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.471 -0.768 . . . . 0.0 109.446 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.8 pt -103.45 144.01 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 110.117 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 41' ' ' LEU . 4.2 mm? -107.08 139.91 40.75 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.67 -0.644 . . . . 0.0 109.508 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.8 -28.62 52.95 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 44' ' ' TYR . 45.8 p -94.82 -72.88 0.6 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -1.167 . . . . 0.0 110.649 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.448 ' N ' ' OG1' ' A' ' 43' ' ' THR . 91.7 m-85 -61.82 -39.28 91.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 110.155 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.91 -34.93 4.84 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.174 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.33 129.64 31.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -1.229 . . . . 0.0 110.293 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 160.14 26.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -111.26 135.23 52.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.378 -1.072 . . . . 0.0 109.831 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.757 ' HE1' HH21 ' A' ' 2' ' ' ARG . 4.7 t-105 -113.33 111.66 22.37 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.443 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 5.5 t -107.76 122.82 47.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.114 -0.991 . . . . 0.0 108.906 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.1 mt -117.81 135.56 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.603 -0.686 . . . . 0.0 110.096 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -174.29 -32.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.41 160.05 54.71 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.531 -0.731 . . . . 0.0 109.155 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -42.03 -78.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.471 2.114 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 51.0 p30 -177.03 39.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.187 -0.945 . . . . 0.0 109.511 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.63 133.85 46.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.827 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 1' ' ' ALA . 2.8 t 47.49 70.12 2.28 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.305 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.44 ' CB ' ' O ' ' A' ' 2' ' ' ARG . 68.2 Cg_endo -82.11 -68.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.832 2.355 . . . . 0.0 112.312 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.89 158.21 43.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.327 -0.858 . . . . 0.0 109.388 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -117.06 122.22 43.55 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.25 81.65 13.53 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.541 -0.724 . . . . 0.0 110.062 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.42 -4.55 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.687 2.258 . . . . 0.0 111.744 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.86 -5.52 58.15 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.569 ' NZ ' ' OD1' ' A' ' 11' ' ' ASN . 29.3 ttpt -60.06 -35.65 75.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -1.183 . . . . 0.0 109.508 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 15.1 m -73.34 154.03 40.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.885 . . . . 0.0 109.514 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.42 ' CE1' ' O ' ' A' ' 64' ' ' LYS . 77.5 m80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.489 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.494 HH21 ' CB ' ' A' ' 54' ' ' PRO . 40.1 ttm180 -127.77 135.33 49.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.434 -0.792 . . . . 0.0 109.65 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.441 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 84.2 m-20 -95.92 145.58 25.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.831 . . . . 0.0 108.898 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -105.1 -83.27 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.883 . . . . 0.0 110.051 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -100.93 13.02 36.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.865 . . . . 0.0 109.536 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.407 ' CG2' ' SG ' ' A' ' 12' ' ' CYS . 27.5 pt -121.68 161.38 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.744 . . . . 0.0 109.987 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.404 ' O ' ' CG1' ' A' ' 27' ' ' VAL . . . -128.43 -2.97 5.52 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -111.04 153.2 43.97 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.517 -0.739 . . . . 0.0 109.111 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -58.55 -26.58 79.22 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.762 2.308 . . . . 0.0 113.14 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.551 ' ND1' HH12 ' A' ' 60' ' ' ARG . 57.4 t60 -145.15 -15.31 0.51 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.962 -1.086 . . . . 0.0 109.728 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -103.54 159.41 15.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.0 109.085 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.407 ' SG ' ' CG2' ' A' ' 6' ' ' ILE . 59.0 m -115.88 172.24 7.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 109.765 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.4 t -99.36 134.42 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.833 . . . . 0.0 109.297 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.426 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.3 p90 -67.85 -36.35 80.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.839 . . . . 0.0 109.45 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.0 tt0 -174.29 95.38 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 108.902 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -63.25 112.88 2.88 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.2 -0.938 . . . . 0.0 109.207 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.7 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 3.2 p90 -76.3 -157.07 0.07 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.191 -0.943 . . . . 0.0 108.911 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.7 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.6 m-20 -61.54 130.51 46.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.025 -1.047 . . . . 0.0 109.255 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.29 26.65 10.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.468 -0.77 . . . . 0.0 109.261 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.22 -45.86 75.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 109.578 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.601 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.0 m -62.46 -50.45 71.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 0.0 109.469 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.601 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.9 m 150.51 33.24 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.43 -71.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.801 -1.187 . . . . 0.0 109.996 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.5 t -61.86 -49.78 74.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 36' ' ' GLY . 2.0 m120 -57.79 -37.53 73.89 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -58.23 -40.86 94.45 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.404 ' CG1' ' O ' ' A' ' 7' ' ' ALA . 64.7 t -61.95 -48.7 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -1.207 . . . . 0.0 109.063 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.5 m -70.8 -22.07 62.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.378 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 64.8 m -63.1 -38.23 90.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.344 -0.848 . . . . 0.0 111.28 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -32.08 51.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.016 . . . . 0.0 109.91 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -55.33 -31.5 61.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 109.333 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.64 3.96 52.52 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 179.4 -26.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -1.154 . . . . 0.0 109.68 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HZ3' ' CB ' ' A' ' 50' ' ' CYS . 32.6 tttt -55.08 130.9 43.64 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.7 p -112.83 140.03 47.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.68 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.588 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.7 166.96 26.81 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.041 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.649 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -140.54 160.46 39.97 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 47.1 t -99.83 121.4 41.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.983 -1.073 . . . . 0.0 109.757 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.556 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 25.1 mt-30 -109.05 167.22 10.26 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.2 pt -93.97 137.47 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.078 -1.013 . . . . 0.0 109.593 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 45' ' ' GLY . 5.8 tt -59.9 -35.04 74.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 108.735 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.434 ' C ' ' OG1' ' A' ' 43' ' ' THR . . . 133.01 -28.36 3.35 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.434 ' OG1' ' C ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 177.55 -40.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -1.021 . . . . 0.0 109.168 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -65.28 -34.72 79.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.787 . . . . 0.0 110.119 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 41' ' ' LEU . . . 175.27 -154.34 17.72 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.349 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 19.6 m120 -121.06 159.9 24.75 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.524 -0.986 . . . . 0.0 109.394 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.1 161.35 25.96 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.489 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -105.89 129.72 53.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -1.044 . . . . 0.0 109.674 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.556 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 0.9 OUTLIER -111.04 116.87 31.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 108.812 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.59 ' CB ' ' HZ3' ' A' ' 34' ' ' LYS . 3.9 t -107.62 119.68 40.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.93 134.8 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.561 -0.712 . . . . 0.0 110.444 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 179.16 -42.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' A' ' 1' ' ' ALA . 46.3 tp -130.03 73.16 81.62 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.497 -0.752 . . . . 0.0 109.677 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.494 ' CB ' HH21 ' A' ' 2' ' ' ARG . 72.0 Cg_endo -84.87 33.02 0.48 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.943 2.428 . . . . 0.0 112.343 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -51.48 -36.26 43.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.095 -1.003 . . . . 0.0 109.126 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -130.07 -24.49 2.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 109.632 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 57' ' ' VAL . 94.6 t 50.4 64.09 8.9 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 109.636 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -94.71 156.65 1.88 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.376 2.717 . . . . 0.0 111.561 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.66 122.26 63.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.422 -0.799 . . . . 0.0 109.137 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.551 HH12 ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -97.97 90.97 5.1 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.24 -0.913 . . . . 0.0 109.579 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -128.88 77.53 77.62 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.492 -0.755 . . . . 0.0 109.709 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -79.03 16.77 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.769 2.313 . . . . 0.0 111.717 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.61 -20.79 43.01 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -60.85 -39.52 89.43 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.403 -1.057 . . . . 0.0 109.47 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 14.1 t -59.15 -34.94 72.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.312 -0.867 . . . . 0.0 109.602 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.446 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.448 ' NH1' ' CZ2' ' A' ' 49' ' ' TRP . 66.0 ttp85 -124.38 130.63 52.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.792 . . . . 0.0 109.514 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -100.06 145.11 28.3 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.093 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -108.56 -85.46 0.53 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.52 -0.738 . . . . 0.0 109.073 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -99.36 -28.28 13.36 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.169 -0.957 . . . . 0.0 109.344 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 90.9 mt -103.56 139.89 23.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.56 -0.713 . . . . 0.0 110.196 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.77 -7.78 18.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.495 -0.753 . . . . 0.0 109.104 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.3 mtmt -126.43 89.54 51.99 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.93 -27.82 6.32 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.278 1.985 . . . . 0.0 112.185 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.556 ' C ' HD21 ' A' ' 11' ' ' ASN . 76.8 m80 -86.01 -19.95 29.58 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.229 -0.92 . . . . 0.0 108.89 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.556 HD21 ' C ' ' A' ' 10' ' ' HIS . 1.7 m-80 -140.62 -150.7 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.801 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 69.0 m -140.65 178.38 7.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.623 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.79 128.15 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.001 . . . . 0.0 109.238 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.484 ' OH ' ' OH ' ' A' ' 23' ' ' TYR . 30.8 p90 -68.27 -34.79 76.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -172.15 93.74 0.14 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.539 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -71.06 125.12 26.03 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.993 -1.067 . . . . 0.0 108.164 179.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 70.5 t80 -91.83 160.09 15.48 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 109.821 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.493 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 89.2 m-20 -42.45 126.81 3.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.69 -11.88 60.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.54 -0.725 . . . . 0.0 109.506 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -52.21 -46.24 65.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.352 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 27.2 m -66.55 -62.23 1.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.178 -0.951 . . . . 0.0 109.25 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.0 m 153.12 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.484 ' OH ' ' OH ' ' A' ' 14' ' ' TYR . 65.9 t80 -58.79 -53.59 56.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.996 . . . . 0.0 110.54 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.7 t -65.68 -40.54 92.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.077 -1.014 . . . . 0.0 109.075 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.626 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.4 m120 -59.41 -38.64 81.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.461 -0.775 . . . . 0.0 109.207 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.427 ' O ' ' CD ' ' A' ' 30' ' ' LYS . . . -62.97 -48.59 79.33 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.19 -43.18 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -1.163 . . . . 0.0 109.065 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.1 t -63.84 -35.05 79.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.51 -0.744 . . . . 0.0 109.71 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 55.3 m -56.13 -42.37 76.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 13.4 mptt -59.87 -38.03 81.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.026 -1.046 . . . . 0.0 109.202 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -58.97 -29.18 66.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.346 -0.846 . . . . 0.0 109.021 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.5 -0.36 55.62 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.63 150.46 47.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.43 -1.041 . . . . 0.0 109.501 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.513 ' H ' ' CB ' ' A' ' 52' ' ' ALA . 7.8 ttmt -57.66 -60.15 4.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.879 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -143.85 161.49 38.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.237 -0.915 . . . . 0.0 109.433 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.27 158.5 27.27 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.582 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 49' ' ' TRP . 30.5 m-85 -136.01 161.2 36.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.504 -0.997 . . . . 0.0 109.16 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 17' ' ' PHE . 0.8 OUTLIER -99.05 123.8 43.6 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.085 -1.009 . . . . 0.0 109.516 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 33.2 tt0 -106.14 154.17 21.06 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.6 pt -93.45 147.1 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.903 -1.123 . . . . 0.0 110.785 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 43' ' ' THR . 78.9 mt -82.4 154.38 25.23 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -44.74 -18.84 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 45' ' ' GLY . 19.3 p -117.74 173.42 6.76 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.76 -0.847 . . . . 0.0 108.783 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -47.7 -8.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 109.888 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -62.32 162.74 27.99 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 51.8 t-20 -140.66 155.77 46.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -1.109 . . . . 0.0 109.842 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 46' ' ' ASN . . . -140.87 174.7 22.55 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -106.32 158.09 17.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -1.099 . . . . 0.0 109.563 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.491 ' N ' ' O ' ' A' ' 37' ' ' TYR . 7.2 t-105 -130.66 140.75 50.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.0 m -135.08 131.49 37.03 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.027 -1.046 . . . . 0.0 110.058 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -125.32 132.87 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.464 -0.772 . . . . 0.0 109.673 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.513 ' CB ' ' H ' ' A' ' 34' ' ' LYS . . . -178.52 -43.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tp -132.84 74.9 73.62 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 109.514 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.27 166.58 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.973 2.449 . . . . 0.0 112.652 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 57.07 45.84 20.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.627 -0.671 . . . . 0.0 110.137 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' A' ' 57' ' ' VAL . 22.0 t-20 -146.11 158.99 43.89 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.152 -0.967 . . . . 0.0 109.355 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 56' ' ' ASN . 2.4 t -37.38 100.24 0.2 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.671 -0.643 . . . . 0.0 109.388 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.427 ' N ' ' O ' ' A' ' 56' ' ' ASN . 98.2 Cg_endo -85.71 -67.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.39 2.06 . . . . 0.0 112.828 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.405 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 72.0 mt -121.48 133.31 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -0.804 . . . . 0.0 109.764 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -130.34 82.76 2.08 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.7 mt -128.3 86.04 58.92 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.513 -0.742 . . . . 0.0 109.755 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.94 -19.37 5.49 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.3 2.0 . . . . 0.0 111.918 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.13 -0.34 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -59.19 -35.44 73.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -1.178 . . . . 0.0 109.683 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.55 130.6 45.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 109.526 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.438 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.73 ' NE ' ' HE1' ' A' ' 49' ' ' TRP . 65.2 ttt180 -128.06 133.74 49.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.773 . . . . 0.0 109.705 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -110.79 151.04 28.26 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -99.5 -69.78 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.239 -0.913 . . . . 0.0 110.728 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -101.16 -4.26 27.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 0.0 110.46 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.9 mt -109.09 139.07 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.885 . . . . 0.0 110.509 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.28 13.44 15.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.406 -0.809 . . . . 0.0 109.226 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.576 ' NZ ' ' CG1' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -125.0 154.77 71.3 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.497 -0.752 . . . . 0.0 109.248 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.34 -36.59 55.11 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.439 2.092 . . . . 0.0 112.352 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -138.55 -3.7 1.67 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -112.11 169.12 9.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -0.816 . . . . 0.0 109.467 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.2 m -116.65 -179.9 3.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.413 -0.804 . . . . 0.0 109.56 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.8 t -99.42 134.39 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.194 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.732 ' HH ' ' HH ' ' A' ' 23' ' ' TYR . 31.2 p90 -69.4 -43.02 74.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.855 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 81.4 tt0 -175.51 99.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.003 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -69.32 103.02 1.86 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.069 -1.019 . . . . 0.0 109.023 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 0.7 OUTLIER -45.62 150.79 0.47 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 108.725 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 60.5 t0 -72.17 115.02 10.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.17 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.48 150.17 35.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.234 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' ' CB ' ' A' ' 21' ' ' SER . 97.4 m-85 -59.36 -40.37 86.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.958 . . . . 0.0 109.241 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER 170.06 78.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.404 -0.81 . . . . 0.0 109.278 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.45 -66.66 0.14 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.033 -1.042 . . . . 0.0 110.024 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.732 ' HH ' ' HH ' ' A' ' 14' ' ' TYR . 66.5 t80 -58.46 -50.73 72.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.952 . . . . 0.0 109.961 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.9 t -68.94 -44.33 73.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.344 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.663 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.2 m120 -59.55 -38.85 82.17 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.389 -0.819 . . . . 0.0 109.286 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.85 98.28 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.576 ' CG1' ' NZ ' ' A' ' 8' ' ' LYS . 83.2 t -66.1 -42.04 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.427 -1.043 . . . . 0.0 109.232 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.2 t -61.87 -34.62 76.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.451 -0.781 . . . . 0.0 109.549 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.0 m -55.54 -42.46 74.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.728 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -60.19 -37.06 79.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.129 -0.982 . . . . 0.0 109.01 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -57.81 -29.82 65.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.465 -0.772 . . . . 0.0 109.03 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.88 -2.36 48.38 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.04 146.67 53.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 109.303 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -57.53 -53.35 59.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.531 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.9 p -144.4 160.49 40.98 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.354 -0.842 . . . . 0.0 109.288 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.84 149.41 21.41 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.351 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 49' ' ' TRP . 85.6 m-85 -125.18 151.36 45.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.576 -0.955 . . . . 0.0 108.804 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.567 ' SG ' ' OD1' ' A' ' 46' ' ' ASN . 48.9 t -100.23 122.82 43.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.042 -1.037 . . . . 0.0 110.219 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.594 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 94.9 mt-30 -120.01 -167.16 1.39 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.1 pt -115.54 156.03 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.443 -0.786 . . . . 0.0 109.793 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.25 -23.53 64.16 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.418 -0.802 . . . . 0.0 109.207 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.24 0.14 50.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 p -154.55 -81.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.8 142.09 51.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.498 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.68 -177.05 41.78 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 39' ' ' GLN . 16.8 t-20 -140.57 160.6 39.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.455 -1.027 . . . . 0.0 108.886 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.24 163.49 26.36 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.548 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.1 m -105.99 153.62 21.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.531 -0.982 . . . . 0.0 109.142 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.73 ' HE1' ' NE ' ' A' ' 2' ' ' ARG . 11.5 t-105 -116.81 137.57 52.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.343 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.7 m -132.63 134.23 44.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.241 -0.912 . . . . 0.0 109.855 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mt -123.6 135.31 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.598 -0.689 . . . . 0.0 110.025 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.33 -59.21 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.388 -0.82 . . . . 0.0 109.326 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.48 79.71 72.94 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -50.13 -179.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.957 2.438 . . . . 0.0 112.665 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 56.64 42.85 26.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.62 -0.675 . . . . 0.0 109.482 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.34 117.42 6.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.257 -0.902 . . . . 0.0 109.34 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 57' ' ' VAL . 13.6 p -124.33 74.43 60.31 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.673 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 59' ' ' ILE . 69.2 Cg_endo -79.76 -61.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.843 2.362 . . . . 0.0 112.118 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 83.3 mt 40.25 61.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.472 -0.768 . . . . 0.0 109.977 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -51.48 -34.57 36.23 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 1.3 mp -64.43 129.53 94.21 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.51 29.06 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.069 1.846 . . . . 0.0 112.186 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.401 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 97.19 3.32 58.9 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -126.76 136.04 51.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.484 -1.01 . . . . 0.0 109.164 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 75.5 m -60.18 -27.33 67.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.938 . . . . 0.0 109.549 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.516 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.71 ' H1 ' ' N ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -125.96 132.87 51.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.422 -0.799 . . . . 0.0 109.317 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -96.99 136.97 36.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.143 -0.973 . . . . 0.0 109.302 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.541 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -103.32 -59.29 1.74 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.388 -0.82 . . . . 0.0 110.333 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -112.5 9.63 19.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.365 -0.835 . . . . 0.0 110.57 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.4 pt -124.99 163.94 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -0.964 . . . . 0.0 110.252 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.24 -13.28 3.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.469 -0.77 . . . . 0.0 109.038 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.39 152.89 38.39 Favored Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.338 -0.851 . . . . 0.0 109.157 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.35 -34.23 67.38 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.543 2.162 . . . . 0.0 112.875 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.707 ' HD1' ' NH2' ' A' ' 60' ' ' ARG . 91.7 m-70 -133.21 3.15 3.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 110.06 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -131.37 168.9 16.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.814 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 40.6 m -114.8 179.65 3.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.504 -0.748 . . . . 0.0 109.505 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.6 t -95.96 135.06 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.23 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.563 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 32.2 p90 -65.18 -44.43 88.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.563 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 83.3 tt0 -175.56 96.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.059 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.411 ' HB3' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -66.23 135.46 54.51 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 108.6 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.714 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 2.1 p90 -108.75 -149.47 0.44 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.485 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.714 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 59.0 t0 -56.56 131.88 49.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.048 -1.033 . . . . 0.0 109.39 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.3 4.48 2.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.793 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -51.5 -43.21 62.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.065 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.9 m -85.06 6.45 25.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.031 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 26' ' ' GLY . 38.1 m 48.39 37.94 9.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.856 . . . . 0.0 109.397 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -59.31 -49.8 76.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.975 . . . . 0.0 109.959 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 33.8 t -69.02 -57.23 5.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.19 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.669 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.2 m120 -57.85 -35.65 71.24 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.07 -40.46 95.62 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.95 -46.72 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.266 -1.138 . . . . 0.0 108.852 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.9 m -70.3 -25.55 63.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.404 -0.81 . . . . 0.0 109.511 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 m -62.79 -29.78 70.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.277 -0.889 . . . . 0.0 111.225 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.489 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 3.9 mptp? -52.86 -34.14 53.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.95 -1.094 . . . . 0.0 110.477 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.64 -33.29 66.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.977 -1.077 . . . . 0.0 109.368 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.45 2.93 55.53 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -171.09 -28.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -1.078 . . . . 0.0 108.903 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.658 ' NZ ' ' SG ' ' A' ' 50' ' ' CYS . 24.4 tttt -53.34 134.37 39.84 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.7 m -116.79 139.24 50.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.4 -0.812 . . . . 0.0 109.618 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.19 156.24 26.4 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 49' ' ' TRP . 49.6 m-85 -127.08 154.18 45.03 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.5 t -99.52 122.51 42.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.004 -1.06 . . . . 0.0 109.275 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -123.99 -172.88 2.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.556 -0.715 . . . . 0.0 109.511 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.62 145.58 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.882 . . . . 0.0 109.403 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 29.7 tp -53.22 -39.19 63.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.15 -56.43 0.74 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.8 m -97.99 -67.88 0.83 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.518 -0.989 . . . . 0.0 108.67 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.64 159.58 41.85 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.87 -164.77 46.87 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.411 HD21 ' HB3' ' A' ' 16' ' ' CYS . 15.8 t30 -140.77 161.69 37.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.3 -1.118 . . . . 0.0 109.389 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.29 159.11 26.14 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.709 -1.234 . . . . 0.0 110.16 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -103.68 157.45 17.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.352 -1.087 . . . . 0.0 109.168 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 4' ' ' ALA . 7.5 t-105 -125.68 122.12 35.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.528 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.658 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -123.2 135.87 54.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.0 109.118 179.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.1 mt -117.95 134.51 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.699 0.761 . . . . 0.0 111.043 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 1' ' ' ALA . . . 169.07 147.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.71 73.7 81.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.673 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -84.37 -93.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.992 2.461 . . . . 0.0 112.367 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -94.37 11.41 30.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 0.0 109.449 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.26 45.01 7.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.407 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.71 ' N ' ' H1 ' ' A' ' 1' ' ' ALA . 10.2 t -68.95 119.58 70.67 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.343 -0.848 . . . . 0.0 109.285 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.88 165.07 7.41 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.277 1.984 . . . . 0.0 111.032 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.3 mm -109.02 130.83 61.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.176 -0.953 . . . . 0.0 109.663 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.707 ' NH2' ' HD1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -119.28 86.72 2.6 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.455 HD12 HG21 ' A' ' 61' ' ' ILE . 1.9 pt -124.43 81.53 59.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.811 . . . . 0.0 109.745 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -53.31 -18.92 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.666 2.244 . . . . 0.0 112.048 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.402 ' HA2' ' HD1' ' A' ' 66' ' ' HIS . . . 162.66 -12.5 0.11 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -58.75 -33.13 69.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -1.171 . . . . 0.0 109.62 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.0 t -56.62 -33.39 66.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.441 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.402 ' HD1' ' HA2' ' A' ' 63' ' ' GLY . 78.8 m80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.457 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -128.46 138.1 52.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.379 -0.826 . . . . 0.0 109.858 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 90.3 m-20 -108.05 150.38 27.23 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.77 -85.46 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -98.67 5.95 47.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.954 -1.091 . . . . 0.0 109.572 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 48' ' ' CYS . 21.5 pt -111.42 149.06 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.544 -0.722 . . . . 0.0 109.744 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.437 ' O ' ' CG1' ' A' ' 27' ' ' VAL . . . -102.57 -1.92 29.46 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.242 -0.911 . . . . 0.0 108.977 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.454 ' HZ3' ' C ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -131.47 173.27 6.07 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.535 -0.728 . . . . 0.0 109.289 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -48.63 -76.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.644 2.23 . . . . 0.0 113.367 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.703 ' ND1' HH11 ' A' ' 60' ' ' ARG . 78.2 m-70 -107.52 -8.87 16.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.162 -0.961 . . . . 0.0 110.159 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -102.31 155.55 18.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.396 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.454 ' C ' ' HZ3' ' A' ' 8' ' ' LYS . 13.9 p -120.98 177.04 5.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.124 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.8 t -104.97 136.24 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 0.0 110.004 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -82.68 -32.28 28.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.0 109.049 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -174.3 98.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.777 . . . . 0.0 109.077 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.411 ' H ' ' ND2' ' A' ' 46' ' ' ASN . 3.7 p -66.18 104.78 1.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.118 -0.989 . . . . 0.0 108.52 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 6.0 p90 -53.58 -42.76 67.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 110.34 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.561 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 54.7 t0 -148.1 78.45 1.44 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.966 -1.084 . . . . 0.0 109.836 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.7 -30.87 71.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.199 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.88 -40.86 73.56 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.433 -0.792 . . . . 0.0 109.256 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.592 ' O ' ' CB ' ' A' ' 22' ' ' SER . 17.5 t -57.57 -52.11 66.73 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.5 m 155.47 10.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.72 -0.613 . . . . 0.0 110.091 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -60.04 -63.22 1.38 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.81 -1.181 . . . . 0.0 110.142 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.28 -51.86 57.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.114 -0.991 . . . . 0.0 108.958 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.57 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.7 m120 -60.02 -35.7 75.65 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -57.81 -43.51 94.63 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 7' ' ' ALA . 91.6 t -62.94 -43.42 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -1.173 . . . . 0.0 108.689 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 60.0 m -64.12 -31.67 72.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.848 . . . . 0.0 109.168 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.4 m -58.83 -48.65 80.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.655 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -64.27 -41.9 96.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.398 -0.814 . . . . 0.0 109.192 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -62.28 -30.82 71.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.535 -0.728 . . . . 0.0 109.048 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.99 2.7 56.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.493 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -66.92 152.9 44.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.335 -1.097 . . . . 0.0 109.631 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.577 ' H ' ' CB ' ' A' ' 52' ' ' ALA . 9.5 ttmt -58.46 -71.3 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 110.111 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.0 p -144.77 169.33 18.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.315 -0.866 . . . . 0.0 110.22 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.515 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -142.12 151.06 22.6 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.13 135.82 54.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.27 -1.135 . . . . 0.0 109.895 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.63 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.5 t -111.48 115.23 28.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.239 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -131.66 166.13 22.15 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.5 pt -104.87 145.86 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.977 . . . . 0.0 111.267 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.08 142.32 41.7 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.21 -30.04 53.92 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.2 m -92.09 -74.07 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.083 -1.245 . . . . 0.0 110.772 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -61.52 -40.62 95.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.191 -0.943 . . . . 0.0 110.482 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.47 -31.31 7.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' ND2' ' H ' ' A' ' 16' ' ' CYS . 20.3 t-20 -140.47 125.08 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.261 . . . . 0.0 110.008 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.31 112.52 0.81 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.63 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -110.6 117.57 33.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -1.087 . . . . 0.0 109.53 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.37 131.44 54.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.493 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 7.1 t -105.45 122.65 46.43 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -112.53 132.67 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.831 . . . . 0.0 110.429 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.577 ' CB ' ' H ' ' A' ' 34' ' ' LYS . . . -175.39 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.665 -0.647 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.93 84.51 62.87 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.57 -0.706 . . . . 0.0 109.732 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.55 -13.07 22.57 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.285 1.99 . . . . 0.0 112.616 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -57.65 -37.46 73.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.051 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.507 ' O ' ' C ' ' A' ' 57' ' ' VAL . 89.2 m-20 -67.05 -40.78 87.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.053 -1.029 . . . . 0.0 110.497 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.507 ' C ' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER 32.93 67.63 1.03 Allowed Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.795 -0.566 . . . . 0.0 109.962 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.471 ' O ' ' C ' ' A' ' 59' ' ' ILE . 68.7 Cg_endo -78.75 -65.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.8 2.333 . . . . 0.0 112.708 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.471 ' C ' ' O ' ' A' ' 58' ' ' PRO . 95.8 mt 39.93 58.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.353 -0.842 . . . . 0.0 109.259 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.703 HH11 ' ND1' ' A' ' 10' ' ' HIS . 12.6 ptm180 -55.03 -37.45 66.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.972 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.97 154.33 38.98 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.184 -0.948 . . . . 0.0 109.545 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.68 -20.33 70.67 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.555 2.17 . . . . 0.0 112.107 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.98 15.95 0.1 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -92.65 155.92 17.42 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.267 -1.137 . . . . 0.0 109.239 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.09 -36.43 65.64 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 83.1 t60 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.423 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -128.11 135.3 49.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.435 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -96.86 147.18 24.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.941 . . . . 0.0 109.376 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -113.45 -94.25 0.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 109.35 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -98.83 7.54 45.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.012 -1.055 . . . . 0.0 108.952 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.5 pt -117.34 155.79 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.701 -0.624 . . . . 0.0 109.87 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.12 5.13 18.39 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.14 165.25 21.38 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.48 -59.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.408 2.072 . . . . 0.0 112.147 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -105.79 -6.4 19.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.798 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -114.31 164.28 14.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.422 -0.799 . . . . 0.0 109.799 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.6 m -112.43 176.89 4.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.614 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.9 t -102.08 130.99 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.236 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.436 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.2 p90 -74.13 -36.32 64.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.294 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.1 tt0 -174.76 99.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -65.5 109.34 2.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.59 ' CE2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -61.45 162.09 8.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.59 ' O ' ' CE2' ' A' ' 17' ' ' PHE . 61.1 t0 -44.22 107.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.113 -0.992 . . . . 0.0 108.993 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.532 ' CB ' ' H ' ' A' ' 24' ' ' CYS . . . -95.61 29.94 2.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.814 . . . . 0.0 109.829 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -53.49 -46.08 69.89 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.115 -0.991 . . . . 0.0 108.865 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.587 ' O ' ' CB ' ' A' ' 22' ' ' SER . 20.2 m -64.53 -49.44 71.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.319 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.587 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.4 m 152.2 26.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -58.61 -56.78 17.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.744 -1.223 . . . . 0.0 109.767 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.532 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 38.1 t -67.27 -42.42 83.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 108.832 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.724 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.0 OUTLIER -59.46 -38.85 81.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.87 -39.3 97.85 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.48 -47.79 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.197 -1.178 . . . . 0.0 109.349 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.74 -31.36 68.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.336 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.8 m -53.46 -48.52 68.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.231 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -64.93 -38.17 90.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.442 -0.786 . . . . 0.0 109.0 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -59.59 -28.43 67.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -0.79 . . . . 0.0 108.988 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.36 0.2 40.57 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.29 145.68 55.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -1.114 . . . . 0.0 109.14 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -60.56 -52.6 64.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 110.135 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -143.55 160.47 40.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.127 -0.983 . . . . 0.0 110.317 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.602 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -139.05 140.15 10.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -130.14 136.72 49.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -1.097 . . . . 0.0 109.755 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.0 t -105.05 130.94 53.13 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.353 -0.842 . . . . 0.0 109.501 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.688 ' NE2' ' N ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -134.67 173.0 12.15 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.493 -0.755 . . . . 0.0 109.274 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.2 pt -95.77 141.3 15.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.13 -34.95 72.65 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.293 -0.88 . . . . 0.0 109.245 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.57 -60.82 0.52 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.67 -70.44 0.75 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.38 -1.071 . . . . 0.0 109.063 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -129.44 151.16 50.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.609 -0.682 . . . . 0.0 109.538 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.45 174.8 40.3 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.44 167.11 22.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.322 -1.105 . . . . 0.0 109.578 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.489 ' O ' ' OE1' ' A' ' 39' ' ' GLN . . . -140.41 150.41 21.59 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -134.0 125.6 28.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -1.067 . . . . 0.0 109.231 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.547 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 2.8 p90 -120.69 141.27 50.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.113 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.9 m -128.98 145.0 51.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.451 -0.78 . . . . 0.0 109.103 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.69 137.85 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.407 ' C ' ' CD2' ' A' ' 53' ' ' LEU . . . -169.66 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.926 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.407 ' CD2' ' C ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -128.0 78.45 75.24 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.892 . . . . 0.0 109.659 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -60.7 -23.66 76.71 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.382 2.055 . . . . 0.0 111.782 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.07 -36.45 77.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 109.785 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.476 ' O ' ' C ' ' A' ' 57' ' ' VAL . 50.6 t-20 -68.06 129.08 38.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.476 ' C ' ' O ' ' A' ' 56' ' ' ASN . 52.5 t -38.15 100.42 0.21 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.803 -0.561 . . . . 0.0 109.539 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 59' ' ' ILE . 75.4 Cg_endo -90.3 155.76 4.58 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.627 2.218 . . . . 0.0 111.69 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 58' ' ' PRO . 89.3 mt 41.25 55.17 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 109.607 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -58.57 -35.87 73.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 63' ' ' GLY . 10.0 pt -60.62 148.56 81.26 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 0.0 109.35 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.79 1.22 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.465 2.11 . . . . 0.0 112.006 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 61' ' ' ILE . . . 100.11 5.82 54.36 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -103.46 122.62 45.28 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.388 -1.066 . . . . 0.0 108.816 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.407 ' O ' ' OXT' ' A' ' 66' ' ' HIS . 81.1 m -64.26 -22.99 67.14 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.428 -0.795 . . . . 0.0 110.006 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.407 ' OXT' ' O ' ' A' ' 65' ' ' CYS . 37.5 m80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.425 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -129.05 135.78 49.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.424 -0.797 . . . . 0.0 109.687 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 87.3 m-20 -103.37 155.91 18.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 108.89 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -110.5 -93.48 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 110.323 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -98.2 -10.88 23.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.067 -1.02 . . . . 0.0 109.64 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.491 ' CG2' ' O ' ' A' ' 11' ' ' ASN . 60.8 mt -111.0 130.58 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.555 -0.716 . . . . 0.0 109.544 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.64 -12.61 19.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.422 -0.799 . . . . 0.0 110.107 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.489 ' HZ1' ' CG2' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -104.08 153.26 39.03 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.274 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.12 -35.8 62.27 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.487 2.125 . . . . 0.0 112.942 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -131.14 -0.9 4.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.948 . . . . 0.0 110.11 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.491 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 34.6 m-80 -125.91 164.55 20.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.342 -0.849 . . . . 0.0 109.78 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.7 m -115.42 160.33 20.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.0 109.476 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.78 131.59 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 29.9 p90 -75.13 -43.46 52.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.93 . . . . 0.0 109.459 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.535 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.3 tt0 -175.9 100.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 109.215 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -68.38 93.37 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.089 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.527 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 21.2 p90 -63.42 -43.32 97.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 109.895 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.527 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 47.8 t0 -153.49 89.45 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.126 -0.984 . . . . 0.0 109.849 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.58 -28.68 69.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.128 -0.983 . . . . 0.0 109.275 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -54.49 -40.37 68.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.473 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 20.6 m -58.64 -48.91 79.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.122 -0.986 . . . . 0.0 109.623 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.8 m 153.57 3.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.75 -0.594 . . . . 0.0 109.944 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.08 -79.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.923 -1.11 . . . . 0.0 110.485 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 t -58.43 -48.29 81.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 36' ' ' GLY . 2.6 m120 -58.35 -36.27 73.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.0 108.835 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.91 -41.12 97.65 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.489 ' CG2' ' HZ1' ' A' ' 8' ' ' LYS . 73.1 t -62.09 -44.32 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.237 -1.154 . . . . 0.0 109.049 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 62.6 m -64.7 -30.76 71.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 109.389 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.8 m -58.81 -44.68 90.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.726 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt -63.1 -44.7 94.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.011 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.74 -30.23 71.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.274 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.71 4.28 58.04 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.518 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.73 155.0 35.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.365 -1.079 . . . . 0.0 109.608 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.563 ' H ' ' CB ' ' A' ' 52' ' ' ALA . 5.6 ttmt -56.24 -71.63 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 110.235 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.58 ' HG ' ' H ' ' A' ' 36' ' ' GLY . 20.7 t -144.34 168.66 19.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 110.05 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.586 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -137.2 154.78 22.51 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -129.78 143.93 51.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -1.102 . . . . 0.0 109.641 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -125.45 128.43 48.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.569 -0.707 . . . . 0.0 109.345 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -140.3 -138.53 0.12 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.221 -0.924 . . . . 0.0 109.589 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.5 pt -93.71 153.21 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.262 -0.898 . . . . 0.0 109.962 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.4 tp -86.68 138.2 31.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.437 -0.789 . . . . 0.0 109.187 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.74 -35.95 8.0 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.2 p -100.52 -99.04 0.25 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.181 -1.187 . . . . 0.0 109.209 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -122.34 147.55 46.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 0.0 109.287 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.34 -162.44 25.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -114.81 166.41 11.79 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.487 -1.008 . . . . 0.0 109.725 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.59 155.48 21.59 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER -137.2 121.33 17.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -1.144 . . . . 0.0 109.974 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -111.31 136.06 50.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.394 -0.817 . . . . 0.0 108.857 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.518 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 6.9 t -111.31 126.65 55.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.0 108.981 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.1 mt -115.45 135.22 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 110.242 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.563 ' CB ' ' H ' ' A' ' 34' ' ' LYS . . . -171.18 -55.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.524 -0.735 . . . . 0.0 109.057 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.86 76.52 76.99 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.481 -0.762 . . . . 0.0 109.235 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.87 -21.37 40.33 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.915 2.41 . . . . 0.0 112.684 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.403 ' C ' HD21 ' A' ' 56' ' ' ASN . 92.3 m-20 -48.74 -35.44 14.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 108.494 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.403 HD21 ' C ' ' A' ' 55' ' ' ASP . 3.1 m120 -109.24 125.53 52.35 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.63 -0.668 . . . . 0.0 109.387 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.7 t -138.29 66.25 44.21 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.915 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -95.2 152.32 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.507 2.804 . . . . 0.0 111.75 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -128.1 121.62 56.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.1 tpt85 -54.97 -36.27 65.19 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.356 -0.84 . . . . 0.0 110.795 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 pp -132.65 154.43 81.49 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.031 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.35 -19.57 28.93 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.479 2.119 . . . . 0.0 112.036 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.79 26.87 0.11 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -104.17 148.18 26.59 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.231 -1.158 . . . . 0.0 109.467 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 71.1 m -117.35 159.76 22.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.489 -0.757 . . . . 0.0 109.148 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.408 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -127.04 129.97 49.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.84 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 5.3 t0 -108.55 153.57 23.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.432 -0.793 . . . . 0.0 109.106 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.587 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -100.28 -81.67 0.46 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.528 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.3 -4.77 31.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.001 . . . . 0.0 109.786 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.456 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 65.7 mt -106.77 143.95 16.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.464 -0.773 . . . . 0.0 110.099 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.84 -10.16 1.34 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.305 -0.872 . . . . 0.0 109.19 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -104.75 157.21 34.66 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 8' ' ' LYS . 45.6 Cg_exo -34.16 -109.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.332 2.688 . . . . 0.0 113.151 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.44 -1.23 57.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.756 -1.215 . . . . 0.0 109.335 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -105.22 154.82 19.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.639 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.3 m -108.1 161.81 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.234 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -66.41 134.31 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.947 . . . . 0.0 109.434 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.7 p90 -78.13 -34.7 49.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 76.9 tt0 -167.61 95.0 0.44 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.265 -0.897 . . . . 0.0 109.08 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' CB ' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -60.6 148.51 37.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.95 -1.094 . . . . 0.0 108.411 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 13.7 t80 -115.69 166.48 11.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.511 -0.743 . . . . 0.0 109.281 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.585 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 88.0 m-20 -42.8 137.21 2.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 109.401 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.96 -8.91 48.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 110.037 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -51.34 -43.79 61.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.045 -1.034 . . . . 0.0 108.726 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -86.11 6.01 31.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.354 -0.841 . . . . 0.0 108.893 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 m 55.33 20.42 3.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.602 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -58.62 -49.41 77.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.774 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.5 t -65.34 -47.96 74.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.152 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.671 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.2 m120 -60.05 -37.63 80.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.389 -0.82 . . . . 0.0 109.185 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.52 -42.22 99.01 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.33 -43.91 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 109.12 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.8 t -64.27 -32.42 74.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.475 -0.765 . . . . 0.0 109.19 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.5 m -59.23 -41.1 87.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.406 -0.809 . . . . 0.0 109.975 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -58.77 -31.2 68.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.128 -0.983 . . . . 0.0 109.272 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.505 ' OD1' ' NZ ' ' A' ' 34' ' ' LYS . 18.2 t-20 -52.6 -34.89 52.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 108.925 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 33' ' ' ALA . . . 157.35 -35.57 0.55 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 32' ' ' GLY . . . 161.45 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -1.152 . . . . 0.0 109.362 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.505 ' NZ ' ' OD1' ' A' ' 31' ' ' ASN . 22.2 mttt -42.87 139.51 1.65 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.434 -0.791 . . . . 0.0 109.96 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.4 p -125.81 113.63 17.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.59 -141.48 4.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.554 ' O ' ' N ' ' A' ' 49' ' ' TRP . 10.3 m-85 -139.82 171.5 14.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.209 -1.171 . . . . 0.0 109.828 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.465 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 13.0 t -99.68 125.63 45.57 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.325 -0.86 . . . . 0.0 109.534 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.659 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 26.7 mt-30 -118.07 -177.5 3.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.641 -0.662 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.6 pt -108.93 157.82 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 110.102 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.7 mt -79.05 144.52 34.55 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.37 -0.832 . . . . 0.0 109.517 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -54.13 -34.93 53.58 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.1 p -94.14 -120.88 0.09 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.331 -1.1 . . . . 0.0 109.073 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.14 136.63 51.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.01 -166.6 18.7 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.465 ' ND2' ' SG ' ' A' ' 38' ' ' CYS . 17.3 t30 -140.51 157.95 44.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.322 -1.105 . . . . 0.0 108.927 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.24 163.67 25.98 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.8 m -107.43 140.41 40.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.476 -1.014 . . . . 0.0 109.758 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.659 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 4.6 t-105 -106.34 128.67 54.18 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.397 -0.815 . . . . 0.0 108.895 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.4 m -115.9 128.51 55.84 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 69.2 mt -126.37 138.36 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 110.327 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.91 -40.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.329 -0.857 . . . . 0.0 109.537 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mp -128.63 159.11 69.71 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.514 -0.741 . . . . 0.0 109.313 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -42.55 -72.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.591 2.194 . . . . 0.0 112.325 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 50.0 p30 -175.37 47.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.44 -0.787 . . . . 0.0 109.534 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -101.2 121.9 42.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.26 -0.9 . . . . 0.0 109.751 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 1' ' ' ALA . 23.7 t 55.73 66.82 3.37 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.623 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.74 -64.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.65 2.233 . . . . 0.0 112.12 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -119.92 113.78 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -0.788 . . . . 0.0 109.203 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -67.49 -35.63 79.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 109.054 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 63' ' ' GLY . 1.6 mp -73.7 136.93 77.14 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.691 -0.63 . . . . 0.0 109.543 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -46.64 -5.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.898 1.732 . . . . 0.0 111.892 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 103.67 5.41 45.1 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 66' ' ' HIS . 33.0 mtmt -58.28 -36.75 73.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.107 -1.231 . . . . 0.0 109.385 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 50.7 t 51.64 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.631 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.716 ' H ' ' ND1' ' A' ' 66' ' ' HIS . 9.9 p-80 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.552 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -108.91 146.05 34.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.427 -0.796 . . . . 0.0 109.306 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 8.9 t0 -136.58 154.31 50.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.874 . . . . 0.0 109.098 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -99.6 -78.31 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 110.898 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.65 -8.96 23.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.067 . . . . 0.0 110.096 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.47 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 68.3 mt -104.65 143.45 16.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.461 -0.774 . . . . 0.0 110.177 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.577 ' O ' ' ND2' ' A' ' 31' ' ' ASN . . . -118.51 13.28 13.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.823 . . . . 0.0 109.354 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.24 155.27 71.56 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -64.86 -39.68 24.46 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.437 2.091 . . . . 0.0 112.416 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -134.57 -1.08 2.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.639 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -116.16 170.21 8.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.47 -0.769 . . . . 0.0 109.488 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 62.5 m -114.46 177.27 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.518 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 t -99.97 135.68 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -70.78 77.44 0.62 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.067 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 55.9 97.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 109.346 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.7 t -64.68 113.21 3.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 108.975 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 8.4 t80 -70.06 139.56 52.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 88.9 m-20 -70.1 131.77 44.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 110.084 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.72 155.05 37.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.406 -0.809 . . . . 0.0 109.109 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 21' ' ' SER . 96.7 m-85 -56.93 -41.02 77.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.09 -1.006 . . . . 0.0 109.24 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 1.4 t 168.98 86.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.409 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.2 t -170.24 -64.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.057 -1.027 . . . . 0.0 110.021 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.78 -56.95 15.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 109.912 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.2 t -70.66 -52.64 19.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.653 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.625 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.5 m120 -57.68 -37.99 74.37 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.408 -0.807 . . . . 0.0 109.469 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.74 -46.66 93.74 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.3 t -67.72 -43.27 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -1.131 . . . . 0.0 109.383 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.5 t -61.22 -38.06 85.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.357 -0.839 . . . . 0.0 109.333 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.8 m -56.93 -40.21 75.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -59.14 -38.34 79.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.012 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 7' ' ' ALA . 82.0 m-20 -59.24 -28.52 66.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.83 . . . . 0.0 109.03 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.72 -0.12 52.51 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.78 148.21 51.55 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -1.064 . . . . 0.0 109.452 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.538 ' H ' ' CB ' ' A' ' 52' ' ' ALA . 3.8 ttmt -58.31 -55.56 33.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.782 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t -144.62 158.81 43.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.347 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -141.74 154.23 24.66 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.563 -1.304 . . . . 0.0 110.211 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 49' ' ' TRP . 48.8 m-85 -127.18 152.83 46.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.489 -1.006 . . . . 0.0 109.242 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.8 t -99.44 119.54 38.17 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.176 -0.953 . . . . 0.0 109.087 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -116.68 -170.82 1.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.696 -0.628 . . . . 0.0 109.693 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 pt -93.57 152.17 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.239 -0.913 . . . . 0.0 109.726 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' GLY . 29.8 tp -88.85 133.95 34.11 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.301 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -45.11 -30.19 2.52 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.8 p -109.45 178.85 4.31 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -50.75 160.58 0.43 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.763 -1.211 . . . . 0.0 109.174 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.59 -167.05 30.76 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -138.97 171.91 13.62 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.338 -1.095 . . . . 0.0 109.407 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.13 163.66 26.29 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.05 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.1 m -103.57 152.2 22.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.424 -1.045 . . . . 0.0 109.255 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.579 ' N ' ' O ' ' A' ' 37' ' ' TYR . 17.3 t-105 -116.2 139.06 50.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.826 . . . . 0.0 109.566 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.8 m -134.38 124.05 25.11 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.287 -0.883 . . . . 0.0 109.9 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 mt -123.98 132.34 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.536 -0.728 . . . . 0.0 109.875 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.538 ' CB ' ' H ' ' A' ' 34' ' ' LYS . . . -177.11 -66.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.822 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 1' ' ' ALA . 17.6 tp -133.14 89.0 34.57 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.417 -0.802 . . . . 0.0 109.9 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -75.61 -25.16 11.2 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.074 1.849 . . . . 0.0 112.292 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -57.96 -35.83 71.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 57' ' ' VAL . 48.9 t-20 -73.29 144.72 46.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.645 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.503 ' C ' ' O ' ' A' ' 56' ' ' ASN . 90.9 t -33.85 97.84 0.12 Allowed Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.949 -0.469 . . . . 0.0 109.795 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' ASN . 89.5 Cg_endo -85.5 -63.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.575 2.184 . . . . 0.0 112.426 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.425 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 73.6 mt -118.21 131.97 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -138.49 -21.9 1.01 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.301 -0.874 . . . . 0.0 109.507 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.23 154.09 38.86 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -67.21 -9.87 26.64 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.696 2.264 . . . . 0.0 112.195 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.3 22.22 45.42 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 66' ' ' HIS . 17.3 tttp -56.38 -35.04 67.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.557 -0.967 . . . . 0.0 109.651 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 57.8 m 57.12 -77.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.414 -0.803 . . . . 0.0 109.592 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 64' ' ' LYS . 94.9 m-70 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.728 ' H1 ' ' H ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -131.93 134.59 45.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.47 -0.769 . . . . 0.0 109.44 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 83.4 m-20 -95.79 150.11 20.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.136 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -109.86 -92.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.511 -0.743 . . . . 0.0 109.955 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -97.91 -17.3 19.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.346 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 11' ' ' ASN . 64.7 mt -106.91 137.61 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.525 -0.734 . . . . 0.0 109.62 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.416 ' C ' ' CD ' ' A' ' 8' ' ' LYS . . . -113.24 14.42 19.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.476 -0.765 . . . . 0.0 109.853 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.466 ' HZ1' ' HH ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -126.23 153.52 74.46 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.346 -0.846 . . . . 0.0 109.15 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.86 -27.74 80.58 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.637 2.225 . . . . 0.0 112.896 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -147.64 -5.99 0.47 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.077 -1.015 . . . . 0.0 109.501 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.439 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 51.2 m-80 -111.52 165.92 11.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.768 . . . . 0.0 109.38 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 24.4 m -119.59 162.19 19.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -0.823 . . . . 0.0 109.089 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.9 130.96 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.104 -0.998 . . . . 0.0 109.207 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.523 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.4 p90 -76.04 -42.11 48.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.523 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 45.1 tp10 -175.29 99.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -63.63 148.65 48.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.162 -0.961 . . . . 0.0 109.024 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.676 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -122.12 -161.14 0.91 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.676 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 89.1 m-20 -57.08 142.45 42.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.988 -1.07 . . . . 0.0 109.308 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.7 7.58 3.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.867 . . . . 0.0 110.103 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -52.25 -45.52 65.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.058 -1.026 . . . . 0.0 109.256 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 t -88.87 -2.58 58.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.949 . . . . 0.0 109.128 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' GLY . 3.1 m 55.6 52.55 10.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.511 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.466 ' HH ' ' HZ1' ' A' ' 8' ' ' LYS . 65.4 t80 -61.75 -53.61 53.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 0.0 109.833 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -70.98 -51.87 23.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.897 . . . . 0.0 109.294 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.634 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.5 m120 -58.76 -37.54 76.47 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.13 -39.47 97.18 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.85 -44.15 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -1.125 . . . . 0.0 109.071 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.2 m -63.78 -32.93 74.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.183 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.2 m -60.98 -50.39 73.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.663 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -65.59 -41.01 93.32 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.44 -0.788 . . . . 0.0 109.359 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -61.26 -30.25 70.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.461 -0.775 . . . . 0.0 109.259 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.36 0.39 50.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -66.85 150.95 48.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.438 -1.036 . . . . 0.0 109.388 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -57.91 -76.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 109.87 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.2 m -143.16 158.87 43.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.329 -0.857 . . . . 0.0 109.681 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.42 162.27 26.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -126.35 140.03 52.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -1.041 . . . . 0.0 109.833 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -116.21 119.37 35.55 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -137.45 176.83 8.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.189 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -92.83 140.29 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.979 -1.076 . . . . 0.0 109.285 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -64.42 -39.42 93.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 108.939 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.512 ' C ' ' HG1' ' A' ' 43' ' ' THR . . . 88.45 5.87 74.76 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.512 ' HG1' ' C ' ' A' ' 42' ' ' GLY . 57.6 m -157.44 -81.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 109.849 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -62.29 -37.0 83.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.917 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 41' ' ' LEU . . . 162.88 -119.08 0.85 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.405 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 17.4 m120 -111.33 150.54 29.57 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.519 -0.989 . . . . 0.0 110.093 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.3 117.53 2.3 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 4' ' ' ALA . 32.9 t -114.95 115.98 27.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.464 -1.021 . . . . 0.0 109.143 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -109.55 137.56 47.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.357 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.425 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 8.2 t -109.39 132.55 54.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.1 122.83 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 0.0 109.814 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.421 ' O ' ' CD1' ' A' ' 53' ' ' LEU . . . -179.07 -146.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.585 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.7 OUTLIER 176.43 -44.71 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.42 -0.8 . . . . 0.0 109.823 179.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 53' ' ' LEU . 42.8 Cg_exo -54.78 -32.68 77.76 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.086 1.858 . . . . 0.0 111.95 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.35 -38.3 86.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.299 -0.876 . . . . 0.0 108.98 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 53' ' ' LEU . 14.5 m120 56.88 46.42 19.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.728 ' H ' ' H1 ' ' A' ' 1' ' ' ALA . 91.9 t -120.62 85.92 39.24 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.365 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -90.91 -172.83 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.293 2.662 . . . . 0.0 111.689 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mm -114.28 130.5 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 7.51 41.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 0.0 110.521 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.63 151.94 61.73 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.778 -1.201 . . . . 0.0 109.865 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.607 ' C ' ' H ' ' A' ' 64' ' ' LYS . 11.3 Cg_endo -57.84 159.74 16.89 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.703 2.269 . . . . 0.0 112.155 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.74 28.25 0.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.607 ' H ' ' C ' ' A' ' 62' ' ' PRO . 35.0 tttt -56.68 -35.63 68.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.104 -1.233 . . . . 0.0 109.303 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 33.8 m 58.46 -74.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.614 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 64' ' ' LYS . 84.6 t60 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -136.52 161.52 35.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.341 -0.849 . . . . 0.0 109.242 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -95.44 145.54 25.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.121 -0.987 . . . . 0.0 109.343 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.512 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -103.08 -81.42 0.5 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 110.797 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -99.52 -15.18 18.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.051 -1.031 . . . . 0.0 110.261 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.9 mt -95.91 143.92 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.367 -0.833 . . . . 0.0 110.12 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.94 21.32 3.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.34 -0.85 . . . . 0.0 109.6 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -115.37 152.15 46.65 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.47 -0.769 . . . . 0.0 109.213 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.21 -32.75 90.88 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.569 2.18 . . . . 0.0 112.816 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -149.65 12.08 0.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.996 -1.065 . . . . 0.0 109.805 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -130.88 -164.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.62 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.1 m -121.0 -178.08 3.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.357 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -98.89 131.95 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.265 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.7 p90 -66.34 -37.45 85.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.531 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.443 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 80.9 tt0 -174.56 99.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.279 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -75.54 125.58 29.31 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.101 -0.999 . . . . 0.0 108.715 179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 18' ' ' ASP . 20.0 t80 -90.87 141.14 29.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.904 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.587 ' O ' ' CE2' ' A' ' 17' ' ' PHE . 60.0 t0 -78.52 121.03 24.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -0.811 . . . . 0.0 109.88 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.82 159.06 43.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.465 -0.772 . . . . 0.0 108.936 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.448 ' O ' ' CB ' ' A' ' 21' ' ' SER . 71.3 t80 -53.62 -43.41 68.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.081 -1.012 . . . . 0.0 109.203 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.503 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER 168.97 78.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.429 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 26' ' ' GLY . 3.5 t -156.01 -66.94 0.11 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.037 -1.039 . . . . 0.0 110.149 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -60.37 -57.26 13.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -68.36 -48.31 65.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 108.943 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.631 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.4 m120 -59.08 -37.17 76.47 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -60.4 -41.48 98.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -62.03 -44.92 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.16 . . . . 0.0 109.128 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.3 m -67.8 -31.59 71.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.798 . . . . 0.0 109.53 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 m -56.88 -48.43 78.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.62 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -65.02 -40.48 94.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.417 -0.802 . . . . 0.0 109.487 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -60.74 -30.18 69.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.402 -0.811 . . . . 0.0 109.297 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.84 0.02 56.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.421 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.95 150.0 48.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.418 -1.049 . . . . 0.0 109.423 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -57.6 -60.24 3.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -0.94 . . . . 0.0 109.947 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.6 p -144.9 161.74 38.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.997 . . . . 0.0 110.193 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.581 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -144.14 154.72 25.86 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.596 ' O ' ' N ' ' A' ' 49' ' ' TRP . 21.6 m-85 -139.8 156.34 46.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.171 -1.194 . . . . 0.0 109.456 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.21 124.75 44.51 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.066 -1.021 . . . . 0.0 109.188 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.565 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 26.0 mt-30 -116.28 179.03 4.11 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.6 pt -93.29 143.25 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.061 -1.024 . . . . 0.0 110.043 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' O ' ' C ' ' A' ' 42' ' ' GLY . 36.0 tp -91.36 142.78 27.31 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.468 -0.77 . . . . 0.0 109.215 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -43.67 -31.76 1.86 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.563 ' HG1' ' H ' ' A' ' 45' ' ' GLY . 21.6 p -87.23 167.51 14.05 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.41 -1.053 . . . . 0.0 108.87 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -54.35 -10.05 0.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 109.49 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.563 ' H ' ' HG1' ' A' ' 43' ' ' THR . . . -82.56 -173.23 49.01 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -137.18 171.23 14.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.481 -1.011 . . . . 0.0 109.109 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -140.17 167.1 25.56 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.034 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -101.31 151.67 21.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.413 -1.051 . . . . 0.0 109.135 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.596 ' N ' ' O ' ' A' ' 37' ' ' TYR . 13.6 t-105 -115.57 137.35 52.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.469 -0.77 . . . . 0.0 109.329 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.421 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -130.31 133.63 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.369 -0.832 . . . . 0.0 109.153 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.4 mt -115.81 121.16 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.804 . . . . 0.0 109.691 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 1' ' ' ALA . . . -169.98 158.64 7.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.37 75.52 73.98 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 0.0 109.777 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.08 -65.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.743 2.295 . . . . 0.0 111.838 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -154.99 -71.02 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.558 -0.714 . . . . 0.0 109.148 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 56' ' ' ASN . 6.4 p30 -173.39 29.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.355 -0.84 . . . . 0.0 109.564 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.5 t -126.98 77.7 74.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 109.866 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.73 -65.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.668 2.245 . . . . 0.0 112.099 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 59' ' ' ILE . 29.3 mm -113.89 130.0 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.69 1.6 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.723 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -130.63 154.43 81.73 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.716 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -72.83 23.91 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.701 2.267 . . . . 0.0 112.073 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 61' ' ' ILE . . . 95.57 10.29 56.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -73.8 136.25 43.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.413 -1.051 . . . . 0.0 109.104 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' HIS . 72.7 m -116.72 159.29 22.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.577 -0.702 . . . . 0.0 109.382 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' CYS . 83.7 t60 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.54 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.755 ' HE ' ' HE1' ' A' ' 49' ' ' TRP . 76.8 ttt180 -128.26 133.67 48.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.44 -0.787 . . . . 0.0 109.571 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -95.67 140.38 30.57 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.558 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -99.83 -79.74 0.49 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -0.91 . . . . 0.0 109.696 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -106.67 15.11 26.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.783 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.9 pt -118.57 156.44 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.354 -0.841 . . . . 0.0 109.778 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.03 -18.57 17.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 109.11 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -137.25 154.99 76.03 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.372 -0.83 . . . . 0.0 109.179 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.38 -29.93 30.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.66 2.24 . . . . 0.0 112.679 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -94.67 -23.68 17.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.133 -0.979 . . . . 0.0 110.295 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -140.72 -179.54 6.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.04 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.528 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 24.6 p -140.07 -177.79 5.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.51 -0.744 . . . . 0.0 109.232 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.7 t -107.33 131.87 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.425 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 28.1 p90 -73.68 -34.59 64.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.144 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.425 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 43.8 tp10 -151.19 89.38 1.51 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.44 -0.787 . . . . 0.0 108.89 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.565 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -59.21 109.49 0.87 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 109.353 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 1.8 t80 -63.15 165.19 7.5 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.368 -0.833 . . . . 0.0 108.943 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.602 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 60.3 t0 -43.54 106.39 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 109.298 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.36 -5.11 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -50.79 -43.61 58.67 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.163 -0.961 . . . . 0.0 109.186 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.7 m -62.7 -50.63 70.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.192 -0.943 . . . . 0.0 109.446 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.6 t 151.49 12.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.35 -71.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.008 -1.058 . . . . 0.0 110.541 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.4 t -60.64 -51.29 70.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.163 -0.961 . . . . 0.0 109.148 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.469 ' O ' ' OG1' ' A' ' 29' ' ' THR . 2.3 m120 -57.72 -36.01 71.44 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 108.666 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.34 -40.18 95.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.83 -48.02 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -1.173 . . . . 0.0 108.855 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.38 -22.57 62.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 51.2 m -64.07 -31.26 72.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.413 -0.804 . . . . 0.0 110.976 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 1.8 mptt -52.77 -35.12 55.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.004 -1.06 . . . . 0.0 110.159 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -56.92 -33.59 67.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.051 -1.03 . . . . 0.0 109.337 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.84 2.17 56.2 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.1 -26.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -1.036 . . . . 0.0 109.216 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.623 ' CE ' ' SG ' ' A' ' 50' ' ' CYS . 16.7 tttp -54.33 131.83 42.73 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.6 p -113.65 139.68 48.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.424 -0.798 . . . . 0.0 109.589 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.19 158.02 27.1 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.526 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -128.81 155.71 44.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.643 -0.916 . . . . 0.0 108.735 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 42.4 t -99.07 122.77 42.75 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.049 -1.032 . . . . 0.0 108.917 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.498 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 24.4 mt-30 -115.68 177.81 4.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.634 -0.666 . . . . 0.0 109.965 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.4 mt -93.69 133.44 34.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.402 -0.811 . . . . 0.0 110.1 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.47 -27.35 68.92 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.617 0.722 . . . . 0.0 109.209 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.29 -7.34 40.18 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.605 -2.198 . . . . 0.0 107.605 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 45' ' ' GLY . 12.8 p -127.79 172.44 10.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 43' ' ' THR . 23.8 p90 -46.48 -12.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.019 -1.051 . . . . 0.0 109.44 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -87.87 -176.92 47.98 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.556 ' ND2' ' SG ' ' A' ' 38' ' ' CYS . 61.8 t30 -140.2 164.54 29.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.531 -0.981 . . . . 0.0 108.889 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 157.82 25.66 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.46 -1.353 . . . . 0.0 110.545 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -107.39 153.45 22.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.488 -1.007 . . . . 0.0 109.354 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.755 ' HE1' ' HE ' ' A' ' 2' ' ' ARG . 5.6 t-105 -125.72 129.46 49.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.372 -0.83 . . . . 0.0 109.256 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.623 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 1.8 t -132.76 131.09 40.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.121 -0.987 . . . . 0.0 109.748 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mt -123.1 140.47 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.746 . . . . 0.0 110.499 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.59 -28.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.711 . . . . 0.0 109.643 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.567 ' C ' ' H ' ' A' ' 55' ' ' ASP . 3.0 mp -129.1 165.96 28.57 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 109.717 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.593 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 50.3 Cg_exo -49.72 -0.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.59 2.194 . . . . 0.0 112.705 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 12.5 t0 89.9 49.8 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.27 0.557 . . . . 0.0 109.785 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -103.53 131.87 50.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.304 -0.872 . . . . 0.0 108.996 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.0 t 52.92 67.69 3.63 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.088 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HG2' ' H ' ' A' ' 59' ' ' ILE . 59.5 Cg_endo -75.65 -65.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.761 2.307 . . . . 0.0 112.471 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.407 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 69.3 mt -116.13 124.68 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.473 -0.767 . . . . 0.0 109.412 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -1.61 10.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.531 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -68.98 149.22 97.9 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.557 -0.714 . . . . 0.0 109.521 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.28 5.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.556 2.171 . . . . 0.0 112.139 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 61' ' ' ILE . . . 99.99 8.12 51.55 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -37.48 71.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.176 -1.19 . . . . 0.0 109.239 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -107.95 158.57 17.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.557 -0.714 . . . . 0.0 109.543 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.436 -179.912 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -136.9 159.4 41.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.589 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -101.35 149.52 23.95 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.291 -0.881 . . . . 0.0 109.129 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -99.34 -65.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.256 -0.903 . . . . 0.0 110.654 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -100.45 -0.94 37.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 109.927 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.5 mt -111.71 133.83 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.935 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.97 -9.25 17.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.419 -0.801 . . . . 0.0 109.549 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.634 ' NZ ' ' CG1' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.09 166.35 12.04 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.502 -0.749 . . . . 0.0 109.246 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.74 -59.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.581 2.187 . . . . 0.0 112.433 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.699 ' HE2' ' NH1' ' A' ' 60' ' ' ARG . 78.4 m80 -102.95 -4.71 24.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.348 -0.845 . . . . 0.0 109.782 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -121.66 161.79 21.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.419 -0.801 . . . . 0.0 109.645 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.5 m -124.14 179.5 4.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.353 -0.842 . . . . 0.0 109.514 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.7 t -98.87 134.18 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.312 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.3 p90 -70.27 -42.04 72.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.851 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 39.1 tp10 -174.68 99.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.097 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB3' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -70.0 143.58 52.54 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.144 -0.973 . . . . 0.0 108.955 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.614 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -120.12 179.31 4.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.404 -0.81 . . . . 0.0 109.033 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.614 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 88.6 m-20 -44.7 128.35 6.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -0.968 . . . . 0.0 109.355 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.607 ' C ' ' H ' ' A' ' 21' ' ' SER . . . -65.17 -36.24 83.59 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.202 -0.936 . . . . 0.0 109.759 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.564 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 66.9 t80 49.25 7.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.17 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.607 ' H ' ' C ' ' A' ' 19' ' ' ALA . 1.2 t 173.3 -54.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.354 -0.842 . . . . 0.0 108.856 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER 160.98 45.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.621 -0.674 . . . . 0.0 109.202 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -60.31 -51.85 67.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.999 -1.063 . . . . 0.0 109.716 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.9 t -70.35 -50.42 39.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.191 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.724 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.0 OUTLIER -59.55 -38.73 81.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 109.296 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.87 -44.04 98.39 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.634 ' CG1' ' NZ ' ' A' ' 8' ' ' LYS . 76.9 t -60.56 -43.55 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -1.179 . . . . 0.0 109.542 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.446 ' SG ' ' CD ' ' A' ' 34' ' ' LYS . 3.6 t -65.07 -35.08 80.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.252 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 m -61.95 -39.16 91.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 110.557 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -56.98 -29.97 63.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.005 -1.059 . . . . 0.0 109.779 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.706 ' ND2' ' HZ1' ' A' ' 34' ' ' LYS . 13.9 t30 -53.59 -35.61 61.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.074 -1.016 . . . . 0.0 109.294 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.03 -42.76 0.27 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 34' ' ' LYS . . . 174.52 -21.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.048 -1.266 . . . . 0.0 109.59 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.706 ' HZ1' ' ND2' ' A' ' 31' ' ' ASN . 13.3 ptpt -43.63 145.37 0.65 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.511 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 91.4 p -103.61 147.77 26.81 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.48 159.96 27.59 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.229 -1.463 . . . . 0.0 111.252 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 49' ' ' TRP . 37.3 m-85 -127.54 154.21 45.43 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.618 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 40.6 t -98.92 118.89 36.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.894 -1.128 . . . . 0.0 109.323 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.609 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 25.9 mt-30 -112.75 171.52 7.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.1 pt -93.25 134.17 31.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.063 -1.023 . . . . 0.0 110.042 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.408 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 41.3 tp -62.79 -28.15 69.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.637 -0.664 . . . . 0.0 109.211 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.75 -6.8 41.38 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 45' ' ' GLY . 20.3 p -127.02 172.62 10.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' THR . 24.6 p90 -44.65 -16.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.033 -1.042 . . . . 0.0 109.367 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -89.26 -178.2 45.75 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.618 ' ND2' ' SG ' ' A' ' 38' ' ' CYS . 7.4 t30 -140.65 168.1 20.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.527 -0.984 . . . . 0.0 108.853 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.4 150.38 21.56 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.473 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.493 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -99.99 145.33 28.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.41 -1.053 . . . . 0.0 108.986 179.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.609 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 11.7 t-105 -111.25 127.89 55.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.392 -0.817 . . . . 0.0 109.408 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.4 m -124.31 134.24 53.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.273 -0.892 . . . . 0.0 109.616 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.574 ' O ' ' CB ' ' A' ' 52' ' ' ALA . 5.2 mt -120.14 141.61 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.544 -0.722 . . . . 0.0 110.076 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 51' ' ' ILE . . . 90.89 65.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.566 0.698 . . . . 0.0 109.574 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.2 tp -128.83 81.46 70.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.606 -0.684 . . . . 0.0 109.173 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.41 -21.29 29.24 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.643 2.229 . . . . 0.0 111.867 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -56.62 -34.3 67.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.72 45.64 5.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.423 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 31.7 m -124.72 77.63 64.44 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.559 -0.713 . . . . 0.0 109.259 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HG2' ' H ' ' A' ' 59' ' ' ILE . 65.6 Cg_endo -79.83 -67.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.679 2.253 . . . . 0.0 112.223 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.424 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 70.4 mt -119.48 129.49 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.699 ' NH1' ' HE2' ' A' ' 10' ' ' HIS . 13.6 ptm180 -153.95 -33.17 0.11 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 108.99 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.405 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -75.92 156.43 84.36 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.607 -0.683 . . . . 0.0 109.419 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.82 -6.86 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.878 2.385 . . . . 0.0 112.227 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 61' ' ' ILE . . . 98.52 11.92 46.22 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -56.17 -35.26 67.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.133 . . . . 0.0 109.467 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.8 p -68.07 151.26 47.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.466 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' HB2' ' H ' ' A' ' 56' ' ' ASN . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -136.57 158.21 44.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.401 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 2.8 t0 -104.98 150.51 24.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.344 -0.847 . . . . 0.0 109.568 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.532 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -99.35 -76.67 0.54 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -108.02 3.49 24.09 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.196 -0.94 . . . . 0.0 109.845 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.454 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 59.2 mt -111.3 138.38 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 110.161 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -110.93 12.68 22.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.455 -0.778 . . . . 0.0 109.421 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.87 155.3 77.73 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.482 -0.761 . . . . 0.0 109.231 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.31 -36.06 47.63 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.551 2.167 . . . . 0.0 112.56 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -138.07 -3.08 1.81 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.536 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.443 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 52.7 m-80 -114.25 167.95 10.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.485 -0.759 . . . . 0.0 109.357 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 62.3 m -118.61 177.06 4.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.412 -0.805 . . . . 0.0 109.828 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.08 135.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 109.086 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 28.2 p90 -66.89 -45.73 77.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.698 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.579 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 82.7 tt0 -175.95 97.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.057 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 144.46 56.54 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 108.589 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.698 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 2.5 p90 -120.67 -153.75 0.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.458 -0.776 . . . . 0.0 109.208 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.698 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.6 m-20 -57.53 141.8 46.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.978 -1.076 . . . . 0.0 109.473 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.89 9.23 3.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.354 -0.841 . . . . 0.0 109.864 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -49.88 -43.44 49.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.982 -1.074 . . . . 0.0 108.597 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.472 ' O ' ' OG ' ' A' ' 22' ' ' SER . 33.6 p -90.15 4.99 48.81 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.432 -0.792 . . . . 0.0 109.075 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 21' ' ' SER . 83.3 p 51.82 33.43 11.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 109.351 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -59.25 -47.1 86.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -65.76 -57.5 7.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.422 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.652 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.3 m120 -60.86 -35.74 77.37 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.472 -0.768 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -58.27 -44.0 95.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.44 -44.36 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -1.118 . . . . 0.0 109.2 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 t -70.04 -31.13 68.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.486 -0.758 . . . . 0.0 109.326 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 48.5 m -61.57 -31.47 71.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 110.673 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.76 -27.14 4.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.984 -1.073 . . . . 0.0 109.885 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -54.82 -30.76 58.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.1 -1.0 . . . . 0.0 109.107 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.96 3.29 45.61 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 176.77 -25.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -1.192 . . . . 0.0 109.629 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -55.25 134.25 49.73 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -112.58 140.79 47.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.397 -0.814 . . . . 0.0 108.984 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.69 164.68 27.38 Favored Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.995 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' TRP . 32.7 m-85 -132.12 160.5 35.83 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.506 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 43.5 t -99.24 120.86 40.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.998 -1.064 . . . . 0.0 109.294 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.503 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 26.1 mt-30 -115.72 174.57 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 109.32 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.9 pt -99.15 155.42 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.898 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.8 mt -78.25 148.44 33.93 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.432 -0.792 . . . . 0.0 109.578 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.68 -35.93 39.17 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 47.7 p -96.07 -125.16 0.12 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.318 -1.107 . . . . 0.0 108.644 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -109.72 126.57 53.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 108.921 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 141.45 -173.87 23.21 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.599 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 54.6 t-20 -140.77 150.33 43.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -1.102 . . . . 0.0 109.559 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.599 ' N ' ' OD1' ' A' ' 46' ' ' ASN . . . -140.11 167.25 25.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.5 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.6 m -101.97 150.26 23.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.236 -1.155 . . . . 0.0 109.621 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.532 ' CE3' ' O ' ' A' ' 4' ' ' ALA . 16.8 t-105 -120.92 121.22 37.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 109.161 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.8 m -117.74 130.38 56.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.324 -0.86 . . . . 0.0 109.682 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 mt -127.76 145.56 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.417 -0.802 . . . . 0.0 110.545 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 176.19 -22.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 tp -153.02 133.15 7.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 108.916 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -38.08 158.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.205 1.937 . . . . 0.0 112.225 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 61.1 t0 -79.0 116.34 19.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 110.063 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.481 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 82.0 m-20 -147.86 -47.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.74 72.2 81.99 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.76 -100.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.829 2.353 . . . . 0.0 112.527 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.42 ' CD1' ' O ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -127.28 125.99 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.349 -0.844 . . . . 0.0 109.417 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -61.58 -34.18 75.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.303 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.416 HG23 ' H ' ' A' ' 63' ' ' GLY . 4.0 mt -62.63 136.73 96.26 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.425 -0.797 . . . . 0.0 108.967 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.78 -1.71 2.91 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.004 1.803 . . . . 0.0 112.483 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.416 ' H ' HG23 ' A' ' 61' ' ' ILE . . . 95.62 11.4 55.47 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.603 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 11.9 pttp -58.62 -32.47 69.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -1.12 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 61.3 m 56.43 -0.61 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.277 -0.889 . . . . 0.0 109.913 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.603 ' ND1' ' O ' ' A' ' 64' ' ' LYS . 72.4 m80 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.417 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.306 0.574 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.0 ptt-85 -137.6 167.45 21.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.378 -0.826 . . . . 0.0 109.511 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 83.7 m-20 -94.35 147.13 23.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 108.691 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -109.93 -83.25 0.56 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.371 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -99.23 6.24 46.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.008 -1.057 . . . . 0.0 109.629 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 pt -117.16 159.17 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.0 110.443 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.414 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . . . -123.39 -20.29 5.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.21 161.27 50.71 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.62 -66.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.43 2.087 . . . . 0.0 112.91 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.534 ' C ' ' ND2' ' A' ' 11' ' ' ASN . 67.6 m-70 -56.81 -39.44 74.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 110.436 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.662 HD21 ' N ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -134.51 173.72 11.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 0.0 110.096 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.2 m -108.24 171.24 7.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.185 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.412 HG13 HD21 ' A' ' 46' ' ' ASN . 1.5 p -49.09 135.24 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.037 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.664 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 19.5 p90 -69.64 -50.43 44.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.051 -1.031 . . . . 0.0 109.345 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.664 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 48.8 tp10 -177.38 91.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.2 t -54.12 97.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 108.926 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 19.3 p90 -76.67 -46.17 26.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 109.689 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 52.9 t0 -145.4 101.01 3.54 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.312 -0.868 . . . . 0.0 109.096 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 22' ' ' SER . . . -60.63 -24.43 65.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.214 -0.929 . . . . 0.0 109.049 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -52.16 -42.22 63.24 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.434 ' C ' ' OG ' ' A' ' 22' ' ' SER . 84.0 p -66.04 -16.17 63.68 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER 72.48 39.25 0.74 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.618 -0.676 . . . . 0.0 110.029 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -60.63 -60.51 3.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.978 -1.076 . . . . 0.0 109.06 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.414 ' SG ' ' CB ' ' A' ' 7' ' ' ALA . 8.1 t -70.58 -48.65 54.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.352 -0.843 . . . . 0.0 108.75 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.9 m120 -57.82 -38.93 76.46 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.8 -39.59 97.67 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.2 -41.52 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.354 -1.086 . . . . 0.0 109.531 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.3 m -61.04 -41.2 96.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.523 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 m -58.22 -51.26 70.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.14 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -67.79 -39.45 84.03 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.54 -0.725 . . . . 0.0 109.125 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.56 ' CG ' HD22 ' A' ' 56' ' ' ASN . 42.0 t-20 -59.29 -31.13 68.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.553 -0.717 . . . . 0.0 109.275 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.27 -0.06 50.63 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.61 149.5 48.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -1.059 . . . . 0.0 109.221 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -58.0 -49.15 77.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 110.245 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.572 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 49.5 m -143.57 162.81 34.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.037 . . . . 0.0 110.198 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -142.72 126.83 2.98 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.543 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 87.2 m-85 -126.11 135.54 51.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.448 -1.03 . . . . 0.0 109.547 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.433 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -110.6 129.94 55.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 0.0 109.888 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.69 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -134.1 168.34 19.0 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.0 pt -98.81 133.43 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.974 . . . . 0.0 109.588 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.2 tp -64.24 -30.59 71.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 109.36 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.95 -4.5 49.43 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 45' ' ' GLY . 18.3 p -126.57 173.72 9.22 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 43' ' ' THR . 26.8 p90 -44.07 -21.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.441 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -87.23 -174.25 48.74 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.412 HD21 HG13 ' A' ' 13' ' ' VAL . 13.0 t30 -137.98 169.83 17.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -1.008 . . . . 0.0 108.911 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' GLN . . . -140.55 125.93 3.01 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.447 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 42.7 t -136.28 128.91 30.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -1.092 . . . . 0.0 108.674 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.69 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 4.1 p90 -113.95 141.29 47.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 109.857 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 35' ' ' SER . 6.0 t -124.72 153.62 42.09 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.1 mm -109.22 126.83 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 109.074 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -173.09 -130.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.978 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.619 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -127.4 166.4 23.27 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.364 -0.835 . . . . 0.0 109.9 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.84 -34.31 24.4 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.466 2.111 . . . . 0.0 112.244 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -56.41 -33.49 65.86 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.56 HD22 ' CG ' ' A' ' 31' ' ' ASN . 46.2 t-20 -96.75 120.13 36.52 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.554 -0.716 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.2 t 57.4 65.87 3.32 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.717 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.69 15.03 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.146 2.564 . . . . 0.0 112.425 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 62.9 mt 55.25 52.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.391 -0.818 . . . . 0.0 109.333 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.408 ' CB ' ' NH1' ' A' ' 60' ' ' ARG . 6.1 ptm85 -61.61 -39.22 90.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.507 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -74.75 154.12 87.2 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.462 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.73 -11.12 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.663 2.242 . . . . 0.0 111.929 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.95 3.82 57.93 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 66' ' ' HIS . 34.2 ttpt -57.8 -36.95 72.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -1.102 . . . . 0.0 109.42 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 84.9 m 54.8 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.819 . . . . 0.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.586 ' N ' ' O ' ' A' ' 64' ' ' LYS . 83.3 t60 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.516 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -127.06 136.77 52.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.811 . . . . 0.0 109.809 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -95.92 144.16 26.48 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.242 -0.911 . . . . 0.0 109.038 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -108.25 -83.55 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 110.212 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -99.54 12.92 35.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.676 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 pt -126.67 165.98 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 110.011 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -120.79 -0.81 10.07 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.11 168.72 8.88 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -80.25 -59.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.537 2.158 . . . . 0.0 112.447 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -104.94 -3.74 22.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.964 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -116.88 175.46 5.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.394 -0.816 . . . . 0.0 109.804 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.2 p -128.66 -179.64 5.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.408 -0.807 . . . . 0.0 109.86 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.88 136.52 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.546 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.7 p90 -65.48 -40.54 93.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 83.8 tt0 -175.32 98.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB3' HD21 ' A' ' 46' ' ' ASN . 10.7 t -68.99 141.7 54.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.035 -1.04 . . . . 0.0 108.524 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.71 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 2.0 p90 -119.3 -154.3 0.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.366 -0.833 . . . . 0.0 109.599 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.71 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 88.4 m-20 -59.68 143.42 50.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.004 . . . . 0.0 109.532 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.62 9.63 7.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.882 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -51.7 -42.92 62.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.04 -1.037 . . . . 0.0 108.535 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.501 ' O ' ' OG ' ' A' ' 22' ' ' SER . 60.1 p -86.49 6.04 32.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.36 -0.837 . . . . 0.0 108.815 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 26' ' ' GLY . 10.5 p 50.19 36.02 11.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.684 . . . . 0.0 109.796 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -61.55 -51.73 67.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.099 -1.001 . . . . 0.0 109.439 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.458 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 29.3 t -68.37 -56.24 9.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 108.871 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.66 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.2 m120 -58.43 -34.88 71.29 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -57.2 -42.88 93.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.93 -47.58 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.241 -1.152 . . . . 0.0 108.628 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 95.2 m -70.37 -24.73 63.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 109.3 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 62.5 m -61.89 -31.12 71.38 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.418 -0.801 . . . . 0.0 110.95 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.47 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 1.8 mptt -52.52 -33.56 45.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.0 110.066 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -56.68 -34.01 66.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 109.404 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.44 4.71 56.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.92 -26.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -1.094 . . . . 0.0 109.29 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.66 ' NZ ' ' SG ' ' A' ' 50' ' ' CYS . 24.6 tttt -51.29 135.22 26.91 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -117.66 139.98 50.28 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.507 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.13 156.46 26.49 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.858 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' TRP . 41.9 m-85 -130.6 153.41 48.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.621 -0.929 . . . . 0.0 108.787 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -99.41 125.66 45.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.972 -1.08 . . . . 0.0 109.64 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.588 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 96.3 mt-30 -111.11 -162.05 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.599 -0.688 . . . . 0.0 109.315 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.0 pt -114.65 157.45 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -0.753 . . . . 0.0 109.807 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.8 mt -86.62 146.39 26.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.306 -0.871 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.77 -33.16 34.48 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.5 p -97.57 -124.12 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.431 -1.04 . . . . 0.0 108.94 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -111.73 132.18 54.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 109.117 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 133.31 -163.96 24.29 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 39' ' ' GLN . 2.3 t30 -140.29 165.72 26.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.222 -1.164 . . . . 0.0 109.386 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.57 162.08 26.17 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 1.0 OUTLIER -107.59 135.69 48.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.401 -1.058 . . . . 0.0 109.512 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CE3' ' OE1' ' A' ' 39' ' ' GLN . 11.4 t-105 -112.18 121.95 46.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.382 -0.824 . . . . 0.0 109.14 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.66 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 1.8 t -125.8 129.92 50.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.222 -0.923 . . . . 0.0 109.523 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mt -121.09 138.64 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.53 -0.731 . . . . 0.0 110.62 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.96 -52.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.526 -0.734 . . . . 0.0 109.534 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.6 tp -127.48 78.76 74.32 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.549 -0.719 . . . . 0.0 109.931 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' ASP . 32.3 Cg_exo -54.03 171.03 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.937 2.425 . . . . 0.0 112.321 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' PRO . 49.4 t0 59.88 146.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 64.08 48.34 3.04 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.312 -0.868 . . . . 0.0 109.142 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.63 103.23 48.34 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -91.31 130.66 1.34 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.626 2.217 . . . . 0.0 110.892 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.613 ' C ' ' H ' ' A' ' 61' ' ' ILE . 3.3 mt -64.38 -32.55 58.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.114 -0.991 . . . . 0.0 110.506 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 55.24 1.53 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.306 -0.871 . . . . 0.0 109.14 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.613 ' H ' ' C ' ' A' ' 59' ' ' ILE . 5.1 mt -130.61 81.05 68.75 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.494 -0.754 . . . . 0.0 109.672 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.11 54.04 4.58 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.916 2.411 . . . . 0.0 111.944 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.77 0.09 75.82 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.81 -40.59 84.56 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.705 -0.879 . . . . 0.0 109.785 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.9 t -59.85 -32.72 70.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.476 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -127.7 138.56 52.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.177 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 79.3 m-20 -99.32 148.59 24.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.012 -1.055 . . . . 0.0 109.396 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.81 -82.88 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 110.473 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -99.03 5.84 46.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.631 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 48' ' ' CYS . 33.5 pt -117.34 161.46 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 110.34 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.03 -5.79 11.96 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.57 156.0 39.52 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.51 -51.5 0.53 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.47 2.114 . . . . 0.0 112.598 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -114.88 1.76 14.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.145 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -125.72 170.4 11.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 109.925 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.8 m -110.23 178.1 4.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.442 -0.787 . . . . 0.0 109.319 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -101.11 126.85 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.612 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -74.75 -32.51 62.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.096 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -172.15 98.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.452 -0.78 . . . . 0.0 108.99 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.3 t -73.46 108.35 6.27 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.014 -1.054 . . . . 0.0 109.004 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.6 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -48.32 148.06 2.06 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.6 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 59.6 t0 -73.43 116.79 14.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.96 . . . . 0.0 110.516 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.52 147.97 40.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.809 . . . . 0.0 109.138 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -58.57 -44.67 89.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.012 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 t 172.93 73.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.42 -0.8 . . . . 0.0 109.244 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 p -152.94 -50.47 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.113 -0.992 . . . . 0.0 110.087 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -58.16 -51.84 68.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.976 -1.078 . . . . 0.0 109.848 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -66.29 -44.35 83.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.148 -0.97 . . . . 0.0 108.757 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.692 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.1 m120 -58.44 -37.38 75.3 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.48 -42.03 98.89 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.67 -43.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -1.116 . . . . 0.0 109.148 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.0 m -63.93 -30.03 71.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.396 -0.815 . . . . 0.0 109.394 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.4 m -57.82 -42.61 84.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -61.91 -45.39 93.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -0.954 . . . . 0.0 108.894 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.28 -29.31 69.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.445 -0.785 . . . . 0.0 109.323 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.22 7.6 55.93 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.487 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -69.85 175.41 4.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -1.014 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -78.62 -77.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.026 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.7 p -143.76 166.7 24.15 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -142.58 154.56 25.26 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.568 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 57.9 m-85 -122.27 133.95 54.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.357 -1.084 . . . . 0.0 109.552 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.649 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 1.1 m -99.81 121.54 41.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.367 -0.833 . . . . 0.0 109.191 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -141.07 -136.54 0.11 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.091 -1.006 . . . . 0.0 109.623 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.1 mt -95.81 139.66 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.2 tp -55.99 -37.13 68.68 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.46 -69.0 0.27 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.4 p -105.66 -63.44 1.25 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -126.84 148.72 49.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.79 -178.86 39.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -122.72 150.94 42.08 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.483 -1.01 . . . . 0.0 109.667 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.92 162.59 26.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.649 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 4.2 t -140.2 135.94 32.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -1.087 . . . . 0.0 109.754 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.18 133.9 51.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.219 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.487 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 12.2 t -99.92 125.51 45.93 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.9 mm -99.46 131.46 46.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 109.48 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.56 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.045 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.84 94.71 48.98 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.383 -0.823 . . . . 0.0 110.305 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.12 -8.95 17.81 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.183 1.922 . . . . 0.0 112.101 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -56.34 -35.81 68.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.324 -0.86 . . . . 0.0 109.935 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 57' ' ' VAL . 3.4 m120 -78.96 142.35 36.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.93 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.516 ' CG1' ' O ' ' A' ' 57' ' ' VAL . 12.2 p -39.72 102.38 0.26 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.629 -0.669 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 59' ' ' ILE . 50.1 Cg_endo -90.61 159.35 4.31 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.714 2.276 . . . . 0.0 111.888 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.514 ' CG2' ' O ' ' A' ' 59' ' ' ILE . 86.0 mt 39.75 60.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.372 -0.83 . . . . 0.0 110.209 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -51.51 -34.55 36.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.451 ' CG2' ' H ' ' A' ' 63' ' ' GLY . 1.4 mp -61.04 130.64 91.47 Favored Pre-proline 0 C--N 1.301 -1.53 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.677 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.29 -25.33 6.97 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.862 1.708 . . . . 0.0 111.949 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.451 ' H ' ' CG2' ' A' ' 61' ' ' ILE . . . 138.41 3.66 1.82 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -106.28 129.62 54.28 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.319 -1.107 . . . . 0.0 109.025 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.516 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 86.3 m -58.6 -28.34 65.51 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.569 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.516 ' CG ' ' O ' ' A' ' 65' ' ' CYS . 98.0 m-70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.482 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -138.24 169.23 18.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -94.14 142.57 27.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 108.42 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -106.07 -84.45 0.51 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 111.101 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -98.89 -19.21 17.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.055 . . . . 0.0 110.402 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.5 mt -106.24 132.87 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.323 -0.861 . . . . 0.0 110.15 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.59 17.74 12.81 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -124.09 155.32 67.84 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.16 -35.91 61.21 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.483 2.122 . . . . 0.0 112.27 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.542 ' CE1' HH11 ' A' ' 60' ' ' ARG . 74.4 m80 -141.8 -3.97 1.1 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.139 -0.976 . . . . 0.0 109.453 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -109.5 172.33 6.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 109.428 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.4 m -122.2 177.26 5.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.629 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -101.05 138.05 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.032 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.29 -61.26 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.456 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -173.89 98.72 0.11 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.414 -0.804 . . . . 0.0 109.121 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 29.7 p -50.62 103.24 0.05 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.253 -0.905 . . . . 0.0 108.906 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.506 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 23.7 p90 -59.91 -39.77 86.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.445 -0.785 . . . . 0.0 110.033 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.506 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 57.6 t0 -143.55 91.54 2.26 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.243 -0.91 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.64 -25.0 67.9 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.245 -0.91 . . . . 0.0 109.046 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -53.76 -38.45 64.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 108.81 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.484 ' O ' ' OG ' ' A' ' 22' ' ' SER . 74.6 m -77.57 7.71 5.23 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 26' ' ' GLY . 12.7 p 60.76 36.37 19.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.565 -0.709 . . . . 0.0 110.045 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -61.89 -54.99 34.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.957 -1.09 . . . . 0.0 108.863 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.31 -52.31 23.76 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.695 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.1 m120 -58.37 -36.74 73.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -60.29 -42.77 98.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.48 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 58.1 t -61.07 -46.94 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -1.157 . . . . 0.0 109.518 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.5 m -70.23 -33.34 71.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.272 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 38.4 m -57.32 -50.5 72.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -65.71 -37.87 87.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.414 -0.804 . . . . 0.0 109.337 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 27' ' ' VAL . 24.4 m120 -58.96 -25.47 63.57 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.42 44.05 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.17 145.68 55.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.445 -1.033 . . . . 0.0 109.248 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -59.37 -51.96 67.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 0.0 109.792 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.4 p -144.35 166.89 23.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.189 -0.945 . . . . 0.0 110.201 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.582 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.38 135.17 6.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -128.46 136.92 51.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -1.08 . . . . 0.0 109.573 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.9 t -109.0 128.62 55.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.462 -0.774 . . . . 0.0 109.585 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.612 ' NE2' ' CH2' ' A' ' 49' ' ' TRP . 0.3 OUTLIER -134.56 171.55 14.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.446 -0.784 . . . . 0.0 109.116 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.9 pt -98.13 134.62 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.13 -0.981 . . . . 0.0 109.503 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 45' ' ' GLY . 24.2 tp -130.1 125.21 34.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.651 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.23 -27.58 73.08 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.6 m -59.37 -46.55 88.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.029 -1.277 . . . . 0.0 110.039 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -125.64 16.3 8.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.447 -0.783 . . . . 0.0 109.156 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 41' ' ' LEU . . . 83.9 -56.85 5.05 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -140.77 146.05 37.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -1.131 . . . . 0.0 109.642 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.27 132.23 5.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.483 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -111.25 126.62 55.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.388 -1.066 . . . . 0.0 109.28 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.612 ' CH2' ' NE2' ' A' ' 39' ' ' GLN . 4.7 p90 -118.36 138.86 52.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.868 . . . . 0.0 109.125 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.3 m -126.1 156.15 40.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mm -110.11 122.89 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.422 -0.799 . . . . 0.0 109.296 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 1' ' ' ALA . . . -179.57 -145.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.5 tp -133.1 78.99 63.58 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.552 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -87.64 22.31 0.92 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.35 2.7 . . . . 0.0 112.057 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -52.45 -35.55 52.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.574 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -56.39 -35.35 67.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 57' ' ' VAL . 13.5 p -131.06 77.9 74.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.359 -0.838 . . . . 0.0 109.585 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 59' ' ' ILE . 73.7 Cg_endo -95.27 87.98 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 123.596 2.864 . . . . 0.0 112.287 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' PRO . 45.8 mt 43.31 55.66 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.031 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.542 HH11 ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -59.72 -41.0 89.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.135 -0.978 . . . . 0.0 109.891 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -62.96 149.72 89.68 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -46.0 -23.59 1.86 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.174 1.916 . . . . 0.0 112.05 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.404 ' H ' HG12 ' A' ' 61' ' ' ILE . . . 138.04 2.93 2.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -93.39 145.97 24.09 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.282 -1.128 . . . . 0.0 109.283 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 66' ' ' HIS . 8.6 t -58.01 -47.19 83.79 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 65' ' ' CYS . 61.8 t60 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.65 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.534 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -136.7 161.81 34.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -0.88 . . . . 0.0 109.409 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -95.1 143.41 26.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.16 -0.962 . . . . 0.0 109.108 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.486 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.79 -65.0 0.99 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.164 -0.96 . . . . 0.0 110.445 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 2.6 m-85 -109.15 0.9 20.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.514 HD11 ' HA2' ' A' ' 63' ' ' GLY . 70.3 mt -106.68 142.04 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 110.433 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.743 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -129.07 -22.7 3.13 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -103.99 157.01 34.87 Favored Pre-proline 0 N--CA 1.487 1.419 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 8' ' ' LYS . 43.9 Cg_exo -34.02 -110.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.444 2.763 . . . . 0.0 113.376 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -85.49 -2.78 58.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.768 -1.208 . . . . 0.0 109.308 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -100.28 151.48 21.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.331 -0.855 . . . . 0.0 109.466 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.67 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 57.2 m -108.27 166.18 10.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.526 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.97 133.04 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.165 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 32.3 p90 -60.71 -41.44 95.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.583 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 82.4 tt0 -175.24 93.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.279 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 47' ' ' GLY . 19.5 p -68.58 134.54 50.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.059 -1.026 . . . . 0.0 108.576 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.692 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 2.6 p90 -109.67 -152.55 0.5 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.299 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.692 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.2 m-20 -57.6 139.24 54.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.044 -1.035 . . . . 0.0 109.192 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.36 9.05 3.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.381 -0.825 . . . . 0.0 109.827 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -51.96 -42.91 63.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 108.896 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.6 m -84.69 7.12 21.52 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.339 -0.85 . . . . 0.0 108.907 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 26' ' ' GLY . 70.5 m 54.38 27.12 7.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.406 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -60.18 -52.81 63.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.1 t -66.39 -51.83 53.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 0.0 108.835 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 29' ' ' THR . 5.4 m-20 -58.65 -36.25 73.81 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.534 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . . . -57.07 -43.42 93.28 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.13 -47.11 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -1.205 . . . . 0.0 109.09 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.7 m -70.49 -24.76 62.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.635 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 25' ' ' ASN . 67.6 m -63.16 -30.39 71.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.232 -0.918 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' NZ ' ' O ' ' A' ' 26' ' ' GLY . 12.7 mptt -51.94 -33.39 37.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.921 -1.112 . . . . 0.0 110.112 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.426 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 9.2 t-20 -56.48 -33.67 66.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.04 -1.038 . . . . 0.0 109.349 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.26 2.63 54.19 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.02 -26.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -1.084 . . . . 0.0 109.132 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.631 ' CE ' ' SG ' ' A' ' 50' ' ' CYS . 15.7 tttp -52.67 137.88 29.98 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -118.23 135.15 54.44 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.143 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -144.4 162.12 27.93 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.275 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -140.65 169.87 16.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -1.078 . . . . 0.0 109.062 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 11.7 t -99.06 124.43 44.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.949 -1.095 . . . . 0.0 110.959 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -119.87 -139.88 0.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 40' ' ' ILE . 30.3 pt -110.96 142.86 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 109.699 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.0 tp -58.73 -37.28 75.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.198 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.84 -59.33 0.62 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.65 -70.63 0.76 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -1.022 . . . . 0.0 108.806 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -128.4 148.94 50.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.575 -0.703 . . . . 0.0 109.223 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.2 -168.23 35.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 16' ' ' CYS . 24.9 m120 -120.93 165.26 15.48 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.47 -1.018 . . . . 0.0 109.608 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -134.94 151.49 20.45 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.743 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -99.53 140.56 33.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -1.17 . . . . 0.0 109.755 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.486 ' CZ3' ' HB1' ' A' ' 4' ' ' ALA . 8.9 t-105 -113.45 128.19 56.36 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.631 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -126.09 135.8 52.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 109.036 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.625 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 4.5 mt -117.16 136.51 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.36 -0.837 . . . . 0.0 111.101 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 51' ' ' ILE . . . 162.17 168.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.534 HD12 ' HB1' ' A' ' 1' ' ' ALA . 3.3 tp -129.24 73.97 81.33 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.674 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 50.3 Cg_exo -49.73 -174.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.643 2.229 . . . . 0.0 111.341 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 56' ' ' ASN . 92.2 m-20 -52.1 -39.06 59.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.972 -1.08 . . . . 0.0 108.801 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER 159.97 -174.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 109.19 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.835 HG12 ' HE ' ' A' ' 60' ' ' ARG . 8.3 t 57.15 68.59 1.99 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.76 -65.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.683 2.255 . . . . 0.0 112.038 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.5 mt -117.29 125.84 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.523 -0.736 . . . . 0.0 109.103 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.835 ' HE ' HG12 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -113.83 1.68 14.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.485 -0.76 . . . . 0.0 109.193 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -132.11 155.18 81.64 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.416 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.4 -0.43 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.585 2.19 . . . . 0.0 111.685 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.514 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 102.42 -1.42 49.94 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -85.21 130.45 34.6 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -1.129 . . . . 0.0 109.479 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.67 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 2.5 m -115.03 158.98 21.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.431 -0.793 . . . . 0.0 109.471 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.424 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 58.3 t-80 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.609 ' H2 ' ' HB2' ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.805 HH21 ' HE1' ' A' ' 49' ' ' TRP . 76.1 ttt180 -126.52 132.32 51.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.447 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 75.8 m-20 -100.17 143.96 29.76 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -106.32 -83.94 0.52 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.462 -0.774 . . . . 0.0 109.266 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CE1' HD11 ' A' ' 41' ' ' LEU . 9.7 m-85 -99.78 -29.83 12.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.533 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.698 HG23 ' HA ' ' A' ' 12' ' ' CYS . 69.9 mt -102.01 138.12 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.521 -0.737 . . . . 0.0 109.665 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -117.0 20.72 13.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.443 -0.786 . . . . 0.0 110.398 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.621 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -126.35 153.13 74.74 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.083 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.409 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 11.3 Cg_endo -57.84 -29.35 85.84 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.533 2.156 . . . . 0.0 112.272 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 9' ' ' PRO . 88.5 m-70 -151.65 -6.8 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.199 -0.938 . . . . 0.0 109.316 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.488 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 56.8 m-80 -105.63 171.16 7.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.779 . . . . 0.0 109.413 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.698 ' HA ' HG23 ' A' ' 6' ' ' ILE . 73.9 m -120.85 177.08 5.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.446 -0.784 . . . . 0.0 109.466 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.54 133.51 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.968 . . . . 0.0 109.402 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -48.68 78.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.376 -0.827 . . . . 0.0 109.317 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' CYS . 11.6 pt-20 177.14 80.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 109.23 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -44.75 156.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.067 -1.021 . . . . 0.0 109.122 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.718 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 3.2 p90 -132.56 -149.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 109.331 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.718 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 59.3 t0 -57.41 132.6 53.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.128 -0.983 . . . . 0.0 109.654 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 22' ' ' SER . . . -74.98 4.48 6.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.0 109.918 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -49.82 -42.75 47.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.066 -1.022 . . . . 0.0 108.859 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.422 ' C ' ' OG ' ' A' ' 22' ' ' SER . 82.6 p -82.35 -5.48 58.63 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 0.0 109.095 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 63.29 34.36 13.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 109.577 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 27' ' ' VAL . 63.6 t80 -58.95 -48.65 80.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.999 -1.063 . . . . 0.0 109.872 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.16 -52.95 28.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 109.031 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.49 -37.64 75.98 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.328 -0.857 . . . . 0.0 108.794 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.53 93.84 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 23' ' ' TYR . 71.1 t -61.82 -42.31 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.353 -1.087 . . . . 0.0 108.798 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 65.0 m -61.66 -32.96 73.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.818 . . . . 0.0 109.372 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.3 m -57.4 -45.73 84.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 109.476 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -64.54 -43.47 93.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 108.81 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.77 -28.96 70.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.558 -0.713 . . . . 0.0 109.153 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.46 -0.87 53.35 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 28' ' ' CYS . . . -67.39 148.4 51.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.38 -1.071 . . . . 0.0 109.263 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -64.82 -60.34 3.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.063 -1.023 . . . . 0.0 110.284 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.2 p -144.21 160.91 40.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.873 -1.142 . . . . 0.0 110.567 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.71 156.17 26.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 49' ' ' TRP . 17.6 m-85 -123.65 146.21 48.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -1.102 . . . . 0.0 109.472 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 37.8 t -99.89 121.63 41.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.19 -0.944 . . . . 0.0 109.076 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -118.38 165.55 13.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.471 -0.768 . . . . 0.0 109.446 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.583 ' C ' HD22 ' A' ' 41' ' ' LEU . 36.8 pt -103.45 144.01 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 110.117 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.583 HD22 ' C ' ' A' ' 40' ' ' ILE . 4.2 mm? -107.08 139.91 40.75 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.67 -0.644 . . . . 0.0 109.508 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.8 -28.62 52.95 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 44' ' ' TYR . 45.8 p -94.82 -72.88 0.6 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -1.167 . . . . 0.0 110.649 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.448 ' N ' ' OG1' ' A' ' 43' ' ' THR . 91.7 m-85 -61.82 -39.28 91.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 110.155 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.91 -34.93 4.84 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.174 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.33 129.64 31.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -1.229 . . . . 0.0 110.293 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 160.14 26.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -111.26 135.23 52.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.378 -1.072 . . . . 0.0 109.831 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.805 ' HE1' HH21 ' A' ' 2' ' ' ARG . 4.7 t-105 -113.33 111.66 22.37 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.447 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 5.5 t -107.76 122.82 47.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.114 -0.991 . . . . 0.0 108.906 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.485 HD12 ' CE2' ' A' ' 37' ' ' TYR . 65.1 mt -117.81 135.56 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.603 -0.686 . . . . 0.0 110.096 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -174.29 -32.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.609 ' HB2' ' H2 ' ' A' ' 1' ' ' ALA . 5.2 mp -124.41 160.05 54.71 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.531 -0.731 . . . . 0.0 109.155 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -42.03 -78.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.471 2.114 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 51.0 p30 -177.03 39.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.187 -0.945 . . . . 0.0 109.511 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.63 133.85 46.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.827 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.53 ' O ' ' HB1' ' A' ' 1' ' ' ALA . 2.8 t 47.49 70.12 2.28 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.305 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.44 ' CB ' ' O ' ' A' ' 2' ' ' ARG . 68.2 Cg_endo -82.11 -68.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.832 2.355 . . . . 0.0 112.312 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.89 158.21 43.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.327 -0.858 . . . . 0.0 109.388 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -117.06 122.22 43.55 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.25 81.65 13.53 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.541 -0.724 . . . . 0.0 110.062 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.42 -4.55 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.687 2.258 . . . . 0.0 111.744 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.86 -5.52 58.15 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.42 ' O ' ' CE1' ' A' ' 66' ' ' HIS . 29.3 ttpt -60.06 -35.65 75.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -1.183 . . . . 0.0 109.508 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 15.1 m -73.34 154.03 40.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.885 . . . . 0.0 109.514 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.42 ' CE1' ' O ' ' A' ' 64' ' ' LYS . 77.5 m80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.489 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.506 HH21 ' CB ' ' A' ' 54' ' ' PRO . 40.1 ttm180 -127.77 135.33 49.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.434 -0.792 . . . . 0.0 109.65 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.441 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 84.2 m-20 -95.92 145.58 25.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.831 . . . . 0.0 108.898 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -105.1 -83.27 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.883 . . . . 0.0 110.051 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -100.93 13.02 36.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.865 . . . . 0.0 109.536 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.422 HG22 ' SG ' ' A' ' 12' ' ' CYS . 27.5 pt -121.68 161.38 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.744 . . . . 0.0 109.987 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -128.43 -2.97 5.52 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.404 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -111.04 153.2 43.97 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.517 -0.739 . . . . 0.0 109.111 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -58.55 -26.58 79.22 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.762 2.308 . . . . 0.0 113.14 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.545 ' CE1' ' NH1' ' A' ' 60' ' ' ARG . 57.4 t60 -145.15 -15.31 0.51 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.962 -1.086 . . . . 0.0 109.728 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -103.54 159.41 15.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.0 109.085 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.422 ' SG ' HG22 ' A' ' 6' ' ' ILE . 59.0 m -115.88 172.24 7.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 109.765 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.4 t -99.36 134.42 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.833 . . . . 0.0 109.297 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.426 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.3 p90 -67.85 -36.35 80.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.839 . . . . 0.0 109.45 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.0 tt0 -174.29 95.38 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 108.902 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -63.25 112.88 2.88 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.2 -0.938 . . . . 0.0 109.207 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.7 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 3.2 p90 -76.3 -157.07 0.07 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.191 -0.943 . . . . 0.0 108.911 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.7 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.6 m-20 -61.54 130.51 46.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.025 -1.047 . . . . 0.0 109.255 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.29 26.65 10.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.468 -0.77 . . . . 0.0 109.261 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.22 -45.86 75.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 109.578 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.601 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.0 m -62.46 -50.45 71.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 0.0 109.469 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.601 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.9 m 150.51 33.24 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.43 -71.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.801 -1.187 . . . . 0.0 109.996 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.5 t -61.86 -49.78 74.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 36' ' ' GLY . 21.2 m-20 -57.79 -37.53 73.89 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -58.23 -40.86 94.45 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 7' ' ' ALA . 64.7 t -61.95 -48.7 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -1.207 . . . . 0.0 109.063 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.5 m -70.8 -22.07 62.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.378 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 64.8 m -63.1 -38.23 90.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.344 -0.848 . . . . 0.0 111.28 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -32.08 51.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.016 . . . . 0.0 109.91 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -55.33 -31.5 61.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 109.333 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 101.64 3.96 52.52 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 179.4 -26.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -1.154 . . . . 0.0 109.68 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.525 ' CE ' ' SG ' ' A' ' 50' ' ' CYS . 32.6 tttt -55.08 130.9 43.64 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.7 p -112.83 140.03 47.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.68 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.445 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -143.7 166.96 26.81 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.041 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.649 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -140.54 160.46 39.97 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 47.1 t -99.83 121.4 41.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.983 -1.073 . . . . 0.0 109.757 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.406 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 80.3 mt-30 -109.05 167.22 10.26 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.2 pt -93.97 137.47 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.078 -1.013 . . . . 0.0 109.593 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 41' ' ' LEU . 5.8 tt -59.9 -35.04 74.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 108.735 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.434 ' C ' ' OG1' ' A' ' 43' ' ' THR . . . 133.01 -28.36 3.35 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.434 ' OG1' ' C ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 177.55 -40.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -1.021 . . . . 0.0 109.168 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.596 ' HB2' HD13 ' A' ' 41' ' ' LEU . 98.7 m-85 -65.28 -34.72 79.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.787 . . . . 0.0 110.119 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 41' ' ' LEU . . . 175.27 -154.34 17.72 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.349 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.414 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 56.7 m-80 -121.06 159.9 24.75 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.524 -0.986 . . . . 0.0 109.394 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.1 161.35 25.96 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.697 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -105.89 129.72 53.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -1.044 . . . . 0.0 109.674 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 3' ' ' ASP . 0.9 OUTLIER -111.04 116.87 31.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 108.812 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.525 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 3.9 t -107.62 119.68 40.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.93 134.8 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.561 -0.712 . . . . 0.0 110.444 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.459 ' HB3' ' HG3' ' A' ' 34' ' ' LYS . . . 179.16 -42.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 53' ' ' LEU . 46.3 tp -130.03 73.16 81.62 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.497 -0.752 . . . . 0.0 109.677 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.506 ' CB ' HH21 ' A' ' 2' ' ' ARG . 72.0 Cg_endo -84.87 33.02 0.48 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.943 2.428 . . . . 0.0 112.343 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -51.48 -36.26 43.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.095 -1.003 . . . . 0.0 109.126 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -130.07 -24.49 2.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 109.632 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 57' ' ' VAL . 94.6 t 50.4 64.09 8.9 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 109.636 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -94.71 156.65 1.88 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.376 2.717 . . . . 0.0 111.561 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.66 122.26 63.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.422 -0.799 . . . . 0.0 109.137 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.545 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -97.97 90.97 5.1 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.24 -0.913 . . . . 0.0 109.579 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -128.88 77.53 77.62 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.492 -0.755 . . . . 0.0 109.709 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -79.03 16.77 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.769 2.313 . . . . 0.0 111.717 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.61 -20.79 43.01 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -60.85 -39.52 89.43 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.403 -1.057 . . . . 0.0 109.47 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 14.1 t -59.15 -34.94 72.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.312 -0.867 . . . . 0.0 109.602 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.446 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.448 ' NH1' ' CZ2' ' A' ' 49' ' ' TRP . 66.0 ttp85 -124.38 130.63 52.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.792 . . . . 0.0 109.514 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -100.06 145.11 28.3 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.093 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -108.56 -85.46 0.53 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.52 -0.738 . . . . 0.0 109.073 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -99.36 -28.28 13.36 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.169 -0.957 . . . . 0.0 109.344 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.582 HG23 ' HA ' ' A' ' 12' ' ' CYS . 90.9 mt -103.56 139.89 23.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.56 -0.713 . . . . 0.0 110.196 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.77 -7.78 18.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.495 -0.753 . . . . 0.0 109.104 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.3 mtmt -126.43 89.54 51.99 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.93 -27.82 6.32 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.278 1.985 . . . . 0.0 112.185 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -86.01 -19.95 29.58 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.229 -0.92 . . . . 0.0 108.89 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 8' ' ' LYS . 5.4 m120 -140.62 -150.7 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.801 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.582 ' HA ' HG23 ' A' ' 6' ' ' ILE . 69.0 m -140.65 178.38 7.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.623 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.79 128.15 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.001 . . . . 0.0 109.238 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.598 ' HH ' ' HH ' ' A' ' 23' ' ' TYR . 30.8 p90 -68.27 -34.79 76.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -172.15 93.74 0.14 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.539 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -71.06 125.12 26.03 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.993 -1.067 . . . . 0.0 108.164 179.202 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 70.5 t80 -91.83 160.09 15.48 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 109.821 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.493 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 89.2 m-20 -42.45 126.81 3.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.69 -11.88 60.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.54 -0.725 . . . . 0.0 109.506 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -52.21 -46.24 65.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.352 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 27.2 m -66.55 -62.23 1.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.178 -0.951 . . . . 0.0 109.25 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.0 m 153.12 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.598 ' HH ' ' HH ' ' A' ' 14' ' ' TYR . 65.9 t80 -58.79 -53.59 56.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.996 . . . . 0.0 110.54 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.7 t -65.68 -40.54 92.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.077 -1.014 . . . . 0.0 109.075 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.44 ' O ' ' OG1' ' A' ' 29' ' ' THR . 10.2 m-20 -59.41 -38.64 81.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.461 -0.775 . . . . 0.0 109.207 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.427 ' O ' ' CD ' ' A' ' 30' ' ' LYS . . . -62.97 -48.59 79.33 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.19 -43.18 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -1.163 . . . . 0.0 109.065 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 33' ' ' ALA . 34.1 t -63.84 -35.05 79.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.51 -0.744 . . . . 0.0 109.71 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 55.3 m -56.13 -42.37 76.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 13.4 mptt -59.87 -38.03 81.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.026 -1.046 . . . . 0.0 109.202 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -58.97 -29.18 66.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.346 -0.846 . . . . 0.0 109.021 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.5 -0.36 55.62 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.553 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -68.63 150.46 47.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.43 -1.041 . . . . 0.0 109.501 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.925 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 7.8 ttmt -57.66 -60.15 4.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.879 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -143.85 161.49 38.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.237 -0.915 . . . . 0.0 109.433 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.27 158.5 27.27 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.582 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 49' ' ' TRP . 30.5 m-85 -136.01 161.2 36.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.504 -0.997 . . . . 0.0 109.16 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 17' ' ' PHE . 0.8 OUTLIER -99.05 123.8 43.6 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.085 -1.009 . . . . 0.0 109.516 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.523 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 33.2 tt0 -106.14 154.17 21.06 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.6 pt -93.45 147.1 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.903 -1.123 . . . . 0.0 110.785 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.742 HD12 ' HA3' ' A' ' 45' ' ' GLY . 78.9 mt -82.4 154.38 25.23 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -44.74 -18.84 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 45' ' ' GLY . 19.3 p -117.74 173.42 6.76 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.76 -0.847 . . . . 0.0 108.783 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -47.7 -8.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 109.888 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.742 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -62.32 162.74 27.99 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 51.8 t-20 -140.66 155.77 46.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -1.109 . . . . 0.0 109.842 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 46' ' ' ASN . . . -140.87 174.7 22.55 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -106.32 158.09 17.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -1.099 . . . . 0.0 109.563 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.491 ' N ' ' O ' ' A' ' 37' ' ' TYR . 7.2 t-105 -130.66 140.75 50.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.0 m -135.08 131.49 37.03 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.027 -1.046 . . . . 0.0 110.058 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -125.32 132.87 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.464 -0.772 . . . . 0.0 109.673 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.925 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -178.52 -43.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tp -132.84 74.9 73.62 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 109.514 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.27 166.58 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.973 2.449 . . . . 0.0 112.652 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 57.07 45.84 20.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.627 -0.671 . . . . 0.0 110.137 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' A' ' 57' ' ' VAL . 22.0 t-20 -146.11 158.99 43.89 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.152 -0.967 . . . . 0.0 109.355 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 56' ' ' ASN . 2.4 t -37.38 100.24 0.2 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.671 -0.643 . . . . 0.0 109.388 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.427 ' N ' ' O ' ' A' ' 56' ' ' ASN . 98.2 Cg_endo -85.71 -67.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.39 2.06 . . . . 0.0 112.828 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.0 mt -121.48 133.31 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -0.804 . . . . 0.0 109.764 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -130.34 82.76 2.08 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.7 mt -128.3 86.04 58.92 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.513 -0.742 . . . . 0.0 109.755 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.94 -19.37 5.49 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.3 2.0 . . . . 0.0 111.918 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.13 -0.34 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -59.19 -35.44 73.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -1.178 . . . . 0.0 109.683 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.55 130.6 45.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 109.526 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.438 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.469 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.763 ' NE ' ' HE1' ' A' ' 49' ' ' TRP . 65.2 ttt180 -128.06 133.74 49.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.773 . . . . 0.0 109.705 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -110.79 151.04 28.26 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.606 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.5 -69.78 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.239 -0.913 . . . . 0.0 110.728 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -101.16 -4.26 27.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 0.0 110.46 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.707 HG22 ' H ' ' A' ' 8' ' ' LYS . 63.9 mt -109.09 139.07 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.885 . . . . 0.0 110.509 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -116.28 13.44 15.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.406 -0.809 . . . . 0.0 109.226 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.707 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -125.0 154.77 71.3 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.497 -0.752 . . . . 0.0 109.248 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.34 -36.59 55.11 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.439 2.092 . . . . 0.0 112.352 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -138.55 -3.7 1.67 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.5 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 55.0 m-80 -112.11 169.12 9.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -0.816 . . . . 0.0 109.467 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.634 ' HA ' HG23 ' A' ' 6' ' ' ILE . 3.2 m -116.65 -179.9 3.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.413 -0.804 . . . . 0.0 109.56 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.585 HG21 ' HB2' ' A' ' 48' ' ' CYS . 43.8 t -99.42 134.39 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.194 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.542 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.2 p90 -69.4 -43.02 74.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.855 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 81.4 tt0 -175.51 99.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.003 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -69.32 103.02 1.86 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.069 -1.019 . . . . 0.0 109.023 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 0.7 OUTLIER -45.62 150.79 0.47 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 108.725 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 60.5 t0 -72.17 115.02 10.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.17 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -145.48 150.17 35.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.234 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' ' CB ' ' A' ' 21' ' ' SER . 97.4 m-85 -59.36 -40.37 86.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.958 . . . . 0.0 109.241 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.447 ' CB ' HD22 ' A' ' 25' ' ' ASN . 0.4 OUTLIER 170.06 78.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.404 -0.81 . . . . 0.0 109.278 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.45 -66.66 0.14 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.033 -1.042 . . . . 0.0 110.024 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.46 -50.73 72.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.952 . . . . 0.0 109.961 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.9 t -68.94 -44.33 73.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.344 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.447 HD22 ' CB ' ' A' ' 21' ' ' SER . 7.6 m-20 -59.55 -38.85 82.17 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.389 -0.819 . . . . 0.0 109.286 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.85 98.28 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.576 ' CG1' ' NZ ' ' A' ' 8' ' ' LYS . 83.2 t -66.1 -42.04 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.427 -1.043 . . . . 0.0 109.232 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 33' ' ' ALA . 43.2 t -61.87 -34.62 76.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.451 -0.781 . . . . 0.0 109.549 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.0 m -55.54 -42.46 74.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.728 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -60.19 -37.06 79.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.129 -0.982 . . . . 0.0 109.01 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -57.81 -29.82 65.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.465 -0.772 . . . . 0.0 109.03 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.88 -2.36 48.38 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . . . -68.04 146.67 53.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 109.303 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -57.53 -53.35 59.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.531 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.9 p -144.4 160.49 40.98 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.354 -0.842 . . . . 0.0 109.288 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.84 149.41 21.41 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.351 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 49' ' ' TRP . 85.6 m-85 -125.18 151.36 45.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.576 -0.955 . . . . 0.0 108.804 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.567 ' SG ' ' OD1' ' A' ' 46' ' ' ASN . 48.9 t -100.23 122.82 43.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.042 -1.037 . . . . 0.0 110.219 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.594 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 94.9 mt-30 -120.01 -167.16 1.39 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.1 pt -115.54 156.03 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.443 -0.786 . . . . 0.0 109.793 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.425 HD23 ' CA ' ' A' ' 46' ' ' ASN . 3.5 mm? -60.25 -23.53 64.16 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.418 -0.802 . . . . 0.0 109.207 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' THR . . . 102.24 0.14 50.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 42' ' ' GLY . 9.1 p -154.55 -81.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.8 142.09 51.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.498 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.68 -177.05 41.78 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 39' ' ' GLN . 16.8 t-20 -140.57 160.6 39.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.455 -1.027 . . . . 0.0 108.886 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.24 163.49 26.36 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.548 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.585 ' HB2' HG21 ' A' ' 13' ' ' VAL . 1.1 m -105.99 153.62 21.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.531 -0.982 . . . . 0.0 109.142 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.763 ' HE1' ' NE ' ' A' ' 2' ' ' ARG . 11.5 t-105 -116.81 137.57 52.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.343 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.7 m -132.63 134.23 44.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.241 -0.912 . . . . 0.0 109.855 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mt -123.6 135.31 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.598 -0.689 . . . . 0.0 110.025 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 33' ' ' ALA . . . -158.33 -59.21 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.388 -0.82 . . . . 0.0 109.326 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.48 79.71 72.94 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -50.13 -179.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.957 2.438 . . . . 0.0 112.665 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 56.64 42.85 26.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.62 -0.675 . . . . 0.0 109.482 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.469 ' ND2' ' HB2' ' A' ' 1' ' ' ALA . 46.8 t-20 -148.34 117.42 6.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.257 -0.902 . . . . 0.0 109.34 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.806 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.6 p -124.33 74.43 60.31 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.673 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 59' ' ' ILE . 69.2 Cg_endo -79.76 -61.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.843 2.362 . . . . 0.0 112.118 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 59' ' ' ILE . 83.3 mt 40.25 61.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.472 -0.768 . . . . 0.0 109.977 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -51.48 -34.57 36.23 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.832 HG22 ' H ' ' A' ' 63' ' ' GLY . 1.3 mp -64.43 129.53 94.21 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.51 29.06 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.069 1.846 . . . . 0.0 112.186 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.832 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 97.19 3.32 58.9 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.675 ' O ' HG23 ' A' ' 61' ' ' ILE . 6.3 mtpm? -126.76 136.04 51.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.484 -1.01 . . . . 0.0 109.164 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 75.5 m -60.18 -27.33 67.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.938 . . . . 0.0 109.549 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.516 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.672 ' H1 ' ' H ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -125.96 132.87 51.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.422 -0.799 . . . . 0.0 109.317 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -96.99 136.97 36.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.143 -0.973 . . . . 0.0 109.302 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.541 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -103.32 -59.29 1.74 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.388 -0.82 . . . . 0.0 110.333 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -112.5 9.63 19.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.365 -0.835 . . . . 0.0 110.57 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.431 HD13 HG21 ' A' ' 59' ' ' ILE . 18.4 pt -124.99 163.94 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -0.964 . . . . 0.0 110.252 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.622 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -131.24 -13.28 3.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.469 -0.77 . . . . 0.0 109.038 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.483 ' HB2' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -102.39 152.89 38.39 Favored Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.338 -0.851 . . . . 0.0 109.157 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.35 -34.23 67.38 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.543 2.162 . . . . 0.0 112.875 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.545 ' ND1' ' NH2' ' A' ' 60' ' ' ARG . 91.7 m-70 -133.21 3.15 3.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 110.06 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.483 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 35.7 m-80 -131.37 168.9 16.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.814 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 40.6 m -114.8 179.65 3.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.504 -0.748 . . . . 0.0 109.505 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.476 HG21 ' SG ' ' A' ' 48' ' ' CYS . 45.6 t -95.96 135.06 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.23 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.563 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 32.2 p90 -65.18 -44.43 88.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.563 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 83.3 tt0 -175.56 96.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.059 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.432 ' HB3' HD22 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -66.23 135.46 54.51 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 108.6 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.714 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 2.1 p90 -108.75 -149.47 0.44 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.485 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.714 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 59.0 t0 -56.56 131.88 49.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.048 -1.033 . . . . 0.0 109.39 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.3 4.48 2.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.793 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -51.5 -43.21 62.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.065 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.9 m -85.06 6.45 25.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.031 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 26' ' ' GLY . 38.1 m 48.39 37.94 9.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.856 . . . . 0.0 109.397 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.469 ' O ' HG23 ' A' ' 27' ' ' VAL . 59.2 t80 -59.31 -49.8 76.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.975 . . . . 0.0 109.959 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 33.8 t -69.02 -57.23 5.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.19 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -57.85 -35.65 71.24 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.07 -40.46 95.62 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 23' ' ' TYR . 74.0 t -61.95 -46.72 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.266 -1.138 . . . . 0.0 108.852 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.9 m -70.3 -25.55 63.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.404 -0.81 . . . . 0.0 109.511 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 m -62.79 -29.78 70.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.277 -0.889 . . . . 0.0 111.225 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.489 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 3.9 mptp? -52.86 -34.14 53.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.95 -1.094 . . . . 0.0 110.477 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -56.64 -33.29 66.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.977 -1.077 . . . . 0.0 109.368 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.45 2.93 55.53 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -171.09 -28.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -1.078 . . . . 0.0 108.903 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.658 ' NZ ' ' SG ' ' A' ' 50' ' ' CYS . 24.4 tttt -53.34 134.37 39.84 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.7 m -116.79 139.24 50.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.4 -0.812 . . . . 0.0 109.618 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.19 156.24 26.4 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 49' ' ' TRP . 49.6 m-85 -127.08 154.18 45.03 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.5 t -99.52 122.51 42.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.004 -1.06 . . . . 0.0 109.275 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -123.99 -172.88 2.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.556 -0.715 . . . . 0.0 109.511 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 42' ' ' GLY . 69.3 mt -93.62 145.58 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.882 . . . . 0.0 109.403 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 44' ' ' TYR . 29.7 tp -53.22 -39.19 63.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.504 ' H ' HG22 ' A' ' 40' ' ' ILE . . . 130.15 -56.43 0.74 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.8 m -97.99 -67.88 0.83 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.518 -0.989 . . . . 0.0 108.67 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.517 ' O ' HD23 ' A' ' 41' ' ' LEU . 27.5 p90 -139.64 159.58 41.85 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.87 -164.77 46.87 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.432 HD22 ' HB3' ' A' ' 16' ' ' CYS . 15.8 t30 -140.77 161.69 37.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.3 -1.118 . . . . 0.0 109.389 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.29 159.11 26.14 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.709 -1.234 . . . . 0.0 110.16 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.622 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -103.68 157.45 17.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.352 -1.087 . . . . 0.0 109.168 179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 4' ' ' ALA . 7.5 t-105 -125.68 122.12 35.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.528 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.658 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -123.2 135.87 54.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.0 109.118 179.385 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 4.1 mt -117.95 134.51 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.699 0.761 . . . . 0.0 111.043 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 51' ' ' ILE . . . 169.07 147.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.71 73.7 81.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.673 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -84.37 -93.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.992 2.461 . . . . 0.0 112.367 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -94.37 11.41 30.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 0.0 109.449 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 62.26 45.01 7.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.407 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.672 ' H ' ' H1 ' ' A' ' 1' ' ' ALA . 10.2 t -68.95 119.58 70.67 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.343 -0.848 . . . . 0.0 109.285 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.88 165.07 7.41 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.277 1.984 . . . . 0.0 111.032 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.527 HG22 HG12 ' A' ' 61' ' ' ILE . 22.3 mm -109.02 130.83 61.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.176 -0.953 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.545 ' NH2' ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -119.28 86.72 2.6 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.527 HG12 HG22 ' A' ' 59' ' ' ILE . 1.9 pt -124.43 81.53 59.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.811 . . . . 0.0 109.745 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -53.31 -18.92 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.666 2.244 . . . . 0.0 112.048 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.66 -12.5 0.11 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -58.75 -33.13 69.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -1.171 . . . . 0.0 109.62 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.0 t -56.62 -33.39 66.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.441 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 78.8 m80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.457 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -128.46 138.1 52.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.379 -0.826 . . . . 0.0 109.858 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 90.3 m-20 -108.05 150.38 27.23 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.77 -85.46 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -98.67 5.95 47.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.954 -1.091 . . . . 0.0 109.572 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.647 HG22 ' HB3' ' A' ' 12' ' ' CYS . 21.5 pt -111.42 149.06 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.544 -0.722 . . . . 0.0 109.744 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.635 ' O ' HG11 ' A' ' 27' ' ' VAL . . . -102.57 -1.92 29.46 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.242 -0.911 . . . . 0.0 108.977 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.47 173.27 6.07 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.535 -0.728 . . . . 0.0 109.289 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -48.63 -76.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.644 2.23 . . . . 0.0 113.367 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.518 ' CG ' HH11 ' A' ' 60' ' ' ARG . 78.2 m-70 -107.52 -8.87 16.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.162 -0.961 . . . . 0.0 110.159 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -102.31 155.55 18.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.396 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.647 ' HB3' HG22 ' A' ' 6' ' ' ILE . 13.9 p -120.98 177.04 5.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.124 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 7' ' ' ALA . 77.8 t -104.97 136.24 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 0.0 110.004 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -82.68 -32.28 28.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.0 109.049 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -174.3 98.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.777 . . . . 0.0 109.077 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' H ' ' ND2' ' A' ' 46' ' ' ASN . 3.7 p -66.18 104.78 1.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.118 -0.989 . . . . 0.0 108.52 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 6.0 p90 -53.58 -42.76 67.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 110.34 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.561 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 54.7 t0 -148.1 78.45 1.44 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.966 -1.084 . . . . 0.0 109.836 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.7 -30.87 71.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.199 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.88 -40.86 73.56 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.433 -0.792 . . . . 0.0 109.256 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.592 ' O ' ' CB ' ' A' ' 22' ' ' SER . 17.5 t -57.57 -52.11 66.73 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.5 m 155.47 10.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.72 -0.613 . . . . 0.0 110.091 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -60.04 -63.22 1.38 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.81 -1.181 . . . . 0.0 110.142 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.28 -51.86 57.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.114 -0.991 . . . . 0.0 108.958 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -60.02 -35.7 75.65 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -57.81 -43.51 94.63 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.635 HG11 ' O ' ' A' ' 7' ' ' ALA . 91.6 t -62.94 -43.42 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -1.173 . . . . 0.0 108.689 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 60.0 m -64.12 -31.67 72.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.848 . . . . 0.0 109.168 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.4 m -58.83 -48.65 80.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.655 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -64.27 -41.9 96.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.398 -0.814 . . . . 0.0 109.192 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -62.28 -30.82 71.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.535 -0.728 . . . . 0.0 109.048 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.99 2.7 56.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.493 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -66.92 152.9 44.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.335 -1.097 . . . . 0.0 109.631 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.775 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 9.5 ttmt -58.46 -71.3 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 110.111 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.0 p -144.77 169.33 18.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.315 -0.866 . . . . 0.0 110.22 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.12 151.06 22.6 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.13 135.82 54.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.27 -1.135 . . . . 0.0 109.895 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.63 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.5 t -111.48 115.23 28.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.239 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -131.66 166.13 22.15 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.5 pt -104.87 145.86 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.977 . . . . 0.0 111.267 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.08 142.32 41.7 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.21 -30.04 53.92 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.2 m -92.09 -74.07 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.083 -1.245 . . . . 0.0 110.772 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -61.52 -40.62 95.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.191 -0.943 . . . . 0.0 110.482 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.47 -31.31 7.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 16' ' ' CYS . 20.3 t-20 -140.47 125.08 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.261 . . . . 0.0 110.008 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.31 112.52 0.81 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.63 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -110.6 117.57 33.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -1.087 . . . . 0.0 109.53 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.37 131.44 54.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.5 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 7.1 t -105.45 122.65 46.43 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -112.53 132.67 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.831 . . . . 0.0 110.429 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.775 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -175.39 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.665 -0.647 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.484 HD23 ' ND2' ' A' ' 56' ' ' ASN . 1.0 OUTLIER -128.93 84.51 62.87 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.57 -0.706 . . . . 0.0 109.732 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.547 ' O ' HG13 ' A' ' 57' ' ' VAL . 36.9 Cg_endo -74.55 -13.07 22.57 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.285 1.99 . . . . 0.0 112.616 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -57.65 -37.46 73.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.051 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.507 ' O ' ' C ' ' A' ' 57' ' ' VAL . 89.2 m-20 -67.05 -40.78 87.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.053 -1.029 . . . . 0.0 110.497 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER 32.93 67.63 1.03 Allowed Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.795 -0.566 . . . . 0.0 109.962 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.471 ' O ' ' C ' ' A' ' 59' ' ' ILE . 68.7 Cg_endo -78.75 -65.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.8 2.333 . . . . 0.0 112.708 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 59' ' ' ILE . 95.8 mt 39.93 58.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.353 -0.842 . . . . 0.0 109.259 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.518 HH11 ' CG ' ' A' ' 10' ' ' HIS . 12.6 ptm180 -55.03 -37.45 66.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.972 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.67 ' O ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -95.97 154.33 38.98 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.184 -0.948 . . . . 0.0 109.545 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.68 -20.33 70.67 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.555 2.17 . . . . 0.0 112.107 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.98 15.95 0.1 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -92.65 155.92 17.42 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.267 -1.137 . . . . 0.0 109.239 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.09 -36.43 65.64 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 83.1 t60 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.423 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.453 ' H ' ' HB3' ' A' ' 58' ' ' PRO . 71.1 ttp85 -128.11 135.3 49.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 87.5 m-20 -96.86 147.18 24.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.941 . . . . 0.0 109.376 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -113.45 -94.25 0.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 109.35 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -98.83 7.54 45.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.012 -1.055 . . . . 0.0 108.952 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.5 pt -117.34 155.79 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.701 -0.624 . . . . 0.0 109.87 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.626 ' H ' HG23 ' A' ' 13' ' ' VAL . . . -112.12 5.13 18.39 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.14 165.25 21.38 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.48 -59.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.408 2.072 . . . . 0.0 112.147 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -105.79 -6.4 19.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.798 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -114.31 164.28 14.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.422 -0.799 . . . . 0.0 109.799 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.6 m -112.43 176.89 4.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.614 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.626 HG23 ' H ' ' A' ' 7' ' ' ALA . 39.9 t -102.08 130.99 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.236 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.436 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.2 p90 -74.13 -36.32 64.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.294 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.1 tt0 -174.76 99.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -65.5 109.34 2.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.59 ' CE2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -61.45 162.09 8.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.59 ' O ' ' CE2' ' A' ' 17' ' ' PHE . 61.1 t0 -44.22 107.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.113 -0.992 . . . . 0.0 108.993 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.584 ' CB ' ' H ' ' A' ' 24' ' ' CYS . . . -95.61 29.94 2.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.814 . . . . 0.0 109.829 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -53.49 -46.08 69.89 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.115 -0.991 . . . . 0.0 108.865 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.587 ' O ' ' CB ' ' A' ' 22' ' ' SER . 20.2 m -64.53 -49.44 71.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.319 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.587 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.4 m 152.2 26.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -58.61 -56.78 17.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.744 -1.223 . . . . 0.0 109.767 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.584 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 38.1 t -67.27 -42.42 83.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 108.832 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 36' ' ' GLY . 5.0 m-20 -59.46 -38.85 81.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.87 -39.3 97.85 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.48 -47.79 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.197 -1.178 . . . . 0.0 109.349 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 1.3 m -70.74 -31.36 68.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.336 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.8 m -53.46 -48.52 68.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.231 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -64.93 -38.17 90.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.442 -0.786 . . . . 0.0 109.0 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -59.59 -28.43 67.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -0.79 . . . . 0.0 108.988 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.36 0.2 40.57 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 28' ' ' CYS . . . -65.29 145.68 55.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -1.114 . . . . 0.0 109.14 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.737 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 4.1 ttmt -60.56 -52.6 64.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 110.135 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -143.55 160.47 40.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.127 -0.983 . . . . 0.0 110.317 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.452 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -139.05 140.15 10.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -130.14 136.72 49.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -1.097 . . . . 0.0 109.755 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.0 t -105.05 130.94 53.13 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.353 -0.842 . . . . 0.0 109.501 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.688 ' NE2' ' N ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -134.67 173.0 12.15 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.493 -0.755 . . . . 0.0 109.274 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.2 pt -95.77 141.3 15.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.453 HD12 ' HA3' ' A' ' 45' ' ' GLY . 76.0 mt -59.13 -34.95 72.65 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.293 -0.88 . . . . 0.0 109.245 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.57 -60.82 0.52 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.67 -70.44 0.75 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.38 -1.071 . . . . 0.0 109.063 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -129.44 151.16 50.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.609 -0.682 . . . . 0.0 109.538 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 93.45 174.8 40.3 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -140.44 167.11 22.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.322 -1.105 . . . . 0.0 109.578 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.489 ' O ' ' OE1' ' A' ' 39' ' ' GLN . . . -140.41 150.41 21.59 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -134.0 125.6 28.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -1.067 . . . . 0.0 109.231 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.547 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 2.8 p90 -120.69 141.27 50.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.113 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.435 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 74.9 m -128.98 145.0 51.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.451 -0.78 . . . . 0.0 109.103 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.69 137.85 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.858 ' C ' HD23 ' A' ' 53' ' ' LEU . . . -169.66 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.926 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.858 HD23 ' C ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -128.0 78.45 75.24 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.892 . . . . 0.0 109.659 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -60.7 -23.66 76.71 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.382 2.055 . . . . 0.0 111.782 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.07 -36.45 77.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 109.785 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.476 ' O ' ' C ' ' A' ' 57' ' ' VAL . 50.6 t-20 -68.06 129.08 38.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.476 ' C ' ' O ' ' A' ' 56' ' ' ASN . 52.5 t -38.15 100.42 0.21 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.803 -0.561 . . . . 0.0 109.539 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HB3' ' H ' ' A' ' 2' ' ' ARG . 75.4 Cg_endo -90.3 155.76 4.58 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.627 2.218 . . . . 0.0 111.69 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 59' ' ' ILE . 89.3 mt 41.25 55.17 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 109.607 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -58.57 -35.87 73.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.476 HG13 ' H ' ' A' ' 63' ' ' GLY . 10.0 pt -60.62 148.56 81.26 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 0.0 109.35 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.79 1.22 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.465 2.11 . . . . 0.0 112.006 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.476 ' H ' HG13 ' A' ' 61' ' ' ILE . . . 100.11 5.82 54.36 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 66' ' ' HIS . 39.3 mtpt -103.46 122.62 45.28 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.388 -1.066 . . . . 0.0 108.816 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.407 ' O ' ' OXT' ' A' ' 66' ' ' HIS . 81.1 m -64.26 -22.99 67.14 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.428 -0.795 . . . . 0.0 110.006 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.407 ' OXT' ' O ' ' A' ' 65' ' ' CYS . 37.5 m80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.425 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -129.05 135.78 49.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.424 -0.797 . . . . 0.0 109.687 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.485 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 87.3 m-20 -103.37 155.91 18.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 108.89 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -110.5 -93.48 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 110.323 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -98.2 -10.88 23.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.067 -1.02 . . . . 0.0 109.64 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.712 HG23 ' HA ' ' A' ' 12' ' ' CYS . 60.8 mt -111.0 130.58 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.555 -0.716 . . . . 0.0 109.544 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.64 -12.61 19.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.422 -0.799 . . . . 0.0 110.107 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.444 ' HB2' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -104.08 153.26 39.03 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.274 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.12 -35.8 62.27 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.487 2.125 . . . . 0.0 112.942 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -131.14 -0.9 4.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.948 . . . . 0.0 110.11 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.491 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 34.6 m-80 -125.91 164.55 20.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.342 -0.849 . . . . 0.0 109.78 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.712 ' HA ' HG23 ' A' ' 6' ' ' ILE . 56.7 m -115.42 160.33 20.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.0 109.476 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.78 131.59 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 29.9 p90 -75.13 -43.46 52.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.93 . . . . 0.0 109.459 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.535 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.3 tt0 -175.9 100.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 109.215 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -68.38 93.37 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.089 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.527 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 21.2 p90 -63.42 -43.32 97.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 109.895 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.527 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 47.8 t0 -153.49 89.45 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.126 -0.984 . . . . 0.0 109.849 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.506 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . . . -64.58 -28.68 69.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.128 -0.983 . . . . 0.0 109.275 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -54.49 -40.37 68.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.473 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 20.6 m -58.64 -48.91 79.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.122 -0.986 . . . . 0.0 109.623 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.8 m 153.57 3.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.75 -0.594 . . . . 0.0 109.944 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.08 -79.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.923 -1.11 . . . . 0.0 110.485 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 t -58.43 -48.29 81.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 36' ' ' GLY . 37.0 m-20 -58.35 -36.27 73.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.0 108.835 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.91 -41.12 97.65 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.09 -44.32 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.237 -1.154 . . . . 0.0 109.049 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 62.6 m -64.7 -30.76 71.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 109.389 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.8 m -58.81 -44.68 90.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.726 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt -63.1 -44.7 94.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.011 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.74 -30.23 71.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.274 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.71 4.28 58.04 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.518 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.73 155.0 35.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.365 -1.079 . . . . 0.0 109.608 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.736 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 5.6 ttmt -56.24 -71.63 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 110.235 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 t -144.34 168.66 19.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 110.05 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.438 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -137.2 154.78 22.51 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -129.78 143.93 51.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -1.102 . . . . 0.0 109.641 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -125.45 128.43 48.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.569 -0.707 . . . . 0.0 109.345 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -140.3 -138.53 0.12 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.221 -0.924 . . . . 0.0 109.589 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 40' ' ' ILE . 22.5 pt -93.71 153.21 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.262 -0.898 . . . . 0.0 109.962 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 44' ' ' TYR . 32.4 tp -86.68 138.2 31.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.437 -0.789 . . . . 0.0 109.187 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.74 -35.95 8.0 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.2 p -100.52 -99.04 0.25 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.181 -1.187 . . . . 0.0 109.209 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.695 ' O ' HD23 ' A' ' 41' ' ' LEU . 95.5 m-85 -122.34 147.55 46.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 0.0 109.287 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.34 -162.44 25.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 40' ' ' ILE . 27.9 m120 -114.81 166.41 11.79 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.487 -1.008 . . . . 0.0 109.725 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.59 155.48 21.59 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER -137.2 121.33 17.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -1.144 . . . . 0.0 109.974 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -111.31 136.06 50.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.394 -0.817 . . . . 0.0 108.857 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.518 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 6.9 t -111.31 126.65 55.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.0 108.981 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.1 mt -115.45 135.22 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 110.242 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.736 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -171.18 -55.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.524 -0.735 . . . . 0.0 109.057 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.86 76.52 76.99 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.481 -0.762 . . . . 0.0 109.235 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.87 -21.37 40.33 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.915 2.41 . . . . 0.0 112.684 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.74 -35.44 14.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 108.494 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -109.24 125.53 52.35 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.63 -0.668 . . . . 0.0 109.387 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.7 t -138.29 66.25 44.21 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.915 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -95.2 152.32 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.507 2.804 . . . . 0.0 111.75 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 61' ' ' ILE . 58.8 mt -128.1 121.62 56.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.1 tpt85 -54.97 -36.27 65.19 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.356 -0.84 . . . . 0.0 110.795 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.798 ' O ' HD12 ' A' ' 61' ' ' ILE . 1.6 pp -132.65 154.43 81.49 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.031 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.35 -19.57 28.93 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.479 2.119 . . . . 0.0 112.036 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.79 26.87 0.11 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -104.17 148.18 26.59 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.231 -1.158 . . . . 0.0 109.467 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 71.1 m -117.35 159.76 22.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.489 -0.757 . . . . 0.0 109.148 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.408 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 56' ' ' ASN . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -127.04 129.97 49.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.84 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.456 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 5.3 t0 -108.55 153.57 23.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.432 -0.793 . . . . 0.0 109.106 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.61 ' HB1' ' CH2' ' A' ' 49' ' ' TRP . . . -100.28 -81.67 0.46 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.528 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.3 -4.77 31.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.001 . . . . 0.0 109.786 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.456 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 65.7 mt -106.77 143.95 16.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.464 -0.773 . . . . 0.0 110.099 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.84 -10.16 1.34 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.305 -0.872 . . . . 0.0 109.19 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -104.75 157.21 34.66 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 8' ' ' LYS . 45.6 Cg_exo -34.16 -109.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.332 2.688 . . . . 0.0 113.151 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.44 -1.23 57.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.756 -1.215 . . . . 0.0 109.335 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -105.22 154.82 19.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.639 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.449 ' HA ' HG23 ' A' ' 6' ' ' ILE . 7.3 m -108.1 161.81 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.234 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.442 HG21 ' HB2' ' A' ' 48' ' ' CYS . 55.9 t -66.41 134.31 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.947 . . . . 0.0 109.434 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.7 p90 -78.13 -34.7 49.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 76.9 tt0 -167.61 95.0 0.44 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.265 -0.897 . . . . 0.0 109.08 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.485 ' CB ' HD22 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -60.6 148.51 37.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.95 -1.094 . . . . 0.0 108.411 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 13.7 t80 -115.69 166.48 11.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.511 -0.743 . . . . 0.0 109.281 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.585 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 88.0 m-20 -42.8 137.21 2.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 109.401 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.96 -8.91 48.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 110.037 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -51.34 -43.79 61.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.045 -1.034 . . . . 0.0 108.726 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -86.11 6.01 31.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.354 -0.841 . . . . 0.0 108.893 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 m 55.33 20.42 3.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.602 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -58.62 -49.41 77.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.774 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.5 t -65.34 -47.96 74.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.152 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -60.05 -37.63 80.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.389 -0.82 . . . . 0.0 109.185 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.52 -42.22 99.01 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.33 -43.91 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 109.12 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.8 t -64.27 -32.42 74.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.475 -0.765 . . . . 0.0 109.19 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.5 m -59.23 -41.1 87.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.406 -0.809 . . . . 0.0 109.975 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -58.77 -31.2 68.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.128 -0.983 . . . . 0.0 109.272 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -52.6 -34.89 52.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 108.925 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.732 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 157.35 -35.57 0.55 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 161.45 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -1.152 . . . . 0.0 109.362 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 33' ' ' ALA . 22.2 mttt -42.87 139.51 1.65 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.434 -0.791 . . . . 0.0 109.96 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.4 p -125.81 113.63 17.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.59 -141.48 4.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.554 ' O ' ' N ' ' A' ' 49' ' ' TRP . 10.3 m-85 -139.82 171.5 14.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.209 -1.171 . . . . 0.0 109.828 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.465 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 13.0 t -99.68 125.63 45.57 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.325 -0.86 . . . . 0.0 109.534 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.509 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 85.0 mt-30 -118.07 -177.5 3.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.641 -0.662 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 40' ' ' ILE . 31.6 pt -108.93 157.82 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 110.102 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.442 HD12 ' HA3' ' A' ' 45' ' ' GLY . 56.7 mt -79.05 144.52 34.55 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.37 -0.832 . . . . 0.0 109.517 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -54.13 -34.93 53.58 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.1 p -94.14 -120.88 0.09 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.331 -1.1 . . . . 0.0 109.073 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.14 136.63 51.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 126.01 -166.6 18.7 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.485 HD22 ' CB ' ' A' ' 16' ' ' CYS . 17.3 t30 -140.51 157.95 44.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.322 -1.105 . . . . 0.0 108.927 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.24 163.67 25.98 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.8 m -107.43 140.41 40.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.476 -1.014 . . . . 0.0 109.758 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.61 ' CH2' ' HB1' ' A' ' 4' ' ' ALA . 4.6 t-105 -106.34 128.67 54.18 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.397 -0.815 . . . . 0.0 108.895 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.4 m -115.9 128.51 55.84 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.494 HD12 ' CE2' ' A' ' 37' ' ' TYR . 69.2 mt -126.37 138.36 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 110.327 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.721 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -168.91 -40.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.329 -0.857 . . . . 0.0 109.537 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.721 HD12 ' O ' ' A' ' 52' ' ' ALA . 5.8 mp -128.63 159.11 69.71 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.514 -0.741 . . . . 0.0 109.313 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -42.55 -72.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.591 2.194 . . . . 0.0 112.325 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 50.0 p30 -175.37 47.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.44 -0.787 . . . . 0.0 109.534 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 1' ' ' ALA . 16.1 t-20 -101.2 121.9 42.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.26 -0.9 . . . . 0.0 109.751 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 1' ' ' ALA . 23.7 t 55.73 66.82 3.37 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.623 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.74 -64.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.65 2.233 . . . . 0.0 112.12 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -119.92 113.78 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -0.788 . . . . 0.0 109.203 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -67.49 -35.63 79.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 109.054 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 63' ' ' GLY . 1.6 mp -73.7 136.93 77.14 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.691 -0.63 . . . . 0.0 109.543 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -46.64 -5.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.898 1.732 . . . . 0.0 111.892 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 103.67 5.41 45.1 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 66' ' ' HIS . 33.0 mtmt -58.28 -36.75 73.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.107 -1.231 . . . . 0.0 109.385 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 50.7 t 51.64 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.631 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 64' ' ' LYS . 9.9 p-80 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.552 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -108.91 146.05 34.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.427 -0.796 . . . . 0.0 109.306 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.47 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 8.9 t0 -136.58 154.31 50.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.874 . . . . 0.0 109.098 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.571 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.6 -78.31 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 110.898 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.65 -8.96 23.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.067 . . . . 0.0 110.096 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.713 HG22 ' H ' ' A' ' 8' ' ' LYS . 68.3 mt -104.65 143.45 16.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.461 -0.774 . . . . 0.0 110.177 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.524 ' O ' ' ND2' ' A' ' 31' ' ' ASN . . . -118.51 13.28 13.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.823 . . . . 0.0 109.354 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.713 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -125.24 155.27 71.56 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -64.86 -39.68 24.46 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.437 2.091 . . . . 0.0 112.416 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -134.57 -1.08 2.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.639 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.495 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 54.2 m-80 -116.16 170.21 8.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.47 -0.769 . . . . 0.0 109.488 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.673 ' HA ' HG23 ' A' ' 6' ' ' ILE . 62.5 m -114.46 177.27 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.518 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 t -99.97 135.68 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -70.78 77.44 0.62 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.067 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 55.9 97.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 109.346 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.7 t -64.68 113.21 3.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 108.975 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 8.4 t80 -70.06 139.56 52.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 88.9 m-20 -70.1 131.77 44.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 110.084 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.72 155.05 37.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.406 -0.809 . . . . 0.0 109.109 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 21' ' ' SER . 96.7 m-85 -56.93 -41.02 77.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.09 -1.006 . . . . 0.0 109.24 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 1.4 t 168.98 86.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.409 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.2 t -170.24 -64.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.057 -1.027 . . . . 0.0 110.021 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.437 ' HH ' ' HE1' ' A' ' 14' ' ' TYR . 64.4 t80 -59.78 -56.95 15.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 109.912 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.2 t -70.66 -52.64 19.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.653 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -57.68 -37.99 74.37 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.408 -0.807 . . . . 0.0 109.469 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.74 -46.66 93.74 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.3 t -67.72 -43.27 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -1.131 . . . . 0.0 109.383 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.5 t -61.22 -38.06 85.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.357 -0.839 . . . . 0.0 109.333 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.8 m -56.93 -40.21 75.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -59.14 -38.34 79.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.012 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 7' ' ' ALA . 9.7 m120 -59.24 -28.52 66.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.83 . . . . 0.0 109.03 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.72 -0.12 52.51 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.78 148.21 51.55 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -1.064 . . . . 0.0 109.452 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.836 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 3.8 ttmt -58.31 -55.56 33.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.782 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t -144.62 158.81 43.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.347 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -141.74 154.23 24.66 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.563 -1.304 . . . . 0.0 110.211 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 49' ' ' TRP . 48.8 m-85 -127.18 152.83 46.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.489 -1.006 . . . . 0.0 109.242 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.8 t -99.44 119.54 38.17 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.176 -0.953 . . . . 0.0 109.087 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -116.68 -170.82 1.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.696 -0.628 . . . . 0.0 109.693 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 pt -93.57 152.17 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.239 -0.913 . . . . 0.0 109.726 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 43' ' ' THR . 29.8 tp -88.85 133.95 34.11 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.301 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -45.11 -30.19 2.52 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.432 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 25.8 p -109.45 178.85 4.31 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -50.75 160.58 0.43 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.763 -1.211 . . . . 0.0 109.174 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.59 -167.05 30.76 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -138.97 171.91 13.62 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.338 -1.095 . . . . 0.0 109.407 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.13 163.66 26.29 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.05 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.1 m -103.57 152.2 22.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.424 -1.045 . . . . 0.0 109.255 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.579 ' N ' ' O ' ' A' ' 37' ' ' TYR . 17.3 t-105 -116.2 139.06 50.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.826 . . . . 0.0 109.566 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.8 m -134.38 124.05 25.11 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.287 -0.883 . . . . 0.0 109.9 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 mt -123.98 132.34 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.536 -0.728 . . . . 0.0 109.875 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.836 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -177.11 -66.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.822 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 1' ' ' ALA . 17.6 tp -133.14 89.0 34.57 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.417 -0.802 . . . . 0.0 109.9 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -75.61 -25.16 11.2 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.074 1.849 . . . . 0.0 112.292 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -57.96 -35.83 71.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 57' ' ' VAL . 48.9 t-20 -73.29 144.72 46.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.645 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.503 ' C ' ' O ' ' A' ' 56' ' ' ASN . 90.9 t -33.85 97.84 0.12 Allowed Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.949 -0.469 . . . . 0.0 109.795 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' ASN . 89.5 Cg_endo -85.5 -63.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.575 2.184 . . . . 0.0 112.426 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.413 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 73.6 mt -118.21 131.97 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -138.49 -21.9 1.01 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.301 -0.874 . . . . 0.0 109.507 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.679 ' O ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -96.23 154.09 38.86 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.735 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -67.21 -9.87 26.64 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.696 2.264 . . . . 0.0 112.195 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.3 22.22 45.42 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 66' ' ' HIS . 17.3 tttp -56.38 -35.04 67.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.557 -0.967 . . . . 0.0 109.651 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 57.8 m 57.12 -77.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.414 -0.803 . . . . 0.0 109.592 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 64' ' ' LYS . 94.9 m-70 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.877 ' H2 ' ' H ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -131.93 134.59 45.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.47 -0.769 . . . . 0.0 109.44 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 83.4 m-20 -95.79 150.11 20.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.136 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -109.86 -92.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.511 -0.743 . . . . 0.0 109.955 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -97.91 -17.3 19.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.346 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.68 HG23 ' HA ' ' A' ' 12' ' ' CYS . 64.7 mt -106.91 137.61 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.525 -0.734 . . . . 0.0 109.62 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.416 ' C ' ' CD ' ' A' ' 8' ' ' LYS . . . -113.24 14.42 19.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.476 -0.765 . . . . 0.0 109.853 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.659 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -126.23 153.52 74.46 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.346 -0.846 . . . . 0.0 109.15 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.86 -27.74 80.58 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.637 2.225 . . . . 0.0 112.896 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -147.64 -5.99 0.47 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.077 -1.015 . . . . 0.0 109.501 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.481 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 51.2 m-80 -111.52 165.92 11.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.768 . . . . 0.0 109.38 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.68 ' HA ' HG23 ' A' ' 6' ' ' ILE . 24.4 m -119.59 162.19 19.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -0.823 . . . . 0.0 109.089 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.9 130.96 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.104 -0.998 . . . . 0.0 109.207 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.523 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.4 p90 -76.04 -42.11 48.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.523 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 45.1 tp10 -175.29 99.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -63.63 148.65 48.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.162 -0.961 . . . . 0.0 109.024 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.676 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -122.12 -161.14 0.91 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.676 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 89.1 m-20 -57.08 142.45 42.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.988 -1.07 . . . . 0.0 109.308 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.7 7.58 3.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.867 . . . . 0.0 110.103 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -52.25 -45.52 65.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.058 -1.026 . . . . 0.0 109.256 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 t -88.87 -2.58 58.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.949 . . . . 0.0 109.128 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 m 55.6 52.55 10.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.511 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 27' ' ' VAL . 65.4 t80 -61.75 -53.61 53.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 0.0 109.833 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -70.98 -51.87 23.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.897 . . . . 0.0 109.294 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -58.76 -37.54 76.47 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.47 97.18 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 23' ' ' TYR . 74.2 t -61.85 -44.15 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -1.125 . . . . 0.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.2 m -63.78 -32.93 74.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.183 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.2 m -60.98 -50.39 73.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.663 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -65.59 -41.01 93.32 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.44 -0.788 . . . . 0.0 109.359 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -61.26 -30.25 70.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.461 -0.775 . . . . 0.0 109.259 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.36 0.39 50.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -66.85 150.95 48.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.438 -1.036 . . . . 0.0 109.388 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -57.91 -76.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 109.87 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.2 m -143.16 158.87 43.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.329 -0.857 . . . . 0.0 109.681 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.42 162.27 26.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -126.35 140.03 52.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -1.041 . . . . 0.0 109.833 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -116.21 119.37 35.55 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -137.45 176.83 8.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.189 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.418 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -92.83 140.29 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.979 -1.076 . . . . 0.0 109.285 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.621 HD13 ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -64.42 -39.42 93.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 108.939 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.45 5.87 74.76 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.6 m -157.44 -81.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 109.849 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -62.29 -37.0 83.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.917 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 41' ' ' LEU . . . 162.88 -119.08 0.85 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.424 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 17.4 m120 -111.33 150.54 29.57 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.519 -0.989 . . . . 0.0 110.093 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.3 117.53 2.3 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 4' ' ' ALA . 32.9 t -114.95 115.98 27.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.464 -1.021 . . . . 0.0 109.143 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -109.55 137.56 47.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.357 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.477 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 8.2 t -109.39 132.55 54.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.1 122.83 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 0.0 109.814 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.423 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -179.07 -146.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.564 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER 176.43 -44.71 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.42 -0.8 . . . . 0.0 109.823 179.456 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 53' ' ' LEU . 42.8 Cg_exo -54.78 -32.68 77.76 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.086 1.858 . . . . 0.0 111.95 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.35 -38.3 86.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.299 -0.876 . . . . 0.0 108.98 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 53' ' ' LEU . 63.1 m-20 56.88 46.42 19.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.877 ' H ' ' H2 ' ' A' ' 1' ' ' ALA . 91.9 t -120.62 85.92 39.24 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.365 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -90.91 -172.83 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.293 2.662 . . . . 0.0 111.689 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 61' ' ' ILE . 29.7 mm -114.28 130.5 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 7.51 41.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 0.0 110.521 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.588 ' H ' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -141.63 151.94 61.73 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.778 -1.201 . . . . 0.0 109.865 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 64' ' ' LYS . 11.3 Cg_endo -57.84 159.74 16.89 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.703 2.269 . . . . 0.0 112.155 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.634 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . -65.74 28.25 0.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 66' ' ' HIS . 35.0 tttt -56.68 -35.63 68.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.104 -1.233 . . . . 0.0 109.303 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 33.8 m 58.46 -74.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.614 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 64' ' ' LYS . 84.6 t60 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -136.52 161.52 35.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.341 -0.849 . . . . 0.0 109.242 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -95.44 145.54 25.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.121 -0.987 . . . . 0.0 109.343 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -103.08 -81.42 0.5 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 110.797 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -99.52 -15.18 18.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.051 -1.031 . . . . 0.0 110.261 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.624 HG23 ' HA ' ' A' ' 12' ' ' CYS . 67.9 mt -95.91 143.92 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.367 -0.833 . . . . 0.0 110.12 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.94 21.32 3.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.34 -0.85 . . . . 0.0 109.6 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.453 ' H ' HG22 ' A' ' 6' ' ' ILE . 8.8 mmtm -115.37 152.15 46.65 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.47 -0.769 . . . . 0.0 109.213 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.21 -32.75 90.88 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.569 2.18 . . . . 0.0 112.816 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -149.65 12.08 0.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.996 -1.065 . . . . 0.0 109.805 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -130.88 -164.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.62 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.624 ' HA ' HG23 ' A' ' 6' ' ' ILE . 84.1 m -121.0 -178.08 3.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.357 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -98.89 131.95 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.265 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.7 p90 -66.34 -37.45 85.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.531 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.443 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 80.9 tt0 -174.56 99.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.279 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -75.54 125.58 29.31 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.101 -0.999 . . . . 0.0 108.715 179.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 18' ' ' ASP . 20.0 t80 -90.87 141.14 29.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.904 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.587 ' O ' ' CE2' ' A' ' 17' ' ' PHE . 60.0 t0 -78.52 121.03 24.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -0.811 . . . . 0.0 109.88 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -140.82 159.06 43.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.465 -0.772 . . . . 0.0 108.936 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.448 ' O ' ' CB ' ' A' ' 21' ' ' SER . 71.3 t80 -53.62 -43.41 68.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.081 -1.012 . . . . 0.0 109.203 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.503 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER 168.97 78.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.429 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 26' ' ' GLY . 3.5 t -156.01 -66.94 0.11 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.037 -1.039 . . . . 0.0 110.149 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -60.37 -57.26 13.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -68.36 -48.31 65.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 108.943 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.65 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.4 m120 -59.08 -37.17 76.47 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -60.4 -41.48 98.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -62.03 -44.92 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.16 . . . . 0.0 109.128 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.3 m -67.8 -31.59 71.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.798 . . . . 0.0 109.53 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 m -56.88 -48.43 78.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.62 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -65.02 -40.48 94.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.417 -0.802 . . . . 0.0 109.487 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -60.74 -30.18 69.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.402 -0.811 . . . . 0.0 109.297 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.84 0.02 56.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . . . -64.95 150.0 48.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.418 -1.049 . . . . 0.0 109.423 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -57.6 -60.24 3.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -0.94 . . . . 0.0 109.947 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.6 p -144.9 161.74 38.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.997 . . . . 0.0 110.193 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.581 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -144.14 154.72 25.86 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.596 ' O ' ' N ' ' A' ' 49' ' ' TRP . 21.6 m-85 -139.8 156.34 46.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.171 -1.194 . . . . 0.0 109.456 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.21 124.75 44.51 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.066 -1.021 . . . . 0.0 109.188 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.411 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 84.3 mt-30 -116.28 179.03 4.11 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.6 pt -93.29 143.25 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.061 -1.024 . . . . 0.0 110.043 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD23 ' OG1' ' A' ' 43' ' ' THR . 36.0 tp -91.36 142.78 27.31 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.468 -0.77 . . . . 0.0 109.215 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -43.67 -31.76 1.86 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.503 ' OG1' HD23 ' A' ' 41' ' ' LEU . 21.6 p -87.23 167.51 14.05 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.41 -1.053 . . . . 0.0 108.87 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -54.35 -10.05 0.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 109.49 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 43' ' ' THR . . . -82.56 -173.23 49.01 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.421 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 2.9 m-20 -137.18 171.23 14.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.481 -1.011 . . . . 0.0 109.109 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -140.17 167.1 25.56 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.034 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -101.31 151.67 21.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.413 -1.051 . . . . 0.0 109.135 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.596 ' N ' ' O ' ' A' ' 37' ' ' TYR . 13.6 t-105 -115.57 137.35 52.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.469 -0.77 . . . . 0.0 109.329 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.421 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -130.31 133.63 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.369 -0.832 . . . . 0.0 109.153 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.415 HD11 ' CE2' ' A' ' 37' ' ' TYR . 3.4 mt -115.81 121.16 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.804 . . . . 0.0 109.691 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 1' ' ' ALA . . . -169.98 158.64 7.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.37 75.52 73.98 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 0.0 109.777 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.08 -65.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.743 2.295 . . . . 0.0 111.838 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -154.99 -71.02 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.558 -0.714 . . . . 0.0 109.148 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 56' ' ' ASN . 6.4 p30 -173.39 29.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.355 -0.84 . . . . 0.0 109.564 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.5 t -126.98 77.7 74.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 109.866 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.73 -65.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.668 2.245 . . . . 0.0 112.099 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 61' ' ' ILE . 29.3 mm -113.89 130.0 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -105.69 1.6 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.723 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.452 ' H ' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -130.63 154.43 81.73 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.716 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -72.83 23.91 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.701 2.267 . . . . 0.0 112.073 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.57 10.29 56.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -73.8 136.25 43.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.413 -1.051 . . . . 0.0 109.104 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' HIS . 72.7 m -116.72 159.29 22.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.577 -0.702 . . . . 0.0 109.382 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' CYS . 83.7 t60 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.54 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.81 ' HE ' ' HE1' ' A' ' 49' ' ' TRP . 76.8 ttt180 -128.26 133.67 48.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.44 -0.787 . . . . 0.0 109.571 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -95.67 140.38 30.57 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.558 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -99.83 -79.74 0.49 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -0.91 . . . . 0.0 109.696 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -106.67 15.11 26.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.783 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 12' ' ' CYS . 21.9 pt -118.57 156.44 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.354 -0.841 . . . . 0.0 109.778 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HB1' HG11 ' A' ' 27' ' ' VAL . . . -99.03 -18.57 17.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 109.11 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.474 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -137.25 154.99 76.03 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.372 -0.83 . . . . 0.0 109.179 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.38 -29.93 30.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.66 2.24 . . . . 0.0 112.679 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -94.67 -23.68 17.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.133 -0.979 . . . . 0.0 110.295 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -140.72 -179.54 6.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.04 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.528 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 24.6 p -140.07 -177.79 5.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.51 -0.744 . . . . 0.0 109.232 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.43 HG11 ' HA ' ' A' ' 16' ' ' CYS . 45.7 t -107.33 131.87 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.425 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 28.1 p90 -73.68 -34.59 64.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.144 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.425 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 43.8 tp10 -151.19 89.38 1.51 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.44 -0.787 . . . . 0.0 108.89 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.565 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -59.21 109.49 0.87 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 109.353 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 1.8 t80 -63.15 165.19 7.5 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.368 -0.833 . . . . 0.0 108.943 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.602 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 60.3 t0 -43.54 106.39 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 109.298 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.36 -5.11 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -50.79 -43.61 58.67 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.163 -0.961 . . . . 0.0 109.186 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.7 m -62.7 -50.63 70.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.192 -0.943 . . . . 0.0 109.446 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.6 t 151.49 12.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.35 -71.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.008 -1.058 . . . . 0.0 110.541 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.4 t -60.64 -51.29 70.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.163 -0.961 . . . . 0.0 109.148 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -57.72 -36.01 71.44 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 108.666 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.34 -40.18 95.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.466 HG11 ' HB1' ' A' ' 7' ' ' ALA . 69.8 t -61.83 -48.02 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -1.173 . . . . 0.0 108.855 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.38 -22.57 62.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 m -64.07 -31.26 72.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.413 -0.804 . . . . 0.0 110.976 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 1.8 mptt -52.77 -35.12 55.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.004 -1.06 . . . . 0.0 110.159 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.45 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 9.8 t-20 -56.92 -33.59 67.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.051 -1.03 . . . . 0.0 109.337 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.84 2.17 56.2 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.1 -26.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -1.036 . . . . 0.0 109.216 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.738 ' HG3' ' HB2' ' A' ' 52' ' ' ALA . 16.7 tttp -54.33 131.83 42.73 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.6 p -113.65 139.68 48.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.424 -0.798 . . . . 0.0 109.589 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.19 158.02 27.1 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.526 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -128.81 155.71 44.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.643 -0.916 . . . . 0.0 108.735 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 42.4 t -99.07 122.77 42.75 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.049 -1.032 . . . . 0.0 108.917 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.498 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 79.2 mt-30 -115.68 177.81 4.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.634 -0.666 . . . . 0.0 109.965 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.773 HG22 ' H ' ' A' ' 42' ' ' GLY . 64.4 mt -93.69 133.44 34.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.402 -0.811 . . . . 0.0 110.1 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.47 -27.35 68.92 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.617 0.722 . . . . 0.0 109.209 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.773 ' H ' HG22 ' A' ' 40' ' ' ILE . . . 106.29 -7.34 40.18 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.605 -2.198 . . . . 0.0 107.605 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 45' ' ' GLY . 12.8 p -127.79 172.44 10.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 43' ' ' THR . 23.8 p90 -46.48 -12.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.019 -1.051 . . . . 0.0 109.44 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -87.87 -176.92 47.98 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.556 ' ND2' ' SG ' ' A' ' 38' ' ' CYS . 61.8 t30 -140.2 164.54 29.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.531 -0.981 . . . . 0.0 108.889 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 157.82 25.66 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.46 -1.353 . . . . 0.0 110.545 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -107.39 153.45 22.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.488 -1.007 . . . . 0.0 109.354 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.81 ' HE1' ' HE ' ' A' ' 2' ' ' ARG . 5.6 t-105 -125.72 129.46 49.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.372 -0.83 . . . . 0.0 109.256 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.623 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 1.8 t -132.76 131.09 40.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.121 -0.987 . . . . 0.0 109.748 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mt -123.1 140.47 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.746 . . . . 0.0 110.499 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.738 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . . . -159.59 -28.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.711 . . . . 0.0 109.643 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 52' ' ' ALA . 3.0 mp -129.1 165.96 28.57 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 109.717 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.593 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 50.3 Cg_exo -49.72 -0.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.59 2.194 . . . . 0.0 112.705 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 12.5 t0 89.9 49.8 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.27 0.557 . . . . 0.0 109.785 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -103.53 131.87 50.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.304 -0.872 . . . . 0.0 108.996 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.821 HG12 ' HE ' ' A' ' 60' ' ' ARG . 83.0 t 52.92 67.69 3.63 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.088 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.65 -65.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.761 2.307 . . . . 0.0 112.471 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.3 mt -116.13 124.68 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.473 -0.767 . . . . 0.0 109.412 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.821 ' HE ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -120.44 -1.61 10.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.514 HG13 ' H ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -68.98 149.22 97.9 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.557 -0.714 . . . . 0.0 109.521 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.28 5.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.556 2.171 . . . . 0.0 112.139 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.514 ' H ' HG13 ' A' ' 61' ' ' ILE . . . 99.99 8.12 51.55 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -37.48 71.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.176 -1.19 . . . . 0.0 109.239 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -107.95 158.57 17.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.557 -0.714 . . . . 0.0 109.543 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.436 -179.912 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -136.9 159.4 41.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.589 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -101.35 149.52 23.95 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.291 -0.881 . . . . 0.0 109.129 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.637 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.34 -65.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.256 -0.903 . . . . 0.0 110.654 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.416 ' CD1' HD12 ' A' ' 41' ' ' LEU . 12.7 m-85 -100.45 -0.94 37.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 109.927 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.499 HG23 ' HA ' ' A' ' 12' ' ' CYS . 53.5 mt -111.71 133.83 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.935 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.729 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -105.97 -9.25 17.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.419 -0.801 . . . . 0.0 109.549 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.634 ' NZ ' ' CG1' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.09 166.35 12.04 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.502 -0.749 . . . . 0.0 109.246 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.74 -59.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.581 2.187 . . . . 0.0 112.433 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.63 ' NE2' ' NH1' ' A' ' 60' ' ' ARG . 78.4 m80 -102.95 -4.71 24.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.348 -0.845 . . . . 0.0 109.782 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -121.66 161.79 21.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.419 -0.801 . . . . 0.0 109.645 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.499 ' HA ' HG23 ' A' ' 6' ' ' ILE . 46.5 m -124.14 179.5 4.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.353 -0.842 . . . . 0.0 109.514 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 48' ' ' CYS . 51.7 t -98.87 134.18 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.312 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.3 p90 -70.27 -42.04 72.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.851 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 39.1 tp10 -174.68 99.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.097 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 143.58 52.54 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.144 -0.973 . . . . 0.0 108.955 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.614 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -120.12 179.31 4.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.404 -0.81 . . . . 0.0 109.033 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.614 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 88.6 m-20 -44.7 128.35 6.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -0.968 . . . . 0.0 109.355 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 21' ' ' SER . . . -65.17 -36.24 83.59 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.202 -0.936 . . . . 0.0 109.759 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.564 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 66.9 t80 49.25 7.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.17 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 19' ' ' ALA . 1.2 t 173.3 -54.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.354 -0.842 . . . . 0.0 108.856 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER 160.98 45.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.621 -0.674 . . . . 0.0 109.202 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.427 ' O ' HG23 ' A' ' 27' ' ' VAL . 69.5 t80 -60.31 -51.85 67.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.999 -1.063 . . . . 0.0 109.716 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.9 t -70.35 -50.42 39.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.191 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 36' ' ' GLY . 4.9 m-20 -59.55 -38.73 81.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 109.296 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.87 -44.04 98.39 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.634 ' CG1' ' NZ ' ' A' ' 8' ' ' LYS . 76.9 t -60.56 -43.55 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -1.179 . . . . 0.0 109.542 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.446 ' SG ' ' CD ' ' A' ' 34' ' ' LYS . 3.6 t -65.07 -35.08 80.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.252 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 m -61.95 -39.16 91.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 110.557 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -56.98 -29.97 63.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.005 -1.059 . . . . 0.0 109.779 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.523 ' OD1' ' NZ ' ' A' ' 34' ' ' LYS . 11.0 t-20 -53.59 -35.61 61.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.074 -1.016 . . . . 0.0 109.294 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 166.03 -42.76 0.27 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 174.52 -21.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.048 -1.266 . . . . 0.0 109.59 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.609 ' HZ3' HD13 ' A' ' 53' ' ' LEU . 13.3 ptpt -43.63 145.37 0.65 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.511 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 91.4 p -103.61 147.77 26.81 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.48 159.96 27.59 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.229 -1.463 . . . . 0.0 111.252 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 49' ' ' TRP . 37.3 m-85 -127.54 154.21 45.43 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.468 ' SG ' ' OD1' ' A' ' 46' ' ' ASN . 40.6 t -98.92 118.89 36.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.894 -1.128 . . . . 0.0 109.323 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.469 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 83.9 mt-30 -112.75 171.52 7.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.429 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 18.1 pt -93.25 134.17 31.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.063 -1.023 . . . . 0.0 110.042 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.463 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 41.3 tp -62.79 -28.15 69.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.637 -0.664 . . . . 0.0 109.211 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.75 -6.8 41.38 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 45' ' ' GLY . 20.3 p -127.02 172.62 10.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' THR . 24.6 p90 -44.65 -16.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.033 -1.042 . . . . 0.0 109.367 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -89.26 -178.2 45.75 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.468 ' OD1' ' SG ' ' A' ' 38' ' ' CYS . 7.0 t-20 -140.65 168.1 20.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.527 -0.984 . . . . 0.0 108.853 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.4 150.38 21.56 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.473 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -99.99 145.33 28.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.41 -1.053 . . . . 0.0 108.986 179.223 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.637 ' CZ3' ' HB1' ' A' ' 4' ' ' ALA . 11.7 t-105 -111.25 127.89 55.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.392 -0.817 . . . . 0.0 109.408 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.4 m -124.31 134.24 53.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.273 -0.892 . . . . 0.0 109.616 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.699 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 5.2 mt -120.14 141.61 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.544 -0.722 . . . . 0.0 110.076 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 51' ' ' ILE . . . 90.89 65.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.566 0.698 . . . . 0.0 109.574 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 ' HZ3' ' A' ' 34' ' ' LYS . 40.2 tp -128.83 81.46 70.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.606 -0.684 . . . . 0.0 109.173 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.41 -21.29 29.24 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.643 2.229 . . . . 0.0 111.867 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -56.62 -34.3 67.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 62.72 45.64 5.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 57' ' ' VAL . 31.7 m -124.72 77.63 64.44 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.559 -0.713 . . . . 0.0 109.259 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HG2' ' H ' ' A' ' 59' ' ' ILE . 65.6 Cg_endo -79.83 -67.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.679 2.253 . . . . 0.0 112.223 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.411 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 70.4 mt -119.48 129.49 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.63 ' NH1' ' NE2' ' A' ' 10' ' ' HIS . 13.6 ptm180 -153.95 -33.17 0.11 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 108.99 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.529 HD12 ' N ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -75.92 156.43 84.36 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.607 -0.683 . . . . 0.0 109.419 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.82 -6.86 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.878 2.385 . . . . 0.0 112.227 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.52 11.92 46.22 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -56.17 -35.26 67.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.133 . . . . 0.0 109.467 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.8 p -68.07 151.26 47.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.466 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.792 ' N ' HD23 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -136.57 158.21 44.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.401 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 2.8 t0 -104.98 150.51 24.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.344 -0.847 . . . . 0.0 109.568 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.532 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -99.35 -76.67 0.54 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -108.02 3.49 24.09 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.196 -0.94 . . . . 0.0 109.845 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 8' ' ' LYS . 59.2 mt -111.3 138.38 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 110.161 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -110.93 12.68 22.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.455 -0.778 . . . . 0.0 109.421 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.738 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -127.87 155.3 77.73 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.482 -0.761 . . . . 0.0 109.231 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.31 -36.06 47.63 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.551 2.167 . . . . 0.0 112.56 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -138.07 -3.08 1.81 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.536 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.493 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 52.7 m-80 -114.25 167.95 10.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.485 -0.759 . . . . 0.0 109.357 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.703 ' HA ' HG23 ' A' ' 6' ' ' ILE . 62.3 m -118.61 177.06 4.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.412 -0.805 . . . . 0.0 109.828 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.08 135.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 109.086 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 28.2 p90 -66.89 -45.73 77.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.698 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.579 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 82.7 tt0 -175.95 97.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.057 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 144.46 56.54 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 108.589 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.698 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 2.5 p90 -120.67 -153.75 0.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.458 -0.776 . . . . 0.0 109.208 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.698 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.6 m-20 -57.53 141.8 46.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.978 -1.076 . . . . 0.0 109.473 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.89 9.23 3.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.354 -0.841 . . . . 0.0 109.864 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -49.88 -43.44 49.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.982 -1.074 . . . . 0.0 108.597 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.413 ' HG ' ' HE1' ' A' ' 17' ' ' PHE . 33.6 p -90.15 4.99 48.81 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.432 -0.792 . . . . 0.0 109.075 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' GLY . 83.3 p 51.82 33.43 11.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 109.351 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -59.25 -47.1 86.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -65.76 -57.5 7.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.422 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -60.86 -35.74 77.37 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.472 -0.768 . . . . 0.0 109.491 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -58.27 -44.0 95.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.44 -44.36 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -1.118 . . . . 0.0 109.2 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 t -70.04 -31.13 68.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.486 -0.758 . . . . 0.0 109.326 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.5 m -61.57 -31.47 71.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 110.673 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.76 -27.14 4.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.984 -1.073 . . . . 0.0 109.885 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -54.82 -30.76 58.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.1 -1.0 . . . . 0.0 109.107 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 103.96 3.29 45.61 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 176.77 -25.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -1.192 . . . . 0.0 109.629 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -55.25 134.25 49.73 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -112.58 140.79 47.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.397 -0.814 . . . . 0.0 108.984 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.69 164.68 27.38 Favored Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.995 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' TRP . 32.7 m-85 -132.12 160.5 35.83 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.506 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 43.5 t -99.24 120.86 40.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.998 -1.064 . . . . 0.0 109.294 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.503 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 84.5 mt-30 -115.72 174.57 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 109.32 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.9 pt -99.15 155.42 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.898 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.634 HD12 ' HA3' ' A' ' 45' ' ' GLY . 72.8 mt -78.25 148.44 33.93 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.432 -0.792 . . . . 0.0 109.578 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.68 -35.93 39.17 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 47.7 p -96.07 -125.16 0.12 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.318 -1.107 . . . . 0.0 108.644 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -109.72 126.57 53.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 108.921 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.634 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 141.45 -173.87 23.21 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.599 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 54.6 t-20 -140.77 150.33 43.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -1.102 . . . . 0.0 109.559 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.599 ' N ' ' OD1' ' A' ' 46' ' ' ASN . . . -140.11 167.25 25.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.624 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 1.6 m -101.97 150.26 23.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.236 -1.155 . . . . 0.0 109.621 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.532 ' CE3' ' O ' ' A' ' 4' ' ' ALA . 16.8 t-105 -120.92 121.22 37.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 109.161 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.8 m -117.74 130.38 56.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.324 -0.86 . . . . 0.0 109.682 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 20.2 mt -127.76 145.56 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.417 -0.802 . . . . 0.0 110.545 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' ILE . . . 176.19 -22.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.792 HD23 ' N ' ' A' ' 1' ' ' ALA . 13.2 tp -153.02 133.15 7.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 108.916 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -38.08 158.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.205 1.937 . . . . 0.0 112.225 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 61.1 t0 -79.0 116.34 19.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 110.063 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.481 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 82.0 m-20 -147.86 -47.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.568 ' H ' ' HB2' ' A' ' 1' ' ' ALA . 21.6 t -129.74 72.2 81.99 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.76 -100.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.829 2.353 . . . . 0.0 112.527 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -127.28 125.99 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.349 -0.844 . . . . 0.0 109.417 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -61.58 -34.18 75.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.303 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 63' ' ' GLY . 4.0 mt -62.63 136.73 96.26 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.425 -0.797 . . . . 0.0 108.967 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.78 -1.71 2.91 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.004 1.803 . . . . 0.0 112.483 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.515 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 95.62 11.4 55.47 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.603 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 11.9 pttp -58.62 -32.47 69.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -1.12 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 61.3 m 56.43 -0.61 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.277 -0.889 . . . . 0.0 109.913 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.603 ' ND1' ' O ' ' A' ' 64' ' ' LYS . 72.4 m80 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.417 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.403 ' HA ' ' N ' ' A' ' 54' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.306 0.574 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.0 ptt-85 -137.6 167.45 21.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.378 -0.826 . . . . 0.0 109.511 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 83.7 m-20 -94.35 147.13 23.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 108.691 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -109.93 -83.25 0.56 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.371 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -99.23 6.24 46.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.008 -1.057 . . . . 0.0 109.629 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.645 HG22 ' SG ' ' A' ' 12' ' ' CYS . 42.1 pt -117.16 159.17 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.637 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . . . -123.39 -20.29 5.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.21 161.27 50.71 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.62 -66.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.43 2.087 . . . . 0.0 112.91 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -56.81 -39.44 74.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 110.436 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.424 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 2.2 m120 -134.51 173.72 11.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 0.0 110.096 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.645 ' SG ' HG22 ' A' ' 6' ' ' ILE . 12.2 m -108.24 171.24 7.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.185 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 p -49.09 135.24 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.037 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.664 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 19.5 p90 -69.64 -50.43 44.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.051 -1.031 . . . . 0.0 109.345 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.664 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 48.8 tp10 -177.38 91.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.2 t -54.12 97.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 108.926 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 19.3 p90 -76.67 -46.17 26.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 109.689 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 52.9 t0 -145.4 101.01 3.54 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.312 -0.868 . . . . 0.0 109.096 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.72 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . . . -60.63 -24.43 65.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.214 -0.929 . . . . 0.0 109.049 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -52.16 -42.22 63.24 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.434 ' C ' ' OG ' ' A' ' 22' ' ' SER . 84.0 p -66.04 -16.17 63.68 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER 72.48 39.25 0.74 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.618 -0.676 . . . . 0.0 110.029 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' HG23 ' A' ' 27' ' ' VAL . 61.6 t80 -60.63 -60.51 3.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.978 -1.076 . . . . 0.0 109.06 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' HB2' ' A' ' 7' ' ' ALA . 8.1 t -70.58 -48.65 54.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.352 -0.843 . . . . 0.0 108.75 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.448 ' CG ' ' O ' ' A' ' 36' ' ' GLY . 18.5 m-20 -57.82 -38.93 76.46 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.8 -39.59 97.67 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 23' ' ' TYR . 78.8 t -62.2 -41.52 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.354 -1.086 . . . . 0.0 109.531 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.3 m -61.04 -41.2 96.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.523 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 m -58.22 -51.26 70.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.14 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -67.79 -39.45 84.03 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.54 -0.725 . . . . 0.0 109.125 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.596 ' CG ' HD21 ' A' ' 56' ' ' ASN . 42.0 t-20 -59.29 -31.13 68.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.553 -0.717 . . . . 0.0 109.275 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.27 -0.06 50.63 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.61 149.5 48.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -1.059 . . . . 0.0 109.221 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -58.0 -49.15 77.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 110.245 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.572 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 49.5 m -143.57 162.81 34.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.037 . . . . 0.0 110.198 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -142.72 126.83 2.98 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.543 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 87.2 m-85 -126.11 135.54 51.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.448 -1.03 . . . . 0.0 109.547 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -110.6 129.94 55.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 0.0 109.888 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.69 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -134.1 168.34 19.0 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.429 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 17.0 pt -98.81 133.43 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.974 . . . . 0.0 109.588 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.535 HD23 ' OG1' ' A' ' 43' ' ' THR . 30.2 tp -64.24 -30.59 71.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 109.36 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.95 -4.5 49.43 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.535 ' OG1' HD23 ' A' ' 41' ' ' LEU . 18.3 p -126.57 173.72 9.22 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 43' ' ' THR . 26.8 p90 -44.07 -21.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.441 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -87.23 -174.25 48.74 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 5.8 t-20 -137.98 169.83 17.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -1.008 . . . . 0.0 108.911 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' GLN . . . -140.55 125.93 3.01 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.447 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 42.7 t -136.28 128.91 30.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -1.092 . . . . 0.0 108.674 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.69 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 4.1 p90 -113.95 141.29 47.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 109.857 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 35' ' ' SER . 6.0 t -124.72 153.62 42.09 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.1 mm -109.22 126.83 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 109.074 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.9 ' C ' HD23 ' A' ' 53' ' ' LEU . . . -173.09 -130.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.978 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.9 HD23 ' C ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -127.4 166.4 23.27 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.364 -0.835 . . . . 0.0 109.9 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' N ' ' HA ' ' A' ' 1' ' ' ALA . 28.1 Cg_endo -67.84 -34.31 24.4 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.466 2.111 . . . . 0.0 112.244 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -56.41 -33.49 65.86 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.596 HD21 ' CG ' ' A' ' 31' ' ' ASN . 46.2 t-20 -96.75 120.13 36.52 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.554 -0.716 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.465 HG23 ' OD1' ' A' ' 56' ' ' ASN . 5.2 t 57.4 65.87 3.32 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.717 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.69 15.03 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.146 2.564 . . . . 0.0 112.425 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 59' ' ' ILE . 62.9 mt 55.25 52.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.391 -0.818 . . . . 0.0 109.333 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.422 HH11 ' HB3' ' A' ' 60' ' ' ARG . 6.1 ptm85 -61.61 -39.22 90.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.507 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -74.75 154.12 87.2 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.462 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.73 -11.12 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.663 2.242 . . . . 0.0 111.929 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.95 3.82 57.93 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 66' ' ' HIS . 34.2 ttpt -57.8 -36.95 72.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -1.102 . . . . 0.0 109.42 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 84.9 m 54.8 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.819 . . . . 0.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.586 ' N ' ' O ' ' A' ' 64' ' ' LYS . 83.3 t60 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.516 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -127.06 136.77 52.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.811 . . . . 0.0 109.809 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -95.92 144.16 26.48 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.242 -0.911 . . . . 0.0 109.038 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -108.25 -83.55 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 110.212 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -99.54 12.92 35.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.676 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 pt -126.67 165.98 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 110.011 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.757 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -120.79 -0.81 10.07 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.11 168.72 8.88 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB2' HH11 ' A' ' 60' ' ' ARG . 70.2 Cg_endo -80.25 -59.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.537 2.158 . . . . 0.0 112.447 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -104.94 -3.74 22.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.964 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -116.88 175.46 5.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.394 -0.816 . . . . 0.0 109.804 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.2 p -128.66 -179.64 5.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.408 -0.807 . . . . 0.0 109.86 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.88 136.52 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.546 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.7 p90 -65.48 -40.54 93.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 83.8 tt0 -175.32 98.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.99 141.7 54.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.035 -1.04 . . . . 0.0 108.524 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.71 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 2.0 p90 -119.3 -154.3 0.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.366 -0.833 . . . . 0.0 109.599 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.71 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 88.4 m-20 -59.68 143.42 50.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.004 . . . . 0.0 109.532 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.62 9.63 7.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.882 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -51.7 -42.92 62.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.04 -1.037 . . . . 0.0 108.535 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.501 ' O ' ' OG ' ' A' ' 22' ' ' SER . 60.1 p -86.49 6.04 32.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.36 -0.837 . . . . 0.0 108.815 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 26' ' ' GLY . 10.5 p 50.19 36.02 11.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.684 . . . . 0.0 109.796 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -61.55 -51.73 67.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.099 -1.001 . . . . 0.0 109.439 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.458 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 29.3 t -68.37 -56.24 9.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 108.871 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 29' ' ' THR . 7.8 m-20 -58.43 -34.88 71.29 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -57.2 -42.88 93.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.93 -47.58 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.241 -1.152 . . . . 0.0 108.628 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 95.2 m -70.37 -24.73 63.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 109.3 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 25' ' ' ASN . 62.5 m -61.89 -31.12 71.38 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.418 -0.801 . . . . 0.0 110.95 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.47 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 1.8 mptt -52.52 -33.56 45.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.0 110.066 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 9.8 t-20 -56.68 -34.01 66.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 109.404 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.44 4.71 56.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.92 -26.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -1.094 . . . . 0.0 109.29 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.712 ' HG3' ' HB2' ' A' ' 52' ' ' ALA . 24.6 tttt -51.29 135.22 26.91 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -117.66 139.98 50.28 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.507 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.13 156.46 26.49 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.858 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' TRP . 41.9 m-85 -130.6 153.41 48.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.621 -0.929 . . . . 0.0 108.787 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -99.41 125.66 45.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.972 -1.08 . . . . 0.0 109.64 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.588 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 96.3 mt-30 -111.11 -162.05 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.599 -0.688 . . . . 0.0 109.315 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.0 pt -114.65 157.45 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -0.753 . . . . 0.0 109.807 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 ' HA3' ' A' ' 45' ' ' GLY . 63.8 mt -86.62 146.39 26.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.306 -0.871 . . . . 0.0 109.498 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.77 -33.16 34.48 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.5 p -97.57 -124.12 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.431 -1.04 . . . . 0.0 108.94 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -111.73 132.18 54.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 109.117 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 133.31 -163.96 24.29 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -140.29 165.72 26.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.222 -1.164 . . . . 0.0 109.386 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.57 162.08 26.17 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.757 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -107.59 135.69 48.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.401 -1.058 . . . . 0.0 109.512 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CE3' ' OE1' ' A' ' 39' ' ' GLN . 11.4 t-105 -112.18 121.95 46.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.382 -0.824 . . . . 0.0 109.14 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.66 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 1.8 t -125.8 129.92 50.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.222 -0.923 . . . . 0.0 109.523 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mt -121.09 138.64 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.53 -0.731 . . . . 0.0 110.62 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . . . -170.96 -52.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.526 -0.734 . . . . 0.0 109.534 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.6 tp -127.48 78.76 74.32 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.549 -0.719 . . . . 0.0 109.931 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' ASP . 32.3 Cg_exo -54.03 171.03 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.937 2.425 . . . . 0.0 112.321 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' PRO . 49.4 t0 59.88 146.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 64.08 48.34 3.04 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.312 -0.868 . . . . 0.0 109.142 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.542 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -107.63 103.23 48.34 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HG2' ' NE ' ' A' ' 60' ' ' ARG . 63.9 Cg_endo -91.31 130.66 1.34 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.626 2.217 . . . . 0.0 110.892 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.622 HG22 ' H ' ' A' ' 61' ' ' ILE . 3.3 mt -64.38 -32.55 58.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.114 -0.991 . . . . 0.0 110.506 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.423 HH11 ' HB2' ' A' ' 9' ' ' PRO . 97.8 mtt180 55.24 1.53 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.306 -0.871 . . . . 0.0 109.14 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 61' ' ' ILE . 5.1 mt -130.61 81.05 68.75 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.494 -0.754 . . . . 0.0 109.672 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.11 54.04 4.58 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.916 2.411 . . . . 0.0 111.944 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.77 0.09 75.82 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.81 -40.59 84.56 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.705 -0.879 . . . . 0.0 109.785 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.9 t -59.85 -32.72 70.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.476 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -127.7 138.56 52.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.177 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.523 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 79.3 m-20 -99.32 148.59 24.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.012 -1.055 . . . . 0.0 109.396 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.81 -82.88 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 110.473 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -99.03 5.84 46.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.631 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 48' ' ' CYS . 33.5 pt -117.34 161.46 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 110.34 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.445 ' O ' HG11 ' A' ' 27' ' ' VAL . . . -116.03 -5.79 11.96 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.423 ' HD3' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -108.57 156.0 39.52 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.51 -51.5 0.53 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.47 2.114 . . . . 0.0 112.598 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -114.88 1.76 14.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.145 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -125.72 170.4 11.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 109.925 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.8 m -110.23 178.1 4.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.442 -0.787 . . . . 0.0 109.319 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.423 HG22 ' HD3' ' A' ' 8' ' ' LYS . 40.6 t -101.11 126.85 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.612 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 26.9 p90 -74.75 -32.51 62.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.096 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 78.7 tt0 -172.15 98.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.452 -0.78 . . . . 0.0 108.99 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.3 t -73.46 108.35 6.27 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.014 -1.054 . . . . 0.0 109.004 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.788 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.32 148.06 2.06 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.6 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 59.6 t0 -73.43 116.79 14.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.96 . . . . 0.0 110.516 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.788 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -140.52 147.97 40.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.809 . . . . 0.0 109.138 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -58.57 -44.67 89.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.012 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.473 ' OG ' ' ND2' ' A' ' 25' ' ' ASN . 2.6 t 172.93 73.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.42 -0.8 . . . . 0.0 109.244 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 p -152.94 -50.47 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.113 -0.992 . . . . 0.0 110.087 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -58.16 -51.84 68.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.976 -1.078 . . . . 0.0 109.848 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -66.29 -44.35 83.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.148 -0.97 . . . . 0.0 108.757 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.473 ' ND2' ' OG ' ' A' ' 21' ' ' SER . 6.4 m-20 -58.44 -37.38 75.3 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.48 -42.03 98.89 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 7' ' ' ALA . 70.9 t -63.67 -43.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -1.116 . . . . 0.0 109.148 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 59.0 m -63.93 -30.03 71.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.396 -0.815 . . . . 0.0 109.394 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.4 m -57.82 -42.61 84.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -61.91 -45.39 93.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -0.954 . . . . 0.0 108.894 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.28 -29.31 69.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.445 -0.785 . . . . 0.0 109.323 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.22 7.6 55.93 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' A' ' 52' ' ' ALA . . . -69.85 175.41 4.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -1.014 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -78.62 -77.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.026 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.7 p -143.76 166.7 24.15 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.58 154.56 25.26 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.568 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 57.9 m-85 -122.27 133.95 54.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.357 -1.084 . . . . 0.0 109.552 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.649 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 1.1 m -99.81 121.54 41.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.367 -0.833 . . . . 0.0 109.191 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -141.07 -136.54 0.11 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.091 -1.006 . . . . 0.0 109.623 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 42' ' ' GLY . 64.1 mt -95.81 139.66 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.2 tp -55.99 -37.13 68.68 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.581 ' H ' HG22 ' A' ' 40' ' ' ILE . . . 158.46 -69.0 0.27 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.4 p -105.66 -63.44 1.25 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -126.84 148.72 49.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.79 -178.86 39.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -122.72 150.94 42.08 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.483 -1.01 . . . . 0.0 109.667 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.92 162.59 26.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.649 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 4.2 t -140.2 135.94 32.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -1.087 . . . . 0.0 109.754 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.18 133.9 51.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.219 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.523 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 12.2 t -99.92 125.51 45.93 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.9 mm -99.46 131.46 46.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 109.48 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . . . -170.56 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.045 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.84 94.71 48.98 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.383 -0.823 . . . . 0.0 110.305 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.12 -8.95 17.81 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.183 1.922 . . . . 0.0 112.101 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -56.34 -35.81 68.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.324 -0.86 . . . . 0.0 109.935 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 57' ' ' VAL . 49.1 m-20 -78.96 142.35 36.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.93 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.772 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.2 p -39.72 102.38 0.26 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.629 -0.669 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 59' ' ' ILE . 50.1 Cg_endo -90.61 159.35 4.31 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.714 2.276 . . . . 0.0 111.888 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 59' ' ' ILE . 86.0 mt 39.75 60.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.372 -0.83 . . . . 0.0 110.209 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -51.51 -34.55 36.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.701 HG22 ' H ' ' A' ' 63' ' ' GLY . 1.4 mp -61.04 130.64 91.47 Favored Pre-proline 0 C--N 1.301 -1.53 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.677 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.29 -25.33 6.97 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.862 1.708 . . . . 0.0 111.949 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.701 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 138.41 3.66 1.82 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -106.28 129.62 54.28 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.319 -1.107 . . . . 0.0 109.025 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.516 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 86.3 m -58.6 -28.34 65.51 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.569 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.516 ' CG ' ' O ' ' A' ' 65' ' ' CYS . 98.0 m-70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.482 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.491 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -138.24 169.23 18.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -94.14 142.57 27.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 108.42 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -106.07 -84.45 0.51 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 111.101 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -98.89 -19.21 17.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.055 . . . . 0.0 110.402 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.529 HG22 ' H ' ' A' ' 8' ' ' LYS . 63.5 mt -106.24 132.87 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.323 -0.861 . . . . 0.0 110.15 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.59 17.74 12.81 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.529 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -124.09 155.32 67.84 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.16 -35.91 61.21 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.483 2.122 . . . . 0.0 112.27 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.557 ' CE1' HH11 ' A' ' 60' ' ' ARG . 74.4 m80 -141.8 -3.97 1.1 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.139 -0.976 . . . . 0.0 109.453 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.489 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 59.1 m-80 -109.5 172.33 6.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 109.428 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HA ' HG23 ' A' ' 6' ' ' ILE . 5.4 m -122.2 177.26 5.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.629 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 48' ' ' CYS . 47.1 t -101.05 138.05 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.032 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.29 -61.26 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.456 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -173.89 98.72 0.11 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.414 -0.804 . . . . 0.0 109.121 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 29.7 p -50.62 103.24 0.05 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.253 -0.905 . . . . 0.0 108.906 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.506 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 23.7 p90 -59.91 -39.77 86.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.445 -0.785 . . . . 0.0 110.033 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.506 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 57.6 t0 -143.55 91.54 2.26 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.243 -0.91 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.64 -25.0 67.9 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.245 -0.91 . . . . 0.0 109.046 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -53.76 -38.45 64.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 108.81 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.6 m -77.57 7.71 5.23 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 26' ' ' GLY . 12.7 p 60.76 36.37 19.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.565 -0.709 . . . . 0.0 110.045 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -61.89 -54.99 34.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.957 -1.09 . . . . 0.0 108.863 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.31 -52.31 23.76 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 36' ' ' GLY . 5.9 m-20 -58.37 -36.74 73.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -60.29 -42.77 98.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.503 HG21 ' HZ2' ' A' ' 8' ' ' LYS . 58.1 t -61.07 -46.94 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -1.157 . . . . 0.0 109.518 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 3.5 m -70.23 -33.34 71.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.272 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.4 m -57.32 -50.5 72.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.431 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -65.71 -37.87 87.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.414 -0.804 . . . . 0.0 109.337 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 27' ' ' VAL . 24.4 m120 -58.96 -25.47 63.57 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.42 44.05 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 28' ' ' CYS . . . -64.17 145.68 55.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.445 -1.033 . . . . 0.0 109.248 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.534 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 2.7 ttmt -59.37 -51.96 67.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 0.0 109.792 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.421 ' HG ' ' HE2' ' A' ' 37' ' ' TYR . 83.4 p -144.35 166.89 23.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.189 -0.945 . . . . 0.0 110.201 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.44 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -143.38 135.17 6.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.421 ' HE2' ' HG ' ' A' ' 35' ' ' SER . 91.6 m-85 -128.46 136.92 51.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -1.08 . . . . 0.0 109.573 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.9 t -109.0 128.62 55.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.462 -0.774 . . . . 0.0 109.585 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.612 ' NE2' ' CH2' ' A' ' 49' ' ' TRP . 0.3 OUTLIER -134.56 171.55 14.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.446 -0.784 . . . . 0.0 109.116 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.9 pt -98.13 134.62 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.13 -0.981 . . . . 0.0 109.503 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 45' ' ' GLY . 24.2 tp -130.1 125.21 34.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.651 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.23 -27.58 73.08 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.448 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 42.6 m -59.37 -46.55 88.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.029 -1.277 . . . . 0.0 110.039 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -125.64 16.3 8.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.447 -0.783 . . . . 0.0 109.156 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 41' ' ' LEU . . . 83.9 -56.85 5.05 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -140.77 146.05 37.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -1.131 . . . . 0.0 109.642 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.27 132.23 5.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.704 ' HB2' HG21 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -111.25 126.62 55.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.388 -1.066 . . . . 0.0 109.28 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.612 ' CH2' ' NE2' ' A' ' 39' ' ' GLN . 4.7 p90 -118.36 138.86 52.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.868 . . . . 0.0 109.125 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.3 m -126.1 156.15 40.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mm -110.11 122.89 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.422 -0.799 . . . . 0.0 109.296 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -179.57 -145.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.491 HD12 ' HB1' ' A' ' 1' ' ' ALA . 9.5 tp -133.1 78.99 63.58 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.552 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -87.64 22.31 0.92 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.35 2.7 . . . . 0.0 112.057 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -52.45 -35.55 52.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.574 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -56.39 -35.35 67.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.791 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.5 p -131.06 77.9 74.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.359 -0.838 . . . . 0.0 109.585 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 59' ' ' ILE . 73.7 Cg_endo -95.27 87.98 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 123.596 2.864 . . . . 0.0 112.287 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' PRO . 45.8 mt 43.31 55.66 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.031 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.557 HH11 ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -59.72 -41.0 89.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.135 -0.978 . . . . 0.0 109.891 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.618 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -62.96 149.72 89.68 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -46.0 -23.59 1.86 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.174 1.916 . . . . 0.0 112.05 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.476 ' H ' HG12 ' A' ' 61' ' ' ILE . . . 138.04 2.93 2.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -93.39 145.97 24.09 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.282 -1.128 . . . . 0.0 109.283 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 66' ' ' HIS . 8.6 t -58.01 -47.19 83.79 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 65' ' ' CYS . 61.8 t60 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.65 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.534 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -136.7 161.81 34.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -0.88 . . . . 0.0 109.409 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -95.1 143.41 26.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.16 -0.962 . . . . 0.0 109.108 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.486 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.79 -65.0 0.99 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.164 -0.96 . . . . 0.0 110.445 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 2.6 m-85 -109.15 0.9 20.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.514 HD11 ' HA2' ' A' ' 63' ' ' GLY . 70.3 mt -106.68 142.04 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 110.433 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.743 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -129.07 -22.7 3.13 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -103.99 157.01 34.87 Favored Pre-proline 0 N--CA 1.487 1.419 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 8' ' ' LYS . 43.9 Cg_exo -34.02 -110.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.444 2.763 . . . . 0.0 113.376 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -85.49 -2.78 58.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.768 -1.208 . . . . 0.0 109.308 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -100.28 151.48 21.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.331 -0.855 . . . . 0.0 109.466 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.67 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 57.2 m -108.27 166.18 10.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.526 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.97 133.04 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.165 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 32.3 p90 -60.71 -41.44 95.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.583 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 82.4 tt0 -175.24 93.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.279 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 47' ' ' GLY . 19.5 p -68.58 134.54 50.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.059 -1.026 . . . . 0.0 108.576 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.692 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 2.6 p90 -109.67 -152.55 0.5 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.299 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.692 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.2 m-20 -57.6 139.24 54.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.044 -1.035 . . . . 0.0 109.192 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.36 9.05 3.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.381 -0.825 . . . . 0.0 109.827 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -51.96 -42.91 63.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 108.896 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.6 m -84.69 7.12 21.52 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.339 -0.85 . . . . 0.0 108.907 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 26' ' ' GLY . 70.5 m 54.38 27.12 7.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.406 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -60.18 -52.81 63.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.1 t -66.39 -51.83 53.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 0.0 108.835 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 29' ' ' THR . 5.4 m-20 -58.65 -36.25 73.81 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.534 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . . . -57.07 -43.42 93.28 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.13 -47.11 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -1.205 . . . . 0.0 109.09 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.7 m -70.49 -24.76 62.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.635 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 25' ' ' ASN . 67.6 m -63.16 -30.39 71.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.232 -0.918 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' NZ ' ' O ' ' A' ' 26' ' ' GLY . 12.7 mptt -51.94 -33.39 37.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.921 -1.112 . . . . 0.0 110.112 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.426 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 9.2 t-20 -56.48 -33.67 66.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.04 -1.038 . . . . 0.0 109.349 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.26 2.63 54.19 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.02 -26.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -1.084 . . . . 0.0 109.132 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.631 ' CE ' ' SG ' ' A' ' 50' ' ' CYS . 15.7 tttp -52.67 137.88 29.98 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -118.23 135.15 54.44 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.143 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -144.4 162.12 27.93 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.275 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -140.65 169.87 16.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -1.078 . . . . 0.0 109.062 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 11.7 t -99.06 124.43 44.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.949 -1.095 . . . . 0.0 110.959 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -119.87 -139.88 0.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 40' ' ' ILE . 30.3 pt -110.96 142.86 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 109.699 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.0 tp -58.73 -37.28 75.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.198 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.84 -59.33 0.62 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.65 -70.63 0.76 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -1.022 . . . . 0.0 108.806 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -128.4 148.94 50.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.575 -0.703 . . . . 0.0 109.223 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.2 -168.23 35.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 16' ' ' CYS . 24.9 m120 -120.93 165.26 15.48 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.47 -1.018 . . . . 0.0 109.608 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -134.94 151.49 20.45 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.743 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -99.53 140.56 33.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -1.17 . . . . 0.0 109.755 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.486 ' CZ3' ' HB1' ' A' ' 4' ' ' ALA . 8.9 t-105 -113.45 128.19 56.36 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.631 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -126.09 135.8 52.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 109.036 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.625 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 4.5 mt -117.16 136.51 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.36 -0.837 . . . . 0.0 111.101 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 51' ' ' ILE . . . 162.17 168.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.534 HD12 ' HB1' ' A' ' 1' ' ' ALA . 3.3 tp -129.24 73.97 81.33 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.674 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 50.3 Cg_exo -49.73 -174.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.643 2.229 . . . . 0.0 111.341 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 56' ' ' ASN . 92.2 m-20 -52.1 -39.06 59.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.972 -1.08 . . . . 0.0 108.801 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER 159.97 -174.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 109.19 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.835 HG12 ' HE ' ' A' ' 60' ' ' ARG . 8.3 t 57.15 68.59 1.99 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.76 -65.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.683 2.255 . . . . 0.0 112.038 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.5 mt -117.29 125.84 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.523 -0.736 . . . . 0.0 109.103 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.835 ' HE ' HG12 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -113.83 1.68 14.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.485 -0.76 . . . . 0.0 109.193 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -132.11 155.18 81.64 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.416 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.4 -0.43 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.585 2.19 . . . . 0.0 111.685 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.514 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 102.42 -1.42 49.94 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -85.21 130.45 34.6 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -1.129 . . . . 0.0 109.479 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.67 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 2.5 m -115.03 158.98 21.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.431 -0.793 . . . . 0.0 109.471 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.424 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 58.3 t-80 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.609 ' H2 ' ' HB2' ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.805 HH21 ' HE1' ' A' ' 49' ' ' TRP . 76.1 ttt180 -126.52 132.32 51.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.447 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 75.8 m-20 -100.17 143.96 29.76 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -106.32 -83.94 0.52 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.462 -0.774 . . . . 0.0 109.266 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CE1' HD11 ' A' ' 41' ' ' LEU . 9.7 m-85 -99.78 -29.83 12.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.533 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.698 HG23 ' HA ' ' A' ' 12' ' ' CYS . 69.9 mt -102.01 138.12 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.521 -0.737 . . . . 0.0 109.665 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -117.0 20.72 13.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.443 -0.786 . . . . 0.0 110.398 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.621 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -126.35 153.13 74.74 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.083 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.409 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 11.3 Cg_endo -57.84 -29.35 85.84 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.533 2.156 . . . . 0.0 112.272 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 9' ' ' PRO . 88.5 m-70 -151.65 -6.8 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.199 -0.938 . . . . 0.0 109.316 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.488 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 56.8 m-80 -105.63 171.16 7.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.779 . . . . 0.0 109.413 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.698 ' HA ' HG23 ' A' ' 6' ' ' ILE . 73.9 m -120.85 177.08 5.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.446 -0.784 . . . . 0.0 109.466 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.54 133.51 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.968 . . . . 0.0 109.402 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -48.68 78.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.376 -0.827 . . . . 0.0 109.317 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' CYS . 11.6 pt-20 177.14 80.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 109.23 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -44.75 156.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.067 -1.021 . . . . 0.0 109.122 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.718 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 3.2 p90 -132.56 -149.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 109.331 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.718 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 59.3 t0 -57.41 132.6 53.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.128 -0.983 . . . . 0.0 109.654 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 22' ' ' SER . . . -74.98 4.48 6.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.0 109.918 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -49.82 -42.75 47.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.066 -1.022 . . . . 0.0 108.859 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.422 ' C ' ' OG ' ' A' ' 22' ' ' SER . 82.6 p -82.35 -5.48 58.63 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 0.0 109.095 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 63.29 34.36 13.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 109.577 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 27' ' ' VAL . 63.6 t80 -58.95 -48.65 80.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.999 -1.063 . . . . 0.0 109.872 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.16 -52.95 28.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 109.031 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.49 -37.64 75.98 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.328 -0.857 . . . . 0.0 108.794 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.53 93.84 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 23' ' ' TYR . 71.1 t -61.82 -42.31 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.353 -1.087 . . . . 0.0 108.798 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 65.0 m -61.66 -32.96 73.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.818 . . . . 0.0 109.372 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.3 m -57.4 -45.73 84.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 109.476 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -64.54 -43.47 93.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 108.81 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.77 -28.96 70.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.558 -0.713 . . . . 0.0 109.153 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.46 -0.87 53.35 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 28' ' ' CYS . . . -67.39 148.4 51.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.38 -1.071 . . . . 0.0 109.263 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -64.82 -60.34 3.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.063 -1.023 . . . . 0.0 110.284 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.2 p -144.21 160.91 40.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.873 -1.142 . . . . 0.0 110.567 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -143.71 156.17 26.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 49' ' ' TRP . 17.6 m-85 -123.65 146.21 48.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -1.102 . . . . 0.0 109.472 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 37.8 t -99.89 121.63 41.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.19 -0.944 . . . . 0.0 109.076 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -118.38 165.55 13.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.471 -0.768 . . . . 0.0 109.446 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.583 ' C ' HD22 ' A' ' 41' ' ' LEU . 36.8 pt -103.45 144.01 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 110.117 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.583 HD22 ' C ' ' A' ' 40' ' ' ILE . 4.2 mm? -107.08 139.91 40.75 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.67 -0.644 . . . . 0.0 109.508 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.8 -28.62 52.95 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 44' ' ' TYR . 45.8 p -94.82 -72.88 0.6 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -1.167 . . . . 0.0 110.649 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.448 ' N ' ' OG1' ' A' ' 43' ' ' THR . 91.7 m-85 -61.82 -39.28 91.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 110.155 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.91 -34.93 4.84 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.174 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.33 129.64 31.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -1.229 . . . . 0.0 110.293 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 160.14 26.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -111.26 135.23 52.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.378 -1.072 . . . . 0.0 109.831 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.805 ' HE1' HH21 ' A' ' 2' ' ' ARG . 4.7 t-105 -113.33 111.66 22.37 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.447 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 5.5 t -107.76 122.82 47.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.114 -0.991 . . . . 0.0 108.906 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.485 HD12 ' CE2' ' A' ' 37' ' ' TYR . 65.1 mt -117.81 135.56 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.603 -0.686 . . . . 0.0 110.096 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -174.29 -32.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.609 ' HB2' ' H2 ' ' A' ' 1' ' ' ALA . 5.2 mp -124.41 160.05 54.71 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.531 -0.731 . . . . 0.0 109.155 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -42.03 -78.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.471 2.114 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 51.0 p30 -177.03 39.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.187 -0.945 . . . . 0.0 109.511 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.63 133.85 46.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.827 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.53 ' O ' ' HB1' ' A' ' 1' ' ' ALA . 2.8 t 47.49 70.12 2.28 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.305 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.44 ' CB ' ' O ' ' A' ' 2' ' ' ARG . 68.2 Cg_endo -82.11 -68.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.832 2.355 . . . . 0.0 112.312 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.89 158.21 43.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.327 -0.858 . . . . 0.0 109.388 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -117.06 122.22 43.55 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.25 81.65 13.53 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.541 -0.724 . . . . 0.0 110.062 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.42 -4.55 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.687 2.258 . . . . 0.0 111.744 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.86 -5.52 58.15 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' O ' ' CE1' ' A' ' 66' ' ' HIS . 29.3 ttpt -60.06 -35.65 75.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -1.183 . . . . 0.0 109.508 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 15.1 m -73.34 154.03 40.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.885 . . . . 0.0 109.514 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.42 ' CE1' ' O ' ' A' ' 64' ' ' LYS . 77.5 m80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.489 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.506 HH21 ' CB ' ' A' ' 54' ' ' PRO . 40.1 ttm180 -127.77 135.33 49.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.434 -0.792 . . . . 0.0 109.65 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.441 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 84.2 m-20 -95.92 145.58 25.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.831 . . . . 0.0 108.898 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -105.1 -83.27 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.883 . . . . 0.0 110.051 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -100.93 13.02 36.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.865 . . . . 0.0 109.536 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.422 HG22 ' SG ' ' A' ' 12' ' ' CYS . 27.5 pt -121.68 161.38 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.744 . . . . 0.0 109.987 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -128.43 -2.97 5.52 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -111.04 153.2 43.97 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.517 -0.739 . . . . 0.0 109.111 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -58.55 -26.58 79.22 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.762 2.308 . . . . 0.0 113.14 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.545 ' CE1' ' NH1' ' A' ' 60' ' ' ARG . 57.4 t60 -145.15 -15.31 0.51 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.962 -1.086 . . . . 0.0 109.728 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -103.54 159.41 15.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.0 109.085 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.422 ' SG ' HG22 ' A' ' 6' ' ' ILE . 59.0 m -115.88 172.24 7.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 109.765 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.4 t -99.36 134.42 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.833 . . . . 0.0 109.297 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.426 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.3 p90 -67.85 -36.35 80.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.839 . . . . 0.0 109.45 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.0 tt0 -174.29 95.38 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 108.902 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -63.25 112.88 2.88 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.2 -0.938 . . . . 0.0 109.207 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.7 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 3.2 p90 -76.3 -157.07 0.07 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.191 -0.943 . . . . 0.0 108.911 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.7 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.6 m-20 -61.54 130.51 46.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.025 -1.047 . . . . 0.0 109.255 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.29 26.65 10.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.468 -0.77 . . . . 0.0 109.261 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.22 -45.86 75.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 109.578 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.601 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.0 m -62.46 -50.45 71.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 0.0 109.469 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.601 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.9 m 150.51 33.24 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.43 -71.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.801 -1.187 . . . . 0.0 109.996 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.5 t -61.86 -49.78 74.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 36' ' ' GLY . 21.2 m-20 -57.79 -37.53 73.89 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -58.23 -40.86 94.45 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 7' ' ' ALA . 64.7 t -61.95 -48.7 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -1.207 . . . . 0.0 109.063 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.5 m -70.8 -22.07 62.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.378 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 64.8 m -63.1 -38.23 90.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.344 -0.848 . . . . 0.0 111.28 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -32.08 51.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.016 . . . . 0.0 109.91 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -55.33 -31.5 61.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 109.333 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 101.64 3.96 52.52 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 179.4 -26.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -1.154 . . . . 0.0 109.68 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.525 ' CE ' ' SG ' ' A' ' 50' ' ' CYS . 32.6 tttt -55.08 130.9 43.64 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.7 p -112.83 140.03 47.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.68 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.445 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -143.7 166.96 26.81 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.041 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.649 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -140.54 160.46 39.97 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 47.1 t -99.83 121.4 41.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.983 -1.073 . . . . 0.0 109.757 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.406 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 80.3 mt-30 -109.05 167.22 10.26 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.2 pt -93.97 137.47 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.078 -1.013 . . . . 0.0 109.593 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 41' ' ' LEU . 5.8 tt -59.9 -35.04 74.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 108.735 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.434 ' C ' ' OG1' ' A' ' 43' ' ' THR . . . 133.01 -28.36 3.35 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.434 ' OG1' ' C ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 177.55 -40.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -1.021 . . . . 0.0 109.168 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.596 ' HB2' HD13 ' A' ' 41' ' ' LEU . 98.7 m-85 -65.28 -34.72 79.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.787 . . . . 0.0 110.119 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 41' ' ' LEU . . . 175.27 -154.34 17.72 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.349 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.414 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 56.7 m-80 -121.06 159.9 24.75 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.524 -0.986 . . . . 0.0 109.394 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.1 161.35 25.96 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.697 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -105.89 129.72 53.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -1.044 . . . . 0.0 109.674 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 3' ' ' ASP . 0.9 OUTLIER -111.04 116.87 31.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 108.812 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.525 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 3.9 t -107.62 119.68 40.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.93 134.8 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.561 -0.712 . . . . 0.0 110.444 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.459 ' HB3' ' HG3' ' A' ' 34' ' ' LYS . . . 179.16 -42.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 53' ' ' LEU . 46.3 tp -130.03 73.16 81.62 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.497 -0.752 . . . . 0.0 109.677 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.506 ' CB ' HH21 ' A' ' 2' ' ' ARG . 72.0 Cg_endo -84.87 33.02 0.48 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.943 2.428 . . . . 0.0 112.343 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -51.48 -36.26 43.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.095 -1.003 . . . . 0.0 109.126 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -130.07 -24.49 2.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 109.632 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 57' ' ' VAL . 94.6 t 50.4 64.09 8.9 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 109.636 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -94.71 156.65 1.88 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.376 2.717 . . . . 0.0 111.561 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.66 122.26 63.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.422 -0.799 . . . . 0.0 109.137 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.545 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -97.97 90.97 5.1 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.24 -0.913 . . . . 0.0 109.579 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -128.88 77.53 77.62 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.492 -0.755 . . . . 0.0 109.709 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -79.03 16.77 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.769 2.313 . . . . 0.0 111.717 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.61 -20.79 43.01 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -60.85 -39.52 89.43 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.403 -1.057 . . . . 0.0 109.47 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 14.1 t -59.15 -34.94 72.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.312 -0.867 . . . . 0.0 109.602 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.446 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.448 ' NH1' ' CZ2' ' A' ' 49' ' ' TRP . 66.0 ttp85 -124.38 130.63 52.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.792 . . . . 0.0 109.514 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -100.06 145.11 28.3 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.093 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -108.56 -85.46 0.53 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.52 -0.738 . . . . 0.0 109.073 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -99.36 -28.28 13.36 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.169 -0.957 . . . . 0.0 109.344 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.582 HG23 ' HA ' ' A' ' 12' ' ' CYS . 90.9 mt -103.56 139.89 23.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.56 -0.713 . . . . 0.0 110.196 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.77 -7.78 18.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.495 -0.753 . . . . 0.0 109.104 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.3 mtmt -126.43 89.54 51.99 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.93 -27.82 6.32 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.278 1.985 . . . . 0.0 112.185 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -86.01 -19.95 29.58 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.229 -0.92 . . . . 0.0 108.89 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 8' ' ' LYS . 5.4 m120 -140.62 -150.7 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.801 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.582 ' HA ' HG23 ' A' ' 6' ' ' ILE . 69.0 m -140.65 178.38 7.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.623 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.79 128.15 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.001 . . . . 0.0 109.238 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.598 ' HH ' ' HH ' ' A' ' 23' ' ' TYR . 30.8 p90 -68.27 -34.79 76.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -172.15 93.74 0.14 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.539 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -71.06 125.12 26.03 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.993 -1.067 . . . . 0.0 108.164 179.202 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 70.5 t80 -91.83 160.09 15.48 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 109.821 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.493 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 89.2 m-20 -42.45 126.81 3.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.69 -11.88 60.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.54 -0.725 . . . . 0.0 109.506 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -52.21 -46.24 65.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.352 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 27.2 m -66.55 -62.23 1.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.178 -0.951 . . . . 0.0 109.25 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.0 m 153.12 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.598 ' HH ' ' HH ' ' A' ' 14' ' ' TYR . 65.9 t80 -58.79 -53.59 56.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.996 . . . . 0.0 110.54 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.7 t -65.68 -40.54 92.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.077 -1.014 . . . . 0.0 109.075 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.44 ' O ' ' OG1' ' A' ' 29' ' ' THR . 10.2 m-20 -59.41 -38.64 81.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.461 -0.775 . . . . 0.0 109.207 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.427 ' O ' ' CD ' ' A' ' 30' ' ' LYS . . . -62.97 -48.59 79.33 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.19 -43.18 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -1.163 . . . . 0.0 109.065 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 33' ' ' ALA . 34.1 t -63.84 -35.05 79.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.51 -0.744 . . . . 0.0 109.71 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 55.3 m -56.13 -42.37 76.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 13.4 mptt -59.87 -38.03 81.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.026 -1.046 . . . . 0.0 109.202 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -58.97 -29.18 66.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.346 -0.846 . . . . 0.0 109.021 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.5 -0.36 55.62 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.553 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -68.63 150.46 47.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.43 -1.041 . . . . 0.0 109.501 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.925 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 7.8 ttmt -57.66 -60.15 4.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.879 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -143.85 161.49 38.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.237 -0.915 . . . . 0.0 109.433 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.27 158.5 27.27 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.582 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 49' ' ' TRP . 30.5 m-85 -136.01 161.2 36.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.504 -0.997 . . . . 0.0 109.16 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 17' ' ' PHE . 0.8 OUTLIER -99.05 123.8 43.6 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.085 -1.009 . . . . 0.0 109.516 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 33.2 tt0 -106.14 154.17 21.06 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.6 pt -93.45 147.1 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.903 -1.123 . . . . 0.0 110.785 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.742 HD12 ' HA3' ' A' ' 45' ' ' GLY . 78.9 mt -82.4 154.38 25.23 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -44.74 -18.84 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 45' ' ' GLY . 19.3 p -117.74 173.42 6.76 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.76 -0.847 . . . . 0.0 108.783 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -47.7 -8.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 109.888 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.742 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -62.32 162.74 27.99 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 51.8 t-20 -140.66 155.77 46.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -1.109 . . . . 0.0 109.842 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 46' ' ' ASN . . . -140.87 174.7 22.55 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -106.32 158.09 17.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -1.099 . . . . 0.0 109.563 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.491 ' N ' ' O ' ' A' ' 37' ' ' TYR . 7.2 t-105 -130.66 140.75 50.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.0 m -135.08 131.49 37.03 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.027 -1.046 . . . . 0.0 110.058 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -125.32 132.87 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.464 -0.772 . . . . 0.0 109.673 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.925 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -178.52 -43.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tp -132.84 74.9 73.62 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 109.514 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.27 166.58 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.973 2.449 . . . . 0.0 112.652 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 57.07 45.84 20.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.627 -0.671 . . . . 0.0 110.137 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' A' ' 57' ' ' VAL . 22.0 t-20 -146.11 158.99 43.89 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.152 -0.967 . . . . 0.0 109.355 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 56' ' ' ASN . 2.4 t -37.38 100.24 0.2 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.671 -0.643 . . . . 0.0 109.388 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.427 ' N ' ' O ' ' A' ' 56' ' ' ASN . 98.2 Cg_endo -85.71 -67.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.39 2.06 . . . . 0.0 112.828 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.0 mt -121.48 133.31 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -0.804 . . . . 0.0 109.764 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -130.34 82.76 2.08 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.7 mt -128.3 86.04 58.92 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.513 -0.742 . . . . 0.0 109.755 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.94 -19.37 5.49 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.3 2.0 . . . . 0.0 111.918 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.13 -0.34 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -59.19 -35.44 73.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -1.178 . . . . 0.0 109.683 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.55 130.6 45.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 109.526 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.438 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.469 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.763 ' NE ' ' HE1' ' A' ' 49' ' ' TRP . 65.2 ttt180 -128.06 133.74 49.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.773 . . . . 0.0 109.705 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -110.79 151.04 28.26 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.606 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.5 -69.78 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.239 -0.913 . . . . 0.0 110.728 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -101.16 -4.26 27.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 0.0 110.46 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.707 HG22 ' H ' ' A' ' 8' ' ' LYS . 63.9 mt -109.09 139.07 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.885 . . . . 0.0 110.509 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -116.28 13.44 15.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.406 -0.809 . . . . 0.0 109.226 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.707 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -125.0 154.77 71.3 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.497 -0.752 . . . . 0.0 109.248 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.34 -36.59 55.11 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.439 2.092 . . . . 0.0 112.352 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -138.55 -3.7 1.67 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.5 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 55.0 m-80 -112.11 169.12 9.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -0.816 . . . . 0.0 109.467 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.634 ' HA ' HG23 ' A' ' 6' ' ' ILE . 3.2 m -116.65 -179.9 3.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.413 -0.804 . . . . 0.0 109.56 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.585 HG21 ' HB2' ' A' ' 48' ' ' CYS . 43.8 t -99.42 134.39 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.194 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.542 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.2 p90 -69.4 -43.02 74.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.855 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 81.4 tt0 -175.51 99.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.003 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -69.32 103.02 1.86 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.069 -1.019 . . . . 0.0 109.023 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 0.7 OUTLIER -45.62 150.79 0.47 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 108.725 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 60.5 t0 -72.17 115.02 10.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.17 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -145.48 150.17 35.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.234 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' ' CB ' ' A' ' 21' ' ' SER . 97.4 m-85 -59.36 -40.37 86.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.958 . . . . 0.0 109.241 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.447 ' CB ' HD22 ' A' ' 25' ' ' ASN . 0.4 OUTLIER 170.06 78.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.404 -0.81 . . . . 0.0 109.278 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.45 -66.66 0.14 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.033 -1.042 . . . . 0.0 110.024 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.46 -50.73 72.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.952 . . . . 0.0 109.961 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.9 t -68.94 -44.33 73.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.344 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.447 HD22 ' CB ' ' A' ' 21' ' ' SER . 7.6 m-20 -59.55 -38.85 82.17 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.389 -0.819 . . . . 0.0 109.286 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.85 98.28 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.576 ' CG1' ' NZ ' ' A' ' 8' ' ' LYS . 83.2 t -66.1 -42.04 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.427 -1.043 . . . . 0.0 109.232 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 33' ' ' ALA . 43.2 t -61.87 -34.62 76.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.451 -0.781 . . . . 0.0 109.549 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.0 m -55.54 -42.46 74.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.728 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -60.19 -37.06 79.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.129 -0.982 . . . . 0.0 109.01 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -57.81 -29.82 65.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.465 -0.772 . . . . 0.0 109.03 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.88 -2.36 48.38 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . . . -68.04 146.67 53.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 109.303 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -57.53 -53.35 59.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.531 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.9 p -144.4 160.49 40.98 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.354 -0.842 . . . . 0.0 109.288 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.84 149.41 21.41 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.351 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 49' ' ' TRP . 85.6 m-85 -125.18 151.36 45.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.576 -0.955 . . . . 0.0 108.804 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.567 ' SG ' ' OD1' ' A' ' 46' ' ' ASN . 48.9 t -100.23 122.82 43.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.042 -1.037 . . . . 0.0 110.219 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.594 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 94.9 mt-30 -120.01 -167.16 1.39 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.1 pt -115.54 156.03 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.443 -0.786 . . . . 0.0 109.793 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.425 HD23 ' CA ' ' A' ' 46' ' ' ASN . 3.5 mm? -60.25 -23.53 64.16 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.418 -0.802 . . . . 0.0 109.207 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' THR . . . 102.24 0.14 50.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 42' ' ' GLY . 9.1 p -154.55 -81.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.8 142.09 51.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.498 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.68 -177.05 41.78 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 39' ' ' GLN . 16.8 t-20 -140.57 160.6 39.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.455 -1.027 . . . . 0.0 108.886 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.24 163.49 26.36 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.548 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.585 ' HB2' HG21 ' A' ' 13' ' ' VAL . 1.1 m -105.99 153.62 21.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.531 -0.982 . . . . 0.0 109.142 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.763 ' HE1' ' NE ' ' A' ' 2' ' ' ARG . 11.5 t-105 -116.81 137.57 52.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.343 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.7 m -132.63 134.23 44.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.241 -0.912 . . . . 0.0 109.855 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mt -123.6 135.31 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.598 -0.689 . . . . 0.0 110.025 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 33' ' ' ALA . . . -158.33 -59.21 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.388 -0.82 . . . . 0.0 109.326 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.48 79.71 72.94 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -50.13 -179.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.957 2.438 . . . . 0.0 112.665 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 56.64 42.85 26.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.62 -0.675 . . . . 0.0 109.482 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.469 ' ND2' ' HB2' ' A' ' 1' ' ' ALA . 46.8 t-20 -148.34 117.42 6.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.257 -0.902 . . . . 0.0 109.34 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.806 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.6 p -124.33 74.43 60.31 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.673 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 59' ' ' ILE . 69.2 Cg_endo -79.76 -61.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.843 2.362 . . . . 0.0 112.118 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 59' ' ' ILE . 83.3 mt 40.25 61.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.472 -0.768 . . . . 0.0 109.977 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -51.48 -34.57 36.23 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.832 HG22 ' H ' ' A' ' 63' ' ' GLY . 1.3 mp -64.43 129.53 94.21 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.51 29.06 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.069 1.846 . . . . 0.0 112.186 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.832 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 97.19 3.32 58.9 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.675 ' O ' HG23 ' A' ' 61' ' ' ILE . 6.3 mtpm? -126.76 136.04 51.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.484 -1.01 . . . . 0.0 109.164 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 75.5 m -60.18 -27.33 67.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.938 . . . . 0.0 109.549 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.516 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.672 ' H1 ' ' H ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -125.96 132.87 51.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.422 -0.799 . . . . 0.0 109.317 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -96.99 136.97 36.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.143 -0.973 . . . . 0.0 109.302 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.541 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -103.32 -59.29 1.74 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.388 -0.82 . . . . 0.0 110.333 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -112.5 9.63 19.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.365 -0.835 . . . . 0.0 110.57 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.431 HD13 HG21 ' A' ' 59' ' ' ILE . 18.4 pt -124.99 163.94 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -0.964 . . . . 0.0 110.252 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.622 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -131.24 -13.28 3.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.469 -0.77 . . . . 0.0 109.038 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.483 ' HB2' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -102.39 152.89 38.39 Favored Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.338 -0.851 . . . . 0.0 109.157 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.35 -34.23 67.38 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.543 2.162 . . . . 0.0 112.875 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.545 ' ND1' ' NH2' ' A' ' 60' ' ' ARG . 91.7 m-70 -133.21 3.15 3.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 110.06 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.483 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 35.7 m-80 -131.37 168.9 16.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.814 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 40.6 m -114.8 179.65 3.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.504 -0.748 . . . . 0.0 109.505 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.476 HG21 ' SG ' ' A' ' 48' ' ' CYS . 45.6 t -95.96 135.06 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.23 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.563 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 32.2 p90 -65.18 -44.43 88.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.563 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 83.3 tt0 -175.56 96.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.059 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.432 ' HB3' HD22 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -66.23 135.46 54.51 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 108.6 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.714 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 2.1 p90 -108.75 -149.47 0.44 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.485 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.714 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 59.0 t0 -56.56 131.88 49.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.048 -1.033 . . . . 0.0 109.39 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.3 4.48 2.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.793 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -51.5 -43.21 62.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.065 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.9 m -85.06 6.45 25.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.031 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 26' ' ' GLY . 38.1 m 48.39 37.94 9.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.856 . . . . 0.0 109.397 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.469 ' O ' HG23 ' A' ' 27' ' ' VAL . 59.2 t80 -59.31 -49.8 76.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.975 . . . . 0.0 109.959 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 33.8 t -69.02 -57.23 5.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.19 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -57.85 -35.65 71.24 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.07 -40.46 95.62 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 23' ' ' TYR . 74.0 t -61.95 -46.72 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.266 -1.138 . . . . 0.0 108.852 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.9 m -70.3 -25.55 63.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.404 -0.81 . . . . 0.0 109.511 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 m -62.79 -29.78 70.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.277 -0.889 . . . . 0.0 111.225 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.489 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 3.9 mptp? -52.86 -34.14 53.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.95 -1.094 . . . . 0.0 110.477 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -56.64 -33.29 66.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.977 -1.077 . . . . 0.0 109.368 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.45 2.93 55.53 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -171.09 -28.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -1.078 . . . . 0.0 108.903 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.658 ' NZ ' ' SG ' ' A' ' 50' ' ' CYS . 24.4 tttt -53.34 134.37 39.84 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.7 m -116.79 139.24 50.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.4 -0.812 . . . . 0.0 109.618 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.19 156.24 26.4 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 49' ' ' TRP . 49.6 m-85 -127.08 154.18 45.03 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.5 t -99.52 122.51 42.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.004 -1.06 . . . . 0.0 109.275 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -123.99 -172.88 2.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.556 -0.715 . . . . 0.0 109.511 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 42' ' ' GLY . 69.3 mt -93.62 145.58 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.882 . . . . 0.0 109.403 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 44' ' ' TYR . 29.7 tp -53.22 -39.19 63.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.504 ' H ' HG22 ' A' ' 40' ' ' ILE . . . 130.15 -56.43 0.74 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.8 m -97.99 -67.88 0.83 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.518 -0.989 . . . . 0.0 108.67 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.517 ' O ' HD23 ' A' ' 41' ' ' LEU . 27.5 p90 -139.64 159.58 41.85 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.87 -164.77 46.87 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.432 HD22 ' HB3' ' A' ' 16' ' ' CYS . 15.8 t30 -140.77 161.69 37.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.3 -1.118 . . . . 0.0 109.389 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.29 159.11 26.14 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.709 -1.234 . . . . 0.0 110.16 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.622 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -103.68 157.45 17.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.352 -1.087 . . . . 0.0 109.168 179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 4' ' ' ALA . 7.5 t-105 -125.68 122.12 35.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.528 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.658 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -123.2 135.87 54.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.0 109.118 179.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 4.1 mt -117.95 134.51 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.699 0.761 . . . . 0.0 111.043 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 51' ' ' ILE . . . 169.07 147.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.71 73.7 81.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.673 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -84.37 -93.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.992 2.461 . . . . 0.0 112.367 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -94.37 11.41 30.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 0.0 109.449 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 62.26 45.01 7.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.407 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.672 ' H ' ' H1 ' ' A' ' 1' ' ' ALA . 10.2 t -68.95 119.58 70.67 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.343 -0.848 . . . . 0.0 109.285 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.88 165.07 7.41 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.277 1.984 . . . . 0.0 111.032 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.527 HG22 HG12 ' A' ' 61' ' ' ILE . 22.3 mm -109.02 130.83 61.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.176 -0.953 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.545 ' NH2' ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -119.28 86.72 2.6 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.527 HG12 HG22 ' A' ' 59' ' ' ILE . 1.9 pt -124.43 81.53 59.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.811 . . . . 0.0 109.745 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -53.31 -18.92 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.666 2.244 . . . . 0.0 112.048 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.66 -12.5 0.11 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -58.75 -33.13 69.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -1.171 . . . . 0.0 109.62 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.0 t -56.62 -33.39 66.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.441 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 78.8 m80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.457 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -128.46 138.1 52.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.379 -0.826 . . . . 0.0 109.858 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 90.3 m-20 -108.05 150.38 27.23 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.77 -85.46 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -98.67 5.95 47.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.954 -1.091 . . . . 0.0 109.572 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.647 HG22 ' HB3' ' A' ' 12' ' ' CYS . 21.5 pt -111.42 149.06 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.544 -0.722 . . . . 0.0 109.744 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.635 ' O ' HG11 ' A' ' 27' ' ' VAL . . . -102.57 -1.92 29.46 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.242 -0.911 . . . . 0.0 108.977 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.47 173.27 6.07 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.535 -0.728 . . . . 0.0 109.289 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -48.63 -76.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.644 2.23 . . . . 0.0 113.367 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.518 ' CG ' HH11 ' A' ' 60' ' ' ARG . 78.2 m-70 -107.52 -8.87 16.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.162 -0.961 . . . . 0.0 110.159 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -102.31 155.55 18.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.396 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.647 ' HB3' HG22 ' A' ' 6' ' ' ILE . 13.9 p -120.98 177.04 5.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.124 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 7' ' ' ALA . 77.8 t -104.97 136.24 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 0.0 110.004 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -82.68 -32.28 28.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.0 109.049 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -174.3 98.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.777 . . . . 0.0 109.077 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' H ' ' ND2' ' A' ' 46' ' ' ASN . 3.7 p -66.18 104.78 1.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.118 -0.989 . . . . 0.0 108.52 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 6.0 p90 -53.58 -42.76 67.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 110.34 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.561 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 54.7 t0 -148.1 78.45 1.44 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.966 -1.084 . . . . 0.0 109.836 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.7 -30.87 71.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.199 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.88 -40.86 73.56 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.433 -0.792 . . . . 0.0 109.256 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.592 ' O ' ' CB ' ' A' ' 22' ' ' SER . 17.5 t -57.57 -52.11 66.73 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.5 m 155.47 10.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.72 -0.613 . . . . 0.0 110.091 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -60.04 -63.22 1.38 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.81 -1.181 . . . . 0.0 110.142 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.28 -51.86 57.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.114 -0.991 . . . . 0.0 108.958 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -60.02 -35.7 75.65 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -57.81 -43.51 94.63 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.635 HG11 ' O ' ' A' ' 7' ' ' ALA . 91.6 t -62.94 -43.42 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -1.173 . . . . 0.0 108.689 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 60.0 m -64.12 -31.67 72.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.848 . . . . 0.0 109.168 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.4 m -58.83 -48.65 80.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.655 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -64.27 -41.9 96.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.398 -0.814 . . . . 0.0 109.192 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -62.28 -30.82 71.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.535 -0.728 . . . . 0.0 109.048 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.99 2.7 56.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.493 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -66.92 152.9 44.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.335 -1.097 . . . . 0.0 109.631 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.775 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 9.5 ttmt -58.46 -71.3 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 110.111 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.0 p -144.77 169.33 18.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.315 -0.866 . . . . 0.0 110.22 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.12 151.06 22.6 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.13 135.82 54.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.27 -1.135 . . . . 0.0 109.895 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.63 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.5 t -111.48 115.23 28.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.239 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -131.66 166.13 22.15 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.5 pt -104.87 145.86 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.977 . . . . 0.0 111.267 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.08 142.32 41.7 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.21 -30.04 53.92 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.2 m -92.09 -74.07 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.083 -1.245 . . . . 0.0 110.772 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -61.52 -40.62 95.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.191 -0.943 . . . . 0.0 110.482 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.47 -31.31 7.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 16' ' ' CYS . 20.3 t-20 -140.47 125.08 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.261 . . . . 0.0 110.008 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.31 112.52 0.81 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.63 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -110.6 117.57 33.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -1.087 . . . . 0.0 109.53 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.37 131.44 54.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.5 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 7.1 t -105.45 122.65 46.43 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -112.53 132.67 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.831 . . . . 0.0 110.429 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.775 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -175.39 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.665 -0.647 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.484 HD23 ' ND2' ' A' ' 56' ' ' ASN . 1.0 OUTLIER -128.93 84.51 62.87 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.57 -0.706 . . . . 0.0 109.732 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.547 ' O ' HG13 ' A' ' 57' ' ' VAL . 36.9 Cg_endo -74.55 -13.07 22.57 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.285 1.99 . . . . 0.0 112.616 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -57.65 -37.46 73.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.051 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.507 ' O ' ' C ' ' A' ' 57' ' ' VAL . 89.2 m-20 -67.05 -40.78 87.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.053 -1.029 . . . . 0.0 110.497 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER 32.93 67.63 1.03 Allowed Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.795 -0.566 . . . . 0.0 109.962 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.471 ' O ' ' C ' ' A' ' 59' ' ' ILE . 68.7 Cg_endo -78.75 -65.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.8 2.333 . . . . 0.0 112.708 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 59' ' ' ILE . 95.8 mt 39.93 58.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.353 -0.842 . . . . 0.0 109.259 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.518 HH11 ' CG ' ' A' ' 10' ' ' HIS . 12.6 ptm180 -55.03 -37.45 66.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.972 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.67 ' O ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -95.97 154.33 38.98 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.184 -0.948 . . . . 0.0 109.545 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.68 -20.33 70.67 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.555 2.17 . . . . 0.0 112.107 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.98 15.95 0.1 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -92.65 155.92 17.42 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.267 -1.137 . . . . 0.0 109.239 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.09 -36.43 65.64 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 83.1 t60 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.423 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.453 ' H ' ' HB3' ' A' ' 58' ' ' PRO . 71.1 ttp85 -128.11 135.3 49.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 87.5 m-20 -96.86 147.18 24.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.941 . . . . 0.0 109.376 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -113.45 -94.25 0.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 109.35 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -98.83 7.54 45.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.012 -1.055 . . . . 0.0 108.952 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.5 pt -117.34 155.79 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.701 -0.624 . . . . 0.0 109.87 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.626 ' H ' HG23 ' A' ' 13' ' ' VAL . . . -112.12 5.13 18.39 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.14 165.25 21.38 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.48 -59.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.408 2.072 . . . . 0.0 112.147 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -105.79 -6.4 19.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.798 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -114.31 164.28 14.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.422 -0.799 . . . . 0.0 109.799 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.6 m -112.43 176.89 4.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.614 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.626 HG23 ' H ' ' A' ' 7' ' ' ALA . 39.9 t -102.08 130.99 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.236 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.436 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.2 p90 -74.13 -36.32 64.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.294 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.1 tt0 -174.76 99.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -65.5 109.34 2.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.59 ' CE2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -61.45 162.09 8.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.59 ' O ' ' CE2' ' A' ' 17' ' ' PHE . 61.1 t0 -44.22 107.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.113 -0.992 . . . . 0.0 108.993 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.584 ' CB ' ' H ' ' A' ' 24' ' ' CYS . . . -95.61 29.94 2.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.814 . . . . 0.0 109.829 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -53.49 -46.08 69.89 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.115 -0.991 . . . . 0.0 108.865 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.587 ' O ' ' CB ' ' A' ' 22' ' ' SER . 20.2 m -64.53 -49.44 71.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.319 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.587 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.4 m 152.2 26.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -58.61 -56.78 17.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.744 -1.223 . . . . 0.0 109.767 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.584 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 38.1 t -67.27 -42.42 83.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 108.832 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 36' ' ' GLY . 5.0 m-20 -59.46 -38.85 81.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.87 -39.3 97.85 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.48 -47.79 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.197 -1.178 . . . . 0.0 109.349 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 1.3 m -70.74 -31.36 68.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.336 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.8 m -53.46 -48.52 68.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.231 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -64.93 -38.17 90.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.442 -0.786 . . . . 0.0 109.0 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -59.59 -28.43 67.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -0.79 . . . . 0.0 108.988 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.36 0.2 40.57 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 28' ' ' CYS . . . -65.29 145.68 55.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -1.114 . . . . 0.0 109.14 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.737 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 4.1 ttmt -60.56 -52.6 64.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 110.135 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -143.55 160.47 40.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.127 -0.983 . . . . 0.0 110.317 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.452 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -139.05 140.15 10.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -130.14 136.72 49.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -1.097 . . . . 0.0 109.755 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.0 t -105.05 130.94 53.13 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.353 -0.842 . . . . 0.0 109.501 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.688 ' NE2' ' N ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -134.67 173.0 12.15 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.493 -0.755 . . . . 0.0 109.274 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.2 pt -95.77 141.3 15.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.453 HD12 ' HA3' ' A' ' 45' ' ' GLY . 76.0 mt -59.13 -34.95 72.65 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.293 -0.88 . . . . 0.0 109.245 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.57 -60.82 0.52 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.67 -70.44 0.75 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.38 -1.071 . . . . 0.0 109.063 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -129.44 151.16 50.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.609 -0.682 . . . . 0.0 109.538 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 93.45 174.8 40.3 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -140.44 167.11 22.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.322 -1.105 . . . . 0.0 109.578 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.489 ' O ' ' OE1' ' A' ' 39' ' ' GLN . . . -140.41 150.41 21.59 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -134.0 125.6 28.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -1.067 . . . . 0.0 109.231 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.547 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 2.8 p90 -120.69 141.27 50.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.113 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.435 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 74.9 m -128.98 145.0 51.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.451 -0.78 . . . . 0.0 109.103 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.69 137.85 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.858 ' C ' HD23 ' A' ' 53' ' ' LEU . . . -169.66 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.926 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.858 HD23 ' C ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -128.0 78.45 75.24 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.892 . . . . 0.0 109.659 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -60.7 -23.66 76.71 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.382 2.055 . . . . 0.0 111.782 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.07 -36.45 77.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 109.785 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.476 ' O ' ' C ' ' A' ' 57' ' ' VAL . 50.6 t-20 -68.06 129.08 38.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.476 ' C ' ' O ' ' A' ' 56' ' ' ASN . 52.5 t -38.15 100.42 0.21 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.803 -0.561 . . . . 0.0 109.539 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HB3' ' H ' ' A' ' 2' ' ' ARG . 75.4 Cg_endo -90.3 155.76 4.58 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.627 2.218 . . . . 0.0 111.69 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 59' ' ' ILE . 89.3 mt 41.25 55.17 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 109.607 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -58.57 -35.87 73.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.476 HG13 ' H ' ' A' ' 63' ' ' GLY . 10.0 pt -60.62 148.56 81.26 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 0.0 109.35 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.79 1.22 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.465 2.11 . . . . 0.0 112.006 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' H ' HG13 ' A' ' 61' ' ' ILE . . . 100.11 5.82 54.36 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 66' ' ' HIS . 39.3 mtpt -103.46 122.62 45.28 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.388 -1.066 . . . . 0.0 108.816 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.407 ' O ' ' OXT' ' A' ' 66' ' ' HIS . 81.1 m -64.26 -22.99 67.14 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.428 -0.795 . . . . 0.0 110.006 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.407 ' OXT' ' O ' ' A' ' 65' ' ' CYS . 37.5 m80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.425 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -129.05 135.78 49.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.424 -0.797 . . . . 0.0 109.687 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.485 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 87.3 m-20 -103.37 155.91 18.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 108.89 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -110.5 -93.48 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 110.323 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -98.2 -10.88 23.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.067 -1.02 . . . . 0.0 109.64 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.712 HG23 ' HA ' ' A' ' 12' ' ' CYS . 60.8 mt -111.0 130.58 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.555 -0.716 . . . . 0.0 109.544 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.64 -12.61 19.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.422 -0.799 . . . . 0.0 110.107 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.444 ' HB2' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -104.08 153.26 39.03 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.274 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.12 -35.8 62.27 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.487 2.125 . . . . 0.0 112.942 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -131.14 -0.9 4.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.948 . . . . 0.0 110.11 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.491 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 34.6 m-80 -125.91 164.55 20.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.342 -0.849 . . . . 0.0 109.78 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.712 ' HA ' HG23 ' A' ' 6' ' ' ILE . 56.7 m -115.42 160.33 20.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.0 109.476 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.78 131.59 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 29.9 p90 -75.13 -43.46 52.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.93 . . . . 0.0 109.459 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.535 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.3 tt0 -175.9 100.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 109.215 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -68.38 93.37 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.089 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.527 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 21.2 p90 -63.42 -43.32 97.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 109.895 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.527 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 47.8 t0 -153.49 89.45 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.126 -0.984 . . . . 0.0 109.849 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.506 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . . . -64.58 -28.68 69.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.128 -0.983 . . . . 0.0 109.275 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -54.49 -40.37 68.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.473 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 20.6 m -58.64 -48.91 79.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.122 -0.986 . . . . 0.0 109.623 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.8 m 153.57 3.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.75 -0.594 . . . . 0.0 109.944 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.08 -79.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.923 -1.11 . . . . 0.0 110.485 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 t -58.43 -48.29 81.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 36' ' ' GLY . 37.0 m-20 -58.35 -36.27 73.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.0 108.835 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.91 -41.12 97.65 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.09 -44.32 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.237 -1.154 . . . . 0.0 109.049 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 62.6 m -64.7 -30.76 71.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 109.389 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.8 m -58.81 -44.68 90.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.726 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt -63.1 -44.7 94.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.011 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.74 -30.23 71.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.274 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.71 4.28 58.04 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.518 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.73 155.0 35.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.365 -1.079 . . . . 0.0 109.608 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.736 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 5.6 ttmt -56.24 -71.63 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 110.235 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 t -144.34 168.66 19.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 110.05 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.438 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -137.2 154.78 22.51 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -129.78 143.93 51.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -1.102 . . . . 0.0 109.641 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -125.45 128.43 48.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.569 -0.707 . . . . 0.0 109.345 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -140.3 -138.53 0.12 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.221 -0.924 . . . . 0.0 109.589 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 40' ' ' ILE . 22.5 pt -93.71 153.21 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.262 -0.898 . . . . 0.0 109.962 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 44' ' ' TYR . 32.4 tp -86.68 138.2 31.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.437 -0.789 . . . . 0.0 109.187 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.74 -35.95 8.0 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.2 p -100.52 -99.04 0.25 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.181 -1.187 . . . . 0.0 109.209 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.695 ' O ' HD23 ' A' ' 41' ' ' LEU . 95.5 m-85 -122.34 147.55 46.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 0.0 109.287 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.34 -162.44 25.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 40' ' ' ILE . 27.9 m120 -114.81 166.41 11.79 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.487 -1.008 . . . . 0.0 109.725 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.59 155.48 21.59 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER -137.2 121.33 17.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -1.144 . . . . 0.0 109.974 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -111.31 136.06 50.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.394 -0.817 . . . . 0.0 108.857 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.518 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 6.9 t -111.31 126.65 55.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.0 108.981 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.1 mt -115.45 135.22 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 110.242 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.736 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -171.18 -55.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.524 -0.735 . . . . 0.0 109.057 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.86 76.52 76.99 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.481 -0.762 . . . . 0.0 109.235 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.87 -21.37 40.33 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.915 2.41 . . . . 0.0 112.684 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.74 -35.44 14.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 108.494 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -109.24 125.53 52.35 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.63 -0.668 . . . . 0.0 109.387 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.7 t -138.29 66.25 44.21 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.915 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -95.2 152.32 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.507 2.804 . . . . 0.0 111.75 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 61' ' ' ILE . 58.8 mt -128.1 121.62 56.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.1 tpt85 -54.97 -36.27 65.19 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.356 -0.84 . . . . 0.0 110.795 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.798 ' O ' HD12 ' A' ' 61' ' ' ILE . 1.6 pp -132.65 154.43 81.49 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.031 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.35 -19.57 28.93 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.479 2.119 . . . . 0.0 112.036 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.79 26.87 0.11 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -104.17 148.18 26.59 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.231 -1.158 . . . . 0.0 109.467 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 71.1 m -117.35 159.76 22.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.489 -0.757 . . . . 0.0 109.148 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.408 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 56' ' ' ASN . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -127.04 129.97 49.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.84 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 5.3 t0 -108.55 153.57 23.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.432 -0.793 . . . . 0.0 109.106 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.61 ' HB1' ' CH2' ' A' ' 49' ' ' TRP . . . -100.28 -81.67 0.46 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.528 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.3 -4.77 31.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.001 . . . . 0.0 109.786 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.456 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 65.7 mt -106.77 143.95 16.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.464 -0.773 . . . . 0.0 110.099 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.84 -10.16 1.34 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.305 -0.872 . . . . 0.0 109.19 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -104.75 157.21 34.66 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 8' ' ' LYS . 45.6 Cg_exo -34.16 -109.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.332 2.688 . . . . 0.0 113.151 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.44 -1.23 57.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.756 -1.215 . . . . 0.0 109.335 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -105.22 154.82 19.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.639 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.449 ' HA ' HG23 ' A' ' 6' ' ' ILE . 7.3 m -108.1 161.81 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.234 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.442 HG21 ' HB2' ' A' ' 48' ' ' CYS . 55.9 t -66.41 134.31 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.947 . . . . 0.0 109.434 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.7 p90 -78.13 -34.7 49.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 76.9 tt0 -167.61 95.0 0.44 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.265 -0.897 . . . . 0.0 109.08 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.485 ' CB ' HD22 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -60.6 148.51 37.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.95 -1.094 . . . . 0.0 108.411 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 13.7 t80 -115.69 166.48 11.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.511 -0.743 . . . . 0.0 109.281 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.585 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 88.0 m-20 -42.8 137.21 2.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 109.401 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.96 -8.91 48.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 110.037 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -51.34 -43.79 61.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.045 -1.034 . . . . 0.0 108.726 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -86.11 6.01 31.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.354 -0.841 . . . . 0.0 108.893 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 m 55.33 20.42 3.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.602 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -58.62 -49.41 77.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.774 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.5 t -65.34 -47.96 74.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.152 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -60.05 -37.63 80.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.389 -0.82 . . . . 0.0 109.185 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.52 -42.22 99.01 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.33 -43.91 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 109.12 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.8 t -64.27 -32.42 74.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.475 -0.765 . . . . 0.0 109.19 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.5 m -59.23 -41.1 87.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.406 -0.809 . . . . 0.0 109.975 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -58.77 -31.2 68.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.128 -0.983 . . . . 0.0 109.272 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -52.6 -34.89 52.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 108.925 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.732 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 157.35 -35.57 0.55 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 161.45 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -1.152 . . . . 0.0 109.362 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 33' ' ' ALA . 22.2 mttt -42.87 139.51 1.65 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.434 -0.791 . . . . 0.0 109.96 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.4 p -125.81 113.63 17.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.59 -141.48 4.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.554 ' O ' ' N ' ' A' ' 49' ' ' TRP . 10.3 m-85 -139.82 171.5 14.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.209 -1.171 . . . . 0.0 109.828 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.465 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 13.0 t -99.68 125.63 45.57 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.325 -0.86 . . . . 0.0 109.534 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.509 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 85.0 mt-30 -118.07 -177.5 3.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.641 -0.662 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 40' ' ' ILE . 31.6 pt -108.93 157.82 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 110.102 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.442 HD12 ' HA3' ' A' ' 45' ' ' GLY . 56.7 mt -79.05 144.52 34.55 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.37 -0.832 . . . . 0.0 109.517 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -54.13 -34.93 53.58 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.1 p -94.14 -120.88 0.09 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.331 -1.1 . . . . 0.0 109.073 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.14 136.63 51.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 126.01 -166.6 18.7 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.485 HD22 ' CB ' ' A' ' 16' ' ' CYS . 17.3 t30 -140.51 157.95 44.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.322 -1.105 . . . . 0.0 108.927 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.24 163.67 25.98 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.8 m -107.43 140.41 40.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.476 -1.014 . . . . 0.0 109.758 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.61 ' CH2' ' HB1' ' A' ' 4' ' ' ALA . 4.6 t-105 -106.34 128.67 54.18 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.397 -0.815 . . . . 0.0 108.895 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.4 m -115.9 128.51 55.84 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.494 HD12 ' CE2' ' A' ' 37' ' ' TYR . 69.2 mt -126.37 138.36 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 110.327 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.721 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -168.91 -40.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.329 -0.857 . . . . 0.0 109.537 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.721 HD12 ' O ' ' A' ' 52' ' ' ALA . 5.8 mp -128.63 159.11 69.71 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.514 -0.741 . . . . 0.0 109.313 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -42.55 -72.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.591 2.194 . . . . 0.0 112.325 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 50.0 p30 -175.37 47.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.44 -0.787 . . . . 0.0 109.534 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 1' ' ' ALA . 16.1 t-20 -101.2 121.9 42.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.26 -0.9 . . . . 0.0 109.751 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 1' ' ' ALA . 23.7 t 55.73 66.82 3.37 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.623 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.74 -64.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.65 2.233 . . . . 0.0 112.12 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -119.92 113.78 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -0.788 . . . . 0.0 109.203 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -67.49 -35.63 79.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 109.054 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 63' ' ' GLY . 1.6 mp -73.7 136.93 77.14 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.691 -0.63 . . . . 0.0 109.543 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -46.64 -5.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.898 1.732 . . . . 0.0 111.892 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 103.67 5.41 45.1 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 66' ' ' HIS . 33.0 mtmt -58.28 -36.75 73.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.107 -1.231 . . . . 0.0 109.385 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 50.7 t 51.64 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.631 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 64' ' ' LYS . 9.9 p-80 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.552 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -108.91 146.05 34.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.427 -0.796 . . . . 0.0 109.306 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 8.9 t0 -136.58 154.31 50.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.874 . . . . 0.0 109.098 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.571 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.6 -78.31 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 110.898 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.65 -8.96 23.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.067 . . . . 0.0 110.096 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.713 HG22 ' H ' ' A' ' 8' ' ' LYS . 68.3 mt -104.65 143.45 16.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.461 -0.774 . . . . 0.0 110.177 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.524 ' O ' ' ND2' ' A' ' 31' ' ' ASN . . . -118.51 13.28 13.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.823 . . . . 0.0 109.354 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.713 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -125.24 155.27 71.56 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -64.86 -39.68 24.46 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.437 2.091 . . . . 0.0 112.416 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -134.57 -1.08 2.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.639 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.495 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 54.2 m-80 -116.16 170.21 8.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.47 -0.769 . . . . 0.0 109.488 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.673 ' HA ' HG23 ' A' ' 6' ' ' ILE . 62.5 m -114.46 177.27 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.518 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 t -99.97 135.68 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -70.78 77.44 0.62 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.067 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 55.9 97.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 109.346 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.7 t -64.68 113.21 3.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 108.975 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 8.4 t80 -70.06 139.56 52.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 88.9 m-20 -70.1 131.77 44.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 110.084 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.72 155.05 37.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.406 -0.809 . . . . 0.0 109.109 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 21' ' ' SER . 96.7 m-85 -56.93 -41.02 77.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.09 -1.006 . . . . 0.0 109.24 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 1.4 t 168.98 86.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.409 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.2 t -170.24 -64.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.057 -1.027 . . . . 0.0 110.021 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.437 ' HH ' ' HE1' ' A' ' 14' ' ' TYR . 64.4 t80 -59.78 -56.95 15.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 109.912 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.2 t -70.66 -52.64 19.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.653 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -57.68 -37.99 74.37 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.408 -0.807 . . . . 0.0 109.469 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.74 -46.66 93.74 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.3 t -67.72 -43.27 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -1.131 . . . . 0.0 109.383 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.5 t -61.22 -38.06 85.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.357 -0.839 . . . . 0.0 109.333 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.8 m -56.93 -40.21 75.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -59.14 -38.34 79.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.012 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 7' ' ' ALA . 9.7 m120 -59.24 -28.52 66.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.83 . . . . 0.0 109.03 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.72 -0.12 52.51 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.78 148.21 51.55 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -1.064 . . . . 0.0 109.452 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.836 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 3.8 ttmt -58.31 -55.56 33.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.782 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t -144.62 158.81 43.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.347 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -141.74 154.23 24.66 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.563 -1.304 . . . . 0.0 110.211 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 49' ' ' TRP . 48.8 m-85 -127.18 152.83 46.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.489 -1.006 . . . . 0.0 109.242 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.8 t -99.44 119.54 38.17 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.176 -0.953 . . . . 0.0 109.087 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -116.68 -170.82 1.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.696 -0.628 . . . . 0.0 109.693 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 pt -93.57 152.17 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.239 -0.913 . . . . 0.0 109.726 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 43' ' ' THR . 29.8 tp -88.85 133.95 34.11 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.301 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -45.11 -30.19 2.52 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.432 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 25.8 p -109.45 178.85 4.31 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -50.75 160.58 0.43 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.763 -1.211 . . . . 0.0 109.174 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.59 -167.05 30.76 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -138.97 171.91 13.62 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.338 -1.095 . . . . 0.0 109.407 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.13 163.66 26.29 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.05 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.1 m -103.57 152.2 22.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.424 -1.045 . . . . 0.0 109.255 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.579 ' N ' ' O ' ' A' ' 37' ' ' TYR . 17.3 t-105 -116.2 139.06 50.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.826 . . . . 0.0 109.566 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.8 m -134.38 124.05 25.11 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.287 -0.883 . . . . 0.0 109.9 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 mt -123.98 132.34 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.536 -0.728 . . . . 0.0 109.875 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.836 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -177.11 -66.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.822 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 1' ' ' ALA . 17.6 tp -133.14 89.0 34.57 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.417 -0.802 . . . . 0.0 109.9 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -75.61 -25.16 11.2 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.074 1.849 . . . . 0.0 112.292 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -57.96 -35.83 71.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 57' ' ' VAL . 48.9 t-20 -73.29 144.72 46.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.645 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.503 ' C ' ' O ' ' A' ' 56' ' ' ASN . 90.9 t -33.85 97.84 0.12 Allowed Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.949 -0.469 . . . . 0.0 109.795 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' ASN . 89.5 Cg_endo -85.5 -63.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.575 2.184 . . . . 0.0 112.426 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.413 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 73.6 mt -118.21 131.97 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -138.49 -21.9 1.01 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.301 -0.874 . . . . 0.0 109.507 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.679 ' O ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -96.23 154.09 38.86 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.735 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -67.21 -9.87 26.64 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.696 2.264 . . . . 0.0 112.195 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.3 22.22 45.42 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 66' ' ' HIS . 17.3 tttp -56.38 -35.04 67.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.557 -0.967 . . . . 0.0 109.651 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 57.8 m 57.12 -77.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.414 -0.803 . . . . 0.0 109.592 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 64' ' ' LYS . 94.9 m-70 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.877 ' H2 ' ' H ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -131.93 134.59 45.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.47 -0.769 . . . . 0.0 109.44 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 83.4 m-20 -95.79 150.11 20.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.136 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -109.86 -92.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.511 -0.743 . . . . 0.0 109.955 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -97.91 -17.3 19.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.346 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.68 HG23 ' HA ' ' A' ' 12' ' ' CYS . 64.7 mt -106.91 137.61 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.525 -0.734 . . . . 0.0 109.62 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.416 ' C ' ' CD ' ' A' ' 8' ' ' LYS . . . -113.24 14.42 19.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.476 -0.765 . . . . 0.0 109.853 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.659 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -126.23 153.52 74.46 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.346 -0.846 . . . . 0.0 109.15 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.86 -27.74 80.58 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.637 2.225 . . . . 0.0 112.896 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -147.64 -5.99 0.47 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.077 -1.015 . . . . 0.0 109.501 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.481 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 51.2 m-80 -111.52 165.92 11.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.768 . . . . 0.0 109.38 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.68 ' HA ' HG23 ' A' ' 6' ' ' ILE . 24.4 m -119.59 162.19 19.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -0.823 . . . . 0.0 109.089 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.9 130.96 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.104 -0.998 . . . . 0.0 109.207 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.523 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.4 p90 -76.04 -42.11 48.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.523 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 45.1 tp10 -175.29 99.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -63.63 148.65 48.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.162 -0.961 . . . . 0.0 109.024 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.676 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -122.12 -161.14 0.91 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.676 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 89.1 m-20 -57.08 142.45 42.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.988 -1.07 . . . . 0.0 109.308 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.7 7.58 3.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.867 . . . . 0.0 110.103 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -52.25 -45.52 65.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.058 -1.026 . . . . 0.0 109.256 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 t -88.87 -2.58 58.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.949 . . . . 0.0 109.128 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 m 55.6 52.55 10.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.511 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 27' ' ' VAL . 65.4 t80 -61.75 -53.61 53.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 0.0 109.833 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -70.98 -51.87 23.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.897 . . . . 0.0 109.294 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -58.76 -37.54 76.47 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.47 97.18 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 23' ' ' TYR . 74.2 t -61.85 -44.15 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -1.125 . . . . 0.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.2 m -63.78 -32.93 74.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.183 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.2 m -60.98 -50.39 73.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.663 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -65.59 -41.01 93.32 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.44 -0.788 . . . . 0.0 109.359 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -61.26 -30.25 70.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.461 -0.775 . . . . 0.0 109.259 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.36 0.39 50.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -66.85 150.95 48.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.438 -1.036 . . . . 0.0 109.388 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -57.91 -76.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 109.87 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.2 m -143.16 158.87 43.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.329 -0.857 . . . . 0.0 109.681 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.42 162.27 26.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -126.35 140.03 52.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -1.041 . . . . 0.0 109.833 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -116.21 119.37 35.55 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -137.45 176.83 8.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.189 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.418 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -92.83 140.29 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.979 -1.076 . . . . 0.0 109.285 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.621 HD13 ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -64.42 -39.42 93.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 108.939 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.45 5.87 74.76 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.6 m -157.44 -81.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 109.849 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -62.29 -37.0 83.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.917 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 41' ' ' LEU . . . 162.88 -119.08 0.85 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.424 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 17.4 m120 -111.33 150.54 29.57 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.519 -0.989 . . . . 0.0 110.093 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.3 117.53 2.3 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 4' ' ' ALA . 32.9 t -114.95 115.98 27.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.464 -1.021 . . . . 0.0 109.143 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -109.55 137.56 47.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.357 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.477 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 8.2 t -109.39 132.55 54.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.1 122.83 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 0.0 109.814 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.423 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -179.07 -146.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.564 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER 176.43 -44.71 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.42 -0.8 . . . . 0.0 109.823 179.456 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 53' ' ' LEU . 42.8 Cg_exo -54.78 -32.68 77.76 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.086 1.858 . . . . 0.0 111.95 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.35 -38.3 86.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.299 -0.876 . . . . 0.0 108.98 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 53' ' ' LEU . 63.1 m-20 56.88 46.42 19.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.877 ' H ' ' H2 ' ' A' ' 1' ' ' ALA . 91.9 t -120.62 85.92 39.24 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.365 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -90.91 -172.83 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.293 2.662 . . . . 0.0 111.689 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 61' ' ' ILE . 29.7 mm -114.28 130.5 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 7.51 41.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 0.0 110.521 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.588 ' H ' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -141.63 151.94 61.73 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.778 -1.201 . . . . 0.0 109.865 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 64' ' ' LYS . 11.3 Cg_endo -57.84 159.74 16.89 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.703 2.269 . . . . 0.0 112.155 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.634 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . -65.74 28.25 0.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 66' ' ' HIS . 35.0 tttt -56.68 -35.63 68.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.104 -1.233 . . . . 0.0 109.303 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 33.8 m 58.46 -74.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.614 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 64' ' ' LYS . 84.6 t60 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -136.52 161.52 35.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.341 -0.849 . . . . 0.0 109.242 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -95.44 145.54 25.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.121 -0.987 . . . . 0.0 109.343 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -103.08 -81.42 0.5 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 110.797 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -99.52 -15.18 18.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.051 -1.031 . . . . 0.0 110.261 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.624 HG23 ' HA ' ' A' ' 12' ' ' CYS . 67.9 mt -95.91 143.92 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.367 -0.833 . . . . 0.0 110.12 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.94 21.32 3.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.34 -0.85 . . . . 0.0 109.6 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.453 ' H ' HG22 ' A' ' 6' ' ' ILE . 8.8 mmtm -115.37 152.15 46.65 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.47 -0.769 . . . . 0.0 109.213 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.21 -32.75 90.88 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.569 2.18 . . . . 0.0 112.816 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -149.65 12.08 0.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.996 -1.065 . . . . 0.0 109.805 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -130.88 -164.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.62 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.624 ' HA ' HG23 ' A' ' 6' ' ' ILE . 84.1 m -121.0 -178.08 3.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.357 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -98.89 131.95 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.265 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.7 p90 -66.34 -37.45 85.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.531 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.443 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 80.9 tt0 -174.56 99.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.279 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -75.54 125.58 29.31 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.101 -0.999 . . . . 0.0 108.715 179.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 18' ' ' ASP . 20.0 t80 -90.87 141.14 29.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.904 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.587 ' O ' ' CE2' ' A' ' 17' ' ' PHE . 60.0 t0 -78.52 121.03 24.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -0.811 . . . . 0.0 109.88 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -140.82 159.06 43.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.465 -0.772 . . . . 0.0 108.936 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.448 ' O ' ' CB ' ' A' ' 21' ' ' SER . 71.3 t80 -53.62 -43.41 68.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.081 -1.012 . . . . 0.0 109.203 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.503 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER 168.97 78.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.429 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 26' ' ' GLY . 3.5 t -156.01 -66.94 0.11 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.037 -1.039 . . . . 0.0 110.149 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -60.37 -57.26 13.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -68.36 -48.31 65.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 108.943 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.65 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.4 m120 -59.08 -37.17 76.47 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -60.4 -41.48 98.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -62.03 -44.92 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.16 . . . . 0.0 109.128 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.3 m -67.8 -31.59 71.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.798 . . . . 0.0 109.53 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 m -56.88 -48.43 78.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.62 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -65.02 -40.48 94.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.417 -0.802 . . . . 0.0 109.487 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -60.74 -30.18 69.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.402 -0.811 . . . . 0.0 109.297 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.84 0.02 56.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . . . -64.95 150.0 48.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.418 -1.049 . . . . 0.0 109.423 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -57.6 -60.24 3.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -0.94 . . . . 0.0 109.947 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.6 p -144.9 161.74 38.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.997 . . . . 0.0 110.193 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.581 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -144.14 154.72 25.86 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.596 ' O ' ' N ' ' A' ' 49' ' ' TRP . 21.6 m-85 -139.8 156.34 46.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.171 -1.194 . . . . 0.0 109.456 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.21 124.75 44.51 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.066 -1.021 . . . . 0.0 109.188 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.411 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 84.3 mt-30 -116.28 179.03 4.11 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.6 pt -93.29 143.25 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.061 -1.024 . . . . 0.0 110.043 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD23 ' OG1' ' A' ' 43' ' ' THR . 36.0 tp -91.36 142.78 27.31 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.468 -0.77 . . . . 0.0 109.215 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -43.67 -31.76 1.86 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.503 ' OG1' HD23 ' A' ' 41' ' ' LEU . 21.6 p -87.23 167.51 14.05 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.41 -1.053 . . . . 0.0 108.87 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -54.35 -10.05 0.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 109.49 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 43' ' ' THR . . . -82.56 -173.23 49.01 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.421 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 2.9 m-20 -137.18 171.23 14.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.481 -1.011 . . . . 0.0 109.109 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -140.17 167.1 25.56 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.034 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -101.31 151.67 21.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.413 -1.051 . . . . 0.0 109.135 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.596 ' N ' ' O ' ' A' ' 37' ' ' TYR . 13.6 t-105 -115.57 137.35 52.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.469 -0.77 . . . . 0.0 109.329 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.421 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -130.31 133.63 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.369 -0.832 . . . . 0.0 109.153 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.415 HD11 ' CE2' ' A' ' 37' ' ' TYR . 3.4 mt -115.81 121.16 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.804 . . . . 0.0 109.691 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 1' ' ' ALA . . . -169.98 158.64 7.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.37 75.52 73.98 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 0.0 109.777 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.08 -65.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.743 2.295 . . . . 0.0 111.838 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -154.99 -71.02 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.558 -0.714 . . . . 0.0 109.148 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 56' ' ' ASN . 6.4 p30 -173.39 29.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.355 -0.84 . . . . 0.0 109.564 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.5 t -126.98 77.7 74.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 109.866 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.73 -65.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.668 2.245 . . . . 0.0 112.099 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 61' ' ' ILE . 29.3 mm -113.89 130.0 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -105.69 1.6 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.723 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.452 ' H ' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -130.63 154.43 81.73 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.716 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -72.83 23.91 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.701 2.267 . . . . 0.0 112.073 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.57 10.29 56.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -73.8 136.25 43.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.413 -1.051 . . . . 0.0 109.104 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' HIS . 72.7 m -116.72 159.29 22.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.577 -0.702 . . . . 0.0 109.382 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' CYS . 83.7 t60 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.54 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.81 ' HE ' ' HE1' ' A' ' 49' ' ' TRP . 76.8 ttt180 -128.26 133.67 48.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.44 -0.787 . . . . 0.0 109.571 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -95.67 140.38 30.57 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.558 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -99.83 -79.74 0.49 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -0.91 . . . . 0.0 109.696 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -106.67 15.11 26.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.783 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 12' ' ' CYS . 21.9 pt -118.57 156.44 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.354 -0.841 . . . . 0.0 109.778 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HB1' HG11 ' A' ' 27' ' ' VAL . . . -99.03 -18.57 17.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 109.11 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.474 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -137.25 154.99 76.03 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.372 -0.83 . . . . 0.0 109.179 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.38 -29.93 30.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.66 2.24 . . . . 0.0 112.679 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -94.67 -23.68 17.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.133 -0.979 . . . . 0.0 110.295 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -140.72 -179.54 6.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.04 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.528 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 24.6 p -140.07 -177.79 5.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.51 -0.744 . . . . 0.0 109.232 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.43 HG11 ' HA ' ' A' ' 16' ' ' CYS . 45.7 t -107.33 131.87 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.425 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 28.1 p90 -73.68 -34.59 64.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.144 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.425 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 43.8 tp10 -151.19 89.38 1.51 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.44 -0.787 . . . . 0.0 108.89 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.565 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -59.21 109.49 0.87 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 109.353 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 1.8 t80 -63.15 165.19 7.5 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.368 -0.833 . . . . 0.0 108.943 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.602 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 60.3 t0 -43.54 106.39 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 109.298 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.36 -5.11 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -50.79 -43.61 58.67 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.163 -0.961 . . . . 0.0 109.186 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.7 m -62.7 -50.63 70.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.192 -0.943 . . . . 0.0 109.446 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.6 t 151.49 12.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.35 -71.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.008 -1.058 . . . . 0.0 110.541 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.4 t -60.64 -51.29 70.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.163 -0.961 . . . . 0.0 109.148 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -57.72 -36.01 71.44 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 108.666 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.34 -40.18 95.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.466 HG11 ' HB1' ' A' ' 7' ' ' ALA . 69.8 t -61.83 -48.02 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -1.173 . . . . 0.0 108.855 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.38 -22.57 62.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 m -64.07 -31.26 72.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.413 -0.804 . . . . 0.0 110.976 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 1.8 mptt -52.77 -35.12 55.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.004 -1.06 . . . . 0.0 110.159 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.45 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 9.8 t-20 -56.92 -33.59 67.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.051 -1.03 . . . . 0.0 109.337 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.84 2.17 56.2 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.1 -26.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -1.036 . . . . 0.0 109.216 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.738 ' HG3' ' HB2' ' A' ' 52' ' ' ALA . 16.7 tttp -54.33 131.83 42.73 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.6 p -113.65 139.68 48.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.424 -0.798 . . . . 0.0 109.589 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.19 158.02 27.1 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.526 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -128.81 155.71 44.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.643 -0.916 . . . . 0.0 108.735 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 42.4 t -99.07 122.77 42.75 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.049 -1.032 . . . . 0.0 108.917 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.498 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 79.2 mt-30 -115.68 177.81 4.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.634 -0.666 . . . . 0.0 109.965 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.773 HG22 ' H ' ' A' ' 42' ' ' GLY . 64.4 mt -93.69 133.44 34.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.402 -0.811 . . . . 0.0 110.1 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.47 -27.35 68.92 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.617 0.722 . . . . 0.0 109.209 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.773 ' H ' HG22 ' A' ' 40' ' ' ILE . . . 106.29 -7.34 40.18 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.605 -2.198 . . . . 0.0 107.605 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 45' ' ' GLY . 12.8 p -127.79 172.44 10.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 43' ' ' THR . 23.8 p90 -46.48 -12.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.019 -1.051 . . . . 0.0 109.44 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -87.87 -176.92 47.98 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.556 ' ND2' ' SG ' ' A' ' 38' ' ' CYS . 61.8 t30 -140.2 164.54 29.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.531 -0.981 . . . . 0.0 108.889 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 157.82 25.66 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.46 -1.353 . . . . 0.0 110.545 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -107.39 153.45 22.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.488 -1.007 . . . . 0.0 109.354 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.81 ' HE1' ' HE ' ' A' ' 2' ' ' ARG . 5.6 t-105 -125.72 129.46 49.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.372 -0.83 . . . . 0.0 109.256 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.623 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 1.8 t -132.76 131.09 40.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.121 -0.987 . . . . 0.0 109.748 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mt -123.1 140.47 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.746 . . . . 0.0 110.499 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.738 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . . . -159.59 -28.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.711 . . . . 0.0 109.643 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 52' ' ' ALA . 3.0 mp -129.1 165.96 28.57 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 109.717 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.593 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 50.3 Cg_exo -49.72 -0.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.59 2.194 . . . . 0.0 112.705 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 12.5 t0 89.9 49.8 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.27 0.557 . . . . 0.0 109.785 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -103.53 131.87 50.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.304 -0.872 . . . . 0.0 108.996 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.821 HG12 ' HE ' ' A' ' 60' ' ' ARG . 83.0 t 52.92 67.69 3.63 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.088 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.65 -65.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.761 2.307 . . . . 0.0 112.471 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.3 mt -116.13 124.68 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.473 -0.767 . . . . 0.0 109.412 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.821 ' HE ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -120.44 -1.61 10.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.514 HG13 ' H ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -68.98 149.22 97.9 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.557 -0.714 . . . . 0.0 109.521 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.28 5.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.556 2.171 . . . . 0.0 112.139 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.514 ' H ' HG13 ' A' ' 61' ' ' ILE . . . 99.99 8.12 51.55 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -37.48 71.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.176 -1.19 . . . . 0.0 109.239 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -107.95 158.57 17.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.557 -0.714 . . . . 0.0 109.543 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.436 -179.912 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -136.9 159.4 41.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.589 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -101.35 149.52 23.95 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.291 -0.881 . . . . 0.0 109.129 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.637 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.34 -65.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.256 -0.903 . . . . 0.0 110.654 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.416 ' CD1' HD12 ' A' ' 41' ' ' LEU . 12.7 m-85 -100.45 -0.94 37.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 109.927 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.499 HG23 ' HA ' ' A' ' 12' ' ' CYS . 53.5 mt -111.71 133.83 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.935 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.729 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -105.97 -9.25 17.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.419 -0.801 . . . . 0.0 109.549 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.634 ' NZ ' ' CG1' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.09 166.35 12.04 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.502 -0.749 . . . . 0.0 109.246 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.74 -59.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.581 2.187 . . . . 0.0 112.433 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.63 ' NE2' ' NH1' ' A' ' 60' ' ' ARG . 78.4 m80 -102.95 -4.71 24.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.348 -0.845 . . . . 0.0 109.782 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -121.66 161.79 21.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.419 -0.801 . . . . 0.0 109.645 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.499 ' HA ' HG23 ' A' ' 6' ' ' ILE . 46.5 m -124.14 179.5 4.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.353 -0.842 . . . . 0.0 109.514 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 48' ' ' CYS . 51.7 t -98.87 134.18 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.312 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.3 p90 -70.27 -42.04 72.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.851 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 39.1 tp10 -174.68 99.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.097 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 143.58 52.54 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.144 -0.973 . . . . 0.0 108.955 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.614 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -120.12 179.31 4.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.404 -0.81 . . . . 0.0 109.033 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.614 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 88.6 m-20 -44.7 128.35 6.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -0.968 . . . . 0.0 109.355 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 21' ' ' SER . . . -65.17 -36.24 83.59 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.202 -0.936 . . . . 0.0 109.759 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.564 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 66.9 t80 49.25 7.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.17 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 19' ' ' ALA . 1.2 t 173.3 -54.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.354 -0.842 . . . . 0.0 108.856 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER 160.98 45.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.621 -0.674 . . . . 0.0 109.202 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.427 ' O ' HG23 ' A' ' 27' ' ' VAL . 69.5 t80 -60.31 -51.85 67.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.999 -1.063 . . . . 0.0 109.716 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.9 t -70.35 -50.42 39.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.191 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 36' ' ' GLY . 4.9 m-20 -59.55 -38.73 81.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 109.296 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.87 -44.04 98.39 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.634 ' CG1' ' NZ ' ' A' ' 8' ' ' LYS . 76.9 t -60.56 -43.55 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -1.179 . . . . 0.0 109.542 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.446 ' SG ' ' CD ' ' A' ' 34' ' ' LYS . 3.6 t -65.07 -35.08 80.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.252 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 m -61.95 -39.16 91.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 110.557 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -56.98 -29.97 63.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.005 -1.059 . . . . 0.0 109.779 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.523 ' OD1' ' NZ ' ' A' ' 34' ' ' LYS . 11.0 t-20 -53.59 -35.61 61.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.074 -1.016 . . . . 0.0 109.294 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 166.03 -42.76 0.27 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 174.52 -21.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.048 -1.266 . . . . 0.0 109.59 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.609 ' HZ3' HD13 ' A' ' 53' ' ' LEU . 13.3 ptpt -43.63 145.37 0.65 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.511 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 91.4 p -103.61 147.77 26.81 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.48 159.96 27.59 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.229 -1.463 . . . . 0.0 111.252 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 49' ' ' TRP . 37.3 m-85 -127.54 154.21 45.43 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.468 ' SG ' ' OD1' ' A' ' 46' ' ' ASN . 40.6 t -98.92 118.89 36.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.894 -1.128 . . . . 0.0 109.323 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.469 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 83.9 mt-30 -112.75 171.52 7.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.429 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 18.1 pt -93.25 134.17 31.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.063 -1.023 . . . . 0.0 110.042 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.463 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 41.3 tp -62.79 -28.15 69.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.637 -0.664 . . . . 0.0 109.211 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.75 -6.8 41.38 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 45' ' ' GLY . 20.3 p -127.02 172.62 10.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' THR . 24.6 p90 -44.65 -16.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.033 -1.042 . . . . 0.0 109.367 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -89.26 -178.2 45.75 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.468 ' OD1' ' SG ' ' A' ' 38' ' ' CYS . 7.0 t-20 -140.65 168.1 20.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.527 -0.984 . . . . 0.0 108.853 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.4 150.38 21.56 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.473 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -99.99 145.33 28.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.41 -1.053 . . . . 0.0 108.986 179.223 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.637 ' CZ3' ' HB1' ' A' ' 4' ' ' ALA . 11.7 t-105 -111.25 127.89 55.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.392 -0.817 . . . . 0.0 109.408 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.4 m -124.31 134.24 53.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.273 -0.892 . . . . 0.0 109.616 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.699 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 5.2 mt -120.14 141.61 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.544 -0.722 . . . . 0.0 110.076 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 51' ' ' ILE . . . 90.89 65.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.566 0.698 . . . . 0.0 109.574 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 ' HZ3' ' A' ' 34' ' ' LYS . 40.2 tp -128.83 81.46 70.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.606 -0.684 . . . . 0.0 109.173 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.41 -21.29 29.24 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.643 2.229 . . . . 0.0 111.867 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -56.62 -34.3 67.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 62.72 45.64 5.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 57' ' ' VAL . 31.7 m -124.72 77.63 64.44 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.559 -0.713 . . . . 0.0 109.259 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HG2' ' H ' ' A' ' 59' ' ' ILE . 65.6 Cg_endo -79.83 -67.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.679 2.253 . . . . 0.0 112.223 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.411 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 70.4 mt -119.48 129.49 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.63 ' NH1' ' NE2' ' A' ' 10' ' ' HIS . 13.6 ptm180 -153.95 -33.17 0.11 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 108.99 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.529 HD12 ' N ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -75.92 156.43 84.36 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.607 -0.683 . . . . 0.0 109.419 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.82 -6.86 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.878 2.385 . . . . 0.0 112.227 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.52 11.92 46.22 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -56.17 -35.26 67.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.133 . . . . 0.0 109.467 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.8 p -68.07 151.26 47.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.466 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.792 ' N ' HD23 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -136.57 158.21 44.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.401 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 2.8 t0 -104.98 150.51 24.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.344 -0.847 . . . . 0.0 109.568 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.532 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -99.35 -76.67 0.54 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -108.02 3.49 24.09 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.196 -0.94 . . . . 0.0 109.845 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 8' ' ' LYS . 59.2 mt -111.3 138.38 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 110.161 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -110.93 12.68 22.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.455 -0.778 . . . . 0.0 109.421 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.738 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -127.87 155.3 77.73 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.482 -0.761 . . . . 0.0 109.231 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.31 -36.06 47.63 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.551 2.167 . . . . 0.0 112.56 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -138.07 -3.08 1.81 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.536 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.493 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 52.7 m-80 -114.25 167.95 10.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.485 -0.759 . . . . 0.0 109.357 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.703 ' HA ' HG23 ' A' ' 6' ' ' ILE . 62.3 m -118.61 177.06 4.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.412 -0.805 . . . . 0.0 109.828 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.08 135.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 109.086 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 28.2 p90 -66.89 -45.73 77.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.698 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.579 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 82.7 tt0 -175.95 97.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.057 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 144.46 56.54 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 108.589 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.698 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 2.5 p90 -120.67 -153.75 0.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.458 -0.776 . . . . 0.0 109.208 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.698 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.6 m-20 -57.53 141.8 46.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.978 -1.076 . . . . 0.0 109.473 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.89 9.23 3.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.354 -0.841 . . . . 0.0 109.864 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -49.88 -43.44 49.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.982 -1.074 . . . . 0.0 108.597 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.413 ' HG ' ' HE1' ' A' ' 17' ' ' PHE . 33.6 p -90.15 4.99 48.81 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.432 -0.792 . . . . 0.0 109.075 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' GLY . 83.3 p 51.82 33.43 11.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 109.351 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -59.25 -47.1 86.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -65.76 -57.5 7.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.422 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -60.86 -35.74 77.37 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.472 -0.768 . . . . 0.0 109.491 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -58.27 -44.0 95.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.44 -44.36 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -1.118 . . . . 0.0 109.2 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 t -70.04 -31.13 68.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.486 -0.758 . . . . 0.0 109.326 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.5 m -61.57 -31.47 71.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 110.673 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.76 -27.14 4.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.984 -1.073 . . . . 0.0 109.885 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -54.82 -30.76 58.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.1 -1.0 . . . . 0.0 109.107 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 103.96 3.29 45.61 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 176.77 -25.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -1.192 . . . . 0.0 109.629 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -55.25 134.25 49.73 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -112.58 140.79 47.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.397 -0.814 . . . . 0.0 108.984 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.69 164.68 27.38 Favored Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.995 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' TRP . 32.7 m-85 -132.12 160.5 35.83 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.506 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 43.5 t -99.24 120.86 40.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.998 -1.064 . . . . 0.0 109.294 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.503 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 84.5 mt-30 -115.72 174.57 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 109.32 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.9 pt -99.15 155.42 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.898 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.634 HD12 ' HA3' ' A' ' 45' ' ' GLY . 72.8 mt -78.25 148.44 33.93 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.432 -0.792 . . . . 0.0 109.578 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.68 -35.93 39.17 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 47.7 p -96.07 -125.16 0.12 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.318 -1.107 . . . . 0.0 108.644 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -109.72 126.57 53.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 108.921 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.634 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 141.45 -173.87 23.21 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.599 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 54.6 t-20 -140.77 150.33 43.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -1.102 . . . . 0.0 109.559 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.599 ' N ' ' OD1' ' A' ' 46' ' ' ASN . . . -140.11 167.25 25.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.624 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 1.6 m -101.97 150.26 23.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.236 -1.155 . . . . 0.0 109.621 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.532 ' CE3' ' O ' ' A' ' 4' ' ' ALA . 16.8 t-105 -120.92 121.22 37.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 109.161 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.8 m -117.74 130.38 56.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.324 -0.86 . . . . 0.0 109.682 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 20.2 mt -127.76 145.56 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.417 -0.802 . . . . 0.0 110.545 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' ILE . . . 176.19 -22.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.792 HD23 ' N ' ' A' ' 1' ' ' ALA . 13.2 tp -153.02 133.15 7.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 108.916 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -38.08 158.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.205 1.937 . . . . 0.0 112.225 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 61.1 t0 -79.0 116.34 19.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 110.063 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.481 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 82.0 m-20 -147.86 -47.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.568 ' H ' ' HB2' ' A' ' 1' ' ' ALA . 21.6 t -129.74 72.2 81.99 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.76 -100.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.829 2.353 . . . . 0.0 112.527 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -127.28 125.99 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.349 -0.844 . . . . 0.0 109.417 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -61.58 -34.18 75.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.303 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 63' ' ' GLY . 4.0 mt -62.63 136.73 96.26 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.425 -0.797 . . . . 0.0 108.967 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.78 -1.71 2.91 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.004 1.803 . . . . 0.0 112.483 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.515 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 95.62 11.4 55.47 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.603 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 11.9 pttp -58.62 -32.47 69.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -1.12 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 61.3 m 56.43 -0.61 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.277 -0.889 . . . . 0.0 109.913 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.603 ' ND1' ' O ' ' A' ' 64' ' ' LYS . 72.4 m80 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.417 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.403 ' HA ' ' N ' ' A' ' 54' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.306 0.574 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.0 ptt-85 -137.6 167.45 21.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.378 -0.826 . . . . 0.0 109.511 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 83.7 m-20 -94.35 147.13 23.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 108.691 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -109.93 -83.25 0.56 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.371 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -99.23 6.24 46.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.008 -1.057 . . . . 0.0 109.629 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.645 HG22 ' SG ' ' A' ' 12' ' ' CYS . 42.1 pt -117.16 159.17 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.637 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . . . -123.39 -20.29 5.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.21 161.27 50.71 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.62 -66.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.43 2.087 . . . . 0.0 112.91 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -56.81 -39.44 74.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 110.436 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.424 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 2.2 m120 -134.51 173.72 11.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 0.0 110.096 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.645 ' SG ' HG22 ' A' ' 6' ' ' ILE . 12.2 m -108.24 171.24 7.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.185 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 p -49.09 135.24 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.037 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.664 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 19.5 p90 -69.64 -50.43 44.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.051 -1.031 . . . . 0.0 109.345 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.664 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 48.8 tp10 -177.38 91.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.2 t -54.12 97.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 108.926 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 19.3 p90 -76.67 -46.17 26.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 109.689 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 52.9 t0 -145.4 101.01 3.54 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.312 -0.868 . . . . 0.0 109.096 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.72 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . . . -60.63 -24.43 65.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.214 -0.929 . . . . 0.0 109.049 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -52.16 -42.22 63.24 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.434 ' C ' ' OG ' ' A' ' 22' ' ' SER . 84.0 p -66.04 -16.17 63.68 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER 72.48 39.25 0.74 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.618 -0.676 . . . . 0.0 110.029 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' HG23 ' A' ' 27' ' ' VAL . 61.6 t80 -60.63 -60.51 3.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.978 -1.076 . . . . 0.0 109.06 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' HB2' ' A' ' 7' ' ' ALA . 8.1 t -70.58 -48.65 54.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.352 -0.843 . . . . 0.0 108.75 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.448 ' CG ' ' O ' ' A' ' 36' ' ' GLY . 18.5 m-20 -57.82 -38.93 76.46 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.8 -39.59 97.67 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 23' ' ' TYR . 78.8 t -62.2 -41.52 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.354 -1.086 . . . . 0.0 109.531 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.3 m -61.04 -41.2 96.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.523 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 m -58.22 -51.26 70.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.14 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -67.79 -39.45 84.03 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.54 -0.725 . . . . 0.0 109.125 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' CG ' HD21 ' A' ' 56' ' ' ASN . 42.0 t-20 -59.29 -31.13 68.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.553 -0.717 . . . . 0.0 109.275 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.27 -0.06 50.63 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.61 149.5 48.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -1.059 . . . . 0.0 109.221 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -58.0 -49.15 77.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 110.245 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.572 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 49.5 m -143.57 162.81 34.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.037 . . . . 0.0 110.198 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -142.72 126.83 2.98 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.543 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 87.2 m-85 -126.11 135.54 51.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.448 -1.03 . . . . 0.0 109.547 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -110.6 129.94 55.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 0.0 109.888 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.69 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -134.1 168.34 19.0 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.429 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 17.0 pt -98.81 133.43 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.974 . . . . 0.0 109.588 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.535 HD23 ' OG1' ' A' ' 43' ' ' THR . 30.2 tp -64.24 -30.59 71.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 109.36 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.95 -4.5 49.43 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.535 ' OG1' HD23 ' A' ' 41' ' ' LEU . 18.3 p -126.57 173.72 9.22 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 43' ' ' THR . 26.8 p90 -44.07 -21.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.441 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -87.23 -174.25 48.74 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 5.8 t-20 -137.98 169.83 17.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -1.008 . . . . 0.0 108.911 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' GLN . . . -140.55 125.93 3.01 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.447 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 42.7 t -136.28 128.91 30.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -1.092 . . . . 0.0 108.674 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.69 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 4.1 p90 -113.95 141.29 47.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 109.857 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 35' ' ' SER . 6.0 t -124.72 153.62 42.09 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.1 mm -109.22 126.83 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 109.074 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.9 ' C ' HD23 ' A' ' 53' ' ' LEU . . . -173.09 -130.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.978 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.9 HD23 ' C ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -127.4 166.4 23.27 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.364 -0.835 . . . . 0.0 109.9 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' N ' ' HA ' ' A' ' 1' ' ' ALA . 28.1 Cg_endo -67.84 -34.31 24.4 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.466 2.111 . . . . 0.0 112.244 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -56.41 -33.49 65.86 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.596 HD21 ' CG ' ' A' ' 31' ' ' ASN . 46.2 t-20 -96.75 120.13 36.52 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.554 -0.716 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.465 HG23 ' OD1' ' A' ' 56' ' ' ASN . 5.2 t 57.4 65.87 3.32 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.717 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.69 15.03 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.146 2.564 . . . . 0.0 112.425 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 59' ' ' ILE . 62.9 mt 55.25 52.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.391 -0.818 . . . . 0.0 109.333 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.422 HH11 ' HB3' ' A' ' 60' ' ' ARG . 6.1 ptm85 -61.61 -39.22 90.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.507 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -74.75 154.12 87.2 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.462 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.73 -11.12 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.663 2.242 . . . . 0.0 111.929 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.95 3.82 57.93 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 66' ' ' HIS . 34.2 ttpt -57.8 -36.95 72.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -1.102 . . . . 0.0 109.42 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 84.9 m 54.8 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.819 . . . . 0.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.586 ' N ' ' O ' ' A' ' 64' ' ' LYS . 83.3 t60 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.516 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -127.06 136.77 52.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.811 . . . . 0.0 109.809 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -95.92 144.16 26.48 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.242 -0.911 . . . . 0.0 109.038 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -108.25 -83.55 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 110.212 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -99.54 12.92 35.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.676 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 pt -126.67 165.98 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 110.011 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.757 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -120.79 -0.81 10.07 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.11 168.72 8.88 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB2' HH11 ' A' ' 60' ' ' ARG . 70.2 Cg_endo -80.25 -59.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.537 2.158 . . . . 0.0 112.447 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -104.94 -3.74 22.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.964 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -116.88 175.46 5.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.394 -0.816 . . . . 0.0 109.804 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.2 p -128.66 -179.64 5.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.408 -0.807 . . . . 0.0 109.86 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.88 136.52 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.546 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.7 p90 -65.48 -40.54 93.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 83.8 tt0 -175.32 98.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.99 141.7 54.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.035 -1.04 . . . . 0.0 108.524 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.71 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 2.0 p90 -119.3 -154.3 0.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.366 -0.833 . . . . 0.0 109.599 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.71 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 88.4 m-20 -59.68 143.42 50.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.004 . . . . 0.0 109.532 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.62 9.63 7.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.882 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -51.7 -42.92 62.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.04 -1.037 . . . . 0.0 108.535 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.501 ' O ' ' OG ' ' A' ' 22' ' ' SER . 60.1 p -86.49 6.04 32.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.36 -0.837 . . . . 0.0 108.815 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 26' ' ' GLY . 10.5 p 50.19 36.02 11.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.684 . . . . 0.0 109.796 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -61.55 -51.73 67.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.099 -1.001 . . . . 0.0 109.439 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.458 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 29.3 t -68.37 -56.24 9.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 108.871 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 29' ' ' THR . 7.8 m-20 -58.43 -34.88 71.29 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -57.2 -42.88 93.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.93 -47.58 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.241 -1.152 . . . . 0.0 108.628 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 95.2 m -70.37 -24.73 63.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 109.3 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 25' ' ' ASN . 62.5 m -61.89 -31.12 71.38 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.418 -0.801 . . . . 0.0 110.95 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.47 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 1.8 mptt -52.52 -33.56 45.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.0 110.066 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 9.8 t-20 -56.68 -34.01 66.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 109.404 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.44 4.71 56.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.92 -26.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -1.094 . . . . 0.0 109.29 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.712 ' HG3' ' HB2' ' A' ' 52' ' ' ALA . 24.6 tttt -51.29 135.22 26.91 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -117.66 139.98 50.28 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.507 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.13 156.46 26.49 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.858 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' TRP . 41.9 m-85 -130.6 153.41 48.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.621 -0.929 . . . . 0.0 108.787 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -99.41 125.66 45.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.972 -1.08 . . . . 0.0 109.64 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.588 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 96.3 mt-30 -111.11 -162.05 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.599 -0.688 . . . . 0.0 109.315 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.0 pt -114.65 157.45 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -0.753 . . . . 0.0 109.807 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 ' HA3' ' A' ' 45' ' ' GLY . 63.8 mt -86.62 146.39 26.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.306 -0.871 . . . . 0.0 109.498 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.77 -33.16 34.48 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.5 p -97.57 -124.12 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.431 -1.04 . . . . 0.0 108.94 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -111.73 132.18 54.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 109.117 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 133.31 -163.96 24.29 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -140.29 165.72 26.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.222 -1.164 . . . . 0.0 109.386 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.57 162.08 26.17 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.757 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -107.59 135.69 48.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.401 -1.058 . . . . 0.0 109.512 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CE3' ' OE1' ' A' ' 39' ' ' GLN . 11.4 t-105 -112.18 121.95 46.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.382 -0.824 . . . . 0.0 109.14 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.66 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 1.8 t -125.8 129.92 50.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.222 -0.923 . . . . 0.0 109.523 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mt -121.09 138.64 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.53 -0.731 . . . . 0.0 110.62 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . . . -170.96 -52.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.526 -0.734 . . . . 0.0 109.534 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.6 tp -127.48 78.76 74.32 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.549 -0.719 . . . . 0.0 109.931 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' ASP . 32.3 Cg_exo -54.03 171.03 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.937 2.425 . . . . 0.0 112.321 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' PRO . 49.4 t0 59.88 146.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 64.08 48.34 3.04 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.312 -0.868 . . . . 0.0 109.142 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.542 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -107.63 103.23 48.34 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HG2' ' NE ' ' A' ' 60' ' ' ARG . 63.9 Cg_endo -91.31 130.66 1.34 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.626 2.217 . . . . 0.0 110.892 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.622 HG22 ' H ' ' A' ' 61' ' ' ILE . 3.3 mt -64.38 -32.55 58.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.114 -0.991 . . . . 0.0 110.506 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.423 HH11 ' HB2' ' A' ' 9' ' ' PRO . 97.8 mtt180 55.24 1.53 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.306 -0.871 . . . . 0.0 109.14 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 61' ' ' ILE . 5.1 mt -130.61 81.05 68.75 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.494 -0.754 . . . . 0.0 109.672 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.11 54.04 4.58 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.916 2.411 . . . . 0.0 111.944 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.77 0.09 75.82 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.81 -40.59 84.56 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.705 -0.879 . . . . 0.0 109.785 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.9 t -59.85 -32.72 70.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.476 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -127.7 138.56 52.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.177 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.523 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 79.3 m-20 -99.32 148.59 24.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.012 -1.055 . . . . 0.0 109.396 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.81 -82.88 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 110.473 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -99.03 5.84 46.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.631 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 48' ' ' CYS . 33.5 pt -117.34 161.46 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 110.34 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.445 ' O ' HG11 ' A' ' 27' ' ' VAL . . . -116.03 -5.79 11.96 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' HD3' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -108.57 156.0 39.52 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.51 -51.5 0.53 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.47 2.114 . . . . 0.0 112.598 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -114.88 1.76 14.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.145 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -125.72 170.4 11.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 109.925 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.8 m -110.23 178.1 4.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.442 -0.787 . . . . 0.0 109.319 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.423 HG22 ' HD3' ' A' ' 8' ' ' LYS . 40.6 t -101.11 126.85 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.612 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 26.9 p90 -74.75 -32.51 62.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.096 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 78.7 tt0 -172.15 98.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.452 -0.78 . . . . 0.0 108.99 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.3 t -73.46 108.35 6.27 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.014 -1.054 . . . . 0.0 109.004 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.788 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.32 148.06 2.06 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.6 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 59.6 t0 -73.43 116.79 14.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.96 . . . . 0.0 110.516 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.788 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -140.52 147.97 40.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.809 . . . . 0.0 109.138 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -58.57 -44.67 89.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.012 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.473 ' OG ' ' ND2' ' A' ' 25' ' ' ASN . 2.6 t 172.93 73.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.42 -0.8 . . . . 0.0 109.244 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 p -152.94 -50.47 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.113 -0.992 . . . . 0.0 110.087 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -58.16 -51.84 68.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.976 -1.078 . . . . 0.0 109.848 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -66.29 -44.35 83.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.148 -0.97 . . . . 0.0 108.757 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.473 ' ND2' ' OG ' ' A' ' 21' ' ' SER . 6.4 m-20 -58.44 -37.38 75.3 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.48 -42.03 98.89 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 7' ' ' ALA . 70.9 t -63.67 -43.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -1.116 . . . . 0.0 109.148 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 59.0 m -63.93 -30.03 71.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.396 -0.815 . . . . 0.0 109.394 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.4 m -57.82 -42.61 84.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -61.91 -45.39 93.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -0.954 . . . . 0.0 108.894 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.28 -29.31 69.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.445 -0.785 . . . . 0.0 109.323 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.22 7.6 55.93 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' A' ' 52' ' ' ALA . . . -69.85 175.41 4.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -1.014 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -78.62 -77.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.026 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.7 p -143.76 166.7 24.15 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.58 154.56 25.26 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.568 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 57.9 m-85 -122.27 133.95 54.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.357 -1.084 . . . . 0.0 109.552 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.649 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 1.1 m -99.81 121.54 41.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.367 -0.833 . . . . 0.0 109.191 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -141.07 -136.54 0.11 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.091 -1.006 . . . . 0.0 109.623 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 42' ' ' GLY . 64.1 mt -95.81 139.66 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.2 tp -55.99 -37.13 68.68 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.581 ' H ' HG22 ' A' ' 40' ' ' ILE . . . 158.46 -69.0 0.27 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.4 p -105.66 -63.44 1.25 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -126.84 148.72 49.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.79 -178.86 39.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -122.72 150.94 42.08 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.483 -1.01 . . . . 0.0 109.667 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.92 162.59 26.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.649 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 4.2 t -140.2 135.94 32.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -1.087 . . . . 0.0 109.754 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.18 133.9 51.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.219 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.523 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 12.2 t -99.92 125.51 45.93 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.9 mm -99.46 131.46 46.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 109.48 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . . . -170.56 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.045 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.84 94.71 48.98 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.383 -0.823 . . . . 0.0 110.305 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.12 -8.95 17.81 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.183 1.922 . . . . 0.0 112.101 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -56.34 -35.81 68.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.324 -0.86 . . . . 0.0 109.935 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 57' ' ' VAL . 49.1 m-20 -78.96 142.35 36.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.93 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.772 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.2 p -39.72 102.38 0.26 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.629 -0.669 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 59' ' ' ILE . 50.1 Cg_endo -90.61 159.35 4.31 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.714 2.276 . . . . 0.0 111.888 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 59' ' ' ILE . 86.0 mt 39.75 60.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.372 -0.83 . . . . 0.0 110.209 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -51.51 -34.55 36.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.701 HG22 ' H ' ' A' ' 63' ' ' GLY . 1.4 mp -61.04 130.64 91.47 Favored Pre-proline 0 C--N 1.301 -1.53 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.677 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.29 -25.33 6.97 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.862 1.708 . . . . 0.0 111.949 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.701 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 138.41 3.66 1.82 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -106.28 129.62 54.28 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.319 -1.107 . . . . 0.0 109.025 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.516 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 86.3 m -58.6 -28.34 65.51 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.569 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.516 ' CG ' ' O ' ' A' ' 65' ' ' CYS . 98.0 m-70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.482 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.491 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -138.24 169.23 18.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -94.14 142.57 27.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 108.42 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -106.07 -84.45 0.51 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 111.101 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -98.89 -19.21 17.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.055 . . . . 0.0 110.402 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.529 HG22 ' H ' ' A' ' 8' ' ' LYS . 63.5 mt -106.24 132.87 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.323 -0.861 . . . . 0.0 110.15 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.59 17.74 12.81 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.529 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -124.09 155.32 67.84 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.16 -35.91 61.21 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.483 2.122 . . . . 0.0 112.27 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.557 ' CE1' HH11 ' A' ' 60' ' ' ARG . 74.4 m80 -141.8 -3.97 1.1 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.139 -0.976 . . . . 0.0 109.453 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.489 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 59.1 m-80 -109.5 172.33 6.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 109.428 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HA ' HG23 ' A' ' 6' ' ' ILE . 5.4 m -122.2 177.26 5.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.629 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 48' ' ' CYS . 47.1 t -101.05 138.05 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.032 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.29 -61.26 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.456 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -173.89 98.72 0.11 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.414 -0.804 . . . . 0.0 109.121 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 29.7 p -50.62 103.24 0.05 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.253 -0.905 . . . . 0.0 108.906 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.506 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 23.7 p90 -59.91 -39.77 86.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.445 -0.785 . . . . 0.0 110.033 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.506 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 57.6 t0 -143.55 91.54 2.26 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.243 -0.91 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.64 -25.0 67.9 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.245 -0.91 . . . . 0.0 109.046 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -53.76 -38.45 64.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 108.81 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.6 m -77.57 7.71 5.23 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 26' ' ' GLY . 12.7 p 60.76 36.37 19.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.565 -0.709 . . . . 0.0 110.045 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -61.89 -54.99 34.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.957 -1.09 . . . . 0.0 108.863 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.31 -52.31 23.76 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 36' ' ' GLY . 5.9 m-20 -58.37 -36.74 73.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -60.29 -42.77 98.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.503 HG21 ' HZ2' ' A' ' 8' ' ' LYS . 58.1 t -61.07 -46.94 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -1.157 . . . . 0.0 109.518 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 3.5 m -70.23 -33.34 71.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.272 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.4 m -57.32 -50.5 72.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.431 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -65.71 -37.87 87.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.414 -0.804 . . . . 0.0 109.337 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 27' ' ' VAL . 24.4 m120 -58.96 -25.47 63.57 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.42 44.05 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 28' ' ' CYS . . . -64.17 145.68 55.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.445 -1.033 . . . . 0.0 109.248 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.534 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 2.7 ttmt -59.37 -51.96 67.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 0.0 109.792 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.421 ' HG ' ' HE2' ' A' ' 37' ' ' TYR . 83.4 p -144.35 166.89 23.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.189 -0.945 . . . . 0.0 110.201 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.44 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -143.38 135.17 6.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.421 ' HE2' ' HG ' ' A' ' 35' ' ' SER . 91.6 m-85 -128.46 136.92 51.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -1.08 . . . . 0.0 109.573 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.9 t -109.0 128.62 55.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.462 -0.774 . . . . 0.0 109.585 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.612 ' NE2' ' CH2' ' A' ' 49' ' ' TRP . 0.3 OUTLIER -134.56 171.55 14.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.446 -0.784 . . . . 0.0 109.116 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.9 pt -98.13 134.62 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.13 -0.981 . . . . 0.0 109.503 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 45' ' ' GLY . 24.2 tp -130.1 125.21 34.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.651 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.23 -27.58 73.08 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.448 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 42.6 m -59.37 -46.55 88.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.029 -1.277 . . . . 0.0 110.039 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -125.64 16.3 8.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.447 -0.783 . . . . 0.0 109.156 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 41' ' ' LEU . . . 83.9 -56.85 5.05 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -140.77 146.05 37.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -1.131 . . . . 0.0 109.642 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.27 132.23 5.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.704 ' HB2' HG21 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -111.25 126.62 55.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.388 -1.066 . . . . 0.0 109.28 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.612 ' CH2' ' NE2' ' A' ' 39' ' ' GLN . 4.7 p90 -118.36 138.86 52.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.868 . . . . 0.0 109.125 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.3 m -126.1 156.15 40.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mm -110.11 122.89 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.422 -0.799 . . . . 0.0 109.296 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -179.57 -145.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.491 HD12 ' HB1' ' A' ' 1' ' ' ALA . 9.5 tp -133.1 78.99 63.58 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.552 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -87.64 22.31 0.92 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.35 2.7 . . . . 0.0 112.057 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -52.45 -35.55 52.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.574 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -56.39 -35.35 67.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.791 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.5 p -131.06 77.9 74.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.359 -0.838 . . . . 0.0 109.585 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 59' ' ' ILE . 73.7 Cg_endo -95.27 87.98 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 123.596 2.864 . . . . 0.0 112.287 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' PRO . 45.8 mt 43.31 55.66 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.031 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.557 HH11 ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -59.72 -41.0 89.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.135 -0.978 . . . . 0.0 109.891 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.618 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -62.96 149.72 89.68 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -46.0 -23.59 1.86 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.174 1.916 . . . . 0.0 112.05 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' H ' HG12 ' A' ' 61' ' ' ILE . . . 138.04 2.93 2.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -93.39 145.97 24.09 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.282 -1.128 . . . . 0.0 109.283 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 66' ' ' HIS . 8.6 t -58.01 -47.19 83.79 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 65' ' ' CYS . 61.8 t60 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.65 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.534 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -136.7 161.81 34.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -0.88 . . . . 0.0 109.409 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -95.1 143.41 26.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.16 -0.962 . . . . 0.0 109.108 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.486 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.79 -65.0 0.99 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.164 -0.96 . . . . 0.0 110.445 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 2.6 m-85 -109.15 0.9 20.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.514 HD11 ' HA2' ' A' ' 63' ' ' GLY . 70.3 mt -106.68 142.04 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 110.433 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.743 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -129.07 -22.7 3.13 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -103.99 157.01 34.87 Favored Pre-proline 0 N--CA 1.487 1.419 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 8' ' ' LYS . 43.9 Cg_exo -34.02 -110.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.444 2.763 . . . . 0.0 113.376 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -85.49 -2.78 58.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.768 -1.208 . . . . 0.0 109.308 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -100.28 151.48 21.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.331 -0.855 . . . . 0.0 109.466 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.67 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 57.2 m -108.27 166.18 10.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.526 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.97 133.04 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.165 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 32.3 p90 -60.71 -41.44 95.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.583 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 82.4 tt0 -175.24 93.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.279 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 47' ' ' GLY . 19.5 p -68.58 134.54 50.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.059 -1.026 . . . . 0.0 108.576 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.692 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 2.6 p90 -109.67 -152.55 0.5 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.299 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.692 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.2 m-20 -57.6 139.24 54.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.044 -1.035 . . . . 0.0 109.192 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.36 9.05 3.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.381 -0.825 . . . . 0.0 109.827 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -51.96 -42.91 63.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 108.896 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.6 m -84.69 7.12 21.52 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.339 -0.85 . . . . 0.0 108.907 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 26' ' ' GLY . 70.5 m 54.38 27.12 7.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.406 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -60.18 -52.81 63.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.1 t -66.39 -51.83 53.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 0.0 108.835 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.72 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -58.65 -36.25 73.81 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.534 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . . . -57.07 -43.42 93.28 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.13 -47.11 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -1.205 . . . . 0.0 109.09 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.7 m -70.49 -24.76 62.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.635 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 25' ' ' ASN . 67.6 m -63.16 -30.39 71.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.232 -0.918 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' NZ ' ' O ' ' A' ' 26' ' ' GLY . 12.7 mptt -51.94 -33.39 37.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.921 -1.112 . . . . 0.0 110.112 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.426 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 29.8 t30 -56.48 -33.67 66.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.04 -1.038 . . . . 0.0 109.349 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.26 2.63 54.19 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.02 -26.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -1.084 . . . . 0.0 109.132 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.631 ' CE ' ' SG ' ' A' ' 50' ' ' CYS . 15.7 tttp -52.67 137.88 29.98 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -118.23 135.15 54.44 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.143 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.535 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -144.4 162.12 27.93 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.275 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.45 ' HA ' HD21 ' A' ' 25' ' ' ASN . 33.1 p90 -140.65 169.87 16.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -1.078 . . . . 0.0 109.062 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 11.7 t -99.06 124.43 44.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.949 -1.095 . . . . 0.0 110.959 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -119.87 -139.88 0.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 40' ' ' ILE . 30.3 pt -110.96 142.86 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 109.699 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.0 tp -58.73 -37.28 75.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.198 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.84 -59.33 0.62 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.65 -70.63 0.76 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -1.022 . . . . 0.0 108.806 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -128.4 148.94 50.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.575 -0.703 . . . . 0.0 109.223 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.2 -168.23 35.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 16' ' ' CYS . 24.9 m120 -120.93 165.26 15.48 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.47 -1.018 . . . . 0.0 109.608 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -134.94 151.49 20.45 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.743 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -99.53 140.56 33.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -1.17 . . . . 0.0 109.755 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.486 ' CZ3' ' HB1' ' A' ' 4' ' ' ALA . 8.9 t-105 -113.45 128.19 56.36 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.631 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -126.09 135.8 52.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 109.036 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.625 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 4.5 mt -117.16 136.51 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.36 -0.837 . . . . 0.0 111.101 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 51' ' ' ILE . . . 162.17 168.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.534 HD12 ' HB1' ' A' ' 1' ' ' ALA . 3.3 tp -129.24 73.97 81.33 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.674 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 50.3 Cg_exo -49.73 -174.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.643 2.229 . . . . 0.0 111.341 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 56' ' ' ASN . 92.2 m-20 -52.1 -39.06 59.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.972 -1.08 . . . . 0.0 108.801 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER 159.97 -174.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 109.19 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.835 HG12 ' HE ' ' A' ' 60' ' ' ARG . 8.3 t 57.15 68.59 1.99 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.76 -65.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.683 2.255 . . . . 0.0 112.038 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.5 mt -117.29 125.84 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.523 -0.736 . . . . 0.0 109.103 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.835 ' HE ' HG12 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -113.83 1.68 14.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.485 -0.76 . . . . 0.0 109.193 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -132.11 155.18 81.64 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.416 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.4 -0.43 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.585 2.19 . . . . 0.0 111.685 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.514 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 102.42 -1.42 49.94 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -85.21 130.45 34.6 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -1.129 . . . . 0.0 109.479 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.67 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 2.5 m -115.03 158.98 21.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.431 -0.793 . . . . 0.0 109.471 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.424 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 58.3 t-80 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.609 ' H2 ' ' HB2' ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.805 HH21 ' HE1' ' A' ' 49' ' ' TRP . 76.1 ttt180 -126.52 132.32 51.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.447 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 75.8 m-20 -100.17 143.96 29.76 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -106.32 -83.94 0.52 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.462 -0.774 . . . . 0.0 109.266 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CE1' HD11 ' A' ' 41' ' ' LEU . 9.7 m-85 -99.78 -29.83 12.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.533 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.698 HG23 ' HA ' ' A' ' 12' ' ' CYS . 69.9 mt -102.01 138.12 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.521 -0.737 . . . . 0.0 109.665 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -117.0 20.72 13.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.443 -0.786 . . . . 0.0 110.398 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.621 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -126.35 153.13 74.74 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.083 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.409 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 11.3 Cg_endo -57.84 -29.35 85.84 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.533 2.156 . . . . 0.0 112.272 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 9' ' ' PRO . 88.5 m-70 -151.65 -6.8 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.199 -0.938 . . . . 0.0 109.316 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.488 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 56.8 m-80 -105.63 171.16 7.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.779 . . . . 0.0 109.413 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.698 ' HA ' HG23 ' A' ' 6' ' ' ILE . 73.9 m -120.85 177.08 5.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.446 -0.784 . . . . 0.0 109.466 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.54 133.51 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.968 . . . . 0.0 109.402 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -48.68 78.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.376 -0.827 . . . . 0.0 109.317 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' CYS . 11.6 pt-20 177.14 80.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 109.23 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -44.75 156.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.067 -1.021 . . . . 0.0 109.122 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.718 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 3.2 p90 -132.56 -149.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 109.331 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.718 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 59.3 t0 -57.41 132.6 53.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.128 -0.983 . . . . 0.0 109.654 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 22' ' ' SER . . . -74.98 4.48 6.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.0 109.918 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -49.82 -42.75 47.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.066 -1.022 . . . . 0.0 108.859 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.422 ' C ' ' OG ' ' A' ' 22' ' ' SER . 82.6 p -82.35 -5.48 58.63 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 0.0 109.095 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 63.29 34.36 13.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 109.577 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 27' ' ' VAL . 63.6 t80 -58.95 -48.65 80.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.999 -1.063 . . . . 0.0 109.872 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.16 -52.95 28.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 109.031 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.709 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.1 m120 -58.49 -37.64 75.98 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.328 -0.857 . . . . 0.0 108.794 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.53 93.84 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 23' ' ' TYR . 71.1 t -61.82 -42.31 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.353 -1.087 . . . . 0.0 108.798 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 65.0 m -61.66 -32.96 73.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.818 . . . . 0.0 109.372 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.3 m -57.4 -45.73 84.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 109.476 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -64.54 -43.47 93.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 108.81 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.77 -28.96 70.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.558 -0.713 . . . . 0.0 109.153 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.46 -0.87 53.35 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 28' ' ' CYS . . . -67.39 148.4 51.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.38 -1.071 . . . . 0.0 109.263 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -64.82 -60.34 3.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.063 -1.023 . . . . 0.0 110.284 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.2 p -144.21 160.91 40.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.873 -1.142 . . . . 0.0 110.567 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.411 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.71 156.17 26.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 49' ' ' TRP . 17.6 m-85 -123.65 146.21 48.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -1.102 . . . . 0.0 109.472 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 37.8 t -99.89 121.63 41.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.19 -0.944 . . . . 0.0 109.076 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -118.38 165.55 13.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.471 -0.768 . . . . 0.0 109.446 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.583 ' C ' HD22 ' A' ' 41' ' ' LEU . 36.8 pt -103.45 144.01 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 110.117 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.583 HD22 ' C ' ' A' ' 40' ' ' ILE . 4.2 mm? -107.08 139.91 40.75 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.67 -0.644 . . . . 0.0 109.508 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.8 -28.62 52.95 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 44' ' ' TYR . 45.8 p -94.82 -72.88 0.6 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -1.167 . . . . 0.0 110.649 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.448 ' N ' ' OG1' ' A' ' 43' ' ' THR . 91.7 m-85 -61.82 -39.28 91.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 110.155 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.91 -34.93 4.84 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.174 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.33 129.64 31.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -1.229 . . . . 0.0 110.293 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 160.14 26.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -111.26 135.23 52.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.378 -1.072 . . . . 0.0 109.831 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.805 ' HE1' HH21 ' A' ' 2' ' ' ARG . 4.7 t-105 -113.33 111.66 22.37 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.447 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 5.5 t -107.76 122.82 47.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.114 -0.991 . . . . 0.0 108.906 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.485 HD12 ' CE2' ' A' ' 37' ' ' TYR . 65.1 mt -117.81 135.56 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.603 -0.686 . . . . 0.0 110.096 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -174.29 -32.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.609 ' HB2' ' H2 ' ' A' ' 1' ' ' ALA . 5.2 mp -124.41 160.05 54.71 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.531 -0.731 . . . . 0.0 109.155 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -42.03 -78.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.471 2.114 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 51.0 p30 -177.03 39.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.187 -0.945 . . . . 0.0 109.511 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.63 133.85 46.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.827 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.53 ' O ' ' HB1' ' A' ' 1' ' ' ALA . 2.8 t 47.49 70.12 2.28 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.305 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.44 ' CB ' ' O ' ' A' ' 2' ' ' ARG . 68.2 Cg_endo -82.11 -68.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.832 2.355 . . . . 0.0 112.312 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.89 158.21 43.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.327 -0.858 . . . . 0.0 109.388 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -117.06 122.22 43.55 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.25 81.65 13.53 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.541 -0.724 . . . . 0.0 110.062 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.42 -4.55 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.687 2.258 . . . . 0.0 111.744 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.86 -5.52 58.15 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.42 ' O ' ' CE1' ' A' ' 66' ' ' HIS . 29.3 ttpt -60.06 -35.65 75.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -1.183 . . . . 0.0 109.508 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 15.1 m -73.34 154.03 40.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.885 . . . . 0.0 109.514 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.42 ' CE1' ' O ' ' A' ' 64' ' ' LYS . 77.5 m80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.489 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.506 HH21 ' CB ' ' A' ' 54' ' ' PRO . 40.1 ttm180 -127.77 135.33 49.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.434 -0.792 . . . . 0.0 109.65 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.441 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 84.2 m-20 -95.92 145.58 25.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.831 . . . . 0.0 108.898 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -105.1 -83.27 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.883 . . . . 0.0 110.051 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -100.93 13.02 36.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.865 . . . . 0.0 109.536 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.422 HG22 ' SG ' ' A' ' 12' ' ' CYS . 27.5 pt -121.68 161.38 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.744 . . . . 0.0 109.987 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -128.43 -2.97 5.52 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.404 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -111.04 153.2 43.97 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.517 -0.739 . . . . 0.0 109.111 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -58.55 -26.58 79.22 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.762 2.308 . . . . 0.0 113.14 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.545 ' CE1' ' NH1' ' A' ' 60' ' ' ARG . 57.4 t60 -145.15 -15.31 0.51 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.962 -1.086 . . . . 0.0 109.728 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -103.54 159.41 15.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.0 109.085 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.422 ' SG ' HG22 ' A' ' 6' ' ' ILE . 59.0 m -115.88 172.24 7.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 109.765 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.4 t -99.36 134.42 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.833 . . . . 0.0 109.297 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.426 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.3 p90 -67.85 -36.35 80.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.839 . . . . 0.0 109.45 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.0 tt0 -174.29 95.38 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 108.902 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -63.25 112.88 2.88 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.2 -0.938 . . . . 0.0 109.207 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.7 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 3.2 p90 -76.3 -157.07 0.07 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.191 -0.943 . . . . 0.0 108.911 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.7 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.6 m-20 -61.54 130.51 46.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.025 -1.047 . . . . 0.0 109.255 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.29 26.65 10.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.468 -0.77 . . . . 0.0 109.261 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.22 -45.86 75.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 109.578 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.601 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.0 m -62.46 -50.45 71.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 0.0 109.469 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.601 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.9 m 150.51 33.24 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.43 -71.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.801 -1.187 . . . . 0.0 109.996 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.5 t -61.86 -49.78 74.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 36' ' ' GLY . 2.0 m120 -57.79 -37.53 73.89 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -58.23 -40.86 94.45 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 7' ' ' ALA . 64.7 t -61.95 -48.7 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -1.207 . . . . 0.0 109.063 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.5 m -70.8 -22.07 62.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.378 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 64.8 m -63.1 -38.23 90.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.344 -0.848 . . . . 0.0 111.28 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -32.08 51.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.016 . . . . 0.0 109.91 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -55.33 -31.5 61.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 109.333 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 101.64 3.96 52.52 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 179.4 -26.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -1.154 . . . . 0.0 109.68 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.525 ' CE ' ' SG ' ' A' ' 50' ' ' CYS . 32.6 tttt -55.08 130.9 43.64 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.7 p -112.83 140.03 47.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.68 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.588 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.7 166.96 26.81 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.041 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.649 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -140.54 160.46 39.97 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 47.1 t -99.83 121.4 41.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.983 -1.073 . . . . 0.0 109.757 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.556 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 25.1 mt-30 -109.05 167.22 10.26 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.2 pt -93.97 137.47 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.078 -1.013 . . . . 0.0 109.593 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 41' ' ' LEU . 5.8 tt -59.9 -35.04 74.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 108.735 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.434 ' C ' ' OG1' ' A' ' 43' ' ' THR . . . 133.01 -28.36 3.35 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.434 ' OG1' ' C ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 177.55 -40.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -1.021 . . . . 0.0 109.168 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.596 ' HB2' HD13 ' A' ' 41' ' ' LEU . 98.7 m-85 -65.28 -34.72 79.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.787 . . . . 0.0 110.119 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 41' ' ' LEU . . . 175.27 -154.34 17.72 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.349 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.414 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 19.6 m120 -121.06 159.9 24.75 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.524 -0.986 . . . . 0.0 109.394 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.1 161.35 25.96 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.697 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -105.89 129.72 53.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -1.044 . . . . 0.0 109.674 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.556 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 0.9 OUTLIER -111.04 116.87 31.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 108.812 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.525 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 3.9 t -107.62 119.68 40.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.93 134.8 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.561 -0.712 . . . . 0.0 110.444 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.459 ' HB3' ' HG3' ' A' ' 34' ' ' LYS . . . 179.16 -42.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 53' ' ' LEU . 46.3 tp -130.03 73.16 81.62 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.497 -0.752 . . . . 0.0 109.677 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.506 ' CB ' HH21 ' A' ' 2' ' ' ARG . 72.0 Cg_endo -84.87 33.02 0.48 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.943 2.428 . . . . 0.0 112.343 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -51.48 -36.26 43.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.095 -1.003 . . . . 0.0 109.126 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -130.07 -24.49 2.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 109.632 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 57' ' ' VAL . 94.6 t 50.4 64.09 8.9 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 109.636 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -94.71 156.65 1.88 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.376 2.717 . . . . 0.0 111.561 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.66 122.26 63.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.422 -0.799 . . . . 0.0 109.137 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.545 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -97.97 90.97 5.1 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.24 -0.913 . . . . 0.0 109.579 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -128.88 77.53 77.62 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.492 -0.755 . . . . 0.0 109.709 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -79.03 16.77 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.769 2.313 . . . . 0.0 111.717 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.61 -20.79 43.01 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -60.85 -39.52 89.43 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.403 -1.057 . . . . 0.0 109.47 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 14.1 t -59.15 -34.94 72.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.312 -0.867 . . . . 0.0 109.602 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.446 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.448 ' NH1' ' CZ2' ' A' ' 49' ' ' TRP . 66.0 ttp85 -124.38 130.63 52.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.792 . . . . 0.0 109.514 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -100.06 145.11 28.3 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.093 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -108.56 -85.46 0.53 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.52 -0.738 . . . . 0.0 109.073 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -99.36 -28.28 13.36 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.169 -0.957 . . . . 0.0 109.344 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.582 HG23 ' HA ' ' A' ' 12' ' ' CYS . 90.9 mt -103.56 139.89 23.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.56 -0.713 . . . . 0.0 110.196 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.77 -7.78 18.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.495 -0.753 . . . . 0.0 109.104 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.3 mtmt -126.43 89.54 51.99 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.93 -27.82 6.32 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.278 1.985 . . . . 0.0 112.185 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.568 ' C ' HD22 ' A' ' 11' ' ' ASN . 76.8 m80 -86.01 -19.95 29.58 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.229 -0.92 . . . . 0.0 108.89 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.568 HD22 ' C ' ' A' ' 10' ' ' HIS . 1.7 m-80 -140.62 -150.7 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.801 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.582 ' HA ' HG23 ' A' ' 6' ' ' ILE . 69.0 m -140.65 178.38 7.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.623 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.79 128.15 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.001 . . . . 0.0 109.238 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.598 ' HH ' ' HH ' ' A' ' 23' ' ' TYR . 30.8 p90 -68.27 -34.79 76.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -172.15 93.74 0.14 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.539 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -71.06 125.12 26.03 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.993 -1.067 . . . . 0.0 108.164 179.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 70.5 t80 -91.83 160.09 15.48 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 109.821 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.493 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 89.2 m-20 -42.45 126.81 3.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.69 -11.88 60.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.54 -0.725 . . . . 0.0 109.506 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -52.21 -46.24 65.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.352 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 27.2 m -66.55 -62.23 1.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.178 -0.951 . . . . 0.0 109.25 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.0 m 153.12 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.598 ' HH ' ' HH ' ' A' ' 14' ' ' TYR . 65.9 t80 -58.79 -53.59 56.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.996 . . . . 0.0 110.54 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.7 t -65.68 -40.54 92.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.077 -1.014 . . . . 0.0 109.075 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.645 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.4 m120 -59.41 -38.64 81.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.461 -0.775 . . . . 0.0 109.207 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.427 ' O ' ' CD ' ' A' ' 30' ' ' LYS . . . -62.97 -48.59 79.33 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.19 -43.18 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -1.163 . . . . 0.0 109.065 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 33' ' ' ALA . 34.1 t -63.84 -35.05 79.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.51 -0.744 . . . . 0.0 109.71 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 55.3 m -56.13 -42.37 76.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 13.4 mptt -59.87 -38.03 81.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.026 -1.046 . . . . 0.0 109.202 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -58.97 -29.18 66.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.346 -0.846 . . . . 0.0 109.021 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.5 -0.36 55.62 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.553 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -68.63 150.46 47.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.43 -1.041 . . . . 0.0 109.501 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.925 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 7.8 ttmt -57.66 -60.15 4.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.879 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -143.85 161.49 38.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.237 -0.915 . . . . 0.0 109.433 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.27 158.5 27.27 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.582 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 49' ' ' TRP . 30.5 m-85 -136.01 161.2 36.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.504 -0.997 . . . . 0.0 109.16 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 17' ' ' PHE . 0.8 OUTLIER -99.05 123.8 43.6 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.085 -1.009 . . . . 0.0 109.516 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.523 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 33.2 tt0 -106.14 154.17 21.06 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.6 pt -93.45 147.1 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.903 -1.123 . . . . 0.0 110.785 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.742 HD12 ' HA3' ' A' ' 45' ' ' GLY . 78.9 mt -82.4 154.38 25.23 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -44.74 -18.84 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 45' ' ' GLY . 19.3 p -117.74 173.42 6.76 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.76 -0.847 . . . . 0.0 108.783 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -47.7 -8.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 109.888 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.742 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -62.32 162.74 27.99 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 51.8 t-20 -140.66 155.77 46.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -1.109 . . . . 0.0 109.842 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 46' ' ' ASN . . . -140.87 174.7 22.55 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -106.32 158.09 17.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -1.099 . . . . 0.0 109.563 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.491 ' N ' ' O ' ' A' ' 37' ' ' TYR . 7.2 t-105 -130.66 140.75 50.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.0 m -135.08 131.49 37.03 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.027 -1.046 . . . . 0.0 110.058 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -125.32 132.87 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.464 -0.772 . . . . 0.0 109.673 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.925 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -178.52 -43.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tp -132.84 74.9 73.62 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 109.514 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.27 166.58 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.973 2.449 . . . . 0.0 112.652 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 57.07 45.84 20.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.627 -0.671 . . . . 0.0 110.137 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' A' ' 57' ' ' VAL . 22.0 t-20 -146.11 158.99 43.89 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.152 -0.967 . . . . 0.0 109.355 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 56' ' ' ASN . 2.4 t -37.38 100.24 0.2 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.671 -0.643 . . . . 0.0 109.388 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.427 ' N ' ' O ' ' A' ' 56' ' ' ASN . 98.2 Cg_endo -85.71 -67.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.39 2.06 . . . . 0.0 112.828 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.0 mt -121.48 133.31 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -0.804 . . . . 0.0 109.764 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -130.34 82.76 2.08 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.7 mt -128.3 86.04 58.92 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.513 -0.742 . . . . 0.0 109.755 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.94 -19.37 5.49 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.3 2.0 . . . . 0.0 111.918 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.13 -0.34 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -59.19 -35.44 73.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -1.178 . . . . 0.0 109.683 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.55 130.6 45.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 109.526 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.438 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.763 ' NE ' ' HE1' ' A' ' 49' ' ' TRP . 65.2 ttt180 -128.06 133.74 49.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.773 . . . . 0.0 109.705 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -110.79 151.04 28.26 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.606 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.5 -69.78 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.239 -0.913 . . . . 0.0 110.728 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -101.16 -4.26 27.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 0.0 110.46 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.707 HG22 ' H ' ' A' ' 8' ' ' LYS . 63.9 mt -109.09 139.07 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.885 . . . . 0.0 110.509 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -116.28 13.44 15.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.406 -0.809 . . . . 0.0 109.226 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.707 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -125.0 154.77 71.3 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.497 -0.752 . . . . 0.0 109.248 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.34 -36.59 55.11 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.439 2.092 . . . . 0.0 112.352 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -138.55 -3.7 1.67 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.5 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 55.0 m-80 -112.11 169.12 9.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -0.816 . . . . 0.0 109.467 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.634 ' HA ' HG23 ' A' ' 6' ' ' ILE . 3.2 m -116.65 -179.9 3.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.413 -0.804 . . . . 0.0 109.56 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.585 HG21 ' HB2' ' A' ' 48' ' ' CYS . 43.8 t -99.42 134.39 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.194 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.542 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.2 p90 -69.4 -43.02 74.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.855 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 81.4 tt0 -175.51 99.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.003 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -69.32 103.02 1.86 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.069 -1.019 . . . . 0.0 109.023 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 0.7 OUTLIER -45.62 150.79 0.47 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 108.725 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 60.5 t0 -72.17 115.02 10.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.17 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -145.48 150.17 35.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.234 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' ' CB ' ' A' ' 21' ' ' SER . 97.4 m-85 -59.36 -40.37 86.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.958 . . . . 0.0 109.241 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER 170.06 78.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.404 -0.81 . . . . 0.0 109.278 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.45 -66.66 0.14 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.033 -1.042 . . . . 0.0 110.024 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.46 -50.73 72.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.952 . . . . 0.0 109.961 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.9 t -68.94 -44.33 73.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.344 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.678 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.2 m120 -59.55 -38.85 82.17 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.389 -0.819 . . . . 0.0 109.286 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.85 98.28 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.576 ' CG1' ' NZ ' ' A' ' 8' ' ' LYS . 83.2 t -66.1 -42.04 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.427 -1.043 . . . . 0.0 109.232 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 33' ' ' ALA . 43.2 t -61.87 -34.62 76.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.451 -0.781 . . . . 0.0 109.549 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.0 m -55.54 -42.46 74.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.728 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -60.19 -37.06 79.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.129 -0.982 . . . . 0.0 109.01 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -57.81 -29.82 65.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.465 -0.772 . . . . 0.0 109.03 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.88 -2.36 48.38 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . . . -68.04 146.67 53.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 109.303 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -57.53 -53.35 59.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.531 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.9 p -144.4 160.49 40.98 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.354 -0.842 . . . . 0.0 109.288 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.84 149.41 21.41 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.351 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 49' ' ' TRP . 85.6 m-85 -125.18 151.36 45.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.576 -0.955 . . . . 0.0 108.804 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.567 ' SG ' ' OD1' ' A' ' 46' ' ' ASN . 48.9 t -100.23 122.82 43.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.042 -1.037 . . . . 0.0 110.219 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.594 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 94.9 mt-30 -120.01 -167.16 1.39 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.1 pt -115.54 156.03 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.443 -0.786 . . . . 0.0 109.793 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.425 HD23 ' CA ' ' A' ' 46' ' ' ASN . 3.5 mm? -60.25 -23.53 64.16 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.418 -0.802 . . . . 0.0 109.207 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' THR . . . 102.24 0.14 50.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 42' ' ' GLY . 9.1 p -154.55 -81.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.8 142.09 51.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.498 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.68 -177.05 41.78 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 39' ' ' GLN . 16.8 t-20 -140.57 160.6 39.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.455 -1.027 . . . . 0.0 108.886 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.24 163.49 26.36 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.548 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.585 ' HB2' HG21 ' A' ' 13' ' ' VAL . 1.1 m -105.99 153.62 21.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.531 -0.982 . . . . 0.0 109.142 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.763 ' HE1' ' NE ' ' A' ' 2' ' ' ARG . 11.5 t-105 -116.81 137.57 52.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.343 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.7 m -132.63 134.23 44.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.241 -0.912 . . . . 0.0 109.855 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mt -123.6 135.31 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.598 -0.689 . . . . 0.0 110.025 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 33' ' ' ALA . . . -158.33 -59.21 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.388 -0.82 . . . . 0.0 109.326 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.48 79.71 72.94 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -50.13 -179.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.957 2.438 . . . . 0.0 112.665 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 56.64 42.85 26.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.62 -0.675 . . . . 0.0 109.482 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.34 117.42 6.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.257 -0.902 . . . . 0.0 109.34 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.806 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.6 p -124.33 74.43 60.31 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.673 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 59' ' ' ILE . 69.2 Cg_endo -79.76 -61.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.843 2.362 . . . . 0.0 112.118 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 59' ' ' ILE . 83.3 mt 40.25 61.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.472 -0.768 . . . . 0.0 109.977 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -51.48 -34.57 36.23 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.832 HG22 ' H ' ' A' ' 63' ' ' GLY . 1.3 mp -64.43 129.53 94.21 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.51 29.06 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.069 1.846 . . . . 0.0 112.186 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.832 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 97.19 3.32 58.9 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.675 ' O ' HG23 ' A' ' 61' ' ' ILE . 6.3 mtpm? -126.76 136.04 51.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.484 -1.01 . . . . 0.0 109.164 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 75.5 m -60.18 -27.33 67.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.938 . . . . 0.0 109.549 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.516 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.672 ' H1 ' ' H ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -125.96 132.87 51.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.422 -0.799 . . . . 0.0 109.317 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -96.99 136.97 36.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.143 -0.973 . . . . 0.0 109.302 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.541 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -103.32 -59.29 1.74 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.388 -0.82 . . . . 0.0 110.333 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -112.5 9.63 19.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.365 -0.835 . . . . 0.0 110.57 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.431 HD13 HG21 ' A' ' 59' ' ' ILE . 18.4 pt -124.99 163.94 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -0.964 . . . . 0.0 110.252 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.622 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -131.24 -13.28 3.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.469 -0.77 . . . . 0.0 109.038 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.483 ' HB2' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -102.39 152.89 38.39 Favored Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.338 -0.851 . . . . 0.0 109.157 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.35 -34.23 67.38 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.543 2.162 . . . . 0.0 112.875 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.545 ' ND1' ' NH2' ' A' ' 60' ' ' ARG . 91.7 m-70 -133.21 3.15 3.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 110.06 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.483 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 35.7 m-80 -131.37 168.9 16.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.814 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 40.6 m -114.8 179.65 3.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.504 -0.748 . . . . 0.0 109.505 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.476 HG21 ' SG ' ' A' ' 48' ' ' CYS . 45.6 t -95.96 135.06 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.23 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.563 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 32.2 p90 -65.18 -44.43 88.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.563 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 83.3 tt0 -175.56 96.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.059 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.432 ' HB3' HD22 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -66.23 135.46 54.51 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 108.6 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.714 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 2.1 p90 -108.75 -149.47 0.44 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.485 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.714 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 59.0 t0 -56.56 131.88 49.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.048 -1.033 . . . . 0.0 109.39 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.3 4.48 2.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.793 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -51.5 -43.21 62.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.065 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.9 m -85.06 6.45 25.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.031 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 26' ' ' GLY . 38.1 m 48.39 37.94 9.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.856 . . . . 0.0 109.397 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.469 ' O ' HG23 ' A' ' 27' ' ' VAL . 59.2 t80 -59.31 -49.8 76.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.975 . . . . 0.0 109.959 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 33.8 t -69.02 -57.23 5.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.19 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.2 m120 -57.85 -35.65 71.24 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.07 -40.46 95.62 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 23' ' ' TYR . 74.0 t -61.95 -46.72 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.266 -1.138 . . . . 0.0 108.852 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.9 m -70.3 -25.55 63.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.404 -0.81 . . . . 0.0 109.511 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 m -62.79 -29.78 70.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.277 -0.889 . . . . 0.0 111.225 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.489 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 3.9 mptp? -52.86 -34.14 53.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.95 -1.094 . . . . 0.0 110.477 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -56.64 -33.29 66.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.977 -1.077 . . . . 0.0 109.368 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.45 2.93 55.53 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -171.09 -28.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -1.078 . . . . 0.0 108.903 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.658 ' NZ ' ' SG ' ' A' ' 50' ' ' CYS . 24.4 tttt -53.34 134.37 39.84 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.7 m -116.79 139.24 50.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.4 -0.812 . . . . 0.0 109.618 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.19 156.24 26.4 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 49' ' ' TRP . 49.6 m-85 -127.08 154.18 45.03 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.5 t -99.52 122.51 42.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.004 -1.06 . . . . 0.0 109.275 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -123.99 -172.88 2.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.556 -0.715 . . . . 0.0 109.511 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 42' ' ' GLY . 69.3 mt -93.62 145.58 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.882 . . . . 0.0 109.403 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 44' ' ' TYR . 29.7 tp -53.22 -39.19 63.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.504 ' H ' HG22 ' A' ' 40' ' ' ILE . . . 130.15 -56.43 0.74 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.8 m -97.99 -67.88 0.83 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.518 -0.989 . . . . 0.0 108.67 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.517 ' O ' HD23 ' A' ' 41' ' ' LEU . 27.5 p90 -139.64 159.58 41.85 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.87 -164.77 46.87 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.432 HD22 ' HB3' ' A' ' 16' ' ' CYS . 15.8 t30 -140.77 161.69 37.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.3 -1.118 . . . . 0.0 109.389 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.29 159.11 26.14 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.709 -1.234 . . . . 0.0 110.16 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.622 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -103.68 157.45 17.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.352 -1.087 . . . . 0.0 109.168 179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 4' ' ' ALA . 7.5 t-105 -125.68 122.12 35.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.528 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.658 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -123.2 135.87 54.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.0 109.118 179.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 4.1 mt -117.95 134.51 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.699 0.761 . . . . 0.0 111.043 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 51' ' ' ILE . . . 169.07 147.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.71 73.7 81.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.673 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -84.37 -93.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.992 2.461 . . . . 0.0 112.367 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -94.37 11.41 30.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 0.0 109.449 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.507 HD22 ' HB2' ' A' ' 1' ' ' ALA . 0.4 OUTLIER 62.26 45.01 7.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.407 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.672 ' H ' ' H1 ' ' A' ' 1' ' ' ALA . 10.2 t -68.95 119.58 70.67 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.343 -0.848 . . . . 0.0 109.285 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.88 165.07 7.41 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.277 1.984 . . . . 0.0 111.032 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.527 HG22 HG12 ' A' ' 61' ' ' ILE . 22.3 mm -109.02 130.83 61.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.176 -0.953 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.545 ' NH2' ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -119.28 86.72 2.6 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.527 HG12 HG22 ' A' ' 59' ' ' ILE . 1.9 pt -124.43 81.53 59.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.811 . . . . 0.0 109.745 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -53.31 -18.92 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.666 2.244 . . . . 0.0 112.048 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.66 -12.5 0.11 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -58.75 -33.13 69.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -1.171 . . . . 0.0 109.62 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.0 t -56.62 -33.39 66.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.441 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 78.8 m80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.457 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -128.46 138.1 52.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.379 -0.826 . . . . 0.0 109.858 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 90.3 m-20 -108.05 150.38 27.23 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.77 -85.46 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -98.67 5.95 47.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.954 -1.091 . . . . 0.0 109.572 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.647 HG22 ' HB3' ' A' ' 12' ' ' CYS . 21.5 pt -111.42 149.06 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.544 -0.722 . . . . 0.0 109.744 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.635 ' O ' HG11 ' A' ' 27' ' ' VAL . . . -102.57 -1.92 29.46 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.242 -0.911 . . . . 0.0 108.977 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.47 173.27 6.07 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.535 -0.728 . . . . 0.0 109.289 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -48.63 -76.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.644 2.23 . . . . 0.0 113.367 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.518 ' CG ' HH11 ' A' ' 60' ' ' ARG . 78.2 m-70 -107.52 -8.87 16.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.162 -0.961 . . . . 0.0 110.159 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -102.31 155.55 18.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.396 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.647 ' HB3' HG22 ' A' ' 6' ' ' ILE . 13.9 p -120.98 177.04 5.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.124 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 7' ' ' ALA . 77.8 t -104.97 136.24 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 0.0 110.004 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -82.68 -32.28 28.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.0 109.049 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -174.3 98.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.777 . . . . 0.0 109.077 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' H ' ' ND2' ' A' ' 46' ' ' ASN . 3.7 p -66.18 104.78 1.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.118 -0.989 . . . . 0.0 108.52 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 6.0 p90 -53.58 -42.76 67.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 110.34 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.561 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 54.7 t0 -148.1 78.45 1.44 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.966 -1.084 . . . . 0.0 109.836 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.7 -30.87 71.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.199 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.88 -40.86 73.56 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.433 -0.792 . . . . 0.0 109.256 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.592 ' O ' ' CB ' ' A' ' 22' ' ' SER . 17.5 t -57.57 -52.11 66.73 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.5 m 155.47 10.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.72 -0.613 . . . . 0.0 110.091 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -60.04 -63.22 1.38 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.81 -1.181 . . . . 0.0 110.142 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.28 -51.86 57.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.114 -0.991 . . . . 0.0 108.958 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.584 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.7 m120 -60.02 -35.7 75.65 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -57.81 -43.51 94.63 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.635 HG11 ' O ' ' A' ' 7' ' ' ALA . 91.6 t -62.94 -43.42 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -1.173 . . . . 0.0 108.689 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 60.0 m -64.12 -31.67 72.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.848 . . . . 0.0 109.168 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.4 m -58.83 -48.65 80.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.655 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -64.27 -41.9 96.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.398 -0.814 . . . . 0.0 109.192 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -62.28 -30.82 71.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.535 -0.728 . . . . 0.0 109.048 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.99 2.7 56.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.493 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -66.92 152.9 44.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.335 -1.097 . . . . 0.0 109.631 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.775 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 9.5 ttmt -58.46 -71.3 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 110.111 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.0 p -144.77 169.33 18.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.315 -0.866 . . . . 0.0 110.22 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.515 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -142.12 151.06 22.6 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.13 135.82 54.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.27 -1.135 . . . . 0.0 109.895 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.63 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.5 t -111.48 115.23 28.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.239 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -131.66 166.13 22.15 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.5 pt -104.87 145.86 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.977 . . . . 0.0 111.267 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.08 142.32 41.7 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.21 -30.04 53.92 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.2 m -92.09 -74.07 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.083 -1.245 . . . . 0.0 110.772 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -61.52 -40.62 95.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.191 -0.943 . . . . 0.0 110.482 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.47 -31.31 7.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 16' ' ' CYS . 20.3 t-20 -140.47 125.08 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.261 . . . . 0.0 110.008 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.31 112.52 0.81 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.63 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -110.6 117.57 33.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -1.087 . . . . 0.0 109.53 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.37 131.44 54.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.5 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 7.1 t -105.45 122.65 46.43 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -112.53 132.67 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.831 . . . . 0.0 110.429 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.775 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -175.39 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.665 -0.647 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.484 HD23 ' ND2' ' A' ' 56' ' ' ASN . 1.0 OUTLIER -128.93 84.51 62.87 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.57 -0.706 . . . . 0.0 109.732 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.547 ' O ' HG13 ' A' ' 57' ' ' VAL . 36.9 Cg_endo -74.55 -13.07 22.57 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.285 1.99 . . . . 0.0 112.616 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -57.65 -37.46 73.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.051 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.507 ' O ' ' C ' ' A' ' 57' ' ' VAL . 89.2 m-20 -67.05 -40.78 87.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.053 -1.029 . . . . 0.0 110.497 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER 32.93 67.63 1.03 Allowed Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.795 -0.566 . . . . 0.0 109.962 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.471 ' O ' ' C ' ' A' ' 59' ' ' ILE . 68.7 Cg_endo -78.75 -65.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.8 2.333 . . . . 0.0 112.708 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 59' ' ' ILE . 95.8 mt 39.93 58.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.353 -0.842 . . . . 0.0 109.259 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.518 HH11 ' CG ' ' A' ' 10' ' ' HIS . 12.6 ptm180 -55.03 -37.45 66.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.972 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.67 ' O ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -95.97 154.33 38.98 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.184 -0.948 . . . . 0.0 109.545 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.68 -20.33 70.67 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.555 2.17 . . . . 0.0 112.107 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.98 15.95 0.1 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -92.65 155.92 17.42 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.267 -1.137 . . . . 0.0 109.239 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.09 -36.43 65.64 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 83.1 t60 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.423 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.453 ' H ' ' HB3' ' A' ' 58' ' ' PRO . 71.1 ttp85 -128.11 135.3 49.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 87.5 m-20 -96.86 147.18 24.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.941 . . . . 0.0 109.376 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -113.45 -94.25 0.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 109.35 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -98.83 7.54 45.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.012 -1.055 . . . . 0.0 108.952 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.5 pt -117.34 155.79 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.701 -0.624 . . . . 0.0 109.87 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.626 ' H ' HG23 ' A' ' 13' ' ' VAL . . . -112.12 5.13 18.39 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.14 165.25 21.38 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.48 -59.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.408 2.072 . . . . 0.0 112.147 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -105.79 -6.4 19.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.798 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -114.31 164.28 14.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.422 -0.799 . . . . 0.0 109.799 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.6 m -112.43 176.89 4.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.614 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.626 HG23 ' H ' ' A' ' 7' ' ' ALA . 39.9 t -102.08 130.99 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.236 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.436 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.2 p90 -74.13 -36.32 64.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.294 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.1 tt0 -174.76 99.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -65.5 109.34 2.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.59 ' CE2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -61.45 162.09 8.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.59 ' O ' ' CE2' ' A' ' 17' ' ' PHE . 61.1 t0 -44.22 107.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.113 -0.992 . . . . 0.0 108.993 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.584 ' CB ' ' H ' ' A' ' 24' ' ' CYS . . . -95.61 29.94 2.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.814 . . . . 0.0 109.829 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -53.49 -46.08 69.89 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.115 -0.991 . . . . 0.0 108.865 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.587 ' O ' ' CB ' ' A' ' 22' ' ' SER . 20.2 m -64.53 -49.44 71.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.319 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.587 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.4 m 152.2 26.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -58.61 -56.78 17.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.744 -1.223 . . . . 0.0 109.767 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.584 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 38.1 t -67.27 -42.42 83.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 108.832 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.747 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -59.46 -38.85 81.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.87 -39.3 97.85 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.48 -47.79 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.197 -1.178 . . . . 0.0 109.349 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 1.3 m -70.74 -31.36 68.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.336 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.8 m -53.46 -48.52 68.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.231 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -64.93 -38.17 90.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.442 -0.786 . . . . 0.0 109.0 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -59.59 -28.43 67.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -0.79 . . . . 0.0 108.988 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.36 0.2 40.57 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 28' ' ' CYS . . . -65.29 145.68 55.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -1.114 . . . . 0.0 109.14 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.737 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 4.1 ttmt -60.56 -52.6 64.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 110.135 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -143.55 160.47 40.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.127 -0.983 . . . . 0.0 110.317 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.602 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -139.05 140.15 10.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -130.14 136.72 49.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -1.097 . . . . 0.0 109.755 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.0 t -105.05 130.94 53.13 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.353 -0.842 . . . . 0.0 109.501 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.688 ' NE2' ' N ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -134.67 173.0 12.15 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.493 -0.755 . . . . 0.0 109.274 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.492 HG22 HD21 ' A' ' 46' ' ' ASN . 34.2 pt -95.77 141.3 15.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.453 HD12 ' HA3' ' A' ' 45' ' ' GLY . 76.0 mt -59.13 -34.95 72.65 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.293 -0.88 . . . . 0.0 109.245 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.57 -60.82 0.52 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.67 -70.44 0.75 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.38 -1.071 . . . . 0.0 109.063 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -129.44 151.16 50.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.609 -0.682 . . . . 0.0 109.538 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 93.45 174.8 40.3 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.492 HD21 HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -140.44 167.11 22.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.322 -1.105 . . . . 0.0 109.578 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.489 ' O ' ' OE1' ' A' ' 39' ' ' GLN . . . -140.41 150.41 21.59 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -134.0 125.6 28.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -1.067 . . . . 0.0 109.231 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.547 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 2.8 p90 -120.69 141.27 50.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.113 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.435 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 74.9 m -128.98 145.0 51.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.451 -0.78 . . . . 0.0 109.103 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.69 137.85 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.858 ' C ' HD23 ' A' ' 53' ' ' LEU . . . -169.66 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.926 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.858 HD23 ' C ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -128.0 78.45 75.24 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.892 . . . . 0.0 109.659 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -60.7 -23.66 76.71 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.382 2.055 . . . . 0.0 111.782 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.07 -36.45 77.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 109.785 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.476 ' O ' ' C ' ' A' ' 57' ' ' VAL . 50.6 t-20 -68.06 129.08 38.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.476 ' C ' ' O ' ' A' ' 56' ' ' ASN . 52.5 t -38.15 100.42 0.21 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.803 -0.561 . . . . 0.0 109.539 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HB3' ' H ' ' A' ' 2' ' ' ARG . 75.4 Cg_endo -90.3 155.76 4.58 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.627 2.218 . . . . 0.0 111.69 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 59' ' ' ILE . 89.3 mt 41.25 55.17 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 109.607 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -58.57 -35.87 73.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.476 HG13 ' H ' ' A' ' 63' ' ' GLY . 10.0 pt -60.62 148.56 81.26 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 0.0 109.35 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.79 1.22 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.465 2.11 . . . . 0.0 112.006 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.476 ' H ' HG13 ' A' ' 61' ' ' ILE . . . 100.11 5.82 54.36 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 66' ' ' HIS . 39.3 mtpt -103.46 122.62 45.28 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.388 -1.066 . . . . 0.0 108.816 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.407 ' O ' ' OXT' ' A' ' 66' ' ' HIS . 81.1 m -64.26 -22.99 67.14 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.428 -0.795 . . . . 0.0 110.006 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.407 ' OXT' ' O ' ' A' ' 65' ' ' CYS . 37.5 m80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.425 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -129.05 135.78 49.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.424 -0.797 . . . . 0.0 109.687 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.485 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 87.3 m-20 -103.37 155.91 18.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 108.89 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -110.5 -93.48 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 110.323 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -98.2 -10.88 23.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.067 -1.02 . . . . 0.0 109.64 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.712 HG23 ' HA ' ' A' ' 12' ' ' CYS . 60.8 mt -111.0 130.58 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.555 -0.716 . . . . 0.0 109.544 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.64 -12.61 19.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.422 -0.799 . . . . 0.0 110.107 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.444 ' HB2' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -104.08 153.26 39.03 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.274 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.12 -35.8 62.27 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.487 2.125 . . . . 0.0 112.942 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -131.14 -0.9 4.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.948 . . . . 0.0 110.11 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.491 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 34.6 m-80 -125.91 164.55 20.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.342 -0.849 . . . . 0.0 109.78 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.712 ' HA ' HG23 ' A' ' 6' ' ' ILE . 56.7 m -115.42 160.33 20.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.0 109.476 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.78 131.59 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 29.9 p90 -75.13 -43.46 52.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.93 . . . . 0.0 109.459 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.535 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.3 tt0 -175.9 100.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 109.215 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -68.38 93.37 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.089 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.527 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 21.2 p90 -63.42 -43.32 97.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 109.895 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.527 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 47.8 t0 -153.49 89.45 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.126 -0.984 . . . . 0.0 109.849 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.506 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . . . -64.58 -28.68 69.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.128 -0.983 . . . . 0.0 109.275 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -54.49 -40.37 68.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.473 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 20.6 m -58.64 -48.91 79.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.122 -0.986 . . . . 0.0 109.623 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.8 m 153.57 3.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.75 -0.594 . . . . 0.0 109.944 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.08 -79.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.923 -1.11 . . . . 0.0 110.485 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 t -58.43 -48.29 81.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 36' ' ' GLY . 2.6 m120 -58.35 -36.27 73.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.0 108.835 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.91 -41.12 97.65 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.09 -44.32 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.237 -1.154 . . . . 0.0 109.049 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 62.6 m -64.7 -30.76 71.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 109.389 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.8 m -58.81 -44.68 90.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.726 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt -63.1 -44.7 94.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.011 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.74 -30.23 71.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.274 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.71 4.28 58.04 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.518 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.73 155.0 35.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.365 -1.079 . . . . 0.0 109.608 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.736 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 5.6 ttmt -56.24 -71.63 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 110.235 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 t -144.34 168.66 19.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 110.05 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.586 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -137.2 154.78 22.51 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -129.78 143.93 51.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -1.102 . . . . 0.0 109.641 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -125.45 128.43 48.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.569 -0.707 . . . . 0.0 109.345 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -140.3 -138.53 0.12 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.221 -0.924 . . . . 0.0 109.589 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 40' ' ' ILE . 22.5 pt -93.71 153.21 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.262 -0.898 . . . . 0.0 109.962 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 44' ' ' TYR . 32.4 tp -86.68 138.2 31.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.437 -0.789 . . . . 0.0 109.187 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.74 -35.95 8.0 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.2 p -100.52 -99.04 0.25 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.181 -1.187 . . . . 0.0 109.209 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.695 ' O ' HD23 ' A' ' 41' ' ' LEU . 95.5 m-85 -122.34 147.55 46.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 0.0 109.287 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.34 -162.44 25.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 40' ' ' ILE . 27.9 m120 -114.81 166.41 11.79 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.487 -1.008 . . . . 0.0 109.725 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.59 155.48 21.59 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER -137.2 121.33 17.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -1.144 . . . . 0.0 109.974 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -111.31 136.06 50.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.394 -0.817 . . . . 0.0 108.857 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.518 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 6.9 t -111.31 126.65 55.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.0 108.981 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.1 mt -115.45 135.22 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 110.242 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.736 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -171.18 -55.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.524 -0.735 . . . . 0.0 109.057 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.86 76.52 76.99 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.481 -0.762 . . . . 0.0 109.235 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.87 -21.37 40.33 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.915 2.41 . . . . 0.0 112.684 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.434 ' C ' HD22 ' A' ' 56' ' ' ASN . 92.3 m-20 -48.74 -35.44 14.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 108.494 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.434 HD22 ' C ' ' A' ' 55' ' ' ASP . 3.1 m120 -109.24 125.53 52.35 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.63 -0.668 . . . . 0.0 109.387 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.7 t -138.29 66.25 44.21 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.915 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -95.2 152.32 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.507 2.804 . . . . 0.0 111.75 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 61' ' ' ILE . 58.8 mt -128.1 121.62 56.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.1 tpt85 -54.97 -36.27 65.19 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.356 -0.84 . . . . 0.0 110.795 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.798 ' O ' HD12 ' A' ' 61' ' ' ILE . 1.6 pp -132.65 154.43 81.49 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.031 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.35 -19.57 28.93 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.479 2.119 . . . . 0.0 112.036 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.79 26.87 0.11 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -104.17 148.18 26.59 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.231 -1.158 . . . . 0.0 109.467 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 71.1 m -117.35 159.76 22.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.489 -0.757 . . . . 0.0 109.148 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.408 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 56' ' ' ASN . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -127.04 129.97 49.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.84 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.456 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 5.3 t0 -108.55 153.57 23.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.432 -0.793 . . . . 0.0 109.106 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.61 ' HB1' ' CH2' ' A' ' 49' ' ' TRP . . . -100.28 -81.67 0.46 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.528 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.3 -4.77 31.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.001 . . . . 0.0 109.786 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.456 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 65.7 mt -106.77 143.95 16.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.464 -0.773 . . . . 0.0 110.099 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.84 -10.16 1.34 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.305 -0.872 . . . . 0.0 109.19 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -104.75 157.21 34.66 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 8' ' ' LYS . 45.6 Cg_exo -34.16 -109.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.332 2.688 . . . . 0.0 113.151 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.44 -1.23 57.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.756 -1.215 . . . . 0.0 109.335 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -105.22 154.82 19.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.639 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.449 ' HA ' HG23 ' A' ' 6' ' ' ILE . 7.3 m -108.1 161.81 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.234 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.442 HG21 ' HB2' ' A' ' 48' ' ' CYS . 55.9 t -66.41 134.31 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.947 . . . . 0.0 109.434 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.7 p90 -78.13 -34.7 49.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 76.9 tt0 -167.61 95.0 0.44 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.265 -0.897 . . . . 0.0 109.08 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.485 ' CB ' HD22 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -60.6 148.51 37.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.95 -1.094 . . . . 0.0 108.411 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 13.7 t80 -115.69 166.48 11.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.511 -0.743 . . . . 0.0 109.281 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.585 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 88.0 m-20 -42.8 137.21 2.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 109.401 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.96 -8.91 48.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 110.037 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -51.34 -43.79 61.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.045 -1.034 . . . . 0.0 108.726 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -86.11 6.01 31.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.354 -0.841 . . . . 0.0 108.893 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 m 55.33 20.42 3.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.602 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -58.62 -49.41 77.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.774 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.5 t -65.34 -47.96 74.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.152 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.2 m120 -60.05 -37.63 80.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.389 -0.82 . . . . 0.0 109.185 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.52 -42.22 99.01 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.33 -43.91 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 109.12 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.8 t -64.27 -32.42 74.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.475 -0.765 . . . . 0.0 109.19 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.5 m -59.23 -41.1 87.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.406 -0.809 . . . . 0.0 109.975 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -58.77 -31.2 68.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.128 -0.983 . . . . 0.0 109.272 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -52.6 -34.89 52.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 108.925 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.732 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 157.35 -35.57 0.55 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 161.45 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -1.152 . . . . 0.0 109.362 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 33' ' ' ALA . 22.2 mttt -42.87 139.51 1.65 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.434 -0.791 . . . . 0.0 109.96 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.4 p -125.81 113.63 17.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.59 -141.48 4.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.554 ' O ' ' N ' ' A' ' 49' ' ' TRP . 10.3 m-85 -139.82 171.5 14.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.209 -1.171 . . . . 0.0 109.828 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.465 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 13.0 t -99.68 125.63 45.57 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.325 -0.86 . . . . 0.0 109.534 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.659 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 26.7 mt-30 -118.07 -177.5 3.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.641 -0.662 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 40' ' ' ILE . 31.6 pt -108.93 157.82 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 110.102 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.442 HD12 ' HA3' ' A' ' 45' ' ' GLY . 56.7 mt -79.05 144.52 34.55 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.37 -0.832 . . . . 0.0 109.517 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -54.13 -34.93 53.58 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.1 p -94.14 -120.88 0.09 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.331 -1.1 . . . . 0.0 109.073 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.14 136.63 51.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 126.01 -166.6 18.7 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.485 HD22 ' CB ' ' A' ' 16' ' ' CYS . 17.3 t30 -140.51 157.95 44.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.322 -1.105 . . . . 0.0 108.927 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.24 163.67 25.98 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.8 m -107.43 140.41 40.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.476 -1.014 . . . . 0.0 109.758 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.659 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 4.6 t-105 -106.34 128.67 54.18 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.397 -0.815 . . . . 0.0 108.895 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.4 m -115.9 128.51 55.84 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.494 HD12 ' CE2' ' A' ' 37' ' ' TYR . 69.2 mt -126.37 138.36 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 110.327 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.721 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -168.91 -40.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.329 -0.857 . . . . 0.0 109.537 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.721 HD12 ' O ' ' A' ' 52' ' ' ALA . 5.8 mp -128.63 159.11 69.71 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.514 -0.741 . . . . 0.0 109.313 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -42.55 -72.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.591 2.194 . . . . 0.0 112.325 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 50.0 p30 -175.37 47.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.44 -0.787 . . . . 0.0 109.534 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 1' ' ' ALA . 16.1 t-20 -101.2 121.9 42.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.26 -0.9 . . . . 0.0 109.751 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 1' ' ' ALA . 23.7 t 55.73 66.82 3.37 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.623 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.74 -64.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.65 2.233 . . . . 0.0 112.12 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -119.92 113.78 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -0.788 . . . . 0.0 109.203 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -67.49 -35.63 79.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 109.054 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 63' ' ' GLY . 1.6 mp -73.7 136.93 77.14 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.691 -0.63 . . . . 0.0 109.543 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -46.64 -5.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.898 1.732 . . . . 0.0 111.892 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 103.67 5.41 45.1 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 66' ' ' HIS . 33.0 mtmt -58.28 -36.75 73.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.107 -1.231 . . . . 0.0 109.385 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 50.7 t 51.64 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.631 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 64' ' ' LYS . 9.9 p-80 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.552 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -108.91 146.05 34.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.427 -0.796 . . . . 0.0 109.306 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.47 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 8.9 t0 -136.58 154.31 50.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.874 . . . . 0.0 109.098 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.571 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.6 -78.31 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 110.898 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.65 -8.96 23.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.067 . . . . 0.0 110.096 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.713 HG22 ' H ' ' A' ' 8' ' ' LYS . 68.3 mt -104.65 143.45 16.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.461 -0.774 . . . . 0.0 110.177 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.577 ' O ' ' ND2' ' A' ' 31' ' ' ASN . . . -118.51 13.28 13.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.823 . . . . 0.0 109.354 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.713 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -125.24 155.27 71.56 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -64.86 -39.68 24.46 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.437 2.091 . . . . 0.0 112.416 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -134.57 -1.08 2.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.639 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.495 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 54.2 m-80 -116.16 170.21 8.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.47 -0.769 . . . . 0.0 109.488 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.673 ' HA ' HG23 ' A' ' 6' ' ' ILE . 62.5 m -114.46 177.27 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.518 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 t -99.97 135.68 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -70.78 77.44 0.62 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.067 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 55.9 97.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 109.346 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.7 t -64.68 113.21 3.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 108.975 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 8.4 t80 -70.06 139.56 52.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 88.9 m-20 -70.1 131.77 44.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 110.084 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.72 155.05 37.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.406 -0.809 . . . . 0.0 109.109 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 21' ' ' SER . 96.7 m-85 -56.93 -41.02 77.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.09 -1.006 . . . . 0.0 109.24 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 1.4 t 168.98 86.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.409 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.2 t -170.24 -64.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.057 -1.027 . . . . 0.0 110.021 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.437 ' HH ' ' HE1' ' A' ' 14' ' ' TYR . 64.4 t80 -59.78 -56.95 15.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 109.912 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.2 t -70.66 -52.64 19.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.653 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.639 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.5 m120 -57.68 -37.99 74.37 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.408 -0.807 . . . . 0.0 109.469 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.74 -46.66 93.74 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.3 t -67.72 -43.27 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -1.131 . . . . 0.0 109.383 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.5 t -61.22 -38.06 85.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.357 -0.839 . . . . 0.0 109.333 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.8 m -56.93 -40.21 75.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -59.14 -38.34 79.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.012 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 7' ' ' ALA . 82.0 m-20 -59.24 -28.52 66.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.83 . . . . 0.0 109.03 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.72 -0.12 52.51 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.78 148.21 51.55 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -1.064 . . . . 0.0 109.452 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.836 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 3.8 ttmt -58.31 -55.56 33.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.782 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t -144.62 158.81 43.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.347 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -141.74 154.23 24.66 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.563 -1.304 . . . . 0.0 110.211 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 49' ' ' TRP . 48.8 m-85 -127.18 152.83 46.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.489 -1.006 . . . . 0.0 109.242 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.8 t -99.44 119.54 38.17 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.176 -0.953 . . . . 0.0 109.087 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -116.68 -170.82 1.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.696 -0.628 . . . . 0.0 109.693 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 pt -93.57 152.17 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.239 -0.913 . . . . 0.0 109.726 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 43' ' ' THR . 29.8 tp -88.85 133.95 34.11 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.301 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -45.11 -30.19 2.52 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.432 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 25.8 p -109.45 178.85 4.31 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -50.75 160.58 0.43 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.763 -1.211 . . . . 0.0 109.174 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.59 -167.05 30.76 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -138.97 171.91 13.62 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.338 -1.095 . . . . 0.0 109.407 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.13 163.66 26.29 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.05 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.1 m -103.57 152.2 22.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.424 -1.045 . . . . 0.0 109.255 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.579 ' N ' ' O ' ' A' ' 37' ' ' TYR . 17.3 t-105 -116.2 139.06 50.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.826 . . . . 0.0 109.566 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.8 m -134.38 124.05 25.11 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.287 -0.883 . . . . 0.0 109.9 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 mt -123.98 132.34 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.536 -0.728 . . . . 0.0 109.875 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.836 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -177.11 -66.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.822 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 1' ' ' ALA . 17.6 tp -133.14 89.0 34.57 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.417 -0.802 . . . . 0.0 109.9 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -75.61 -25.16 11.2 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.074 1.849 . . . . 0.0 112.292 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -57.96 -35.83 71.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 57' ' ' VAL . 48.9 t-20 -73.29 144.72 46.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.645 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.503 ' C ' ' O ' ' A' ' 56' ' ' ASN . 90.9 t -33.85 97.84 0.12 Allowed Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.949 -0.469 . . . . 0.0 109.795 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' ASN . 89.5 Cg_endo -85.5 -63.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.575 2.184 . . . . 0.0 112.426 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.413 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 73.6 mt -118.21 131.97 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -138.49 -21.9 1.01 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.301 -0.874 . . . . 0.0 109.507 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.679 ' O ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -96.23 154.09 38.86 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -67.21 -9.87 26.64 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.696 2.264 . . . . 0.0 112.195 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.3 22.22 45.42 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 66' ' ' HIS . 17.3 tttp -56.38 -35.04 67.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.557 -0.967 . . . . 0.0 109.651 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 57.8 m 57.12 -77.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.414 -0.803 . . . . 0.0 109.592 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 64' ' ' LYS . 94.9 m-70 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.877 ' H2 ' ' H ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -131.93 134.59 45.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.47 -0.769 . . . . 0.0 109.44 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 83.4 m-20 -95.79 150.11 20.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.136 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -109.86 -92.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.511 -0.743 . . . . 0.0 109.955 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -97.91 -17.3 19.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.346 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.68 HG23 ' HA ' ' A' ' 12' ' ' CYS . 64.7 mt -106.91 137.61 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.525 -0.734 . . . . 0.0 109.62 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.416 ' C ' ' CD ' ' A' ' 8' ' ' LYS . . . -113.24 14.42 19.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.476 -0.765 . . . . 0.0 109.853 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.659 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -126.23 153.52 74.46 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.346 -0.846 . . . . 0.0 109.15 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.86 -27.74 80.58 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.637 2.225 . . . . 0.0 112.896 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -147.64 -5.99 0.47 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.077 -1.015 . . . . 0.0 109.501 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.481 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 51.2 m-80 -111.52 165.92 11.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.768 . . . . 0.0 109.38 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.68 ' HA ' HG23 ' A' ' 6' ' ' ILE . 24.4 m -119.59 162.19 19.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -0.823 . . . . 0.0 109.089 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.9 130.96 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.104 -0.998 . . . . 0.0 109.207 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.523 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.4 p90 -76.04 -42.11 48.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.523 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 45.1 tp10 -175.29 99.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -63.63 148.65 48.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.162 -0.961 . . . . 0.0 109.024 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.676 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -122.12 -161.14 0.91 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.676 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 89.1 m-20 -57.08 142.45 42.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.988 -1.07 . . . . 0.0 109.308 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.7 7.58 3.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.867 . . . . 0.0 110.103 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -52.25 -45.52 65.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.058 -1.026 . . . . 0.0 109.256 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 t -88.87 -2.58 58.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.949 . . . . 0.0 109.128 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 m 55.6 52.55 10.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.511 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 27' ' ' VAL . 65.4 t80 -61.75 -53.61 53.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 0.0 109.833 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -70.98 -51.87 23.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.897 . . . . 0.0 109.294 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.652 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.5 m120 -58.76 -37.54 76.47 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.47 97.18 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 23' ' ' TYR . 74.2 t -61.85 -44.15 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -1.125 . . . . 0.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.2 m -63.78 -32.93 74.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.183 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.2 m -60.98 -50.39 73.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.663 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -65.59 -41.01 93.32 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.44 -0.788 . . . . 0.0 109.359 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -61.26 -30.25 70.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.461 -0.775 . . . . 0.0 109.259 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.36 0.39 50.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.425 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -66.85 150.95 48.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.438 -1.036 . . . . 0.0 109.388 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -57.91 -76.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 109.87 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.2 m -143.16 158.87 43.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.329 -0.857 . . . . 0.0 109.681 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.42 162.27 26.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -126.35 140.03 52.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -1.041 . . . . 0.0 109.833 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -116.21 119.37 35.55 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -137.45 176.83 8.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.189 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.418 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -92.83 140.29 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.979 -1.076 . . . . 0.0 109.285 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.621 HD13 ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -64.42 -39.42 93.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 108.939 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.45 5.87 74.76 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.6 m -157.44 -81.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 109.849 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -62.29 -37.0 83.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.917 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 41' ' ' LEU . . . 162.88 -119.08 0.85 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.424 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 17.4 m120 -111.33 150.54 29.57 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.519 -0.989 . . . . 0.0 110.093 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.3 117.53 2.3 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 4' ' ' ALA . 32.9 t -114.95 115.98 27.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.464 -1.021 . . . . 0.0 109.143 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -109.55 137.56 47.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.357 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.477 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 8.2 t -109.39 132.55 54.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.1 122.83 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 0.0 109.814 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.423 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -179.07 -146.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.585 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.7 OUTLIER 176.43 -44.71 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.42 -0.8 . . . . 0.0 109.823 179.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 53' ' ' LEU . 42.8 Cg_exo -54.78 -32.68 77.76 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.086 1.858 . . . . 0.0 111.95 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.35 -38.3 86.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.299 -0.876 . . . . 0.0 108.98 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 53' ' ' LEU . 14.5 m120 56.88 46.42 19.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.877 ' H ' ' H2 ' ' A' ' 1' ' ' ALA . 91.9 t -120.62 85.92 39.24 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.365 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -90.91 -172.83 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.293 2.662 . . . . 0.0 111.689 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 61' ' ' ILE . 29.7 mm -114.28 130.5 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 7.51 41.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 0.0 110.521 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.588 ' H ' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -141.63 151.94 61.73 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.778 -1.201 . . . . 0.0 109.865 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 64' ' ' LYS . 11.3 Cg_endo -57.84 159.74 16.89 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.703 2.269 . . . . 0.0 112.155 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.634 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . -65.74 28.25 0.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 66' ' ' HIS . 35.0 tttt -56.68 -35.63 68.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.104 -1.233 . . . . 0.0 109.303 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 33.8 m 58.46 -74.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.614 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 64' ' ' LYS . 84.6 t60 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -136.52 161.52 35.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.341 -0.849 . . . . 0.0 109.242 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -95.44 145.54 25.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.121 -0.987 . . . . 0.0 109.343 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -103.08 -81.42 0.5 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 110.797 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -99.52 -15.18 18.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.051 -1.031 . . . . 0.0 110.261 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.624 HG23 ' HA ' ' A' ' 12' ' ' CYS . 67.9 mt -95.91 143.92 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.367 -0.833 . . . . 0.0 110.12 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.94 21.32 3.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.34 -0.85 . . . . 0.0 109.6 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.453 ' H ' HG22 ' A' ' 6' ' ' ILE . 8.8 mmtm -115.37 152.15 46.65 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.47 -0.769 . . . . 0.0 109.213 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.21 -32.75 90.88 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.569 2.18 . . . . 0.0 112.816 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -149.65 12.08 0.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.996 -1.065 . . . . 0.0 109.805 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -130.88 -164.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.62 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.624 ' HA ' HG23 ' A' ' 6' ' ' ILE . 84.1 m -121.0 -178.08 3.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.357 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -98.89 131.95 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.265 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.7 p90 -66.34 -37.45 85.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.531 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.443 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 80.9 tt0 -174.56 99.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.279 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -75.54 125.58 29.31 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.101 -0.999 . . . . 0.0 108.715 179.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 18' ' ' ASP . 20.0 t80 -90.87 141.14 29.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.904 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.587 ' O ' ' CE2' ' A' ' 17' ' ' PHE . 60.0 t0 -78.52 121.03 24.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -0.811 . . . . 0.0 109.88 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -140.82 159.06 43.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.465 -0.772 . . . . 0.0 108.936 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.448 ' O ' ' CB ' ' A' ' 21' ' ' SER . 71.3 t80 -53.62 -43.41 68.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.081 -1.012 . . . . 0.0 109.203 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.503 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER 168.97 78.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.429 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 26' ' ' GLY . 3.5 t -156.01 -66.94 0.11 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.037 -1.039 . . . . 0.0 110.149 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -60.37 -57.26 13.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -68.36 -48.31 65.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 108.943 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.65 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.4 m120 -59.08 -37.17 76.47 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -60.4 -41.48 98.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -62.03 -44.92 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.16 . . . . 0.0 109.128 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.3 m -67.8 -31.59 71.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.798 . . . . 0.0 109.53 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 m -56.88 -48.43 78.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.62 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -65.02 -40.48 94.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.417 -0.802 . . . . 0.0 109.487 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -60.74 -30.18 69.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.402 -0.811 . . . . 0.0 109.297 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.84 0.02 56.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . . . -64.95 150.0 48.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.418 -1.049 . . . . 0.0 109.423 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -57.6 -60.24 3.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -0.94 . . . . 0.0 109.947 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.6 p -144.9 161.74 38.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.997 . . . . 0.0 110.193 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.581 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -144.14 154.72 25.86 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.596 ' O ' ' N ' ' A' ' 49' ' ' TRP . 21.6 m-85 -139.8 156.34 46.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.171 -1.194 . . . . 0.0 109.456 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.21 124.75 44.51 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.066 -1.021 . . . . 0.0 109.188 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.565 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 26.0 mt-30 -116.28 179.03 4.11 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.6 pt -93.29 143.25 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.061 -1.024 . . . . 0.0 110.043 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD23 ' OG1' ' A' ' 43' ' ' THR . 36.0 tp -91.36 142.78 27.31 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.468 -0.77 . . . . 0.0 109.215 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -43.67 -31.76 1.86 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.503 ' OG1' HD23 ' A' ' 41' ' ' LEU . 21.6 p -87.23 167.51 14.05 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.41 -1.053 . . . . 0.0 108.87 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -54.35 -10.05 0.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 109.49 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 43' ' ' THR . . . -82.56 -173.23 49.01 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.421 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 2.9 m-20 -137.18 171.23 14.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.481 -1.011 . . . . 0.0 109.109 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -140.17 167.1 25.56 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.034 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -101.31 151.67 21.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.413 -1.051 . . . . 0.0 109.135 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.596 ' N ' ' O ' ' A' ' 37' ' ' TYR . 13.6 t-105 -115.57 137.35 52.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.469 -0.77 . . . . 0.0 109.329 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.421 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -130.31 133.63 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.369 -0.832 . . . . 0.0 109.153 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.415 HD11 ' CE2' ' A' ' 37' ' ' TYR . 3.4 mt -115.81 121.16 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.804 . . . . 0.0 109.691 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 1' ' ' ALA . . . -169.98 158.64 7.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.37 75.52 73.98 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 0.0 109.777 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.08 -65.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.743 2.295 . . . . 0.0 111.838 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -154.99 -71.02 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.558 -0.714 . . . . 0.0 109.148 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 56' ' ' ASN . 6.4 p30 -173.39 29.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.355 -0.84 . . . . 0.0 109.564 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.5 t -126.98 77.7 74.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 109.866 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.73 -65.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.668 2.245 . . . . 0.0 112.099 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 61' ' ' ILE . 29.3 mm -113.89 130.0 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -105.69 1.6 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.723 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.452 ' H ' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -130.63 154.43 81.73 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.716 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -72.83 23.91 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.701 2.267 . . . . 0.0 112.073 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.57 10.29 56.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -73.8 136.25 43.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.413 -1.051 . . . . 0.0 109.104 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' HIS . 72.7 m -116.72 159.29 22.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.577 -0.702 . . . . 0.0 109.382 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' CYS . 83.7 t60 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.54 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.81 ' HE ' ' HE1' ' A' ' 49' ' ' TRP . 76.8 ttt180 -128.26 133.67 48.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.44 -0.787 . . . . 0.0 109.571 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -95.67 140.38 30.57 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.558 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -99.83 -79.74 0.49 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -0.91 . . . . 0.0 109.696 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -106.67 15.11 26.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.783 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 12' ' ' CYS . 21.9 pt -118.57 156.44 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.354 -0.841 . . . . 0.0 109.778 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HB1' HG11 ' A' ' 27' ' ' VAL . . . -99.03 -18.57 17.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 109.11 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.474 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -137.25 154.99 76.03 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.372 -0.83 . . . . 0.0 109.179 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.38 -29.93 30.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.66 2.24 . . . . 0.0 112.679 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -94.67 -23.68 17.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.133 -0.979 . . . . 0.0 110.295 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -140.72 -179.54 6.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.04 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.528 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 24.6 p -140.07 -177.79 5.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.51 -0.744 . . . . 0.0 109.232 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.43 HG11 ' HA ' ' A' ' 16' ' ' CYS . 45.7 t -107.33 131.87 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.425 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 28.1 p90 -73.68 -34.59 64.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.144 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.425 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 43.8 tp10 -151.19 89.38 1.51 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.44 -0.787 . . . . 0.0 108.89 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.565 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -59.21 109.49 0.87 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 109.353 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 1.8 t80 -63.15 165.19 7.5 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.368 -0.833 . . . . 0.0 108.943 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.602 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 60.3 t0 -43.54 106.39 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 109.298 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.36 -5.11 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -50.79 -43.61 58.67 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.163 -0.961 . . . . 0.0 109.186 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.7 m -62.7 -50.63 70.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.192 -0.943 . . . . 0.0 109.446 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.6 t 151.49 12.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.35 -71.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.008 -1.058 . . . . 0.0 110.541 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.4 t -60.64 -51.29 70.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.163 -0.961 . . . . 0.0 109.148 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.478 HD22 ' N ' ' A' ' 25' ' ' ASN . 2.3 m120 -57.72 -36.01 71.44 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 108.666 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.34 -40.18 95.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.466 HG11 ' HB1' ' A' ' 7' ' ' ALA . 69.8 t -61.83 -48.02 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -1.173 . . . . 0.0 108.855 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.38 -22.57 62.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 m -64.07 -31.26 72.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.413 -0.804 . . . . 0.0 110.976 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 1.8 mptt -52.77 -35.12 55.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.004 -1.06 . . . . 0.0 110.159 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.45 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 31.7 t30 -56.92 -33.59 67.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.051 -1.03 . . . . 0.0 109.337 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.84 2.17 56.2 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.1 -26.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -1.036 . . . . 0.0 109.216 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.738 ' HG3' ' HB2' ' A' ' 52' ' ' ALA . 16.7 tttp -54.33 131.83 42.73 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.6 p -113.65 139.68 48.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.424 -0.798 . . . . 0.0 109.589 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.19 158.02 27.1 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.526 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -128.81 155.71 44.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.643 -0.916 . . . . 0.0 108.735 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 42.4 t -99.07 122.77 42.75 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.049 -1.032 . . . . 0.0 108.917 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.498 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 24.4 mt-30 -115.68 177.81 4.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.634 -0.666 . . . . 0.0 109.965 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.773 HG22 ' H ' ' A' ' 42' ' ' GLY . 64.4 mt -93.69 133.44 34.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.402 -0.811 . . . . 0.0 110.1 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.47 -27.35 68.92 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.617 0.722 . . . . 0.0 109.209 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.773 ' H ' HG22 ' A' ' 40' ' ' ILE . . . 106.29 -7.34 40.18 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.605 -2.198 . . . . 0.0 107.605 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 45' ' ' GLY . 12.8 p -127.79 172.44 10.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 43' ' ' THR . 23.8 p90 -46.48 -12.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.019 -1.051 . . . . 0.0 109.44 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -87.87 -176.92 47.98 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.556 ' ND2' ' SG ' ' A' ' 38' ' ' CYS . 61.8 t30 -140.2 164.54 29.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.531 -0.981 . . . . 0.0 108.889 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 157.82 25.66 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.46 -1.353 . . . . 0.0 110.545 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -107.39 153.45 22.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.488 -1.007 . . . . 0.0 109.354 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.81 ' HE1' ' HE ' ' A' ' 2' ' ' ARG . 5.6 t-105 -125.72 129.46 49.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.372 -0.83 . . . . 0.0 109.256 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.623 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 1.8 t -132.76 131.09 40.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.121 -0.987 . . . . 0.0 109.748 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mt -123.1 140.47 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.746 . . . . 0.0 110.499 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.738 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . . . -159.59 -28.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.711 . . . . 0.0 109.643 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 52' ' ' ALA . 3.0 mp -129.1 165.96 28.57 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 109.717 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.593 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 50.3 Cg_exo -49.72 -0.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.59 2.194 . . . . 0.0 112.705 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 12.5 t0 89.9 49.8 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.27 0.557 . . . . 0.0 109.785 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -103.53 131.87 50.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.304 -0.872 . . . . 0.0 108.996 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.821 HG12 ' HE ' ' A' ' 60' ' ' ARG . 83.0 t 52.92 67.69 3.63 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.088 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.65 -65.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.761 2.307 . . . . 0.0 112.471 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.3 mt -116.13 124.68 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.473 -0.767 . . . . 0.0 109.412 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.821 ' HE ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -120.44 -1.61 10.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.514 HG13 ' H ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -68.98 149.22 97.9 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.557 -0.714 . . . . 0.0 109.521 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.28 5.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.556 2.171 . . . . 0.0 112.139 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.514 ' H ' HG13 ' A' ' 61' ' ' ILE . . . 99.99 8.12 51.55 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -37.48 71.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.176 -1.19 . . . . 0.0 109.239 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -107.95 158.57 17.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.557 -0.714 . . . . 0.0 109.543 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.436 -179.912 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -136.9 159.4 41.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.589 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -101.35 149.52 23.95 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.291 -0.881 . . . . 0.0 109.129 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.637 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.34 -65.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.256 -0.903 . . . . 0.0 110.654 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.416 ' CD1' HD12 ' A' ' 41' ' ' LEU . 12.7 m-85 -100.45 -0.94 37.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 109.927 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.499 HG23 ' HA ' ' A' ' 12' ' ' CYS . 53.5 mt -111.71 133.83 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.935 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.729 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -105.97 -9.25 17.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.419 -0.801 . . . . 0.0 109.549 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.634 ' NZ ' ' CG1' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.09 166.35 12.04 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.502 -0.749 . . . . 0.0 109.246 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.74 -59.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.581 2.187 . . . . 0.0 112.433 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.63 ' NE2' ' NH1' ' A' ' 60' ' ' ARG . 78.4 m80 -102.95 -4.71 24.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.348 -0.845 . . . . 0.0 109.782 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -121.66 161.79 21.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.419 -0.801 . . . . 0.0 109.645 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.499 ' HA ' HG23 ' A' ' 6' ' ' ILE . 46.5 m -124.14 179.5 4.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.353 -0.842 . . . . 0.0 109.514 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 48' ' ' CYS . 51.7 t -98.87 134.18 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.312 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.3 p90 -70.27 -42.04 72.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.851 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 39.1 tp10 -174.68 99.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.097 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HB3' HD22 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -70.0 143.58 52.54 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.144 -0.973 . . . . 0.0 108.955 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.614 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -120.12 179.31 4.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.404 -0.81 . . . . 0.0 109.033 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.614 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 88.6 m-20 -44.7 128.35 6.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -0.968 . . . . 0.0 109.355 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 21' ' ' SER . . . -65.17 -36.24 83.59 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.202 -0.936 . . . . 0.0 109.759 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.564 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 66.9 t80 49.25 7.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.17 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 19' ' ' ALA . 1.2 t 173.3 -54.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.354 -0.842 . . . . 0.0 108.856 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER 160.98 45.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.621 -0.674 . . . . 0.0 109.202 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.427 ' O ' HG23 ' A' ' 27' ' ' VAL . 69.5 t80 -60.31 -51.85 67.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.999 -1.063 . . . . 0.0 109.716 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.9 t -70.35 -50.42 39.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.191 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.736 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -59.55 -38.73 81.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 109.296 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.87 -44.04 98.39 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.634 ' CG1' ' NZ ' ' A' ' 8' ' ' LYS . 76.9 t -60.56 -43.55 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -1.179 . . . . 0.0 109.542 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.446 ' SG ' ' CD ' ' A' ' 34' ' ' LYS . 3.6 t -65.07 -35.08 80.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.252 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 m -61.95 -39.16 91.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 110.557 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -56.98 -29.97 63.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.005 -1.059 . . . . 0.0 109.779 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.683 ' ND2' ' NZ ' ' A' ' 34' ' ' LYS . 13.9 t30 -53.59 -35.61 61.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.074 -1.016 . . . . 0.0 109.294 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 166.03 -42.76 0.27 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 174.52 -21.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.048 -1.266 . . . . 0.0 109.59 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.683 ' NZ ' ' ND2' ' A' ' 31' ' ' ASN . 13.3 ptpt -43.63 145.37 0.65 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.511 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 91.4 p -103.61 147.77 26.81 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.48 159.96 27.59 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.229 -1.463 . . . . 0.0 111.252 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 49' ' ' TRP . 37.3 m-85 -127.54 154.21 45.43 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.618 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 40.6 t -98.92 118.89 36.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.894 -1.128 . . . . 0.0 109.323 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.609 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 25.9 mt-30 -112.75 171.52 7.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.1 pt -93.25 134.17 31.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.063 -1.023 . . . . 0.0 110.042 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.463 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 41.3 tp -62.79 -28.15 69.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.637 -0.664 . . . . 0.0 109.211 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.75 -6.8 41.38 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 45' ' ' GLY . 20.3 p -127.02 172.62 10.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' THR . 24.6 p90 -44.65 -16.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.033 -1.042 . . . . 0.0 109.367 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -89.26 -178.2 45.75 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.618 ' ND2' ' SG ' ' A' ' 38' ' ' CYS . 7.4 t30 -140.65 168.1 20.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.527 -0.984 . . . . 0.0 108.853 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.4 150.38 21.56 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.473 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -99.99 145.33 28.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.41 -1.053 . . . . 0.0 108.986 179.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.637 ' CZ3' ' HB1' ' A' ' 4' ' ' ALA . 11.7 t-105 -111.25 127.89 55.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.392 -0.817 . . . . 0.0 109.408 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.4 m -124.31 134.24 53.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.273 -0.892 . . . . 0.0 109.616 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.699 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 5.2 mt -120.14 141.61 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.544 -0.722 . . . . 0.0 110.076 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 51' ' ' ILE . . . 90.89 65.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.566 0.698 . . . . 0.0 109.574 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.512 HD13 ' NZ ' ' A' ' 34' ' ' LYS . 40.2 tp -128.83 81.46 70.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.606 -0.684 . . . . 0.0 109.173 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.41 -21.29 29.24 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.643 2.229 . . . . 0.0 111.867 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -56.62 -34.3 67.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.72 45.64 5.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 57' ' ' VAL . 31.7 m -124.72 77.63 64.44 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.559 -0.713 . . . . 0.0 109.259 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HG2' ' H ' ' A' ' 59' ' ' ILE . 65.6 Cg_endo -79.83 -67.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.679 2.253 . . . . 0.0 112.223 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.411 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 70.4 mt -119.48 129.49 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.63 ' NH1' ' NE2' ' A' ' 10' ' ' HIS . 13.6 ptm180 -153.95 -33.17 0.11 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 108.99 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.529 HD12 ' N ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -75.92 156.43 84.36 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.607 -0.683 . . . . 0.0 109.419 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.82 -6.86 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.878 2.385 . . . . 0.0 112.227 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.52 11.92 46.22 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -56.17 -35.26 67.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.133 . . . . 0.0 109.467 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.8 p -68.07 151.26 47.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.466 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.792 ' N ' HD23 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -136.57 158.21 44.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.401 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 2.8 t0 -104.98 150.51 24.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.344 -0.847 . . . . 0.0 109.568 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.532 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -99.35 -76.67 0.54 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -108.02 3.49 24.09 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.196 -0.94 . . . . 0.0 109.845 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 8' ' ' LYS . 59.2 mt -111.3 138.38 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 110.161 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -110.93 12.68 22.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.455 -0.778 . . . . 0.0 109.421 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.738 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -127.87 155.3 77.73 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.482 -0.761 . . . . 0.0 109.231 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.31 -36.06 47.63 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.551 2.167 . . . . 0.0 112.56 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -138.07 -3.08 1.81 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.536 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.493 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 52.7 m-80 -114.25 167.95 10.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.485 -0.759 . . . . 0.0 109.357 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.703 ' HA ' HG23 ' A' ' 6' ' ' ILE . 62.3 m -118.61 177.06 4.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.412 -0.805 . . . . 0.0 109.828 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.08 135.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 109.086 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 28.2 p90 -66.89 -45.73 77.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.698 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.579 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 82.7 tt0 -175.95 97.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.057 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 144.46 56.54 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 108.589 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.698 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 2.5 p90 -120.67 -153.75 0.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.458 -0.776 . . . . 0.0 109.208 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.698 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.6 m-20 -57.53 141.8 46.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.978 -1.076 . . . . 0.0 109.473 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.89 9.23 3.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.354 -0.841 . . . . 0.0 109.864 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -49.88 -43.44 49.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.982 -1.074 . . . . 0.0 108.597 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.413 ' HG ' ' HE1' ' A' ' 17' ' ' PHE . 33.6 p -90.15 4.99 48.81 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.432 -0.792 . . . . 0.0 109.075 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' GLY . 83.3 p 51.82 33.43 11.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 109.351 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -59.25 -47.1 86.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -65.76 -57.5 7.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.422 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.674 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.3 m120 -60.86 -35.74 77.37 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.472 -0.768 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -58.27 -44.0 95.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.44 -44.36 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -1.118 . . . . 0.0 109.2 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 t -70.04 -31.13 68.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.486 -0.758 . . . . 0.0 109.326 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.5 m -61.57 -31.47 71.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 110.673 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.76 -27.14 4.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.984 -1.073 . . . . 0.0 109.885 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -54.82 -30.76 58.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.1 -1.0 . . . . 0.0 109.107 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 103.96 3.29 45.61 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 176.77 -25.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -1.192 . . . . 0.0 109.629 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -55.25 134.25 49.73 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -112.58 140.79 47.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.397 -0.814 . . . . 0.0 108.984 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.69 164.68 27.38 Favored Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.995 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' TRP . 32.7 m-85 -132.12 160.5 35.83 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.506 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 43.5 t -99.24 120.86 40.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.998 -1.064 . . . . 0.0 109.294 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.503 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 26.1 mt-30 -115.72 174.57 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 109.32 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.9 pt -99.15 155.42 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.898 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.634 HD12 ' HA3' ' A' ' 45' ' ' GLY . 72.8 mt -78.25 148.44 33.93 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.432 -0.792 . . . . 0.0 109.578 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.68 -35.93 39.17 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 47.7 p -96.07 -125.16 0.12 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.318 -1.107 . . . . 0.0 108.644 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -109.72 126.57 53.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 108.921 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.634 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 141.45 -173.87 23.21 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.599 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 54.6 t-20 -140.77 150.33 43.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -1.102 . . . . 0.0 109.559 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.599 ' N ' ' OD1' ' A' ' 46' ' ' ASN . . . -140.11 167.25 25.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.624 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 1.6 m -101.97 150.26 23.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.236 -1.155 . . . . 0.0 109.621 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.532 ' CE3' ' O ' ' A' ' 4' ' ' ALA . 16.8 t-105 -120.92 121.22 37.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 109.161 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.8 m -117.74 130.38 56.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.324 -0.86 . . . . 0.0 109.682 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 20.2 mt -127.76 145.56 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.417 -0.802 . . . . 0.0 110.545 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' ILE . . . 176.19 -22.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.792 HD23 ' N ' ' A' ' 1' ' ' ALA . 13.2 tp -153.02 133.15 7.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 108.916 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -38.08 158.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.205 1.937 . . . . 0.0 112.225 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 61.1 t0 -79.0 116.34 19.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 110.063 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.481 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 82.0 m-20 -147.86 -47.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.568 ' H ' ' HB2' ' A' ' 1' ' ' ALA . 21.6 t -129.74 72.2 81.99 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.76 -100.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.829 2.353 . . . . 0.0 112.527 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -127.28 125.99 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.349 -0.844 . . . . 0.0 109.417 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -61.58 -34.18 75.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.303 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 63' ' ' GLY . 4.0 mt -62.63 136.73 96.26 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.425 -0.797 . . . . 0.0 108.967 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.78 -1.71 2.91 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.004 1.803 . . . . 0.0 112.483 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.515 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 95.62 11.4 55.47 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.603 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 11.9 pttp -58.62 -32.47 69.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -1.12 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 61.3 m 56.43 -0.61 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.277 -0.889 . . . . 0.0 109.913 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.603 ' ND1' ' O ' ' A' ' 64' ' ' LYS . 72.4 m80 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.417 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.403 ' HA ' ' N ' ' A' ' 54' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.306 0.574 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.0 ptt-85 -137.6 167.45 21.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.378 -0.826 . . . . 0.0 109.511 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 83.7 m-20 -94.35 147.13 23.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 108.691 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -109.93 -83.25 0.56 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.371 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -99.23 6.24 46.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.008 -1.057 . . . . 0.0 109.629 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.645 HG22 ' SG ' ' A' ' 12' ' ' CYS . 42.1 pt -117.16 159.17 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.637 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . . . -123.39 -20.29 5.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.21 161.27 50.71 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.62 -66.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.43 2.087 . . . . 0.0 112.91 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.534 ' C ' ' ND2' ' A' ' 11' ' ' ASN . 67.6 m-70 -56.81 -39.44 74.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 110.436 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.684 HD22 ' N ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -134.51 173.72 11.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 0.0 110.096 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.645 ' SG ' HG22 ' A' ' 6' ' ' ILE . 12.2 m -108.24 171.24 7.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.185 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.547 HG11 HD22 ' A' ' 46' ' ' ASN . 1.5 p -49.09 135.24 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.037 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.664 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 19.5 p90 -69.64 -50.43 44.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.051 -1.031 . . . . 0.0 109.345 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.664 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 48.8 tp10 -177.38 91.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.2 t -54.12 97.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 108.926 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 19.3 p90 -76.67 -46.17 26.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 109.689 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 52.9 t0 -145.4 101.01 3.54 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.312 -0.868 . . . . 0.0 109.096 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.72 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . . . -60.63 -24.43 65.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.214 -0.929 . . . . 0.0 109.049 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -52.16 -42.22 63.24 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.434 ' C ' ' OG ' ' A' ' 22' ' ' SER . 84.0 p -66.04 -16.17 63.68 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER 72.48 39.25 0.74 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.618 -0.676 . . . . 0.0 110.029 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' HG23 ' A' ' 27' ' ' VAL . 61.6 t80 -60.63 -60.51 3.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.978 -1.076 . . . . 0.0 109.06 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' HB2' ' A' ' 7' ' ' ALA . 8.1 t -70.58 -48.65 54.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.352 -0.843 . . . . 0.0 108.75 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.536 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.9 m120 -57.82 -38.93 76.46 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.8 -39.59 97.67 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 23' ' ' TYR . 78.8 t -62.2 -41.52 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.354 -1.086 . . . . 0.0 109.531 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.3 m -61.04 -41.2 96.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.523 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 m -58.22 -51.26 70.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.14 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -67.79 -39.45 84.03 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.54 -0.725 . . . . 0.0 109.125 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.596 ' CG ' HD21 ' A' ' 56' ' ' ASN . 42.0 t-20 -59.29 -31.13 68.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.553 -0.717 . . . . 0.0 109.275 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.27 -0.06 50.63 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.61 149.5 48.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -1.059 . . . . 0.0 109.221 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -58.0 -49.15 77.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 110.245 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.572 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 49.5 m -143.57 162.81 34.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.037 . . . . 0.0 110.198 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -142.72 126.83 2.98 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.543 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 87.2 m-85 -126.11 135.54 51.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.448 -1.03 . . . . 0.0 109.547 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -110.6 129.94 55.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 0.0 109.888 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.69 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -134.1 168.34 19.0 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.0 pt -98.81 133.43 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.974 . . . . 0.0 109.588 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.535 HD23 ' OG1' ' A' ' 43' ' ' THR . 30.2 tp -64.24 -30.59 71.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 109.36 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.95 -4.5 49.43 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.535 ' OG1' HD23 ' A' ' 41' ' ' LEU . 18.3 p -126.57 173.72 9.22 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 43' ' ' THR . 26.8 p90 -44.07 -21.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.441 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -87.23 -174.25 48.74 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.547 HD22 HG11 ' A' ' 13' ' ' VAL . 13.0 t30 -137.98 169.83 17.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -1.008 . . . . 0.0 108.911 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' GLN . . . -140.55 125.93 3.01 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.447 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 42.7 t -136.28 128.91 30.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -1.092 . . . . 0.0 108.674 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.69 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 4.1 p90 -113.95 141.29 47.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 109.857 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 35' ' ' SER . 6.0 t -124.72 153.62 42.09 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.1 mm -109.22 126.83 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 109.074 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.9 ' C ' HD23 ' A' ' 53' ' ' LEU . . . -173.09 -130.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.978 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.9 HD23 ' C ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -127.4 166.4 23.27 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.364 -0.835 . . . . 0.0 109.9 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' N ' ' HA ' ' A' ' 1' ' ' ALA . 28.1 Cg_endo -67.84 -34.31 24.4 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.466 2.111 . . . . 0.0 112.244 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -56.41 -33.49 65.86 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.596 HD21 ' CG ' ' A' ' 31' ' ' ASN . 46.2 t-20 -96.75 120.13 36.52 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.554 -0.716 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.465 HG23 ' OD1' ' A' ' 56' ' ' ASN . 5.2 t 57.4 65.87 3.32 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.717 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.69 15.03 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.146 2.564 . . . . 0.0 112.425 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 59' ' ' ILE . 62.9 mt 55.25 52.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.391 -0.818 . . . . 0.0 109.333 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.422 HH11 ' HB3' ' A' ' 60' ' ' ARG . 6.1 ptm85 -61.61 -39.22 90.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.507 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -74.75 154.12 87.2 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.462 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.73 -11.12 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.663 2.242 . . . . 0.0 111.929 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.95 3.82 57.93 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 66' ' ' HIS . 34.2 ttpt -57.8 -36.95 72.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -1.102 . . . . 0.0 109.42 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 84.9 m 54.8 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.819 . . . . 0.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.586 ' N ' ' O ' ' A' ' 64' ' ' LYS . 83.3 t60 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.516 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -127.06 136.77 52.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.811 . . . . 0.0 109.809 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -95.92 144.16 26.48 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.242 -0.911 . . . . 0.0 109.038 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -108.25 -83.55 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 110.212 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -99.54 12.92 35.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.676 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 pt -126.67 165.98 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 110.011 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.757 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -120.79 -0.81 10.07 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.11 168.72 8.88 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB2' HH11 ' A' ' 60' ' ' ARG . 70.2 Cg_endo -80.25 -59.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.537 2.158 . . . . 0.0 112.447 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -104.94 -3.74 22.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.964 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -116.88 175.46 5.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.394 -0.816 . . . . 0.0 109.804 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.2 p -128.66 -179.64 5.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.408 -0.807 . . . . 0.0 109.86 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.88 136.52 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.546 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.7 p90 -65.48 -40.54 93.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 83.8 tt0 -175.32 98.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HB3' HD22 ' A' ' 46' ' ' ASN . 10.7 t -68.99 141.7 54.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.035 -1.04 . . . . 0.0 108.524 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.71 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 2.0 p90 -119.3 -154.3 0.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.366 -0.833 . . . . 0.0 109.599 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.71 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 88.4 m-20 -59.68 143.42 50.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.004 . . . . 0.0 109.532 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.62 9.63 7.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.882 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -51.7 -42.92 62.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.04 -1.037 . . . . 0.0 108.535 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.501 ' O ' ' OG ' ' A' ' 22' ' ' SER . 60.1 p -86.49 6.04 32.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.36 -0.837 . . . . 0.0 108.815 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 26' ' ' GLY . 10.5 p 50.19 36.02 11.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.684 . . . . 0.0 109.796 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -61.55 -51.73 67.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.099 -1.001 . . . . 0.0 109.439 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.458 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 29.3 t -68.37 -56.24 9.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 108.871 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.679 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.2 m120 -58.43 -34.88 71.29 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -57.2 -42.88 93.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.93 -47.58 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.241 -1.152 . . . . 0.0 108.628 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 95.2 m -70.37 -24.73 63.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 109.3 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 25' ' ' ASN . 62.5 m -61.89 -31.12 71.38 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.418 -0.801 . . . . 0.0 110.95 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.47 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 1.8 mptt -52.52 -33.56 45.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.0 110.066 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 35.3 t30 -56.68 -34.01 66.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 109.404 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.44 4.71 56.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.92 -26.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -1.094 . . . . 0.0 109.29 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.712 ' HG3' ' HB2' ' A' ' 52' ' ' ALA . 24.6 tttt -51.29 135.22 26.91 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -117.66 139.98 50.28 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.507 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.13 156.46 26.49 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.858 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' TRP . 41.9 m-85 -130.6 153.41 48.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.621 -0.929 . . . . 0.0 108.787 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -99.41 125.66 45.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.972 -1.08 . . . . 0.0 109.64 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.588 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 96.3 mt-30 -111.11 -162.05 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.599 -0.688 . . . . 0.0 109.315 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.0 pt -114.65 157.45 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -0.753 . . . . 0.0 109.807 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 ' HA3' ' A' ' 45' ' ' GLY . 63.8 mt -86.62 146.39 26.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.306 -0.871 . . . . 0.0 109.498 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.77 -33.16 34.48 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.5 p -97.57 -124.12 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.431 -1.04 . . . . 0.0 108.94 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -111.73 132.18 54.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 109.117 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 133.31 -163.96 24.29 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 39' ' ' GLN . 2.3 t30 -140.29 165.72 26.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.222 -1.164 . . . . 0.0 109.386 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.57 162.08 26.17 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.757 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -107.59 135.69 48.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.401 -1.058 . . . . 0.0 109.512 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CE3' ' OE1' ' A' ' 39' ' ' GLN . 11.4 t-105 -112.18 121.95 46.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.382 -0.824 . . . . 0.0 109.14 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.66 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 1.8 t -125.8 129.92 50.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.222 -0.923 . . . . 0.0 109.523 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mt -121.09 138.64 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.53 -0.731 . . . . 0.0 110.62 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . . . -170.96 -52.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.526 -0.734 . . . . 0.0 109.534 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.6 tp -127.48 78.76 74.32 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.549 -0.719 . . . . 0.0 109.931 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' ASP . 32.3 Cg_exo -54.03 171.03 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.937 2.425 . . . . 0.0 112.321 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' PRO . 49.4 t0 59.88 146.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 64.08 48.34 3.04 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.312 -0.868 . . . . 0.0 109.142 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.542 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -107.63 103.23 48.34 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HG2' ' NE ' ' A' ' 60' ' ' ARG . 63.9 Cg_endo -91.31 130.66 1.34 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.626 2.217 . . . . 0.0 110.892 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.622 HG22 ' H ' ' A' ' 61' ' ' ILE . 3.3 mt -64.38 -32.55 58.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.114 -0.991 . . . . 0.0 110.506 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.423 HH11 ' HB2' ' A' ' 9' ' ' PRO . 97.8 mtt180 55.24 1.53 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.306 -0.871 . . . . 0.0 109.14 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 61' ' ' ILE . 5.1 mt -130.61 81.05 68.75 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.494 -0.754 . . . . 0.0 109.672 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.11 54.04 4.58 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.916 2.411 . . . . 0.0 111.944 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.77 0.09 75.82 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.81 -40.59 84.56 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.705 -0.879 . . . . 0.0 109.785 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.9 t -59.85 -32.72 70.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.476 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -127.7 138.56 52.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.177 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.523 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 79.3 m-20 -99.32 148.59 24.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.012 -1.055 . . . . 0.0 109.396 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.81 -82.88 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 110.473 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -99.03 5.84 46.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.631 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 48' ' ' CYS . 33.5 pt -117.34 161.46 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 110.34 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.445 ' O ' HG11 ' A' ' 27' ' ' VAL . . . -116.03 -5.79 11.96 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.423 ' HD3' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -108.57 156.0 39.52 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.51 -51.5 0.53 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.47 2.114 . . . . 0.0 112.598 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -114.88 1.76 14.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.145 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -125.72 170.4 11.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 109.925 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.8 m -110.23 178.1 4.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.442 -0.787 . . . . 0.0 109.319 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.423 HG22 ' HD3' ' A' ' 8' ' ' LYS . 40.6 t -101.11 126.85 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.612 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 26.9 p90 -74.75 -32.51 62.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.096 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 78.7 tt0 -172.15 98.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.452 -0.78 . . . . 0.0 108.99 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.3 t -73.46 108.35 6.27 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.014 -1.054 . . . . 0.0 109.004 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.788 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.32 148.06 2.06 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.6 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 59.6 t0 -73.43 116.79 14.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.96 . . . . 0.0 110.516 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.788 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -140.52 147.97 40.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.809 . . . . 0.0 109.138 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -58.57 -44.67 89.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.012 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 t 172.93 73.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.42 -0.8 . . . . 0.0 109.244 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 p -152.94 -50.47 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.113 -0.992 . . . . 0.0 110.087 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -58.16 -51.84 68.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.976 -1.078 . . . . 0.0 109.848 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -66.29 -44.35 83.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.148 -0.97 . . . . 0.0 108.757 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.699 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.1 m120 -58.44 -37.38 75.3 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.48 -42.03 98.89 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 7' ' ' ALA . 70.9 t -63.67 -43.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -1.116 . . . . 0.0 109.148 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 59.0 m -63.93 -30.03 71.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.396 -0.815 . . . . 0.0 109.394 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.4 m -57.82 -42.61 84.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -61.91 -45.39 93.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -0.954 . . . . 0.0 108.894 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.28 -29.31 69.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.445 -0.785 . . . . 0.0 109.323 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.22 7.6 55.93 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' A' ' 52' ' ' ALA . . . -69.85 175.41 4.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -1.014 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -78.62 -77.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.026 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.7 p -143.76 166.7 24.15 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -142.58 154.56 25.26 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.568 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 57.9 m-85 -122.27 133.95 54.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.357 -1.084 . . . . 0.0 109.552 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.649 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 1.1 m -99.81 121.54 41.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.367 -0.833 . . . . 0.0 109.191 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -141.07 -136.54 0.11 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.091 -1.006 . . . . 0.0 109.623 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 42' ' ' GLY . 64.1 mt -95.81 139.66 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.2 tp -55.99 -37.13 68.68 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.581 ' H ' HG22 ' A' ' 40' ' ' ILE . . . 158.46 -69.0 0.27 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.4 p -105.66 -63.44 1.25 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -126.84 148.72 49.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.79 -178.86 39.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -122.72 150.94 42.08 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.483 -1.01 . . . . 0.0 109.667 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.92 162.59 26.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.649 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 4.2 t -140.2 135.94 32.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -1.087 . . . . 0.0 109.754 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.18 133.9 51.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.219 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.523 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 12.2 t -99.92 125.51 45.93 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.9 mm -99.46 131.46 46.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 109.48 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . . . -170.56 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.045 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD21 ' ND2' ' A' ' 56' ' ' ASN . 0.7 OUTLIER -120.84 94.71 48.98 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.383 -0.823 . . . . 0.0 110.305 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.12 -8.95 17.81 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.183 1.922 . . . . 0.0 112.101 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -56.34 -35.81 68.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.324 -0.86 . . . . 0.0 109.935 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 57' ' ' VAL . 3.4 m120 -78.96 142.35 36.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.93 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.772 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.2 p -39.72 102.38 0.26 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.629 -0.669 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 59' ' ' ILE . 50.1 Cg_endo -90.61 159.35 4.31 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.714 2.276 . . . . 0.0 111.888 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 59' ' ' ILE . 86.0 mt 39.75 60.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.372 -0.83 . . . . 0.0 110.209 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -51.51 -34.55 36.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.701 HG22 ' H ' ' A' ' 63' ' ' GLY . 1.4 mp -61.04 130.64 91.47 Favored Pre-proline 0 C--N 1.301 -1.53 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.677 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.29 -25.33 6.97 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.862 1.708 . . . . 0.0 111.949 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.701 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 138.41 3.66 1.82 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -106.28 129.62 54.28 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.319 -1.107 . . . . 0.0 109.025 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.516 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 86.3 m -58.6 -28.34 65.51 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.569 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.516 ' CG ' ' O ' ' A' ' 65' ' ' CYS . 98.0 m-70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.482 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.491 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -138.24 169.23 18.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -94.14 142.57 27.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 108.42 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -106.07 -84.45 0.51 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 111.101 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -98.89 -19.21 17.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.055 . . . . 0.0 110.402 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.529 HG22 ' H ' ' A' ' 8' ' ' LYS . 63.5 mt -106.24 132.87 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.323 -0.861 . . . . 0.0 110.15 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.59 17.74 12.81 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.529 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -124.09 155.32 67.84 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.16 -35.91 61.21 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.483 2.122 . . . . 0.0 112.27 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.557 ' CE1' HH11 ' A' ' 60' ' ' ARG . 74.4 m80 -141.8 -3.97 1.1 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.139 -0.976 . . . . 0.0 109.453 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.489 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 59.1 m-80 -109.5 172.33 6.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 109.428 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HA ' HG23 ' A' ' 6' ' ' ILE . 5.4 m -122.2 177.26 5.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.629 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 48' ' ' CYS . 47.1 t -101.05 138.05 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.032 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.29 -61.26 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.456 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -173.89 98.72 0.11 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.414 -0.804 . . . . 0.0 109.121 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 29.7 p -50.62 103.24 0.05 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.253 -0.905 . . . . 0.0 108.906 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.506 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 23.7 p90 -59.91 -39.77 86.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.445 -0.785 . . . . 0.0 110.033 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.506 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 57.6 t0 -143.55 91.54 2.26 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.243 -0.91 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.64 -25.0 67.9 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.245 -0.91 . . . . 0.0 109.046 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -53.76 -38.45 64.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 108.81 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.6 m -77.57 7.71 5.23 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 26' ' ' GLY . 12.7 p 60.76 36.37 19.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.565 -0.709 . . . . 0.0 110.045 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -61.89 -54.99 34.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.957 -1.09 . . . . 0.0 108.863 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.31 -52.31 23.76 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.715 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.1 m120 -58.37 -36.74 73.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -60.29 -42.77 98.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.503 HG21 ' HZ2' ' A' ' 8' ' ' LYS . 58.1 t -61.07 -46.94 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -1.157 . . . . 0.0 109.518 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 3.5 m -70.23 -33.34 71.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.272 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.4 m -57.32 -50.5 72.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.431 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -65.71 -37.87 87.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.414 -0.804 . . . . 0.0 109.337 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 27' ' ' VAL . 24.4 m120 -58.96 -25.47 63.57 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.42 44.05 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 28' ' ' CYS . . . -64.17 145.68 55.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.445 -1.033 . . . . 0.0 109.248 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.534 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 2.7 ttmt -59.37 -51.96 67.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 0.0 109.792 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.421 ' HG ' ' HE2' ' A' ' 37' ' ' TYR . 83.4 p -144.35 166.89 23.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.189 -0.945 . . . . 0.0 110.201 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.582 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.38 135.17 6.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.421 ' HE2' ' HG ' ' A' ' 35' ' ' SER . 91.6 m-85 -128.46 136.92 51.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -1.08 . . . . 0.0 109.573 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.9 t -109.0 128.62 55.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.462 -0.774 . . . . 0.0 109.585 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.612 ' NE2' ' CH2' ' A' ' 49' ' ' TRP . 0.3 OUTLIER -134.56 171.55 14.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.446 -0.784 . . . . 0.0 109.116 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.9 pt -98.13 134.62 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.13 -0.981 . . . . 0.0 109.503 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 45' ' ' GLY . 24.2 tp -130.1 125.21 34.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.651 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.23 -27.58 73.08 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.448 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 42.6 m -59.37 -46.55 88.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.029 -1.277 . . . . 0.0 110.039 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -125.64 16.3 8.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.447 -0.783 . . . . 0.0 109.156 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 41' ' ' LEU . . . 83.9 -56.85 5.05 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -140.77 146.05 37.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -1.131 . . . . 0.0 109.642 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.27 132.23 5.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.704 ' HB2' HG21 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -111.25 126.62 55.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.388 -1.066 . . . . 0.0 109.28 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.612 ' CH2' ' NE2' ' A' ' 39' ' ' GLN . 4.7 p90 -118.36 138.86 52.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.868 . . . . 0.0 109.125 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.3 m -126.1 156.15 40.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mm -110.11 122.89 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.422 -0.799 . . . . 0.0 109.296 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -179.57 -145.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.491 HD12 ' HB1' ' A' ' 1' ' ' ALA . 9.5 tp -133.1 78.99 63.58 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.552 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -87.64 22.31 0.92 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.35 2.7 . . . . 0.0 112.057 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -52.45 -35.55 52.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.574 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -56.39 -35.35 67.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.791 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.5 p -131.06 77.9 74.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.359 -0.838 . . . . 0.0 109.585 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 59' ' ' ILE . 73.7 Cg_endo -95.27 87.98 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 123.596 2.864 . . . . 0.0 112.287 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' PRO . 45.8 mt 43.31 55.66 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.031 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.557 HH11 ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -59.72 -41.0 89.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.135 -0.978 . . . . 0.0 109.891 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.618 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -62.96 149.72 89.68 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -46.0 -23.59 1.86 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.174 1.916 . . . . 0.0 112.05 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.476 ' H ' HG12 ' A' ' 61' ' ' ILE . . . 138.04 2.93 2.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -93.39 145.97 24.09 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.282 -1.128 . . . . 0.0 109.283 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 66' ' ' HIS . 8.6 t -58.01 -47.19 83.79 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 65' ' ' CYS . 61.8 t60 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.65 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.534 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -136.7 161.81 34.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.293 -0.88 . . . . 0.0 109.409 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -95.1 143.41 26.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.16 -0.962 . . . . 0.0 109.108 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.486 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.79 -65.0 0.99 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.164 -0.96 . . . . 0.0 110.445 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 2.6 m-85 -109.15 0.9 20.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.514 HD11 ' HA2' ' A' ' 63' ' ' GLY . 70.3 mt -106.68 142.04 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 110.433 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.743 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -129.07 -22.7 3.13 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -103.99 157.01 34.87 Favored Pre-proline 0 N--CA 1.487 1.419 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 8' ' ' LYS . 43.9 Cg_exo -34.02 -110.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.444 2.763 . . . . 0.0 113.376 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -85.49 -2.78 58.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.768 -1.208 . . . . 0.0 109.308 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -100.28 151.48 21.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.331 -0.855 . . . . 0.0 109.466 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.67 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 57.2 m -108.27 166.18 10.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.526 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.97 133.04 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.165 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 32.3 p90 -60.71 -41.44 95.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.583 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 82.4 tt0 -175.24 93.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.279 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' ' O ' ' A' ' 47' ' ' GLY . 19.5 p -68.58 134.54 50.13 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.059 -1.026 . . . . 0.0 108.576 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.692 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 2.6 p90 -109.67 -152.55 0.5 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.426 -0.796 . . . . 0.0 109.299 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.692 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.2 m-20 -57.6 139.24 54.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.044 -1.035 . . . . 0.0 109.192 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.36 9.05 3.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.381 -0.825 . . . . 0.0 109.827 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -51.96 -42.91 63.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 0.0 108.896 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.6 m -84.69 7.12 21.52 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.339 -0.85 . . . . 0.0 108.907 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 26' ' ' GLY . 70.5 m 54.38 27.12 7.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.406 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -60.18 -52.81 63.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.1 t -66.39 -51.83 53.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 0.0 108.835 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.72 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -58.65 -36.25 73.81 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.534 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . . . -57.07 -43.42 93.28 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.13 -47.11 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -1.205 . . . . 0.0 109.09 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.7 m -70.49 -24.76 62.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.635 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 25' ' ' ASN . 67.6 m -63.16 -30.39 71.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.232 -0.918 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' NZ ' ' O ' ' A' ' 26' ' ' GLY . 12.7 mptt -51.94 -33.39 37.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.921 -1.112 . . . . 0.0 110.112 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.426 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 29.8 t30 -56.48 -33.67 66.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.04 -1.038 . . . . 0.0 109.349 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.26 2.63 54.19 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.02 -26.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.358 -1.084 . . . . 0.0 109.132 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.631 ' CE ' ' SG ' ' A' ' 50' ' ' CYS . 15.7 tttp -52.67 137.88 29.98 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.6 m -118.23 135.15 54.44 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.143 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.535 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -144.4 162.12 27.93 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.275 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.45 ' HA ' HD21 ' A' ' 25' ' ' ASN . 33.1 p90 -140.65 169.87 16.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -1.078 . . . . 0.0 109.062 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 11.7 t -99.06 124.43 44.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.949 -1.095 . . . . 0.0 110.959 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -119.87 -139.88 0.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 40' ' ' ILE . 30.3 pt -110.96 142.86 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 109.699 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.0 tp -58.73 -37.28 75.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.198 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.84 -59.33 0.62 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.65 -70.63 0.76 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.463 -1.022 . . . . 0.0 108.806 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -128.4 148.94 50.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.575 -0.703 . . . . 0.0 109.223 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.2 -168.23 35.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 16' ' ' CYS . 24.9 m120 -120.93 165.26 15.48 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.47 -1.018 . . . . 0.0 109.608 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -134.94 151.49 20.45 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.743 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -99.53 140.56 33.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -1.17 . . . . 0.0 109.755 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.486 ' CZ3' ' HB1' ' A' ' 4' ' ' ALA . 8.9 t-105 -113.45 128.19 56.36 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.631 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -126.09 135.8 52.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 109.036 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.625 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 4.5 mt -117.16 136.51 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.36 -0.837 . . . . 0.0 111.101 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 51' ' ' ILE . . . 162.17 168.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.534 HD12 ' HB1' ' A' ' 1' ' ' ALA . 3.3 tp -129.24 73.97 81.33 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 109.674 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 50.3 Cg_exo -49.73 -174.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.643 2.229 . . . . 0.0 111.341 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 56' ' ' ASN . 92.2 m-20 -52.1 -39.06 59.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.972 -1.08 . . . . 0.0 108.801 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 55' ' ' ASP . 0.8 OUTLIER 159.97 -174.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 109.19 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.835 HG12 ' HE ' ' A' ' 60' ' ' ARG . 8.3 t 57.15 68.59 1.99 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.76 -65.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.683 2.255 . . . . 0.0 112.038 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.5 mt -117.29 125.84 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.523 -0.736 . . . . 0.0 109.103 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.835 ' HE ' HG12 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -113.83 1.68 14.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.485 -0.76 . . . . 0.0 109.193 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -132.11 155.18 81.64 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.367 -0.833 . . . . 0.0 109.416 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.4 -0.43 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.585 2.19 . . . . 0.0 111.685 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.514 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 102.42 -1.42 49.94 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -85.21 130.45 34.6 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.28 -1.129 . . . . 0.0 109.479 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.67 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 2.5 m -115.03 158.98 21.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.431 -0.793 . . . . 0.0 109.471 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.424 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 58.3 t-80 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.609 ' H2 ' ' HB2' ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.805 HH21 ' HE1' ' A' ' 49' ' ' TRP . 76.1 ttt180 -126.52 132.32 51.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.386 -0.821 . . . . 0.0 109.563 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.447 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 75.8 m-20 -100.17 143.96 29.76 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -106.32 -83.94 0.52 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.462 -0.774 . . . . 0.0 109.266 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.536 ' CE1' HD11 ' A' ' 41' ' ' LEU . 9.7 m-85 -99.78 -29.83 12.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.533 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.698 HG23 ' HA ' ' A' ' 12' ' ' CYS . 69.9 mt -102.01 138.12 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.521 -0.737 . . . . 0.0 109.665 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -117.0 20.72 13.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.443 -0.786 . . . . 0.0 110.398 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.621 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -126.35 153.13 74.74 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.083 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.409 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 11.3 Cg_endo -57.84 -29.35 85.84 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.533 2.156 . . . . 0.0 112.272 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 9' ' ' PRO . 88.5 m-70 -151.65 -6.8 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.199 -0.938 . . . . 0.0 109.316 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.488 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 56.8 m-80 -105.63 171.16 7.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.779 . . . . 0.0 109.413 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.698 ' HA ' HG23 ' A' ' 6' ' ' ILE . 73.9 m -120.85 177.08 5.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.446 -0.784 . . . . 0.0 109.466 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.54 133.51 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.968 . . . . 0.0 109.402 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -48.68 78.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.376 -0.827 . . . . 0.0 109.317 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' CYS . 11.6 pt-20 177.14 80.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 109.23 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -44.75 156.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.067 -1.021 . . . . 0.0 109.122 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.718 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 3.2 p90 -132.56 -149.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.887 . . . . 0.0 109.331 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.718 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 59.3 t0 -57.41 132.6 53.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.128 -0.983 . . . . 0.0 109.654 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 22' ' ' SER . . . -74.98 4.48 6.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.427 -0.796 . . . . 0.0 109.918 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -49.82 -42.75 47.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.066 -1.022 . . . . 0.0 108.859 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.422 ' C ' ' OG ' ' A' ' 22' ' ' SER . 82.6 p -82.35 -5.48 58.63 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 0.0 109.095 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 63.29 34.36 13.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 109.577 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 27' ' ' VAL . 63.6 t80 -58.95 -48.65 80.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.999 -1.063 . . . . 0.0 109.872 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.16 -52.95 28.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 109.031 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.709 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.1 m120 -58.49 -37.64 75.98 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.328 -0.857 . . . . 0.0 108.794 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.53 93.84 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 23' ' ' TYR . 71.1 t -61.82 -42.31 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.353 -1.087 . . . . 0.0 108.798 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 65.0 m -61.66 -32.96 73.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.818 . . . . 0.0 109.372 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.3 m -57.4 -45.73 84.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 109.476 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -64.54 -43.47 93.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 108.81 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.77 -28.96 70.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.558 -0.713 . . . . 0.0 109.153 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.46 -0.87 53.35 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 28' ' ' CYS . . . -67.39 148.4 51.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.38 -1.071 . . . . 0.0 109.263 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -64.82 -60.34 3.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.063 -1.023 . . . . 0.0 110.284 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.2 p -144.21 160.91 40.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.873 -1.142 . . . . 0.0 110.567 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.71 156.17 26.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 49' ' ' TRP . 17.6 m-85 -123.65 146.21 48.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -1.102 . . . . 0.0 109.472 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 37.8 t -99.89 121.63 41.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.19 -0.944 . . . . 0.0 109.076 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -118.38 165.55 13.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.471 -0.768 . . . . 0.0 109.446 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.583 ' C ' HD22 ' A' ' 41' ' ' LEU . 36.8 pt -103.45 144.01 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 110.117 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.583 HD22 ' C ' ' A' ' 40' ' ' ILE . 4.2 mm? -107.08 139.91 40.75 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.67 -0.644 . . . . 0.0 109.508 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.8 -28.62 52.95 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 44' ' ' TYR . 45.8 p -94.82 -72.88 0.6 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -1.167 . . . . 0.0 110.649 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.448 ' N ' ' OG1' ' A' ' 43' ' ' THR . 91.7 m-85 -61.82 -39.28 91.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 110.155 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.91 -34.93 4.84 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.79 -1.195 . . . . 0.0 110.174 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.33 129.64 31.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -1.229 . . . . 0.0 110.293 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 160.14 26.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -111.26 135.23 52.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.378 -1.072 . . . . 0.0 109.831 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.805 ' HE1' HH21 ' A' ' 2' ' ' ARG . 4.7 t-105 -113.33 111.66 22.37 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.447 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 5.5 t -107.76 122.82 47.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.114 -0.991 . . . . 0.0 108.906 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.485 HD12 ' CE2' ' A' ' 37' ' ' TYR . 65.1 mt -117.81 135.56 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.603 -0.686 . . . . 0.0 110.096 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -174.29 -32.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.609 ' HB2' ' H2 ' ' A' ' 1' ' ' ALA . 5.2 mp -124.41 160.05 54.71 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.531 -0.731 . . . . 0.0 109.155 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -42.03 -78.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.471 2.114 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 51.0 p30 -177.03 39.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.187 -0.945 . . . . 0.0 109.511 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -102.63 133.85 46.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 109.827 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.53 ' O ' ' HB1' ' A' ' 1' ' ' ALA . 2.8 t 47.49 70.12 2.28 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.305 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.44 ' CB ' ' O ' ' A' ' 2' ' ' ARG . 68.2 Cg_endo -82.11 -68.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.832 2.355 . . . . 0.0 112.312 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.3 pt -132.89 158.21 43.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.327 -0.858 . . . . 0.0 109.388 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -117.06 122.22 43.55 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.25 81.65 13.53 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.541 -0.724 . . . . 0.0 110.062 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.42 -4.55 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.687 2.258 . . . . 0.0 111.744 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.86 -5.52 58.15 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' O ' ' CE1' ' A' ' 66' ' ' HIS . 29.3 ttpt -60.06 -35.65 75.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -1.183 . . . . 0.0 109.508 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 15.1 m -73.34 154.03 40.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.885 . . . . 0.0 109.514 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.42 ' CE1' ' O ' ' A' ' 64' ' ' LYS . 77.5 m80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.489 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.506 HH21 ' CB ' ' A' ' 54' ' ' PRO . 40.1 ttm180 -127.77 135.33 49.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.434 -0.792 . . . . 0.0 109.65 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.441 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 84.2 m-20 -95.92 145.58 25.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.371 -0.831 . . . . 0.0 108.898 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -105.1 -83.27 0.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.883 . . . . 0.0 110.051 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -100.93 13.02 36.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.865 . . . . 0.0 109.536 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.422 HG22 ' SG ' ' A' ' 12' ' ' CYS . 27.5 pt -121.68 161.38 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.744 . . . . 0.0 109.987 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -128.43 -2.97 5.52 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -111.04 153.2 43.97 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.517 -0.739 . . . . 0.0 109.111 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -58.55 -26.58 79.22 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.762 2.308 . . . . 0.0 113.14 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.545 ' CE1' ' NH1' ' A' ' 60' ' ' ARG . 57.4 t60 -145.15 -15.31 0.51 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.962 -1.086 . . . . 0.0 109.728 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -103.54 159.41 15.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.0 109.085 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.422 ' SG ' HG22 ' A' ' 6' ' ' ILE . 59.0 m -115.88 172.24 7.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 109.765 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.4 t -99.36 134.42 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.833 . . . . 0.0 109.297 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.426 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.3 p90 -67.85 -36.35 80.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.839 . . . . 0.0 109.45 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.0 tt0 -174.29 95.38 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.382 -0.824 . . . . 0.0 108.902 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -63.25 112.88 2.88 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.2 -0.938 . . . . 0.0 109.207 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.7 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 3.2 p90 -76.3 -157.07 0.07 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.191 -0.943 . . . . 0.0 108.911 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.7 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.6 m-20 -61.54 130.51 46.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.025 -1.047 . . . . 0.0 109.255 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.29 26.65 10.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.468 -0.77 . . . . 0.0 109.261 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.22 -45.86 75.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 109.578 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.601 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.0 m -62.46 -50.45 71.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 0.0 109.469 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.601 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.9 m 150.51 33.24 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -58.43 -71.39 0.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.801 -1.187 . . . . 0.0 109.996 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.5 t -61.86 -49.78 74.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.943 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 36' ' ' GLY . 2.0 m120 -57.79 -37.53 73.89 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -58.23 -40.86 94.45 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 7' ' ' ALA . 64.7 t -61.95 -48.7 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -1.207 . . . . 0.0 109.063 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 86.5 m -70.8 -22.07 62.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.378 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 64.8 m -63.1 -38.23 90.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.344 -0.848 . . . . 0.0 111.28 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -32.08 51.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.016 . . . . 0.0 109.91 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -55.33 -31.5 61.75 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 109.333 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 101.64 3.96 52.52 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 179.4 -26.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -1.154 . . . . 0.0 109.68 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.525 ' CE ' ' SG ' ' A' ' 50' ' ' CYS . 32.6 tttt -55.08 130.9 43.64 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.7 p -112.83 140.03 47.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.68 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.588 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.7 166.96 26.81 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.041 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.649 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -140.54 160.46 39.97 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 47.1 t -99.83 121.4 41.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.983 -1.073 . . . . 0.0 109.757 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.556 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 25.1 mt-30 -109.05 167.22 10.26 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.2 pt -93.97 137.47 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.078 -1.013 . . . . 0.0 109.593 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.797 ' O ' HD23 ' A' ' 41' ' ' LEU . 5.8 tt -59.9 -35.04 74.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.346 -0.846 . . . . 0.0 108.735 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.434 ' C ' ' OG1' ' A' ' 43' ' ' THR . . . 133.01 -28.36 3.35 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.434 ' OG1' ' C ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 177.55 -40.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.465 -1.021 . . . . 0.0 109.168 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.596 ' HB2' HD13 ' A' ' 41' ' ' LEU . 98.7 m-85 -65.28 -34.72 79.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.787 . . . . 0.0 110.119 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 41' ' ' LEU . . . 175.27 -154.34 17.72 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.464 -1.35 . . . . 0.0 110.349 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.414 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 19.6 m120 -121.06 159.9 24.75 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.524 -0.986 . . . . 0.0 109.394 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.1 161.35 25.96 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.697 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -105.89 129.72 53.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.424 -1.044 . . . . 0.0 109.674 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.556 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 0.9 OUTLIER -111.04 116.87 31.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 108.812 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.525 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 3.9 t -107.62 119.68 40.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.93 134.8 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.561 -0.712 . . . . 0.0 110.444 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.459 ' HB3' ' HG3' ' A' ' 34' ' ' LYS . . . 179.16 -42.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 53' ' ' LEU . 46.3 tp -130.03 73.16 81.62 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.497 -0.752 . . . . 0.0 109.677 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.506 ' CB ' HH21 ' A' ' 2' ' ' ARG . 72.0 Cg_endo -84.87 33.02 0.48 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.943 2.428 . . . . 0.0 112.343 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -51.48 -36.26 43.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.095 -1.003 . . . . 0.0 109.126 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -130.07 -24.49 2.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 109.632 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 57' ' ' VAL . 94.6 t 50.4 64.09 8.9 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 0.0 109.636 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -94.71 156.65 1.88 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.376 2.717 . . . . 0.0 111.561 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.66 122.26 63.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.422 -0.799 . . . . 0.0 109.137 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.545 ' NH1' ' CE1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -97.97 90.97 5.1 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.24 -0.913 . . . . 0.0 109.579 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -128.88 77.53 77.62 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.492 -0.755 . . . . 0.0 109.709 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -79.03 16.77 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.769 2.313 . . . . 0.0 111.717 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.61 -20.79 43.01 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -60.85 -39.52 89.43 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.403 -1.057 . . . . 0.0 109.47 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 14.1 t -59.15 -34.94 72.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.312 -0.867 . . . . 0.0 109.602 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.2 t60 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.446 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.448 ' NH1' ' CZ2' ' A' ' 49' ' ' TRP . 66.0 ttp85 -124.38 130.63 52.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.792 . . . . 0.0 109.514 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -100.06 145.11 28.3 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.093 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -108.56 -85.46 0.53 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.52 -0.738 . . . . 0.0 109.073 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -99.36 -28.28 13.36 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.169 -0.957 . . . . 0.0 109.344 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.582 HG23 ' HA ' ' A' ' 12' ' ' CYS . 90.9 mt -103.56 139.89 23.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.56 -0.713 . . . . 0.0 110.196 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.77 -7.78 18.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.495 -0.753 . . . . 0.0 109.104 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 11' ' ' ASN . 1.3 mtmt -126.43 89.54 51.99 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.93 -27.82 6.32 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.278 1.985 . . . . 0.0 112.185 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.568 ' C ' HD22 ' A' ' 11' ' ' ASN . 76.8 m80 -86.01 -19.95 29.58 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.229 -0.92 . . . . 0.0 108.89 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.568 HD22 ' C ' ' A' ' 10' ' ' HIS . 1.7 m-80 -140.62 -150.7 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.801 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.582 ' HA ' HG23 ' A' ' 6' ' ' ILE . 69.0 m -140.65 178.38 7.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.623 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.79 128.15 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.001 . . . . 0.0 109.238 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.598 ' HH ' ' HH ' ' A' ' 23' ' ' TYR . 30.8 p90 -68.27 -34.79 76.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -172.15 93.74 0.14 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.539 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -71.06 125.12 26.03 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.993 -1.067 . . . . 0.0 108.164 179.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 70.5 t80 -91.83 160.09 15.48 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.267 -0.896 . . . . 0.0 109.821 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.493 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 89.2 m-20 -42.45 126.81 3.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.69 -11.88 60.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.54 -0.725 . . . . 0.0 109.506 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -52.21 -46.24 65.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.352 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 27.2 m -66.55 -62.23 1.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.178 -0.951 . . . . 0.0 109.25 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.0 m 153.12 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.598 ' HH ' ' HH ' ' A' ' 14' ' ' TYR . 65.9 t80 -58.79 -53.59 56.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.996 . . . . 0.0 110.54 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.7 t -65.68 -40.54 92.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.077 -1.014 . . . . 0.0 109.075 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.645 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.4 m120 -59.41 -38.64 81.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.461 -0.775 . . . . 0.0 109.207 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.427 ' O ' ' CD ' ' A' ' 30' ' ' LYS . . . -62.97 -48.59 79.33 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -66.19 -43.18 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.223 -1.163 . . . . 0.0 109.065 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 33' ' ' ALA . 34.1 t -63.84 -35.05 79.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.51 -0.744 . . . . 0.0 109.71 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 25' ' ' ASN . 55.3 m -56.13 -42.37 76.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.903 . . . . 0.0 110.008 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 13.4 mptt -59.87 -38.03 81.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.026 -1.046 . . . . 0.0 109.202 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -58.97 -29.18 66.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.346 -0.846 . . . . 0.0 109.021 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.5 -0.36 55.62 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.553 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -68.63 150.46 47.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.43 -1.041 . . . . 0.0 109.501 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.925 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 7.8 ttmt -57.66 -60.15 4.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 109.879 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -143.85 161.49 38.54 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.237 -0.915 . . . . 0.0 109.433 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.27 158.5 27.27 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.582 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 49' ' ' TRP . 30.5 m-85 -136.01 161.2 36.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.504 -0.997 . . . . 0.0 109.16 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 17' ' ' PHE . 0.8 OUTLIER -99.05 123.8 43.6 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.085 -1.009 . . . . 0.0 109.516 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 33.2 tt0 -106.14 154.17 21.06 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.6 pt -93.45 147.1 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.903 -1.123 . . . . 0.0 110.785 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.742 HD12 ' HA3' ' A' ' 45' ' ' GLY . 78.9 mt -82.4 154.38 25.23 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -44.74 -18.84 0.13 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.592 ' O ' ' N ' ' A' ' 45' ' ' GLY . 19.3 p -117.74 173.42 6.76 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.76 -0.847 . . . . 0.0 108.783 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -47.7 -8.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.105 -0.997 . . . . 0.0 109.888 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.742 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . -62.32 162.74 27.99 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 51.8 t-20 -140.66 155.77 46.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -1.109 . . . . 0.0 109.842 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 46' ' ' ASN . . . -140.87 174.7 22.55 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.6 OUTLIER -106.32 158.09 17.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -1.099 . . . . 0.0 109.563 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.491 ' N ' ' O ' ' A' ' 37' ' ' TYR . 7.2 t-105 -130.66 140.75 50.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.482 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.0 m -135.08 131.49 37.03 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.027 -1.046 . . . . 0.0 110.058 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -125.32 132.87 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.464 -0.772 . . . . 0.0 109.673 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.925 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -178.52 -43.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tp -132.84 74.9 73.62 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 109.514 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.27 166.58 9.01 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.973 2.449 . . . . 0.0 112.652 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 57.07 45.84 20.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.627 -0.671 . . . . 0.0 110.137 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' A' ' 57' ' ' VAL . 22.0 t-20 -146.11 158.99 43.89 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.152 -0.967 . . . . 0.0 109.355 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 56' ' ' ASN . 2.4 t -37.38 100.24 0.2 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.671 -0.643 . . . . 0.0 109.388 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.427 ' N ' ' O ' ' A' ' 56' ' ' ASN . 98.2 Cg_endo -85.71 -67.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.39 2.06 . . . . 0.0 112.828 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.0 mt -121.48 133.31 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -0.804 . . . . 0.0 109.764 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -130.34 82.76 2.08 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.7 mt -128.3 86.04 58.92 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.513 -0.742 . . . . 0.0 109.755 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.94 -19.37 5.49 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.3 2.0 . . . . 0.0 111.918 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.13 -0.34 0.41 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -59.19 -35.44 73.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -1.178 . . . . 0.0 109.683 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.55 130.6 45.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 0.0 109.526 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.438 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.763 ' NE ' ' HE1' ' A' ' 49' ' ' TRP . 65.2 ttt180 -128.06 133.74 49.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.773 . . . . 0.0 109.705 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -110.79 151.04 28.26 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.606 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.5 -69.78 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.239 -0.913 . . . . 0.0 110.728 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -101.16 -4.26 27.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 0.0 110.46 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.707 HG22 ' H ' ' A' ' 8' ' ' LYS . 63.9 mt -109.09 139.07 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.885 . . . . 0.0 110.509 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -116.28 13.44 15.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.406 -0.809 . . . . 0.0 109.226 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.707 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -125.0 154.77 71.3 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.497 -0.752 . . . . 0.0 109.248 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.34 -36.59 55.11 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.439 2.092 . . . . 0.0 112.352 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -138.55 -3.7 1.67 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.5 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 55.0 m-80 -112.11 169.12 9.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -0.816 . . . . 0.0 109.467 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.634 ' HA ' HG23 ' A' ' 6' ' ' ILE . 3.2 m -116.65 -179.9 3.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.413 -0.804 . . . . 0.0 109.56 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.585 HG21 ' HB2' ' A' ' 48' ' ' CYS . 43.8 t -99.42 134.39 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.194 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.542 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.2 p90 -69.4 -43.02 74.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.855 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 81.4 tt0 -175.51 99.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.003 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -69.32 103.02 1.86 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.069 -1.019 . . . . 0.0 109.023 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 0.7 OUTLIER -45.62 150.79 0.47 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 108.725 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 60.5 t0 -72.17 115.02 10.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.17 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -145.48 150.17 35.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.234 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' ' CB ' ' A' ' 21' ' ' SER . 97.4 m-85 -59.36 -40.37 86.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.958 . . . . 0.0 109.241 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER 170.06 78.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.404 -0.81 . . . . 0.0 109.278 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.45 -66.66 0.14 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.033 -1.042 . . . . 0.0 110.024 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -58.46 -50.73 72.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.952 . . . . 0.0 109.961 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.9 t -68.94 -44.33 73.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.344 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.678 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.2 m120 -59.55 -38.85 82.17 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.389 -0.819 . . . . 0.0 109.286 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.96 -43.85 98.28 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.576 ' CG1' ' NZ ' ' A' ' 8' ' ' LYS . 83.2 t -66.1 -42.04 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.427 -1.043 . . . . 0.0 109.232 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 33' ' ' ALA . 43.2 t -61.87 -34.62 76.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.451 -0.781 . . . . 0.0 109.549 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.0 m -55.54 -42.46 74.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.728 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -60.19 -37.06 79.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.129 -0.982 . . . . 0.0 109.01 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -57.81 -29.82 65.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.465 -0.772 . . . . 0.0 109.03 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.88 -2.36 48.38 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . . . -68.04 146.67 53.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 109.303 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -57.53 -53.35 59.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.926 . . . . 0.0 109.531 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.9 p -144.4 160.49 40.98 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.354 -0.842 . . . . 0.0 109.288 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.465 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.84 149.41 21.41 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.351 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.527 ' O ' ' N ' ' A' ' 49' ' ' TRP . 85.6 m-85 -125.18 151.36 45.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.576 -0.955 . . . . 0.0 108.804 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.567 ' SG ' ' OD1' ' A' ' 46' ' ' ASN . 48.9 t -100.23 122.82 43.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.042 -1.037 . . . . 0.0 110.219 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.594 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 94.9 mt-30 -120.01 -167.16 1.39 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.1 pt -115.54 156.03 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.443 -0.786 . . . . 0.0 109.793 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.425 HD23 ' CA ' ' A' ' 46' ' ' ASN . 3.5 mm? -60.25 -23.53 64.16 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.418 -0.802 . . . . 0.0 109.207 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' THR . . . 102.24 0.14 50.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 42' ' ' GLY . 9.1 p -154.55 -81.95 0.08 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.8 142.09 51.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.498 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.68 -177.05 41.78 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 39' ' ' GLN . 16.8 t-20 -140.57 160.6 39.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.455 -1.027 . . . . 0.0 108.886 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.24 163.49 26.36 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.548 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.585 ' HB2' HG21 ' A' ' 13' ' ' VAL . 1.1 m -105.99 153.62 21.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.531 -0.982 . . . . 0.0 109.142 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.763 ' HE1' ' NE ' ' A' ' 2' ' ' ARG . 11.5 t-105 -116.81 137.57 52.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 109.343 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.7 m -132.63 134.23 44.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.241 -0.912 . . . . 0.0 109.855 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mt -123.6 135.31 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.598 -0.689 . . . . 0.0 110.025 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 33' ' ' ALA . . . -158.33 -59.21 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.388 -0.82 . . . . 0.0 109.326 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.48 79.71 72.94 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -50.13 -179.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.957 2.438 . . . . 0.0 112.665 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 56.64 42.85 26.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.62 -0.675 . . . . 0.0 109.482 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.34 117.42 6.8 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.257 -0.902 . . . . 0.0 109.34 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.806 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.6 p -124.33 74.43 60.31 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.673 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 59' ' ' ILE . 69.2 Cg_endo -79.76 -61.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.843 2.362 . . . . 0.0 112.118 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.773 HG22 ' O ' ' A' ' 59' ' ' ILE . 83.3 mt 40.25 61.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.472 -0.768 . . . . 0.0 109.977 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -51.48 -34.57 36.23 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.832 HG22 ' H ' ' A' ' 63' ' ' GLY . 1.3 mp -64.43 129.53 94.21 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.51 29.06 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.069 1.846 . . . . 0.0 112.186 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.832 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 97.19 3.32 58.9 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.675 ' O ' HG23 ' A' ' 61' ' ' ILE . 6.3 mtpm? -126.76 136.04 51.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.484 -1.01 . . . . 0.0 109.164 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 75.5 m -60.18 -27.33 67.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.938 . . . . 0.0 109.549 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.516 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.672 ' H1 ' ' H ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -125.96 132.87 51.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.422 -0.799 . . . . 0.0 109.317 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -96.99 136.97 36.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.143 -0.973 . . . . 0.0 109.302 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.541 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -103.32 -59.29 1.74 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.388 -0.82 . . . . 0.0 110.333 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -112.5 9.63 19.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.365 -0.835 . . . . 0.0 110.57 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.431 HD13 HG21 ' A' ' 59' ' ' ILE . 18.4 pt -124.99 163.94 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -0.964 . . . . 0.0 110.252 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.622 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -131.24 -13.28 3.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.469 -0.77 . . . . 0.0 109.038 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.483 ' HB2' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -102.39 152.89 38.39 Favored Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.338 -0.851 . . . . 0.0 109.157 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.35 -34.23 67.38 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.543 2.162 . . . . 0.0 112.875 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.545 ' ND1' ' NH2' ' A' ' 60' ' ' ARG . 91.7 m-70 -133.21 3.15 3.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 110.06 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.483 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 35.7 m-80 -131.37 168.9 16.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.814 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 40.6 m -114.8 179.65 3.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.504 -0.748 . . . . 0.0 109.505 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.476 HG21 ' SG ' ' A' ' 48' ' ' CYS . 45.6 t -95.96 135.06 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.23 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.563 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 32.2 p90 -65.18 -44.43 88.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.563 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 83.3 tt0 -175.56 96.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.059 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.432 ' HB3' HD22 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -66.23 135.46 54.51 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.105 -0.997 . . . . 0.0 108.6 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.714 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 2.1 p90 -108.75 -149.47 0.44 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.485 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.714 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 59.0 t0 -56.56 131.88 49.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.048 -1.033 . . . . 0.0 109.39 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.3 4.48 2.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.44 -0.787 . . . . 0.0 109.793 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -51.5 -43.21 62.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.175 -0.953 . . . . 0.0 109.065 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.9 m -85.06 6.45 25.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.031 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 26' ' ' GLY . 38.1 m 48.39 37.94 9.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.856 . . . . 0.0 109.397 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.469 ' O ' HG23 ' A' ' 27' ' ' VAL . 59.2 t80 -59.31 -49.8 76.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.975 . . . . 0.0 109.959 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 33.8 t -69.02 -57.23 5.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.19 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.2 m120 -57.85 -35.65 71.24 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.07 -40.46 95.62 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 23' ' ' TYR . 74.0 t -61.95 -46.72 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.266 -1.138 . . . . 0.0 108.852 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.9 m -70.3 -25.55 63.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.404 -0.81 . . . . 0.0 109.511 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 m -62.79 -29.78 70.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.277 -0.889 . . . . 0.0 111.225 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.489 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 3.9 mptp? -52.86 -34.14 53.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.95 -1.094 . . . . 0.0 110.477 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -56.64 -33.29 66.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.977 -1.077 . . . . 0.0 109.368 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.45 2.93 55.53 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -171.09 -28.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -1.078 . . . . 0.0 108.903 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.658 ' NZ ' ' SG ' ' A' ' 50' ' ' CYS . 24.4 tttt -53.34 134.37 39.84 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.7 m -116.79 139.24 50.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.4 -0.812 . . . . 0.0 109.618 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.19 156.24 26.4 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.989 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.427 ' N ' ' O ' ' A' ' 49' ' ' TRP . 49.6 m-85 -127.08 154.18 45.03 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.5 t -99.52 122.51 42.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.004 -1.06 . . . . 0.0 109.275 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -123.99 -172.88 2.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.556 -0.715 . . . . 0.0 109.511 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 42' ' ' GLY . 69.3 mt -93.62 145.58 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.882 . . . . 0.0 109.403 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 44' ' ' TYR . 29.7 tp -53.22 -39.19 63.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.504 ' H ' HG22 ' A' ' 40' ' ' ILE . . . 130.15 -56.43 0.74 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.8 m -97.99 -67.88 0.83 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.518 -0.989 . . . . 0.0 108.67 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.517 ' O ' HD23 ' A' ' 41' ' ' LEU . 27.5 p90 -139.64 159.58 41.85 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.87 -164.77 46.87 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.432 HD22 ' HB3' ' A' ' 16' ' ' CYS . 15.8 t30 -140.77 161.69 37.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.3 -1.118 . . . . 0.0 109.389 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.29 159.11 26.14 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.709 -1.234 . . . . 0.0 110.16 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.622 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 0.8 OUTLIER -103.68 157.45 17.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.352 -1.087 . . . . 0.0 109.168 179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 4' ' ' ALA . 7.5 t-105 -125.68 122.12 35.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.528 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.658 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -123.2 135.87 54.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.0 109.118 179.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 4.1 mt -117.95 134.51 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.699 0.761 . . . . 0.0 111.043 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 51' ' ' ILE . . . 169.07 147.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.71 73.7 81.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.673 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -84.37 -93.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.992 2.461 . . . . 0.0 112.367 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -94.37 11.41 30.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 0.0 109.449 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.507 HD22 ' HB2' ' A' ' 1' ' ' ALA . 0.4 OUTLIER 62.26 45.01 7.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.407 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.672 ' H ' ' H1 ' ' A' ' 1' ' ' ALA . 10.2 t -68.95 119.58 70.67 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.343 -0.848 . . . . 0.0 109.285 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -87.88 165.07 7.41 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.277 1.984 . . . . 0.0 111.032 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.527 HG22 HG12 ' A' ' 61' ' ' ILE . 22.3 mm -109.02 130.83 61.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.176 -0.953 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.545 ' NH2' ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -119.28 86.72 2.6 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.527 HG12 HG22 ' A' ' 59' ' ' ILE . 1.9 pt -124.43 81.53 59.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.811 . . . . 0.0 109.745 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -53.31 -18.92 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.666 2.244 . . . . 0.0 112.048 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 162.66 -12.5 0.11 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -58.75 -33.13 69.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -1.171 . . . . 0.0 109.62 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.0 t -56.62 -33.39 66.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.441 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 78.8 m80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.457 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -128.46 138.1 52.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.379 -0.826 . . . . 0.0 109.858 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 90.3 m-20 -108.05 150.38 27.23 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.77 -85.46 0.49 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 110.283 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -98.67 5.95 47.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.954 -1.091 . . . . 0.0 109.572 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.647 HG22 ' HB3' ' A' ' 12' ' ' CYS . 21.5 pt -111.42 149.06 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.544 -0.722 . . . . 0.0 109.744 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.635 ' O ' HG11 ' A' ' 27' ' ' VAL . . . -102.57 -1.92 29.46 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.242 -0.911 . . . . 0.0 108.977 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.47 173.27 6.07 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.535 -0.728 . . . . 0.0 109.289 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -48.63 -76.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.644 2.23 . . . . 0.0 113.367 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.518 ' CG ' HH11 ' A' ' 60' ' ' ARG . 78.2 m-70 -107.52 -8.87 16.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.162 -0.961 . . . . 0.0 110.159 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -102.31 155.55 18.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.396 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.647 ' HB3' HG22 ' A' ' 6' ' ' ILE . 13.9 p -120.98 177.04 5.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.124 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 7' ' ' ALA . 77.8 t -104.97 136.24 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 0.0 110.004 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -82.68 -32.28 28.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.0 109.049 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -174.3 98.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.777 . . . . 0.0 109.077 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' H ' ' ND2' ' A' ' 46' ' ' ASN . 3.7 p -66.18 104.78 1.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.118 -0.989 . . . . 0.0 108.52 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.561 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 6.0 p90 -53.58 -42.76 67.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 110.34 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.561 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 54.7 t0 -148.1 78.45 1.44 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.966 -1.084 . . . . 0.0 109.836 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.7 -30.87 71.21 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.199 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.88 -40.86 73.56 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.433 -0.792 . . . . 0.0 109.256 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.592 ' O ' ' CB ' ' A' ' 22' ' ' SER . 17.5 t -57.57 -52.11 66.73 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.5 m 155.47 10.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.72 -0.613 . . . . 0.0 110.091 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -60.04 -63.22 1.38 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.81 -1.181 . . . . 0.0 110.142 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.28 -51.86 57.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.114 -0.991 . . . . 0.0 108.958 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.584 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.7 m120 -60.02 -35.7 75.65 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -57.81 -43.51 94.63 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.635 HG11 ' O ' ' A' ' 7' ' ' ALA . 91.6 t -62.94 -43.42 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -1.173 . . . . 0.0 108.689 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 60.0 m -64.12 -31.67 72.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.848 . . . . 0.0 109.168 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.4 m -58.83 -48.65 80.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.655 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -64.27 -41.9 96.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.398 -0.814 . . . . 0.0 109.192 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -62.28 -30.82 71.4 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.535 -0.728 . . . . 0.0 109.048 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.99 2.7 56.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.493 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -66.92 152.9 44.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.335 -1.097 . . . . 0.0 109.631 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.775 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 9.5 ttmt -58.46 -71.3 0.12 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 110.111 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.0 p -144.77 169.33 18.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.315 -0.866 . . . . 0.0 110.22 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.515 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -142.12 151.06 22.6 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.13 135.82 54.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.27 -1.135 . . . . 0.0 109.895 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.63 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.5 t -111.48 115.23 28.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.61 -0.681 . . . . 0.0 109.239 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -131.66 166.13 22.15 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.5 pt -104.87 145.86 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.977 . . . . 0.0 111.267 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.08 142.32 41.7 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.21 -30.04 53.92 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.2 m -92.09 -74.07 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.083 -1.245 . . . . 0.0 110.772 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -61.52 -40.62 95.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.191 -0.943 . . . . 0.0 110.482 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.47 -31.31 7.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 16' ' ' CYS . 20.3 t-20 -140.47 125.08 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.261 . . . . 0.0 110.008 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.31 112.52 0.81 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.63 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -110.6 117.57 33.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -1.087 . . . . 0.0 109.53 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.37 131.44 54.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.458 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.5 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 7.1 t -105.45 122.65 46.43 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -112.53 132.67 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.831 . . . . 0.0 110.429 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.775 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -175.39 -56.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.665 -0.647 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.484 HD23 ' ND2' ' A' ' 56' ' ' ASN . 1.0 OUTLIER -128.93 84.51 62.87 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.57 -0.706 . . . . 0.0 109.732 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.547 ' O ' HG13 ' A' ' 57' ' ' VAL . 36.9 Cg_endo -74.55 -13.07 22.57 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.285 1.99 . . . . 0.0 112.616 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -57.65 -37.46 73.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.051 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.507 ' O ' ' C ' ' A' ' 57' ' ' VAL . 89.2 m-20 -67.05 -40.78 87.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.053 -1.029 . . . . 0.0 110.497 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER 32.93 67.63 1.03 Allowed Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.795 -0.566 . . . . 0.0 109.962 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.471 ' O ' ' C ' ' A' ' 59' ' ' ILE . 68.7 Cg_endo -78.75 -65.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.8 2.333 . . . . 0.0 112.708 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 59' ' ' ILE . 95.8 mt 39.93 58.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.353 -0.842 . . . . 0.0 109.259 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.518 HH11 ' CG ' ' A' ' 10' ' ' HIS . 12.6 ptm180 -55.03 -37.45 66.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.302 -0.874 . . . . 0.0 109.972 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.67 ' O ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -95.97 154.33 38.98 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.184 -0.948 . . . . 0.0 109.545 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.68 -20.33 70.67 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.555 2.17 . . . . 0.0 112.107 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 148.98 15.95 0.1 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -92.65 155.92 17.42 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.267 -1.137 . . . . 0.0 109.239 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.09 -36.43 65.64 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 83.1 t60 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.423 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.453 ' H ' ' HB3' ' A' ' 58' ' ' PRO . 71.1 ttp85 -128.11 135.3 49.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 87.5 m-20 -96.86 147.18 24.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.941 . . . . 0.0 109.376 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -113.45 -94.25 0.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 109.35 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -98.83 7.54 45.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.012 -1.055 . . . . 0.0 108.952 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.5 pt -117.34 155.79 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.701 -0.624 . . . . 0.0 109.87 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.626 ' H ' HG23 ' A' ' 13' ' ' VAL . . . -112.12 5.13 18.39 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.14 165.25 21.38 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.48 -59.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.408 2.072 . . . . 0.0 112.147 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -105.79 -6.4 19.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.798 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -114.31 164.28 14.13 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.422 -0.799 . . . . 0.0 109.799 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 11.6 m -112.43 176.89 4.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.614 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.626 HG23 ' H ' ' A' ' 7' ' ' ALA . 39.9 t -102.08 130.99 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 109.236 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.436 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.2 p90 -74.13 -36.32 64.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.294 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.1 tt0 -174.76 99.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.553 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -65.5 109.34 2.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.59 ' CE2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -61.45 162.09 8.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.59 ' O ' ' CE2' ' A' ' 17' ' ' PHE . 61.1 t0 -44.22 107.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.113 -0.992 . . . . 0.0 108.993 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.584 ' CB ' ' H ' ' A' ' 24' ' ' CYS . . . -95.61 29.94 2.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.814 . . . . 0.0 109.829 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -53.49 -46.08 69.89 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.115 -0.991 . . . . 0.0 108.865 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.587 ' O ' ' CB ' ' A' ' 22' ' ' SER . 20.2 m -64.53 -49.44 71.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.319 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.587 ' CB ' ' O ' ' A' ' 21' ' ' SER . 2.4 m 152.2 26.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -58.61 -56.78 17.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.744 -1.223 . . . . 0.0 109.767 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.584 ' H ' ' CB ' ' A' ' 19' ' ' ALA . 38.1 t -67.27 -42.42 83.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 108.832 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.747 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -59.46 -38.85 81.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.87 -39.3 97.85 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.48 -47.79 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.197 -1.178 . . . . 0.0 109.349 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 1.3 m -70.74 -31.36 68.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.336 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.8 m -53.46 -48.52 68.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.231 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -64.93 -38.17 90.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.442 -0.786 . . . . 0.0 109.0 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -59.59 -28.43 67.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -0.79 . . . . 0.0 108.988 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.36 0.2 40.57 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 28' ' ' CYS . . . -65.29 145.68 55.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -1.114 . . . . 0.0 109.14 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.737 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 4.1 ttmt -60.56 -52.6 64.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 110.135 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -143.55 160.47 40.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.127 -0.983 . . . . 0.0 110.317 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.602 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -139.05 140.15 10.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -130.14 136.72 49.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -1.097 . . . . 0.0 109.755 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.0 t -105.05 130.94 53.13 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.353 -0.842 . . . . 0.0 109.501 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.688 ' NE2' ' N ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -134.67 173.0 12.15 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.493 -0.755 . . . . 0.0 109.274 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.492 HG22 HD21 ' A' ' 46' ' ' ASN . 34.2 pt -95.77 141.3 15.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.453 HD12 ' HA3' ' A' ' 45' ' ' GLY . 76.0 mt -59.13 -34.95 72.65 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.293 -0.88 . . . . 0.0 109.245 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.57 -60.82 0.52 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.67 -70.44 0.75 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.38 -1.071 . . . . 0.0 109.063 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -129.44 151.16 50.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.609 -0.682 . . . . 0.0 109.538 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 93.45 174.8 40.3 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.492 HD21 HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -140.44 167.11 22.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.322 -1.105 . . . . 0.0 109.578 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.489 ' O ' ' OE1' ' A' ' 39' ' ' GLN . . . -140.41 150.41 21.59 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -134.0 125.6 28.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -1.067 . . . . 0.0 109.231 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.547 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 2.8 p90 -120.69 141.27 50.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.113 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.435 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 74.9 m -128.98 145.0 51.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.451 -0.78 . . . . 0.0 109.103 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.69 137.85 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.858 ' C ' HD23 ' A' ' 53' ' ' LEU . . . -169.66 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.926 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.858 HD23 ' C ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -128.0 78.45 75.24 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.892 . . . . 0.0 109.659 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -60.7 -23.66 76.71 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.382 2.055 . . . . 0.0 111.782 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.07 -36.45 77.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 109.785 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.476 ' O ' ' C ' ' A' ' 57' ' ' VAL . 50.6 t-20 -68.06 129.08 38.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.476 ' C ' ' O ' ' A' ' 56' ' ' ASN . 52.5 t -38.15 100.42 0.21 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.803 -0.561 . . . . 0.0 109.539 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HB3' ' H ' ' A' ' 2' ' ' ARG . 75.4 Cg_endo -90.3 155.76 4.58 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.627 2.218 . . . . 0.0 111.69 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 59' ' ' ILE . 89.3 mt 41.25 55.17 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 109.607 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -58.57 -35.87 73.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.476 HG13 ' H ' ' A' ' 63' ' ' GLY . 10.0 pt -60.62 148.56 81.26 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 0.0 109.35 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.79 1.22 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.465 2.11 . . . . 0.0 112.006 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' H ' HG13 ' A' ' 61' ' ' ILE . . . 100.11 5.82 54.36 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 66' ' ' HIS . 39.3 mtpt -103.46 122.62 45.28 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.388 -1.066 . . . . 0.0 108.816 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.407 ' O ' ' OXT' ' A' ' 66' ' ' HIS . 81.1 m -64.26 -22.99 67.14 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.428 -0.795 . . . . 0.0 110.006 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.407 ' OXT' ' O ' ' A' ' 65' ' ' CYS . 37.5 m80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.425 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -129.05 135.78 49.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.424 -0.797 . . . . 0.0 109.687 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.485 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 87.3 m-20 -103.37 155.91 18.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.372 -0.83 . . . . 0.0 108.89 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -110.5 -93.48 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 110.323 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -98.2 -10.88 23.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.067 -1.02 . . . . 0.0 109.64 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.712 HG23 ' HA ' ' A' ' 12' ' ' CYS . 60.8 mt -111.0 130.58 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.555 -0.716 . . . . 0.0 109.544 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.64 -12.61 19.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.422 -0.799 . . . . 0.0 110.107 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.444 ' HB2' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -104.08 153.26 39.03 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.274 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.12 -35.8 62.27 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.487 2.125 . . . . 0.0 112.942 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -131.14 -0.9 4.08 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.948 . . . . 0.0 110.11 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.491 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 34.6 m-80 -125.91 164.55 20.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.342 -0.849 . . . . 0.0 109.78 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.712 ' HA ' HG23 ' A' ' 6' ' ' ILE . 56.7 m -115.42 160.33 20.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.0 109.476 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.78 131.59 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 29.9 p90 -75.13 -43.46 52.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.93 . . . . 0.0 109.459 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.535 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 84.3 tt0 -175.9 100.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 109.215 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -68.38 93.37 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.089 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.527 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 21.2 p90 -63.42 -43.32 97.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.877 . . . . 0.0 109.895 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.527 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 47.8 t0 -153.49 89.45 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.126 -0.984 . . . . 0.0 109.849 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.506 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . . . -64.58 -28.68 69.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.128 -0.983 . . . . 0.0 109.275 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -54.49 -40.37 68.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.473 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 20.6 m -58.64 -48.91 79.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.122 -0.986 . . . . 0.0 109.623 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.8 m 153.57 3.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.75 -0.594 . . . . 0.0 109.944 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.08 -79.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.923 -1.11 . . . . 0.0 110.485 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 t -58.43 -48.29 81.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 36' ' ' GLY . 2.6 m120 -58.35 -36.27 73.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.0 108.835 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.91 -41.12 97.65 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.09 -44.32 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.237 -1.154 . . . . 0.0 109.049 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 62.6 m -64.7 -30.76 71.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 109.389 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.8 m -58.81 -44.68 90.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.726 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt -63.1 -44.7 94.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.011 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.74 -30.23 71.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.274 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.71 4.28 58.04 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.518 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.73 155.0 35.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.365 -1.079 . . . . 0.0 109.608 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.736 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 5.6 ttmt -56.24 -71.63 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 110.235 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 t -144.34 168.66 19.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.252 -0.905 . . . . 0.0 110.05 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.586 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -137.2 154.78 22.51 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -129.78 143.93 51.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -1.102 . . . . 0.0 109.641 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.582 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -125.45 128.43 48.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.569 -0.707 . . . . 0.0 109.345 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -140.3 -138.53 0.12 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.221 -0.924 . . . . 0.0 109.589 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 40' ' ' ILE . 22.5 pt -93.71 153.21 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.262 -0.898 . . . . 0.0 109.962 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 44' ' ' TYR . 32.4 tp -86.68 138.2 31.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.437 -0.789 . . . . 0.0 109.187 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.74 -35.95 8.0 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.2 p -100.52 -99.04 0.25 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.181 -1.187 . . . . 0.0 109.209 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.695 ' O ' HD23 ' A' ' 41' ' ' LEU . 95.5 m-85 -122.34 147.55 46.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 0.0 109.287 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.34 -162.44 25.81 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 40' ' ' ILE . 27.9 m120 -114.81 166.41 11.79 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.487 -1.008 . . . . 0.0 109.725 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.59 155.48 21.59 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.528 ' SG ' ' CB ' ' A' ' 38' ' ' CYS . 0.1 OUTLIER -137.2 121.33 17.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -1.144 . . . . 0.0 109.974 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -111.31 136.06 50.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.394 -0.817 . . . . 0.0 108.857 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.518 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 6.9 t -111.31 126.65 55.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.498 -0.751 . . . . 0.0 108.981 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 75.1 mt -115.45 135.22 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.449 -0.782 . . . . 0.0 110.242 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.736 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -171.18 -55.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.524 -0.735 . . . . 0.0 109.057 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.86 76.52 76.99 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.481 -0.762 . . . . 0.0 109.235 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -56.87 -21.37 40.33 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.915 2.41 . . . . 0.0 112.684 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.434 ' C ' HD22 ' A' ' 56' ' ' ASN . 92.3 m-20 -48.74 -35.44 14.16 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 108.494 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.434 HD22 ' C ' ' A' ' 55' ' ' ASP . 3.1 m120 -109.24 125.53 52.35 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.63 -0.668 . . . . 0.0 109.387 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.7 t -138.29 66.25 44.21 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.915 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -95.2 152.32 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.507 2.804 . . . . 0.0 111.75 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 61' ' ' ILE . 58.8 mt -128.1 121.62 56.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.1 tpt85 -54.97 -36.27 65.19 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.356 -0.84 . . . . 0.0 110.795 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.798 ' O ' HD12 ' A' ' 61' ' ' ILE . 1.6 pp -132.65 154.43 81.49 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.031 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.35 -19.57 28.93 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.479 2.119 . . . . 0.0 112.036 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.79 26.87 0.11 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -104.17 148.18 26.59 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.231 -1.158 . . . . 0.0 109.467 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 71.1 m -117.35 159.76 22.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.489 -0.757 . . . . 0.0 109.148 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.408 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 56' ' ' ASN . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -127.04 129.97 49.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.84 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 5.3 t0 -108.55 153.57 23.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.432 -0.793 . . . . 0.0 109.106 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.61 ' HB1' ' CH2' ' A' ' 49' ' ' TRP . . . -100.28 -81.67 0.46 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 110.528 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.3 -4.77 31.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.099 -1.001 . . . . 0.0 109.786 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.456 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 65.7 mt -106.77 143.95 16.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.464 -0.773 . . . . 0.0 110.099 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.84 -10.16 1.34 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.305 -0.872 . . . . 0.0 109.19 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -104.75 157.21 34.66 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' A' ' 8' ' ' LYS . 45.6 Cg_exo -34.16 -109.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.332 2.688 . . . . 0.0 113.151 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -88.44 -1.23 57.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.756 -1.215 . . . . 0.0 109.335 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -105.22 154.82 19.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.639 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.449 ' HA ' HG23 ' A' ' 6' ' ' ILE . 7.3 m -108.1 161.81 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.234 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.442 HG21 ' HB2' ' A' ' 48' ' ' CYS . 55.9 t -66.41 134.31 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.947 . . . . 0.0 109.434 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.7 p90 -78.13 -34.7 49.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 76.9 tt0 -167.61 95.0 0.44 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.265 -0.897 . . . . 0.0 109.08 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.485 ' CB ' HD22 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -60.6 148.51 37.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.95 -1.094 . . . . 0.0 108.411 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 13.7 t80 -115.69 166.48 11.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.511 -0.743 . . . . 0.0 109.281 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.585 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 88.0 m-20 -42.8 137.21 2.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 109.401 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.96 -8.91 48.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.419 -0.801 . . . . 0.0 110.037 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -51.34 -43.79 61.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.045 -1.034 . . . . 0.0 108.726 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -86.11 6.01 31.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.354 -0.841 . . . . 0.0 108.893 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 m 55.33 20.42 3.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.602 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -58.62 -49.41 77.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.774 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.5 t -65.34 -47.96 74.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.152 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.2 m120 -60.05 -37.63 80.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.389 -0.82 . . . . 0.0 109.185 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.52 -42.22 99.01 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.33 -43.91 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 109.12 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.8 t -64.27 -32.42 74.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.475 -0.765 . . . . 0.0 109.19 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.5 m -59.23 -41.1 87.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.406 -0.809 . . . . 0.0 109.975 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -58.77 -31.2 68.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.128 -0.983 . . . . 0.0 109.272 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -52.6 -34.89 52.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.877 . . . . 0.0 108.925 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.732 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 157.35 -35.57 0.55 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 161.45 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -1.152 . . . . 0.0 109.362 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 33' ' ' ALA . 22.2 mttt -42.87 139.51 1.65 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.434 -0.791 . . . . 0.0 109.96 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.4 p -125.81 113.63 17.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.59 -141.48 4.55 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.554 ' O ' ' N ' ' A' ' 49' ' ' TRP . 10.3 m-85 -139.82 171.5 14.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.209 -1.171 . . . . 0.0 109.828 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.465 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 13.0 t -99.68 125.63 45.57 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.325 -0.86 . . . . 0.0 109.534 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.659 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 26.7 mt-30 -118.07 -177.5 3.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.641 -0.662 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 40' ' ' ILE . 31.6 pt -108.93 157.82 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 110.102 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.442 HD12 ' HA3' ' A' ' 45' ' ' GLY . 56.7 mt -79.05 144.52 34.55 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.37 -0.832 . . . . 0.0 109.517 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -54.13 -34.93 53.58 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.1 p -94.14 -120.88 0.09 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.331 -1.1 . . . . 0.0 109.073 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -112.14 136.63 51.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 126.01 -166.6 18.7 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.485 HD22 ' CB ' ' A' ' 16' ' ' CYS . 17.3 t30 -140.51 157.95 44.73 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.322 -1.105 . . . . 0.0 108.927 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.24 163.67 25.98 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.8 m -107.43 140.41 40.42 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.476 -1.014 . . . . 0.0 109.758 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.659 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 4.6 t-105 -106.34 128.67 54.18 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.397 -0.815 . . . . 0.0 108.895 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.4 m -115.9 128.51 55.84 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.494 HD12 ' CE2' ' A' ' 37' ' ' TYR . 69.2 mt -126.37 138.36 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 110.327 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.721 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -168.91 -40.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.329 -0.857 . . . . 0.0 109.537 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.721 HD12 ' O ' ' A' ' 52' ' ' ALA . 5.8 mp -128.63 159.11 69.71 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.514 -0.741 . . . . 0.0 109.313 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -42.55 -72.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.591 2.194 . . . . 0.0 112.325 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 50.0 p30 -175.37 47.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.44 -0.787 . . . . 0.0 109.534 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 1' ' ' ALA . 16.1 t-20 -101.2 121.9 42.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.26 -0.9 . . . . 0.0 109.751 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 1' ' ' ALA . 23.7 t 55.73 66.82 3.37 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.623 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.74 -64.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.65 2.233 . . . . 0.0 112.12 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -119.92 113.78 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -0.788 . . . . 0.0 109.203 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -67.49 -35.63 79.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 109.054 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 63' ' ' GLY . 1.6 mp -73.7 136.93 77.14 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.691 -0.63 . . . . 0.0 109.543 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -46.64 -5.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.898 1.732 . . . . 0.0 111.892 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 103.67 5.41 45.1 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 66' ' ' HIS . 33.0 mtmt -58.28 -36.75 73.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.107 -1.231 . . . . 0.0 109.385 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 50.7 t 51.64 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.631 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 64' ' ' LYS . 9.9 p-80 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.552 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -108.91 146.05 34.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.427 -0.796 . . . . 0.0 109.306 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 8.9 t0 -136.58 154.31 50.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.301 -0.874 . . . . 0.0 109.098 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.571 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.6 -78.31 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 110.898 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.65 -8.96 23.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.067 . . . . 0.0 110.096 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.713 HG22 ' H ' ' A' ' 8' ' ' LYS . 68.3 mt -104.65 143.45 16.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.461 -0.774 . . . . 0.0 110.177 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.577 ' O ' ' ND2' ' A' ' 31' ' ' ASN . . . -118.51 13.28 13.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.823 . . . . 0.0 109.354 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.713 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -125.24 155.27 71.56 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -64.86 -39.68 24.46 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.437 2.091 . . . . 0.0 112.416 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -134.57 -1.08 2.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.639 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.495 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 54.2 m-80 -116.16 170.21 8.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.47 -0.769 . . . . 0.0 109.488 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.673 ' HA ' HG23 ' A' ' 6' ' ' ILE . 62.5 m -114.46 177.27 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 109.518 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 t -99.97 135.68 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -70.78 77.44 0.62 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.067 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 55.9 97.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 109.346 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.7 t -64.68 113.21 3.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 108.975 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 8.4 t80 -70.06 139.56 52.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 88.9 m-20 -70.1 131.77 44.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 110.084 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.72 155.05 37.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.406 -0.809 . . . . 0.0 109.109 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 21' ' ' SER . 96.7 m-85 -56.93 -41.02 77.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.09 -1.006 . . . . 0.0 109.24 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 1.4 t 168.98 86.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.409 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.2 t -170.24 -64.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.057 -1.027 . . . . 0.0 110.021 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.437 ' HH ' ' HE1' ' A' ' 14' ' ' TYR . 64.4 t80 -59.78 -56.95 15.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 109.912 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.2 t -70.66 -52.64 19.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.653 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.639 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.5 m120 -57.68 -37.99 74.37 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.408 -0.807 . . . . 0.0 109.469 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.74 -46.66 93.74 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.3 t -67.72 -43.27 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -1.131 . . . . 0.0 109.383 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.5 t -61.22 -38.06 85.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.357 -0.839 . . . . 0.0 109.333 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.8 m -56.93 -40.21 75.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -59.14 -38.34 79.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.012 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 7' ' ' ALA . 82.0 m-20 -59.24 -28.52 66.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.83 . . . . 0.0 109.03 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.72 -0.12 52.51 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.78 148.21 51.55 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -1.064 . . . . 0.0 109.452 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.836 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 3.8 ttmt -58.31 -55.56 33.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.782 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t -144.62 158.81 43.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.347 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -141.74 154.23 24.66 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.563 -1.304 . . . . 0.0 110.211 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 49' ' ' TRP . 48.8 m-85 -127.18 152.83 46.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.489 -1.006 . . . . 0.0 109.242 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.8 t -99.44 119.54 38.17 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.176 -0.953 . . . . 0.0 109.087 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -116.68 -170.82 1.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.696 -0.628 . . . . 0.0 109.693 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 pt -93.57 152.17 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.239 -0.913 . . . . 0.0 109.726 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 43' ' ' THR . 29.8 tp -88.85 133.95 34.11 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.497 -0.752 . . . . 0.0 109.301 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -45.11 -30.19 2.52 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.432 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 25.8 p -109.45 178.85 4.31 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -50.75 160.58 0.43 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.763 -1.211 . . . . 0.0 109.174 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.59 -167.05 30.76 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -138.97 171.91 13.62 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.338 -1.095 . . . . 0.0 109.407 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.13 163.66 26.29 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.05 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.1 m -103.57 152.2 22.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.424 -1.045 . . . . 0.0 109.255 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.579 ' N ' ' O ' ' A' ' 37' ' ' TYR . 17.3 t-105 -116.2 139.06 50.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.826 . . . . 0.0 109.566 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.8 m -134.38 124.05 25.11 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.287 -0.883 . . . . 0.0 109.9 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.5 mt -123.98 132.34 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.536 -0.728 . . . . 0.0 109.875 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.836 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -177.11 -66.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.822 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 1' ' ' ALA . 17.6 tp -133.14 89.0 34.57 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.417 -0.802 . . . . 0.0 109.9 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -75.61 -25.16 11.2 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.074 1.849 . . . . 0.0 112.292 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -57.96 -35.83 71.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 57' ' ' VAL . 48.9 t-20 -73.29 144.72 46.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.645 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.503 ' C ' ' O ' ' A' ' 56' ' ' ASN . 90.9 t -33.85 97.84 0.12 Allowed Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.949 -0.469 . . . . 0.0 109.795 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' ASN . 89.5 Cg_endo -85.5 -63.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.575 2.184 . . . . 0.0 112.426 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.413 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 73.6 mt -118.21 131.97 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -138.49 -21.9 1.01 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.301 -0.874 . . . . 0.0 109.507 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.679 ' O ' HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -96.23 154.09 38.86 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.521 -179.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -67.21 -9.87 26.64 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.696 2.264 . . . . 0.0 112.195 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.3 22.22 45.42 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 66' ' ' HIS . 17.3 tttp -56.38 -35.04 67.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.557 -0.967 . . . . 0.0 109.651 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 57.8 m 57.12 -77.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.414 -0.803 . . . . 0.0 109.592 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 64' ' ' LYS . 94.9 m-70 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.877 ' H2 ' ' H ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -131.93 134.59 45.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.47 -0.769 . . . . 0.0 109.44 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 83.4 m-20 -95.79 150.11 20.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.136 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -109.86 -92.52 0.44 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.511 -0.743 . . . . 0.0 109.955 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -97.91 -17.3 19.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.346 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.68 HG23 ' HA ' ' A' ' 12' ' ' CYS . 64.7 mt -106.91 137.61 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.525 -0.734 . . . . 0.0 109.62 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.416 ' C ' ' CD ' ' A' ' 8' ' ' LYS . . . -113.24 14.42 19.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.476 -0.765 . . . . 0.0 109.853 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.659 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -126.23 153.52 74.46 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.346 -0.846 . . . . 0.0 109.15 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.86 -27.74 80.58 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.637 2.225 . . . . 0.0 112.896 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -147.64 -5.99 0.47 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.077 -1.015 . . . . 0.0 109.501 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.481 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 51.2 m-80 -111.52 165.92 11.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.768 . . . . 0.0 109.38 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.68 ' HA ' HG23 ' A' ' 6' ' ' ILE . 24.4 m -119.59 162.19 19.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -0.823 . . . . 0.0 109.089 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.9 130.96 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.104 -0.998 . . . . 0.0 109.207 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.523 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.4 p90 -76.04 -42.11 48.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.523 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 45.1 tp10 -175.29 99.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -63.63 148.65 48.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.162 -0.961 . . . . 0.0 109.024 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.676 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -122.12 -161.14 0.91 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.676 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 89.1 m-20 -57.08 142.45 42.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.988 -1.07 . . . . 0.0 109.308 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.7 7.58 3.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.867 . . . . 0.0 110.103 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -52.25 -45.52 65.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.058 -1.026 . . . . 0.0 109.256 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 t -88.87 -2.58 58.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.949 . . . . 0.0 109.128 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 m 55.6 52.55 10.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.511 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 27' ' ' VAL . 65.4 t80 -61.75 -53.61 53.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 0.0 109.833 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -70.98 -51.87 23.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.897 . . . . 0.0 109.294 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.652 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.5 m120 -58.76 -37.54 76.47 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.47 97.18 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 23' ' ' TYR . 74.2 t -61.85 -44.15 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.288 -1.125 . . . . 0.0 109.071 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 66.2 m -63.78 -32.93 74.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 0.0 109.183 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.2 m -60.98 -50.39 73.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.663 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -65.59 -41.01 93.32 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.44 -0.788 . . . . 0.0 109.359 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -61.26 -30.25 70.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.461 -0.775 . . . . 0.0 109.259 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.36 0.39 50.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.425 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -66.85 150.95 48.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.438 -1.036 . . . . 0.0 109.388 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -57.91 -76.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 109.87 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.2 m -143.16 158.87 43.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.329 -0.857 . . . . 0.0 109.681 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.42 162.27 26.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -126.35 140.03 52.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -1.041 . . . . 0.0 109.833 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -116.21 119.37 35.55 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -137.45 176.83 8.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.189 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.418 ' H ' HG23 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -92.83 140.29 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.979 -1.076 . . . . 0.0 109.285 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.621 HD13 ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -64.42 -39.42 93.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 108.939 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.45 5.87 74.76 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.6 m -157.44 -81.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -1.139 . . . . 0.0 109.849 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -62.29 -37.0 83.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.917 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 41' ' ' LEU . . . 162.88 -119.08 0.85 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.424 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 17.4 m120 -111.33 150.54 29.57 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.519 -0.989 . . . . 0.0 110.093 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.3 117.53 2.3 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 4' ' ' ALA . 32.9 t -114.95 115.98 27.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.464 -1.021 . . . . 0.0 109.143 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -109.55 137.56 47.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.357 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.477 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 8.2 t -109.39 132.55 54.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.1 122.83 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 0.0 109.814 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.423 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -179.07 -146.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.585 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.7 OUTLIER 176.43 -44.71 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.42 -0.8 . . . . 0.0 109.823 179.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 53' ' ' LEU . 42.8 Cg_exo -54.78 -32.68 77.76 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.086 1.858 . . . . 0.0 111.95 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.35 -38.3 86.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.299 -0.876 . . . . 0.0 108.98 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 53' ' ' LEU . 14.5 m120 56.88 46.42 19.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.32 -0.862 . . . . 0.0 109.471 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.877 ' H ' ' H2 ' ' A' ' 1' ' ' ALA . 91.9 t -120.62 85.92 39.24 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.489 -0.757 . . . . 0.0 109.365 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -90.91 -172.83 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.293 2.662 . . . . 0.0 111.689 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 61' ' ' ILE . 29.7 mm -114.28 130.5 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 7.51 41.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 0.0 110.521 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.588 ' H ' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -141.63 151.94 61.73 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.778 -1.201 . . . . 0.0 109.865 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.583 ' C ' ' H ' ' A' ' 64' ' ' LYS . 11.3 Cg_endo -57.84 159.74 16.89 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.703 2.269 . . . . 0.0 112.155 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.634 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . -65.74 28.25 0.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 66' ' ' HIS . 35.0 tttt -56.68 -35.63 68.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.104 -1.233 . . . . 0.0 109.303 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 33.8 m 58.46 -74.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.614 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.591 ' N ' ' O ' ' A' ' 64' ' ' LYS . 84.6 t60 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 52' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -136.52 161.52 35.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.341 -0.849 . . . . 0.0 109.242 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -95.44 145.54 25.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.121 -0.987 . . . . 0.0 109.343 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -103.08 -81.42 0.5 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 110.797 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -99.52 -15.18 18.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.051 -1.031 . . . . 0.0 110.261 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.624 HG23 ' HA ' ' A' ' 12' ' ' CYS . 67.9 mt -95.91 143.92 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.367 -0.833 . . . . 0.0 110.12 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.94 21.32 3.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.34 -0.85 . . . . 0.0 109.6 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.453 ' H ' HG22 ' A' ' 6' ' ' ILE . 8.8 mmtm -115.37 152.15 46.65 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.47 -0.769 . . . . 0.0 109.213 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.21 -32.75 90.88 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.569 2.18 . . . . 0.0 112.816 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -149.65 12.08 0.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.996 -1.065 . . . . 0.0 109.805 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -130.88 -164.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.62 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.624 ' HA ' HG23 ' A' ' 6' ' ' ILE . 84.1 m -121.0 -178.08 3.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.357 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -98.89 131.95 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.265 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.7 p90 -66.34 -37.45 85.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.531 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.443 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 80.9 tt0 -174.56 99.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.279 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.547 ' SG ' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -75.54 125.58 29.31 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.101 -0.999 . . . . 0.0 108.715 179.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 18' ' ' ASP . 20.0 t80 -90.87 141.14 29.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.904 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.587 ' O ' ' CE2' ' A' ' 17' ' ' PHE . 60.0 t0 -78.52 121.03 24.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.402 -0.811 . . . . 0.0 109.88 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -140.82 159.06 43.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.465 -0.772 . . . . 0.0 108.936 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.448 ' O ' ' CB ' ' A' ' 21' ' ' SER . 71.3 t80 -53.62 -43.41 68.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.081 -1.012 . . . . 0.0 109.203 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.503 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER 168.97 78.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.229 -0.919 . . . . 0.0 109.429 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 26' ' ' GLY . 3.5 t -156.01 -66.94 0.11 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.037 -1.039 . . . . 0.0 110.149 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -60.37 -57.26 13.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -68.36 -48.31 65.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 108.943 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.65 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.4 m120 -59.08 -37.17 76.47 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -60.4 -41.48 98.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -62.03 -44.92 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.16 . . . . 0.0 109.128 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.3 m -67.8 -31.59 71.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.798 . . . . 0.0 109.53 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 m -56.88 -48.43 78.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.62 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -65.02 -40.48 94.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.417 -0.802 . . . . 0.0 109.487 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -60.74 -30.18 69.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.402 -0.811 . . . . 0.0 109.297 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.84 0.02 56.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . . . -64.95 150.0 48.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.418 -1.049 . . . . 0.0 109.423 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -57.6 -60.24 3.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.196 -0.94 . . . . 0.0 109.947 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.6 p -144.9 161.74 38.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.997 . . . . 0.0 110.193 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.581 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -144.14 154.72 25.86 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.596 ' O ' ' N ' ' A' ' 49' ' ' TRP . 21.6 m-85 -139.8 156.34 46.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.171 -1.194 . . . . 0.0 109.456 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.21 124.75 44.51 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.066 -1.021 . . . . 0.0 109.188 178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.565 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 26.0 mt-30 -116.28 179.03 4.11 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.6 pt -93.29 143.25 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.061 -1.024 . . . . 0.0 110.043 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD23 ' OG1' ' A' ' 43' ' ' THR . 36.0 tp -91.36 142.78 27.31 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.468 -0.77 . . . . 0.0 109.215 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 41' ' ' LEU . . . -43.67 -31.76 1.86 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.503 ' OG1' HD23 ' A' ' 41' ' ' LEU . 21.6 p -87.23 167.51 14.05 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.41 -1.053 . . . . 0.0 108.87 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -54.35 -10.05 0.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.146 -0.971 . . . . 0.0 109.49 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 43' ' ' THR . . . -82.56 -173.23 49.01 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.421 ' HA ' ' H ' ' A' ' 41' ' ' LEU . 2.9 m-20 -137.18 171.23 14.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.481 -1.011 . . . . 0.0 109.109 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -140.17 167.1 25.56 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.034 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.48 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -101.31 151.67 21.61 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.413 -1.051 . . . . 0.0 109.135 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.596 ' N ' ' O ' ' A' ' 37' ' ' TYR . 13.6 t-105 -115.57 137.35 52.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.469 -0.77 . . . . 0.0 109.329 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.421 ' SG ' ' CB ' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -130.31 133.63 46.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.369 -0.832 . . . . 0.0 109.153 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.415 HD11 ' CE2' ' A' ' 37' ' ' TYR . 3.4 mt -115.81 121.16 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.413 -0.804 . . . . 0.0 109.691 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 1' ' ' ALA . . . -169.98 158.64 7.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.37 75.52 73.98 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 0.0 109.777 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.08 -65.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.743 2.295 . . . . 0.0 111.838 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -154.99 -71.02 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.558 -0.714 . . . . 0.0 109.148 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 56' ' ' ASN . 6.4 p30 -173.39 29.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.355 -0.84 . . . . 0.0 109.564 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.5 t -126.98 77.7 74.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 109.866 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.73 -65.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.668 2.245 . . . . 0.0 112.099 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 61' ' ' ILE . 29.3 mm -113.89 130.0 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -105.69 1.6 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.723 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.452 ' H ' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -130.63 154.43 81.73 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.716 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -72.83 23.91 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.701 2.267 . . . . 0.0 112.073 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.57 10.29 56.91 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -73.8 136.25 43.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.413 -1.051 . . . . 0.0 109.104 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 66' ' ' HIS . 72.7 m -116.72 159.29 22.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.577 -0.702 . . . . 0.0 109.382 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' CYS . 83.7 t60 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.54 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.81 ' HE ' ' HE1' ' A' ' 49' ' ' TRP . 76.8 ttt180 -128.26 133.67 48.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.44 -0.787 . . . . 0.0 109.571 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -95.67 140.38 30.57 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.268 -0.895 . . . . 0.0 109.084 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.558 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -99.83 -79.74 0.49 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -0.91 . . . . 0.0 109.696 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -106.67 15.11 26.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.783 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 12' ' ' CYS . 21.9 pt -118.57 156.44 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.354 -0.841 . . . . 0.0 109.778 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.466 ' HB1' HG11 ' A' ' 27' ' ' VAL . . . -99.03 -18.57 17.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.273 -0.892 . . . . 0.0 109.11 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.474 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -137.25 154.99 76.03 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.372 -0.83 . . . . 0.0 109.179 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.38 -29.93 30.75 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.66 2.24 . . . . 0.0 112.679 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -94.67 -23.68 17.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.133 -0.979 . . . . 0.0 110.295 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -140.72 -179.54 6.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.986 -1.071 . . . . 0.0 110.04 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.528 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 24.6 p -140.07 -177.79 5.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.51 -0.744 . . . . 0.0 109.232 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.43 HG11 ' HA ' ' A' ' 16' ' ' CYS . 45.7 t -107.33 131.87 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.425 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 28.1 p90 -73.68 -34.59 64.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.144 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.425 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 43.8 tp10 -151.19 89.38 1.51 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.44 -0.787 . . . . 0.0 108.89 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.565 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -59.21 109.49 0.87 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 109.353 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 1.8 t80 -63.15 165.19 7.5 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.368 -0.833 . . . . 0.0 108.943 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.602 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 60.3 t0 -43.54 106.39 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 109.298 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.36 -5.11 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -50.79 -43.61 58.67 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.163 -0.961 . . . . 0.0 109.186 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.585 ' O ' ' CB ' ' A' ' 22' ' ' SER . 21.7 m -62.7 -50.63 70.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.192 -0.943 . . . . 0.0 109.446 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 21' ' ' SER . 1.6 t 151.49 12.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -57.35 -71.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.008 -1.058 . . . . 0.0 110.541 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.4 t -60.64 -51.29 70.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.163 -0.961 . . . . 0.0 109.148 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.478 HD22 ' N ' ' A' ' 25' ' ' ASN . 2.3 m120 -57.72 -36.01 71.44 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 108.666 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -59.34 -40.18 95.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.466 HG11 ' HB1' ' A' ' 7' ' ' ALA . 69.8 t -61.83 -48.02 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -1.173 . . . . 0.0 108.855 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.38 -22.57 62.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.2 m -64.07 -31.26 72.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.413 -0.804 . . . . 0.0 110.976 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 1.8 mptt -52.77 -35.12 55.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.004 -1.06 . . . . 0.0 110.159 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.45 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 31.7 t30 -56.92 -33.59 67.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.051 -1.03 . . . . 0.0 109.337 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.84 2.17 56.2 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.1 -26.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -1.036 . . . . 0.0 109.216 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.738 ' HG3' ' HB2' ' A' ' 52' ' ' ALA . 16.7 tttp -54.33 131.83 42.73 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 96.6 p -113.65 139.68 48.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.424 -0.798 . . . . 0.0 109.589 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.19 158.02 27.1 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.526 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -128.81 155.71 44.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.643 -0.916 . . . . 0.0 108.735 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 42.4 t -99.07 122.77 42.75 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.049 -1.032 . . . . 0.0 108.917 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.498 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 24.4 mt-30 -115.68 177.81 4.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.634 -0.666 . . . . 0.0 109.965 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.773 HG22 ' H ' ' A' ' 42' ' ' GLY . 64.4 mt -93.69 133.44 34.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.402 -0.811 . . . . 0.0 110.1 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.6 tp -64.47 -27.35 68.92 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.617 0.722 . . . . 0.0 109.209 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.773 ' H ' HG22 ' A' ' 40' ' ' ILE . . . 106.29 -7.34 40.18 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.605 -2.198 . . . . 0.0 107.605 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 45' ' ' GLY . 12.8 p -127.79 172.44 10.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 43' ' ' THR . 23.8 p90 -46.48 -12.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.019 -1.051 . . . . 0.0 109.44 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -87.87 -176.92 47.98 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.556 ' ND2' ' SG ' ' A' ' 38' ' ' CYS . 61.8 t30 -140.2 164.54 29.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.531 -0.981 . . . . 0.0 108.889 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 157.82 25.66 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.46 -1.353 . . . . 0.0 110.545 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -107.39 153.45 22.76 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.488 -1.007 . . . . 0.0 109.354 179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.81 ' HE1' ' HE ' ' A' ' 2' ' ' ARG . 5.6 t-105 -125.72 129.46 49.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.372 -0.83 . . . . 0.0 109.256 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.623 ' SG ' ' CE ' ' A' ' 34' ' ' LYS . 1.8 t -132.76 131.09 40.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.121 -0.987 . . . . 0.0 109.748 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mt -123.1 140.47 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.746 . . . . 0.0 110.499 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.738 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . . . -159.59 -28.91 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.711 . . . . 0.0 109.643 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 52' ' ' ALA . 3.0 mp -129.1 165.96 28.57 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 109.717 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.593 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 50.3 Cg_exo -49.72 -0.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.59 2.194 . . . . 0.0 112.705 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 12.5 t0 89.9 49.8 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.27 0.557 . . . . 0.0 109.785 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -103.53 131.87 50.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.304 -0.872 . . . . 0.0 108.996 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.821 HG12 ' HE ' ' A' ' 60' ' ' ARG . 83.0 t 52.92 67.69 3.63 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.088 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.65 -65.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.761 2.307 . . . . 0.0 112.471 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.3 mt -116.13 124.68 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.473 -0.767 . . . . 0.0 109.412 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.821 ' HE ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -120.44 -1.61 10.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.514 HG13 ' H ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -68.98 149.22 97.9 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.557 -0.714 . . . . 0.0 109.521 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.28 5.99 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.556 2.171 . . . . 0.0 112.139 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.514 ' H ' HG13 ' A' ' 61' ' ' ILE . . . 99.99 8.12 51.55 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -37.48 71.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.176 -1.19 . . . . 0.0 109.239 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -107.95 158.57 17.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.557 -0.714 . . . . 0.0 109.543 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.436 -179.912 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -136.9 159.4 41.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.589 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -101.35 149.52 23.95 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.291 -0.881 . . . . 0.0 109.129 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.637 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -99.34 -65.64 0.95 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.256 -0.903 . . . . 0.0 110.654 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.416 ' CD1' HD12 ' A' ' 41' ' ' LEU . 12.7 m-85 -100.45 -0.94 37.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -0.929 . . . . 0.0 109.927 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.499 HG23 ' HA ' ' A' ' 12' ' ' CYS . 53.5 mt -111.71 133.83 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.935 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.729 ' HB2' ' HB3' ' A' ' 48' ' ' CYS . . . -105.97 -9.25 17.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.419 -0.801 . . . . 0.0 109.549 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.634 ' NZ ' ' CG1' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -115.09 166.35 12.04 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.502 -0.749 . . . . 0.0 109.246 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.74 -59.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.581 2.187 . . . . 0.0 112.433 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.63 ' NE2' ' NH1' ' A' ' 60' ' ' ARG . 78.4 m80 -102.95 -4.71 24.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.348 -0.845 . . . . 0.0 109.782 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -121.66 161.79 21.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.419 -0.801 . . . . 0.0 109.645 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.499 ' HA ' HG23 ' A' ' 6' ' ' ILE . 46.5 m -124.14 179.5 4.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.353 -0.842 . . . . 0.0 109.514 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 48' ' ' CYS . 51.7 t -98.87 134.18 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.312 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 31.3 p90 -70.27 -42.04 72.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.851 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 39.1 tp10 -174.68 99.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.097 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HB3' HD22 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -70.0 143.58 52.54 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.144 -0.973 . . . . 0.0 108.955 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.614 ' CZ ' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -120.12 179.31 4.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.404 -0.81 . . . . 0.0 109.033 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.614 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 88.6 m-20 -44.7 128.35 6.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -0.968 . . . . 0.0 109.355 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 21' ' ' SER . . . -65.17 -36.24 83.59 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.202 -0.936 . . . . 0.0 109.759 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.564 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 66.9 t80 49.25 7.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.17 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 19' ' ' ALA . 1.2 t 173.3 -54.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.354 -0.842 . . . . 0.0 108.856 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER 160.98 45.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.621 -0.674 . . . . 0.0 109.202 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.427 ' O ' HG23 ' A' ' 27' ' ' VAL . 69.5 t80 -60.31 -51.85 67.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.999 -1.063 . . . . 0.0 109.716 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.9 t -70.35 -50.42 39.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 0.0 109.191 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.736 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -59.55 -38.73 81.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 109.296 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.87 -44.04 98.39 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.634 ' CG1' ' NZ ' ' A' ' 8' ' ' LYS . 76.9 t -60.56 -43.55 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -1.179 . . . . 0.0 109.542 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.446 ' SG ' ' CD ' ' A' ' 34' ' ' LYS . 3.6 t -65.07 -35.08 80.0 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.387 -0.821 . . . . 0.0 109.252 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 m -61.95 -39.16 91.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 110.557 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -56.98 -29.97 63.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.005 -1.059 . . . . 0.0 109.779 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.683 ' ND2' ' NZ ' ' A' ' 34' ' ' LYS . 13.9 t30 -53.59 -35.61 61.03 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.074 -1.016 . . . . 0.0 109.294 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 166.03 -42.76 0.27 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 174.52 -21.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.048 -1.266 . . . . 0.0 109.59 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.683 ' NZ ' ' ND2' ' A' ' 31' ' ' ASN . 13.3 ptpt -43.63 145.37 0.65 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.511 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 91.4 p -103.61 147.77 26.81 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.48 159.96 27.59 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.229 -1.463 . . . . 0.0 111.252 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.473 ' O ' ' N ' ' A' ' 49' ' ' TRP . 37.3 m-85 -127.54 154.21 45.43 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.618 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 40.6 t -98.92 118.89 36.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.894 -1.128 . . . . 0.0 109.323 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.609 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 25.9 mt-30 -112.75 171.52 7.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.1 pt -93.25 134.17 31.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.063 -1.023 . . . . 0.0 110.042 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.463 ' H ' ' HA ' ' A' ' 46' ' ' ASN . 41.3 tp -62.79 -28.15 69.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.637 -0.664 . . . . 0.0 109.211 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.75 -6.8 41.38 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 45' ' ' GLY . 20.3 p -127.02 172.62 10.33 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' THR . 24.6 p90 -44.65 -16.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.033 -1.042 . . . . 0.0 109.367 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -89.26 -178.2 45.75 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.618 ' ND2' ' SG ' ' A' ' 38' ' ' CYS . 7.4 t30 -140.65 168.1 20.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.527 -0.984 . . . . 0.0 108.853 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.4 150.38 21.56 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.473 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -99.99 145.33 28.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.41 -1.053 . . . . 0.0 108.986 179.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.637 ' CZ3' ' HB1' ' A' ' 4' ' ' ALA . 11.7 t-105 -111.25 127.89 55.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.392 -0.817 . . . . 0.0 109.408 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.4 m -124.31 134.24 53.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.273 -0.892 . . . . 0.0 109.616 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.699 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 5.2 mt -120.14 141.61 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.544 -0.722 . . . . 0.0 110.076 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 51' ' ' ILE . . . 90.89 65.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.566 0.698 . . . . 0.0 109.574 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.512 HD13 ' NZ ' ' A' ' 34' ' ' LYS . 40.2 tp -128.83 81.46 70.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.606 -0.684 . . . . 0.0 109.173 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.41 -21.29 29.24 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.643 2.229 . . . . 0.0 111.867 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -56.62 -34.3 67.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.72 45.64 5.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 57' ' ' VAL . 31.7 m -124.72 77.63 64.44 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.559 -0.713 . . . . 0.0 109.259 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HG2' ' H ' ' A' ' 59' ' ' ILE . 65.6 Cg_endo -79.83 -67.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.679 2.253 . . . . 0.0 112.223 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.411 ' H ' ' HG2' ' A' ' 58' ' ' PRO . 70.4 mt -119.48 129.49 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.63 ' NH1' ' NE2' ' A' ' 10' ' ' HIS . 13.6 ptm180 -153.95 -33.17 0.11 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 108.99 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.529 HD12 ' N ' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -75.92 156.43 84.36 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.607 -0.683 . . . . 0.0 109.419 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.82 -6.86 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.878 2.385 . . . . 0.0 112.227 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.52 11.92 46.22 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -56.17 -35.26 67.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -1.133 . . . . 0.0 109.467 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.8 p -68.07 151.26 47.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.466 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.792 ' N ' HD23 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -136.57 158.21 44.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.401 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 6' ' ' ILE . 2.8 t0 -104.98 150.51 24.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.344 -0.847 . . . . 0.0 109.568 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.532 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -99.35 -76.67 0.54 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 110.351 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -108.02 3.49 24.09 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.196 -0.94 . . . . 0.0 109.845 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 8' ' ' LYS . 59.2 mt -111.3 138.38 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 110.161 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -110.93 12.68 22.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.455 -0.778 . . . . 0.0 109.421 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.738 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -127.87 155.3 77.73 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.482 -0.761 . . . . 0.0 109.231 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.31 -36.06 47.63 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.551 2.167 . . . . 0.0 112.56 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -138.07 -3.08 1.81 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.536 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.493 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 52.7 m-80 -114.25 167.95 10.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.485 -0.759 . . . . 0.0 109.357 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.703 ' HA ' HG23 ' A' ' 6' ' ' ILE . 62.3 m -118.61 177.06 4.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.412 -0.805 . . . . 0.0 109.828 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.7 t -96.08 135.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 0.0 109.086 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 28.2 p90 -66.89 -45.73 77.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.698 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.579 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 82.7 tt0 -175.95 97.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.057 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 144.46 56.54 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 108.589 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.698 ' CD2' ' N ' ' A' ' 18' ' ' ASP . 2.5 p90 -120.67 -153.75 0.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.458 -0.776 . . . . 0.0 109.208 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.698 ' N ' ' CD2' ' A' ' 17' ' ' PHE . 88.6 m-20 -57.53 141.8 46.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.978 -1.076 . . . . 0.0 109.473 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.89 9.23 3.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.354 -0.841 . . . . 0.0 109.864 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -49.88 -43.44 49.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.982 -1.074 . . . . 0.0 108.597 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.413 ' HG ' ' HE1' ' A' ' 17' ' ' PHE . 33.6 p -90.15 4.99 48.81 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.432 -0.792 . . . . 0.0 109.075 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' GLY . 83.3 p 51.82 33.43 11.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 109.351 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -59.25 -47.1 86.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -65.76 -57.5 7.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.422 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.674 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.3 m120 -60.86 -35.74 77.37 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.472 -0.768 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -58.27 -44.0 95.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.44 -44.36 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -1.118 . . . . 0.0 109.2 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 t -70.04 -31.13 68.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.486 -0.758 . . . . 0.0 109.326 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.5 m -61.57 -31.47 71.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 110.673 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.76 -27.14 4.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.984 -1.073 . . . . 0.0 109.885 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -54.82 -30.76 58.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.1 -1.0 . . . . 0.0 109.107 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 33' ' ' ALA . . . 103.96 3.29 45.61 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 32' ' ' GLY . . . 176.77 -25.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -1.192 . . . . 0.0 109.629 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -55.25 134.25 49.73 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -112.58 140.79 47.04 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.397 -0.814 . . . . 0.0 108.984 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.69 164.68 27.38 Favored Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.995 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' TRP . 32.7 m-85 -132.12 160.5 35.83 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.506 ' SG ' ' ND2' ' A' ' 46' ' ' ASN . 43.5 t -99.24 120.86 40.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.998 -1.064 . . . . 0.0 109.294 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.503 ' O ' ' OD1' ' A' ' 46' ' ' ASN . 26.1 mt-30 -115.72 174.57 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 109.32 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.9 pt -99.15 155.42 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.898 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.634 HD12 ' HA3' ' A' ' 45' ' ' GLY . 72.8 mt -78.25 148.44 33.93 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.432 -0.792 . . . . 0.0 109.578 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.68 -35.93 39.17 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 47.7 p -96.07 -125.16 0.12 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.318 -1.107 . . . . 0.0 108.644 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -109.72 126.57 53.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 108.921 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.634 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 141.45 -173.87 23.21 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.599 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 54.6 t-20 -140.77 150.33 43.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -1.102 . . . . 0.0 109.559 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.599 ' N ' ' OD1' ' A' ' 46' ' ' ASN . . . -140.11 167.25 25.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.624 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 1.6 m -101.97 150.26 23.39 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.236 -1.155 . . . . 0.0 109.621 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.532 ' CE3' ' O ' ' A' ' 4' ' ' ALA . 16.8 t-105 -120.92 121.22 37.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 109.161 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.8 m -117.74 130.38 56.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.324 -0.86 . . . . 0.0 109.682 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 20.2 mt -127.76 145.56 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.417 -0.802 . . . . 0.0 110.545 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' ILE . . . 176.19 -22.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.792 HD23 ' N ' ' A' ' 1' ' ' ALA . 13.2 tp -153.02 133.15 7.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 108.916 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -38.08 158.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.205 1.937 . . . . 0.0 112.225 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 61.1 t0 -79.0 116.34 19.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 110.063 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.481 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 82.0 m-20 -147.86 -47.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.568 ' H ' ' HB2' ' A' ' 1' ' ' ALA . 21.6 t -129.74 72.2 81.99 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.76 -100.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.829 2.353 . . . . 0.0 112.527 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -127.28 125.99 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.349 -0.844 . . . . 0.0 109.417 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -61.58 -34.18 75.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.303 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 63' ' ' GLY . 4.0 mt -62.63 136.73 96.26 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.425 -0.797 . . . . 0.0 108.967 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.78 -1.71 2.91 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.004 1.803 . . . . 0.0 112.483 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.515 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 95.62 11.4 55.47 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.603 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 11.9 pttp -58.62 -32.47 69.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -1.12 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 61.3 m 56.43 -0.61 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.277 -0.889 . . . . 0.0 109.913 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.603 ' ND1' ' O ' ' A' ' 64' ' ' LYS . 72.4 m80 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.417 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.403 ' HA ' ' N ' ' A' ' 54' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.306 0.574 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.0 ptt-85 -137.6 167.45 21.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.378 -0.826 . . . . 0.0 109.511 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 83.7 m-20 -94.35 147.13 23.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 108.691 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -109.93 -83.25 0.56 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.371 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -99.23 6.24 46.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.008 -1.057 . . . . 0.0 109.629 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.645 HG22 ' SG ' ' A' ' 12' ' ' CYS . 42.1 pt -117.16 159.17 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.637 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . . . -123.39 -20.29 5.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.21 161.27 50.71 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.62 -66.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.43 2.087 . . . . 0.0 112.91 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.534 ' C ' ' ND2' ' A' ' 11' ' ' ASN . 67.6 m-70 -56.81 -39.44 74.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 110.436 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.684 HD22 ' N ' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -134.51 173.72 11.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 0.0 110.096 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.645 ' SG ' HG22 ' A' ' 6' ' ' ILE . 12.2 m -108.24 171.24 7.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.185 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.547 HG11 HD22 ' A' ' 46' ' ' ASN . 1.5 p -49.09 135.24 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.037 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.664 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 19.5 p90 -69.64 -50.43 44.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.051 -1.031 . . . . 0.0 109.345 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.664 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 48.8 tp10 -177.38 91.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.2 t -54.12 97.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 108.926 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 19.3 p90 -76.67 -46.17 26.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 109.689 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 52.9 t0 -145.4 101.01 3.54 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.312 -0.868 . . . . 0.0 109.096 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.72 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . . . -60.63 -24.43 65.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.214 -0.929 . . . . 0.0 109.049 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -52.16 -42.22 63.24 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.434 ' C ' ' OG ' ' A' ' 22' ' ' SER . 84.0 p -66.04 -16.17 63.68 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER 72.48 39.25 0.74 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.618 -0.676 . . . . 0.0 110.029 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.478 ' O ' HG23 ' A' ' 27' ' ' VAL . 61.6 t80 -60.63 -60.51 3.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.978 -1.076 . . . . 0.0 109.06 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' HB2' ' A' ' 7' ' ' ALA . 8.1 t -70.58 -48.65 54.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.352 -0.843 . . . . 0.0 108.75 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.536 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.9 m120 -57.82 -38.93 76.46 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -61.8 -39.59 97.67 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 23' ' ' TYR . 78.8 t -62.2 -41.52 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.354 -1.086 . . . . 0.0 109.531 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.3 m -61.04 -41.2 96.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.523 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 m -58.22 -51.26 70.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.14 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -67.79 -39.45 84.03 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.54 -0.725 . . . . 0.0 109.125 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' CG ' HD21 ' A' ' 56' ' ' ASN . 42.0 t-20 -59.29 -31.13 68.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.553 -0.717 . . . . 0.0 109.275 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.27 -0.06 50.63 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' CB ' ' SG ' ' A' ' 50' ' ' CYS . . . -64.61 149.5 48.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -1.059 . . . . 0.0 109.221 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -58.0 -49.15 77.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 110.245 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.572 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 49.5 m -143.57 162.81 34.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.037 . . . . 0.0 110.198 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -142.72 126.83 2.98 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.543 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 87.2 m-85 -126.11 135.54 51.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.448 -1.03 . . . . 0.0 109.547 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -110.6 129.94 55.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 0.0 109.888 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.69 ' NE2' ' CE3' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -134.1 168.34 19.0 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.0 pt -98.81 133.43 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.974 . . . . 0.0 109.588 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.535 HD23 ' OG1' ' A' ' 43' ' ' THR . 30.2 tp -64.24 -30.59 71.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 109.36 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.95 -4.5 49.43 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.535 ' OG1' HD23 ' A' ' 41' ' ' LEU . 18.3 p -126.57 173.72 9.22 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' C ' ' O ' ' A' ' 43' ' ' THR . 26.8 p90 -44.07 -21.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.441 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -87.23 -174.25 48.74 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.547 HD22 HG11 ' A' ' 13' ' ' VAL . 13.0 t30 -137.98 169.83 17.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -1.008 . . . . 0.0 108.911 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 39' ' ' GLN . . . -140.55 125.93 3.01 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.447 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 42.7 t -136.28 128.91 30.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -1.092 . . . . 0.0 108.674 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.69 ' CE3' ' NE2' ' A' ' 39' ' ' GLN . 4.1 p90 -113.95 141.29 47.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.192 -0.943 . . . . 0.0 109.857 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 35' ' ' SER . 6.0 t -124.72 153.62 42.09 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.1 mm -109.22 126.83 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 109.074 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.9 ' C ' HD23 ' A' ' 53' ' ' LEU . . . -173.09 -130.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.978 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.9 HD23 ' C ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -127.4 166.4 23.27 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.364 -0.835 . . . . 0.0 109.9 -179.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' N ' ' HA ' ' A' ' 1' ' ' ALA . 28.1 Cg_endo -67.84 -34.31 24.4 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.466 2.111 . . . . 0.0 112.244 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -56.41 -33.49 65.86 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.596 HD21 ' CG ' ' A' ' 31' ' ' ASN . 46.2 t-20 -96.75 120.13 36.52 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.554 -0.716 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.465 HG23 ' OD1' ' A' ' 56' ' ' ASN . 5.2 t 57.4 65.87 3.32 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.717 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.69 15.03 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.146 2.564 . . . . 0.0 112.425 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 59' ' ' ILE . 62.9 mt 55.25 52.23 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.391 -0.818 . . . . 0.0 109.333 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.422 HH11 ' HB3' ' A' ' 60' ' ' ARG . 6.1 ptm85 -61.61 -39.22 90.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.507 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -74.75 154.12 87.2 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.462 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.73 -11.12 10.91 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.663 2.242 . . . . 0.0 111.929 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.95 3.82 57.93 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 66' ' ' HIS . 34.2 ttpt -57.8 -36.95 72.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -1.102 . . . . 0.0 109.42 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 84.9 m 54.8 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.819 . . . . 0.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.586 ' N ' ' O ' ' A' ' 64' ' ' LYS . 83.3 t60 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.516 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -127.06 136.77 52.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.811 . . . . 0.0 109.809 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -95.92 144.16 26.48 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.242 -0.911 . . . . 0.0 109.038 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -108.25 -83.55 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.844 . . . . 0.0 110.212 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -99.54 12.92 35.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.676 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 pt -126.67 165.98 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 110.011 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.757 ' HB2' ' CB ' ' A' ' 48' ' ' CYS . . . -120.79 -0.81 10.07 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.11 168.72 8.88 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB2' HH11 ' A' ' 60' ' ' ARG . 70.2 Cg_endo -80.25 -59.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.537 2.158 . . . . 0.0 112.447 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -104.94 -3.74 22.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.964 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -116.88 175.46 5.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.394 -0.816 . . . . 0.0 109.804 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.2 p -128.66 -179.64 5.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.408 -0.807 . . . . 0.0 109.86 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.88 136.52 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.546 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CG ' ' N ' ' A' ' 15' ' ' GLU . 33.7 p90 -65.48 -40.54 93.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 83.8 tt0 -175.32 98.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.354 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HB3' HD22 ' A' ' 46' ' ' ASN . 10.7 t -68.99 141.7 54.84 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.035 -1.04 . . . . 0.0 108.524 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.71 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 2.0 p90 -119.3 -154.3 0.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.366 -0.833 . . . . 0.0 109.599 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.71 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 88.4 m-20 -59.68 143.42 50.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.094 -1.004 . . . . 0.0 109.532 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.62 9.63 7.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.882 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -51.7 -42.92 62.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.04 -1.037 . . . . 0.0 108.535 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.501 ' O ' ' OG ' ' A' ' 22' ' ' SER . 60.1 p -86.49 6.04 32.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.36 -0.837 . . . . 0.0 108.815 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 26' ' ' GLY . 10.5 p 50.19 36.02 11.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.684 . . . . 0.0 109.796 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -61.55 -51.73 67.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.099 -1.001 . . . . 0.0 109.439 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.458 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 29.3 t -68.37 -56.24 9.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 108.871 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.679 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.2 m120 -58.43 -34.88 71.29 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -57.2 -42.88 93.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.93 -47.58 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.241 -1.152 . . . . 0.0 108.628 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 95.2 m -70.37 -24.73 63.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 109.3 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 25' ' ' ASN . 62.5 m -61.89 -31.12 71.38 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.418 -0.801 . . . . 0.0 110.95 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.47 ' CD ' ' O ' ' A' ' 26' ' ' GLY . 1.8 mptt -52.52 -33.56 45.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.0 110.066 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 35.3 t30 -56.68 -34.01 66.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 109.404 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.44 4.71 56.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.92 -26.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -1.094 . . . . 0.0 109.29 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.712 ' HG3' ' HB2' ' A' ' 52' ' ' ALA . 24.6 tttt -51.29 135.22 26.91 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -117.66 139.98 50.28 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.507 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 49' ' ' TRP . . . -143.13 156.46 26.49 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.858 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' TRP . 41.9 m-85 -130.6 153.41 48.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.621 -0.929 . . . . 0.0 108.787 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 0.9 OUTLIER -99.41 125.66 45.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.972 -1.08 . . . . 0.0 109.64 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.588 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 96.3 mt-30 -111.11 -162.05 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.599 -0.688 . . . . 0.0 109.315 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.0 pt -114.65 157.45 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -0.753 . . . . 0.0 109.807 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 ' HA3' ' A' ' 45' ' ' GLY . 63.8 mt -86.62 146.39 26.35 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.306 -0.871 . . . . 0.0 109.498 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.77 -33.16 34.48 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.5 p -97.57 -124.12 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.431 -1.04 . . . . 0.0 108.94 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -111.73 132.18 54.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 109.117 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 41' ' ' LEU . . . 133.31 -163.96 24.29 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 39' ' ' GLN . 2.3 t30 -140.29 165.72 26.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.222 -1.164 . . . . 0.0 109.386 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.57 162.08 26.17 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.757 ' CB ' ' HB2' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -107.59 135.69 48.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.401 -1.058 . . . . 0.0 109.512 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CE3' ' OE1' ' A' ' 39' ' ' GLN . 11.4 t-105 -112.18 121.95 46.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.382 -0.824 . . . . 0.0 109.14 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.66 ' SG ' ' NZ ' ' A' ' 34' ' ' LYS . 1.8 t -125.8 129.92 50.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.222 -0.923 . . . . 0.0 109.523 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mt -121.09 138.64 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.53 -0.731 . . . . 0.0 110.62 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . . . -170.96 -52.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.526 -0.734 . . . . 0.0 109.534 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.6 tp -127.48 78.76 74.32 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.549 -0.719 . . . . 0.0 109.931 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' ASP . 32.3 Cg_exo -54.03 171.03 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.937 2.425 . . . . 0.0 112.321 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' PRO . 49.4 t0 59.88 146.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 64.08 48.34 3.04 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.312 -0.868 . . . . 0.0 109.142 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.542 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -107.63 103.23 48.34 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HG2' ' NE ' ' A' ' 60' ' ' ARG . 63.9 Cg_endo -91.31 130.66 1.34 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.626 2.217 . . . . 0.0 110.892 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.622 HG22 ' H ' ' A' ' 61' ' ' ILE . 3.3 mt -64.38 -32.55 58.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.114 -0.991 . . . . 0.0 110.506 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.423 HH11 ' HB2' ' A' ' 9' ' ' PRO . 97.8 mtt180 55.24 1.53 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.306 -0.871 . . . . 0.0 109.14 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 61' ' ' ILE . 5.1 mt -130.61 81.05 68.75 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.494 -0.754 . . . . 0.0 109.672 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.11 54.04 4.58 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.916 2.411 . . . . 0.0 111.944 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.77 0.09 75.82 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.81 -40.59 84.56 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.705 -0.879 . . . . 0.0 109.785 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.9 t -59.85 -32.72 70.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.476 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -127.7 138.56 52.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.177 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.523 ' HB2' ' H ' ' A' ' 50' ' ' CYS . 79.3 m-20 -99.32 148.59 24.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.012 -1.055 . . . . 0.0 109.396 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.81 -82.88 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.344 -0.847 . . . . 0.0 110.473 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -99.03 5.84 46.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.631 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 48' ' ' CYS . 33.5 pt -117.34 161.46 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.776 . . . . 0.0 110.34 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.445 ' O ' HG11 ' A' ' 27' ' ' VAL . . . -116.03 -5.79 11.96 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' HD3' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -108.57 156.0 39.52 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.51 -51.5 0.53 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.47 2.114 . . . . 0.0 112.598 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -114.88 1.76 14.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.145 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -125.72 170.4 11.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.315 -0.865 . . . . 0.0 109.925 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.8 m -110.23 178.1 4.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.442 -0.787 . . . . 0.0 109.319 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.423 HG22 ' HD3' ' A' ' 8' ' ' LYS . 40.6 t -101.11 126.85 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.612 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 15' ' ' GLU . 26.9 p90 -74.75 -32.51 62.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.096 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 78.7 tt0 -172.15 98.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.452 -0.78 . . . . 0.0 108.99 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.3 t -73.46 108.35 6.27 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.014 -1.054 . . . . 0.0 109.004 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.788 ' CE2' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.32 148.06 2.06 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.6 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 59.6 t0 -73.43 116.79 14.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.96 . . . . 0.0 110.516 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.788 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -140.52 147.97 40.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.405 -0.809 . . . . 0.0 109.138 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -58.57 -44.67 89.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.012 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 t 172.93 73.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.42 -0.8 . . . . 0.0 109.244 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 p -152.94 -50.47 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.113 -0.992 . . . . 0.0 110.087 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -58.16 -51.84 68.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.976 -1.078 . . . . 0.0 109.848 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -66.29 -44.35 83.76 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.148 -0.97 . . . . 0.0 108.757 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.699 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.1 m120 -58.44 -37.38 75.3 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.48 -42.03 98.89 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 7' ' ' ALA . 70.9 t -63.67 -43.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -1.116 . . . . 0.0 109.148 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 59.0 m -63.93 -30.03 71.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.396 -0.815 . . . . 0.0 109.394 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.4 m -57.82 -42.61 84.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.671 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -61.91 -45.39 93.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.174 -0.954 . . . . 0.0 108.894 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.28 -29.31 69.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.445 -0.785 . . . . 0.0 109.323 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.22 7.6 55.93 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' A' ' 52' ' ' ALA . . . -69.85 175.41 4.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -1.014 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -78.62 -77.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.026 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.7 p -143.76 166.7 24.15 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.287 -0.883 . . . . 0.0 110.079 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -142.58 154.56 25.26 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.568 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 57.9 m-85 -122.27 133.95 54.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.357 -1.084 . . . . 0.0 109.552 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.649 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 1.1 m -99.81 121.54 41.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.367 -0.833 . . . . 0.0 109.191 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -141.07 -136.54 0.11 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.091 -1.006 . . . . 0.0 109.623 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 42' ' ' GLY . 64.1 mt -95.81 139.66 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.2 tp -55.99 -37.13 68.68 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.581 ' H ' HG22 ' A' ' 40' ' ' ILE . . . 158.46 -69.0 0.27 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.4 p -105.66 -63.44 1.25 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -126.84 148.72 49.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.79 -178.86 39.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -122.72 150.94 42.08 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.483 -1.01 . . . . 0.0 109.667 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.92 162.59 26.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.649 ' SG ' ' SG ' ' A' ' 38' ' ' CYS . 4.2 t -140.2 135.94 32.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -1.087 . . . . 0.0 109.754 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.18 133.9 51.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.219 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.523 ' H ' ' HB2' ' A' ' 3' ' ' ASP . 12.2 t -99.92 125.51 45.93 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.9 mm -99.46 131.46 46.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.434 -0.791 . . . . 0.0 109.48 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . . . -170.56 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.045 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD21 ' ND2' ' A' ' 56' ' ' ASN . 0.7 OUTLIER -120.84 94.71 48.98 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.383 -0.823 . . . . 0.0 110.305 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.12 -8.95 17.81 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.183 1.922 . . . . 0.0 112.101 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -56.34 -35.81 68.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.324 -0.86 . . . . 0.0 109.935 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 57' ' ' VAL . 3.4 m120 -78.96 142.35 36.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.93 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.772 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.2 p -39.72 102.38 0.26 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.629 -0.669 . . . . 0.0 109.311 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 59' ' ' ILE . 50.1 Cg_endo -90.61 159.35 4.31 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.714 2.276 . . . . 0.0 111.888 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 59' ' ' ILE . 86.0 mt 39.75 60.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.372 -0.83 . . . . 0.0 110.209 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -51.51 -34.55 36.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.701 HG22 ' H ' ' A' ' 63' ' ' GLY . 1.4 mp -61.04 130.64 91.47 Favored Pre-proline 0 C--N 1.301 -1.53 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.677 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.29 -25.33 6.97 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.862 1.708 . . . . 0.0 111.949 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.701 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 138.41 3.66 1.82 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -106.28 129.62 54.28 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.319 -1.107 . . . . 0.0 109.025 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.516 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 86.3 m -58.6 -28.34 65.51 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.569 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.516 ' CG ' ' O ' ' A' ' 65' ' ' CYS . 98.0 m-70 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.482 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.491 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -138.24 169.23 18.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -94.14 142.57 27.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.966 . . . . 0.0 108.42 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 48' ' ' CYS . . . -106.07 -84.45 0.51 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 111.101 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -98.89 -19.21 17.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.055 . . . . 0.0 110.402 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.529 HG22 ' H ' ' A' ' 8' ' ' LYS . 63.5 mt -106.24 132.87 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.323 -0.861 . . . . 0.0 110.15 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -119.59 17.74 12.81 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.529 ' H ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -124.09 155.32 67.84 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.16 -35.91 61.21 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.483 2.122 . . . . 0.0 112.27 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.557 ' CE1' HH11 ' A' ' 60' ' ' ARG . 74.4 m80 -141.8 -3.97 1.1 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.139 -0.976 . . . . 0.0 109.453 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.489 ' H ' ' HB2' ' A' ' 8' ' ' LYS . 59.1 m-80 -109.5 172.33 6.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 109.428 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HA ' HG23 ' A' ' 6' ' ' ILE . 5.4 m -122.2 177.26 5.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.492 -0.755 . . . . 0.0 109.629 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 48' ' ' CYS . 47.1 t -101.05 138.05 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -0.802 . . . . 0.0 109.032 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.29 -61.26 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.456 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -173.89 98.72 0.11 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.414 -0.804 . . . . 0.0 109.121 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 16' ' ' CYS . 29.7 p -50.62 103.24 0.05 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.253 -0.905 . . . . 0.0 108.906 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.506 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 23.7 p90 -59.91 -39.77 86.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.445 -0.785 . . . . 0.0 110.033 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.506 ' N ' ' CG ' ' A' ' 17' ' ' PHE . 57.6 t0 -143.55 91.54 2.26 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.243 -0.91 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.64 -25.0 67.9 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.245 -0.91 . . . . 0.0 109.046 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -53.76 -38.45 64.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.327 -0.858 . . . . 0.0 108.81 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.6 m -77.57 7.71 5.23 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 26' ' ' GLY . 12.7 p 60.76 36.37 19.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.565 -0.709 . . . . 0.0 110.045 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -61.89 -54.99 34.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.957 -1.09 . . . . 0.0 108.863 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.1 t -70.31 -52.31 23.76 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.715 HD22 ' N ' ' A' ' 25' ' ' ASN . 1.1 m120 -58.37 -36.74 73.95 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 22' ' ' SER . . . -60.29 -42.77 98.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.503 HG21 ' HZ2' ' A' ' 8' ' ' LYS . 58.1 t -61.07 -46.94 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -1.157 . . . . 0.0 109.518 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 33' ' ' ALA . 3.5 m -70.23 -33.34 71.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.272 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.4 m -57.32 -50.5 72.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 109.431 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -65.71 -37.87 87.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.414 -0.804 . . . . 0.0 109.337 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 27' ' ' VAL . 24.4 m120 -58.96 -25.47 63.57 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.42 44.05 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 28' ' ' CYS . . . -64.17 145.68 55.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.445 -1.033 . . . . 0.0 109.248 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.534 ' H ' ' HB2' ' A' ' 52' ' ' ALA . 2.7 ttmt -59.37 -51.96 67.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 0.0 109.792 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.421 ' HG ' ' HE2' ' A' ' 37' ' ' TYR . 83.4 p -144.35 166.89 23.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.189 -0.945 . . . . 0.0 110.201 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.582 ' O ' ' ND2' ' A' ' 25' ' ' ASN . . . -143.38 135.17 6.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.421 ' HE2' ' HG ' ' A' ' 35' ' ' SER . 91.6 m-85 -128.46 136.92 51.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -1.08 . . . . 0.0 109.573 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.9 t -109.0 128.62 55.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.462 -0.774 . . . . 0.0 109.585 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.612 ' NE2' ' CH2' ' A' ' 49' ' ' TRP . 0.3 OUTLIER -134.56 171.55 14.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.446 -0.784 . . . . 0.0 109.116 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.9 pt -98.13 134.62 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.13 -0.981 . . . . 0.0 109.503 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 45' ' ' GLY . 24.2 tp -130.1 125.21 34.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.651 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.23 -27.58 73.08 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.448 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 42.6 m -59.37 -46.55 88.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.029 -1.277 . . . . 0.0 110.039 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -125.64 16.3 8.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.447 -0.783 . . . . 0.0 109.156 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 41' ' ' LEU . . . 83.9 -56.85 5.05 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -140.77 146.05 37.18 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -1.131 . . . . 0.0 109.642 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.27 132.23 5.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.704 ' HB2' HG21 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -111.25 126.62 55.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.388 -1.066 . . . . 0.0 109.28 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.612 ' CH2' ' NE2' ' A' ' 39' ' ' GLN . 4.7 p90 -118.36 138.86 52.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.868 . . . . 0.0 109.125 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.3 m -126.1 156.15 40.49 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mm -110.11 122.89 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.422 -0.799 . . . . 0.0 109.296 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB2' ' H ' ' A' ' 34' ' ' LYS . . . -179.57 -145.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.491 HD12 ' HB1' ' A' ' 1' ' ' ALA . 9.5 tp -133.1 78.99 63.58 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.552 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -87.64 22.31 0.92 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.35 2.7 . . . . 0.0 112.057 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -52.45 -35.55 52.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.574 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -56.39 -35.35 67.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.529 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.791 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.5 p -131.06 77.9 74.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.359 -0.838 . . . . 0.0 109.585 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 59' ' ' ILE . 73.7 Cg_endo -95.27 87.98 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 123.596 2.864 . . . . 0.0 112.287 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' PRO . 45.8 mt 43.31 55.66 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.031 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.557 HH11 ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -59.72 -41.0 89.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.135 -0.978 . . . . 0.0 109.891 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.618 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -62.96 149.72 89.68 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -46.0 -23.59 1.86 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.174 1.916 . . . . 0.0 112.05 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' H ' HG12 ' A' ' 61' ' ' ILE . . . 138.04 2.93 2.05 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -93.39 145.97 24.09 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.282 -1.128 . . . . 0.0 109.283 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 66' ' ' HIS . 8.6 t -58.01 -47.19 83.79 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.441 ' C ' ' O ' ' A' ' 65' ' ' CYS . 61.8 t60 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.65 -179.852 . . . . . . . . 1 1 . 1 stop_ save_